MOLECULAR DETECTION OF FOODBORNE PATHOGENS
MOLECULAR DETECTION OF FOODBORNE PATHOGENS EDITED BY
DONGYOU LIU
Boca Ra...
226 downloads
2233 Views
12MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
MOLECULAR DETECTION OF FOODBORNE PATHOGENS
MOLECULAR DETECTION OF FOODBORNE PATHOGENS EDITED BY
DONGYOU LIU
Boca Raton London New York
CRC Press is an imprint of the Taylor & Francis Group, an informa business
CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number: 978-1-4200-7643-1 (Hardback) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. Library of Congress Cataloging-in-Publication Data Molecular detection of foodborne pathogens / [edited by] Dongyou Liu. p. ; cm. Includes bibliographical references and index. ISBN 978-1-4200-7643-1 (hard back : alk. paper) 1. Foodborne diseases--Molecular diagnosis. 2. Food--Microbiology. I. Liu, Dongyou. II. Title. [DNLM: 1. Food Contamination--analysis. 2. Food Poisoning--microbiology. 3. Molecular Diagnostic Techniques--methods. WA 701 M718 2009] QR201.F62M65 2009 615.9’54--dc22 Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the CRC Press Web site at http://www.crcpress.com
2009017320
This book is dedicated to my parents, Jiaye Liu and Yunlian Li, whose unselfish sacrifice and unrelenting love have been a constant source of inspiration in my pursuit of knowledge and betterment.
Contents Preface........................................................................................................................................................................................xiii Editor........................................................................................................................................................................................... xv Contributors...............................................................................................................................................................................xvii Chapter 1. Molecular Detection: Principles and Methods......................................................................................................... 1 Lisa Gorski and Andrew Csordas
Section I Foodborne Viruses Chapter 2. Adenoviruses.......................................................................................................................................................... 23 Charles P. Gerba and Roberto A. Rodríguez Chapter 3. Astroviruses........................................................................................................................................................... 33 Edina Meleg and Ferenc Jakab Chapter 4. Avian Influenza Virus............................................................................................................................................ 49 Giovanni Cattoli and Isabella Monne Chapter 5. Hepatitis A and E Viruses...................................................................................................................................... 63 Hiroshi Ushijima, Pattara Khamrin, and Niwat Maneekarn Chapter 6. Noroviruses............................................................................................................................................................ 75 Anna Charlotte Schultz, Jan Vinjé, and Birgit Nørrung Chapter 7. Rotaviruses............................................................................................................................................................. 91 Dongyou Liu, Larry A. Hanson, and Lesya M. Pinchuk Chapter 8. Sapoviruses...........................................................................................................................................................101 Grant S. Hansman Chapter 9. Slow Viral Diseases..............................................................................................................................................113 Takashi Onodera, Guangai Xue, Akikazu Sakudo, Gianluigi Zanusso, and Katsuaki Sugiura
Section II Foodborne Gram-Positive Bacteria Chapter 10. Bacillus................................................................................................................................................................. 129 Noura Raddadi, Aurora Rizzi, Lorenzo Brusetti, Sara Borin, Isabella Tamagnini, and Daniele Daffonchio
vii
viii
Contents
Chapter 11. Clostridium.......................................................................................................................................................... 145 Annamari Heikinheimo, Miia Lindström, Dongyou Liu, and Hannu Korkeala Chapter 12. Enterococcus........................................................................................................................................................ 157 Teresa Semedo-Lemsaddek, Rogério Tenreiro, Paula Lopes Alves, and Maria Teresa Barreto Crespo Chapter 13. Helicobacter..........................................................................................................................................................181 Norihisa Noguchi Chapter 14. Kocuria................................................................................................................................................................. 201 Edoardo Carretto and Daniela Barbarini Chapter 15. Listeria................................................................................................................................................................. 207 Dongyou Liu and Hans-Jürgen Busse Chapter 16. Micrococcus......................................................................................................................................................... 221 Friederike Hilbert and Hans-Jürgen Busse Chapter 17. Mycobacterium..................................................................................................................................................... 229 Irene R. Grant and Catherine E.D. Rees Chapter 18. Staphylococcus..................................................................................................................................................... 245 Paolo Moroni, Giuliano Pisoni, Paola Cremonesi, and Bianca Castiglioni Chapter 19. Streptococcus....................................................................................................................................................... 259 Mark van der Linden, Romney S. Haylett, Ralf René Reinert, and Lothar Rink
Section III Foodborne Gram-Negative Bacteria Chapter 20. Aeromonas............................................................................................................................................................ 273 Germán Naharro, Jorge Riaño, Laura de Castro, Sonia Alvarez, and José María Luengo Chapter 21. Arcobacter............................................................................................................................................................ 289 Kurt Houf Chapter 22. Bacteriodes........................................................................................................................................................... 307 Rama Chaudhry, Anubhav Pandey, and Nidhi Sharma Chapter 23. Brucella.................................................................................................................................................................317 Sascha Al Dahouk, Karsten Nöckler, and Herbert Tomaso Chapter 24. Burkholderia.........................................................................................................................................................331 Karlene H. Lynch and Jonathan J. Dennis
ix
Contents
Chapter 25. Campylobacter..................................................................................................................................................... 345 Aurora Fernández Astorga and Rodrigo Alonso Chapter 26. Enterobacter......................................................................................................................................................... 361 Angelika Lehner, Roger Stephan, Carol Iversen, and Seamus Fanning Chapter 27. Escherichia........................................................................................................................................................... 369 Devendra H. Shah, Smriti Shringi, Thomas E. Besser, and Douglas R. Call Chapter 28. Klebsiella.............................................................................................................................................................. 391 Beatriz Meurer Moreira, Marco Antonio Lemos Miguel, Angela Christina Dias de Castro, Maria Silvana Alves, and Rubens Clayton da Silva Dias Chapter 29. Plesiomonas......................................................................................................................................................... 405 Jesús A. Santos, Andrés Otero, and María-Luisa García-López Chapter 30. Proteus..................................................................................................................................................................417 Antoni Róz∙alski and Paweł Sta˛ czek Chapter 31. Pseudomonas........................................................................................................................................................431 Olga Zaborina and John Alverdy Chapter 32. Salmonella............................................................................................................................................................ 447 Charlotta Löfström, Jeffrey Hoorfar, Jenny Schelin, Peter Rådström, and Burkhard Malorny Chapter 33. Serratia................................................................................................................................................................. 459 Zhi-Qing Hu, Wei-Hua Zhao, and Zhuting Hu Chapter 34. Shigella................................................................................................................................................................. 471 Benjamin R. Warren, Keith A. Lampel, and Keith R. Schneider Chapter 35. Vibrio.................................................................................................................................................................... 485 Asim K. Bej Chapter 36. Yersinia................................................................................................................................................................. 501 Mikael Skurnik, Peter Rådström, Rickard Knutsson, Bo Segerman, Saija Hallanvuo, Susanne Thisted Lambertz, Hannu Korkeala, and Maria Fredriksson-Ahomaa
Section IV Foodborne Fungi Chapter 37. Alternaria............................................................................................................................................................. 521 Dongyou Liu, Stephen B. Pruett, and Cody Coyne Chapter 38. Aspergillus............................................................................................................................................................ 529 Giancarlo Perrone, Antonia Gallo, and Antonia Susca
x
Contents
Chapter 39. Candida................................................................................................................................................................ 549 P. Lewis White, Samantha J. Hibbitts, Michael D. Perry, and Rosemary A. Barnes Chapter 40. Debaryomyces...................................................................................................................................................... 565 Juan J. Córdoba, Maria J. Andrade, Elena Bermúdez, Félix Núñez, Miguel A. Asensio, and Mar Rodríguez Chapter 41. Fusarium.............................................................................................................................................................. 577 Antonio Moretti and Antonia Susca Chapter 42. Penicillium........................................................................................................................................................... 593 Joëlle Dupont Chapter 43. Rhodotorula......................................................................................................................................................... 603 Diego Libkind and José Paulo Sampaio Chapter 44. Saccharomyces......................................................................................................................................................619 Franca Rossi and Sandra Torriani
Section V Foodborne Protozoa Chapter 45. Acanthamoeba...................................................................................................................................................... 639 Hélène Yera, Pablo Goldschmidt, Christine Chaumeil, Muriel Cornet, and Marie-Laure Dardé Chapter 46. Cryptosporidium.................................................................................................................................................. 651 Una Ryan and Simone M. Cacciò Chapter 47. Cyclospora........................................................................................................................................................... 667 Dongyou Liu, G. Todd Pharr, and Frank W. Austin Chapter 48. Entamoeba........................................................................................................................................................... 677 Damien Stark and John Ellis Chapter 49. Encephalitozoon and Enterocytozoon................................................................................................................. 691 Jaco J. Verweij and Dongyou Liu Chapter 50. Giardia................................................................................................................................................................. 701 Yaoyu Feng and Lihua Xiao Chapter 51. Isospora.................................................................................................................................................................717 Somchai Jongwutiwes and Chaturong Putaporntip
xi
Contents
Chapter 52. Sarcocystis........................................................................................................................................................... 731 Benjamin M. Rosenthal Chapter 53. Toxoplasma...........................................................................................................................................................741 Chunlei Su and J.P. Dubey
Section VI Foodborne Helminthes Chapter 54. Anisakis................................................................................................................................................................ 757 Stefano D’Amelio, Marina Busi, Sofia Ingrosso, Lia Paggi, and Elisabetta Giuffra Chapter 55. Clonorchis............................................................................................................................................................ 769 Heinz Mehlhorn, Boris Müller, and Jürgen Schmidt Chapter 56. Diphyllobothrium . .............................................................................................................................................. 781 Jean Dupouy-Camet and Hélène Yera Chapter 57. Fasciola................................................................................................................................................................ 789 Xing-Quan Zhu, Qing-Jun Zhuang, Rui-Qing Lin, and Wei-Yi Huang Chapter 58. Heterophyidae...................................................................................................................................................... 795 Ron Dzikowski and Michael G. Levy Chapter 59. Metagonimus........................................................................................................................................................ 805 Jae-Ran Yu and Jong-Yil Chai Chapter 60. Opisthorchis......................................................................................................................................................... 813 Paiboon Sithithaworn, Thewarach Laha, and Ross H. Andrews Chapter 61. Paragonimus........................................................................................................................................................ 827 Kanwar Narain, Takeshi Agatsuma, and David Blair Chapter 62. Taenia................................................................................................................................................................... 839 Akira Ito, Minoru Nakao, Yasuhito Sako, Kazuhiro Nakaya, Tetsuya Yanagida, and Munehiro Okamoto Chapter 63. Trichinella............................................................................................................................................................ 851 Edoardo Pozio and Giuseppe La Rosa Index.......................................................................................................................................................................................... 865
Preface Foodborne pathogens are microorganisms (e.g., bacteria, viruses, fungi, and parasites) that are capable of infecting humans via contaminated food and/or water. In recent years, diseases caused by foodborne pathogens have become an important public health problem worldwide, resulting in significant morbidity and mortality. Currently, there are over 250 known foodborne diseases. Due to the introduction of pathogens to other geographic regions through population movement and globalization of the food supply, new foodborne infections are continuously emerging. Furthermore, pathogen evolution, changes in human immune status and life-style as well as food manufacturing practices also contribute to increased incidences of foodborne illnesses. As a consequence, large outbreaks of foodborne diseases have been reported with alarming frequencies. It is well known that one of the most effective ways to control and prevent human foodborne infections is to implement a surveillance system that includes a capability to rapidly and precisely detect, identify, and monitor foodborne pathogens at the nucleic acid level. The purpose of this book is to bring out an all-encompassing volume on the detection and identification of major foodborne bacterial, fungal, viral, and parasitic pathogens using state-of-art molecular techniques. Each chapter includes a concise review of the pathogen concerned with respect to its biology, epidemiology, and pathogenesis; a summary of the molecular detection methods available; a description of clinical/food sample collection and preparation procedures; a selection of robust, effective, step-wise molecular detection protocols for each pathogen; and a discussion on the challenges and continuing research needs to further extend the utility and performance of molecular diagnostic methods for foodborne diseases. With each chapter written by scientists with expertise in their respective foodborne pathogen research, this book provides comprehensive coverage of the molecular methodologies for the detection and identification of major foodborne pathogens. It is an indispensable tool for clinical, food, and industrial laboratory scientists involved in the diagnosis of foodborne diseases; a convenient textbook for prospective undergraduate and graduate students intending to pursue a career in food microbiology and medical technology; and a reliable reference for upcoming and experienced laboratory scientists wishing to develop and polish their skills in the molecular detection of major foodborne pathogens. Given the number of foodborne pathogens covered, and the breadth and depth of the topics discussed, an inclusive book like this is undoubtedly beyond the capacity of an individual’s effort. It is my fortune and honor to have a large panel of international scientists as chapter contributors, whose willingness to share their technical insights on foodborne pathogen detection has made this book possible. Moreover, the professionalism and dedication of senior editor, Steve Zollo, and other editorial staff at CRC Press have contributed to its enhanced presentation. I hope the readers will find it as stimulating and rewarding as I do through reading this book, which by presenting relevant background information and ready-to-run molecular detection protocols will serve to save readers’ time and patients’ lives. Dongyou Liu, PhD
xiii
Editor Dongyou Liu, PhD, is currently a member of the research faculty in the Department of Basic Sciences, College of Veterinary Medicine at Mississippi State University in Starkville. In 1982, he graduated with a veterinary science degree from Hunan Agricultural University in China. After one year of postgraduate training under the supervision of Professor Kong Fangyao at Beijing Agricultural University (presently China Agricultural University) in China, he completed his PhD study on the immunological diagnosis of human hydatid disease due to the parasitic tapeworm Echinococcus granulosus in the laboratory of Drs. Michael D. Rickard and Marshall W. Lightowlers at the University of Melbourne School of Veterinary Science in Australia in 1989. During the past two decades, he has worked in several research and clinical laboratories in Australia and the United States, with an emphasis on molecular microbiology, especially in the development of nucleic acid-based assays for species- and virulence-specific determination of microbial pathogens such as ovine footrot bacterium (Dichelobacter nodosus), dermatophyte fungi (Trichophyton, Microsporum, and Epidermophyton), and listeriae (Listeria species). He is the editor of the Handbook of Listeria monocytogenes and the Handbook of Nucleic Acid Purification, both of which have been published recently by Taylor & Francis/CRC Press.
xv
Contributors Takeshi Agatsuma Department of Environmental Health Sciences Kochi Medical School Nankoku City, Kochi, Japan Rodrigo Alonso Departamento de Inmunología, Microbiología y Parasitología Facultad de Farmacia Universidad del Pais Vasco/Euskal Herriko Unibertsitatea Vitoria-Gasteiz, Spain Sonia Alvarez Department of Animal Health University of León León, Spain John Alverdy Center for Surgical Infection Research and Therapeutics University of Chicago Chicago, Illinois Maria Silvana Alves Faculdade de Farmácia e Bioquímica Universidade Federal de Juiz de Fora Minas Gerais, Brazil Paula Lopes Alves Instituto de Biologia Experimental e Tecnológica (IBET) Av. da República, Quinta do Marquês Oeiras, Portugal M.J. Andrade Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Ross H. Andrews School of Pharmacy and Medical Sciences University of South Australia Adelaide, Australia M.A. Asensio Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain
Aurora Fernández Astorga Departamento de Inmunología, Microbiología y Parasitología Facultad de Farmacia Universidad del Pais Vasco/Euskal Herriko Unibertsitatea Vitoria-Gasteiz, Spain Frank W. Austin Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Daniela Barbarini Bacteriology Laboratory Infectious Diseases, Laboratories of Experimental Researches Fondazione “IRCCS Policlinico San Matteo” Pavia, Italy Rosemary A. Barnes Department of Medical Microbiology Cardiff University University Hospital of Wales Cardiff, Wales, United Kingdom Asim K. Bej Department of Biology University of Alabama at Birmingham Birmingham, Alabama E. Bermúdez Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Thomas E. Besser Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington David Blair School of Marine and Tropical Biology James Cook University Townsville, Australia Sara Borin Department of Food Science and Microbiology University of Milan Milan, Italy xvii
xviii
Contributors
Lorenzo Brusetti Department of Food Science and Microbiology University of Milan Milan, Italy
Jong-Yil Chai Department of Parasitology and Tropical Medicine Seoul National University College of Medicine Seoul, Korea
Marina Busi Department of Public Health Science Sapienza University of Rome Rome, Italy
Rama Chaudhry Department of Microbiology All India Institute of Medical Sciences New Delhi, India
Hans-Jürgen Busse Institute of Bacteriology, Mycology and Hygiene University of Veterinary Medicine Vienna, Austria
Christine Chaumeil Laboratoire du Centre National d’Ophtalmologie des Quinze-Vingts Paris, France
Simone M. Cacciò Department of Infectious, Parasitic and Immunomediated Diseases Istituto Superiore di Sanità Rome, Italy
J.J. Córdoba Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain
Douglas R. Call Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington
Muriel Cornet Laboratoire de Microbiologie Hôpital Hôtel-Dieu Paris, France
Edoardo Carretto Bacteriology Laboratory Infectious Diseases, Laboratories of Experimental Researches Fondazione “IRCCS Policlinico San Matteo” Pavia, Italy Bianca Castiglioni Institute of Agricultural Biology and Biotechnology Italian National Research Council Milan, Italy Angela Christina Dias de Castro Instituto de Microbiologia Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil Laura de Castro Department of Animal Health University of León León, Spain Giovanni Cattoli Istituto Zooprofilattico Sperimentale delle Venezie Research and Development Department OIE/FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza OIE Collaborating Center for Epidemiology, Training and Control of Emerging Avian Diseases Legnaro, Padova, Italy
Cody Coyne Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Paola Cremonesi Institute of Agricultural Biology and Biotechnology Italian National Research Council Milan, Italy Maria Teresa Barreto Crespo Instituto de Biologia Experimental e Tecnológica (IBET) Av. da República, Quinta do Marquês Oeiras, Portugal Andrew Csordas Institute for Collaborative Biotechnologies University of California, Santa Barbara Santa Barbara, California Daniele Daffonchio Department of Food Science and Microbiology University of Milan Milan, Italy Sascha Al Dahouk Department of Internal Medicine III RWTH Aachen University Aachen, Germany
xix
Contributors
Stefano D’Amelio Department of Public Health Science Sapienza University of Rome Rome, Italy
Yaoyu Feng School of Resource and Environmental Engineering East China University of Science and Technology Shanghai, People’s Republic of China
Marie-Laure Dardé Laboratoire de Parasitologie-Mycologie CHU Limoges, France
Maria Fredriksson-Ahomaa Institute of Hygiene and Technology of Food of Animal Origin Ludwig-Maximilian University Munich, Germany
Jonathan J. Dennis Department of Biological Sciences University of Alberta Edmonton, Alberta, Canada Rubens Clayton da Silva Dias Division of Infectious Diseases and Immunity School of Public Health University of California Berkeley, California J.P. Dubey United States Department of Agriculture, Agricultural Research Service Animal and Natural Resources Institute Animal Parasitic Diseases Laboratory Beltsville, Maryland Joëlle Dupont Muséum National d’Histoire Naturelle Département Systématique et Evolution Paris, France Jean Dupouy-Camet Laboratoire de Parasitologie-Mycologie Hôpital Cochin AP-H Université Paris Descartes Paris, France Ron Dzikowski Department of Microbiology & Molecular Genetics The Kuvin Center for the Study of Infectious and Tropical Diseases The Institute for Medical Research Israel-Canada The Hebrew University–Hadassah Medical School Jerusalem, Israel John Ellis Department of Medical and Molecular Biosciences University of Technology Sydney Broadway, Australia Seamus Fanning Centre for Food Safety, School of Agriculture, Food Science and Veterinary Medicine Veterinary Sciences Centre University College Dublin Dublin, Ireland
Antonia Gallo Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy María-Luisa García-López Department of Food Hygiene and Food Microbiology University of León León, Spain Charles P. Gerba Department of Soil, Water and Environmental Science University of Arizona Tucson, Arizona Elisabetta Giuffra Parco Tecnologico Padano Lodi, Italy Pablo Goldschmidt Laboratoire du Centre National d’Ophtalmologie des Quinze-Vingts Paris, France Lisa Gorski Produce Safety and Microbiology Research Unit United States Department of Agriculture Agricultural Research Service Western Regional Research Center Albany, California Irene R. Grant School of Biological Sciences Queen’s University Belfast Belfast, Northern Ireland, United Kingdom Saija Hallanvuo Department of Animal Diseases and Food Safety Research Finnish Food Safety Authority Evira Helsinki, Finland Grant S. Hansman Department of Virology II National Institute of Infectious Diseases Musashi-murayama Tokyo, Japan
xx
Larry A. Hanson Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Romney S. Haylett Institute of Immunology RWTH Aachen University Hospital Aachen, Germany Annamari Heikinheimo Department of Food and Environmental Hygiene University of Helsinki Helsinki, Finland Samantha J. Hibbitts Department of Obstetrics and Gynaecology Cardiff University University Hospital of Wales Cardiff, Wales, United Kingdom Friederike Hilbert Institute of Meat Hygiene, Meat Technology and Food Science University of Veterinary Medicine Vienna, Austria Jeffrey Hoorfar National Food Institute Technical University of Denmark Søborg, Denmark Kurt Houf Department of Veterinary Public Health and Food Safety Ghent University Merelbeke, Belgium Zhi-Qing Hu Department of Microbiology and Immunology Showa University School of Medicine Tokyo, Japan Zhuting Hu Department of Biology International Christian University Tokyo, Japan
Contributors
Akira Ito Department of Parasitology Asahikawa Medical College Asahikawa, Japan Carol Iversen Centre for Food Safety, School of Agriculture, Food Science and Veterinary Medicine Veterinary Sciences Centre University College Dublin Dublin, Ireland Ferenc Jakab Department of Genetics and Molecular Biology Institute of Biology, Faculty of Sciences University of Pécs Pécs, Hungary Somchai Jongwutiwes Molecular Biology of Malaria and Opportunistic Parasites Research Unit Department of Parasitology Chulalongkorn University Bangkok, Thailand Pattara Khamrin Aino Health Science Center Aino University Tokyo, Japan Rickard Knutsson Department of Bacteriology National Veterinary Institute Uppsala, Sweden Hannu Korkeala Department of Food and Environmental Hygiene University of Helsinki Helsinki, Finland Thewarach Laha Department of Parasitology Liver Fluke and Cholangiocarcinoma Research Center Khon Kaen University Khon Kaen, Thailand
Wei-Yi Huang Department of Veterinary Medicine College of Animal Science and Technology Guangxi University Nanning, Guangxi, People’s Republic of China
Susanne Thisted Lambertz Research and Development Department National Food Administration Uppsala, Sweden
Sofia Ingrosso Department of Public Health Science Sapienza University of Rome Rome, Italy
Keith A. Lampel Food and Drug Administration Division of Microbiology College Park, Maryland
xxi
Contributors
Angelika Lehner Institute for Food Safety and Hygiene University of Zurich Zurich, Switzerland
Burkhard Malorny Federal Institute for Risk Assessment National Salmonella Reference Laboratory Berlin, Germany
Michael G. Levy Department of Population Health and Pathobiology College of Veterinary Medicine North Carolina State University Raleigh, North Carolina
Niwat Maneekarn Department of Microbiology, Chiang Mai University Chiang Mai, Thailand
Diego Libkind Laboratorio de Microbiología Aplicada y Biotecnología Instituto de Investigaciones en Biodiversidad y Medio Ambiente (INIBIOMA) Universidad Nacional del Comahue CRUB – Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET) Bariloche, Río Negro, Argentina Rui-Qing Lin Laboratory of Parasitology College of Veterinary Medicine South China Agricultural University Guangzhou, Guangdong, People’s Republic of China Mark van der Linden Institute of Medical Microbiology and National Reference Center for Streptococci RWTH Aachen University Hospital Aachen, Germany Miia Lindström Department of Food and Environmental Hygiene University of Helsinki Helsinki, Finland Dongyou Liu Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Charlotta Löfström National Food Institute Technical University of Denmark Søborg, Denmark
Heinz Mehlhorn Department of Parasitology Heinrich Heine University Düsseldorf, Germany Edina Meleg Department of Biophysics Faculty of Medicine University of Pécs Pécs, Hungary Marco Antonio Lemos Miguel Instituto de Microbiologia Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil Isabella Monne Istituto Zooprofilattico Sperimentale delle Venezie Research and Development Department OIE/FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza OIE Collaborating Center for Epidemiology, Training and Control of Emerging Avian Diseases Legnaro, Padova, Italy Beatriz Meurer Moreira Instituto de Microbiologia Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil Antonio Moretti Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy
José María Luengo Department of Biochemistry and Molecular Biology University of León León, Spain
Paolo Moroni Department of Veterinary Pathology Hygiene and Public Health University of Milan Milan, Italy
Karlene H. Lynch Department of Biological Sciences University of Alberta Edmonton, Alberta, Canada
Boris Müller Department of Parasitology Heinrich Heine University Düsseldorf, Germany
xxii
Contributors
Germán Naharro Department of Animal Health University of León León, Spain
Lia Paggi Department of Public Health Science Sapienza University of Rome Rome, Italy
Minoru Nakao Department of Parasitology Asahikawa Medical College Asahikawa, Japan
Anubhav Pandey Department of Microbiology All India Institute of Medical Sciences New Delhi, India
Kazuhiro Nakaya Laboratory Animals for Medical Research Asahikawa Medical College Asahikawa, Japan
Giancarlo Perrone Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy
Kanwar Narain Regional Medical Research Centre, N.E. Region Indian Council of Medical Research Dibrugarh, Assam, India
Michael D. Perry NPHS Microbiology Cardiff University Hospital of Wales Cardiff, Wales, United Kingdom
Karsten Nöckler Federal Institute for Risk Assessment Berlin, Germany Norihisa Noguchi Department of Microbiology School of Pharmacy Tokyo University of Pharmacy and Life Sciences Hachioji, Tokyo, Japan Birgit Nørrung Department of Veterinary Pathobiology University of Copenhagen Frederiksberg C, Denmark F. Nuñez Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Munehiro Okamoto Department of Parasitology School of Veterinary Medicine Tottori University Tottori, Japan Takashi Onodera Department of Molecular Immunology, School of Agricultural and Life Sciences University of Tokyo Bunkyo-ku, Tokyo, Japan Andrés Otero Department of Food Hygiene and Food Microbiology University of León León, Spain
G. Todd Pharr Department of Basic Sciences College of Veterinary Medicine, Mississippi State University Mississippi State, Mississippi Lesya M. Pinchuk Department of Basic Sciences College of Veterinary Medicine Mississippi State University Mississippi State, Mississippi Giuliano Pisoni Department of Veterinary Pathology Hygiene and Public Health University of Milan Milan, Italy Edoardo Pozio Department of Infectious, Parasitic and Immunomediated Diseases Istituto Superiore di Sanità Rome, Italy Stephen B. Pruett Department of Basic Sciences College of Veterinary Medicine, Mississippi State University Mississippi State, Mississippi Chaturong Putaporntip Molecular Biology of Malaria and Opportunistic Parasites Research Unit Department of Parasitology Chulalongkorn University Bangkok, Thailand
xxiii
Contributors
Noura Raddadi Department of Food Science and Microbiology University of Milan Milan, Italy
Franca Rossi Dipartimento di Biotecnologie Universita degli Studi di Verona Verona, Italy
Peter Rådström Applied Microbiology Lund Institute of Technology Lund University Lund, Sweden
Antoni Róz∙ alski Institute of Microbiology and Immunology University of Łódz´ Łódz´, Poland
Catherine E.D. Rees School of Biosciences University of Nottingham Sutton Bonington Campus Leicestershire, England, United Kingdom Ralf René Reinert Wyeth Vaccines Research Paris la Défense, France Jorge Riaño Department of Animal Health University of León León, Spain Lothar Rink Institute of Immunology RWTH Aachen University Hospital Aachen, Germany Aurora Rizzi Department of Food Science and Microbiology University of Milan Milan, Italy M. Rodríguez Higiene y Seguridad Alimentaria Facultad de Veterinaria Universidad de Extremadura Cáceres, Spain Roberto A. Rodríguez Department of Environmental Science and Engineering University of North Carolina Chapel Hill, North Carolina Giuseppe La Rosa Department of Infectious, Parasitic and Immunomediated Diseases Istituto Superiore di Sanità Rome, Italy Benjamin M. Rosenthal United States Department of Agriculture Agricultural Research Service Animal Natural Resources Institute Animal Parasitic Diseases Laboratory Beltsville, Maryland
Una Ryan Division of Health Sciences School of Veterinary and Biomedical Science Murdoch University Perth, Australia Yasuhito Sako Department of Parasitology Asahikawa Medical College Asahikawa, Japan Akikazu Sakudo Department of Virology, Research Institute for Microbial Diseases Osaka University Suita, Osaka, Japan José Paulo Sampaio Centro de Recursos Microbiológicos Departamento de Ciências da Vida Universidade Nova de Lisboa Caparica, Portugal Jesús A. Santos Department of Food Hygiene and Food Microbiology University of León León, Spain Jenny Schelin Applied Microbiology Lund Institute of Technology Lund University Lund, Sweden Jürgen Schmidt Department of Parasitology Heinrich Heine University Düsseldorf, Germany Keith R. Schneider Food Science and Human Nutrition Department University of Florida Gainesville, Florida Anna Charlotte Schultz National Food Institute Technical University of Denmark (DTU) Søborg, Denmark
xxiv
Contributors
Bo Segerman Department of Bacteriology National Veterinary Institute Uppsala, Sweden
Roger Stephan Institute for Food Safety and Hygiene University of Zurich Zurich, Switzerland
Teresa Semedo-Lemsaddek Universidade de Lisboa Center for Biodiversity Functional and Integrative Genomics (BioFIG) Edifício ICAT, Campus da FCUL, Campo Grande Lisbon, Portugal
Chunlei Su Department of Microbiology University of Tennessee Knoxville, Tennessee
Devendra H. Shah Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington Nidhi Sharma Department of Microbiology All India Institute of Medical Sciences New Delhi, India Smriti Shringi Department of Veterinary Microbiology and Pathology College of Veterinary Medicine Washington State University Pullman, Washington Paiboon Sithithaworn Department of Parasitology Liver Fluke and Cholangiocarcinoma Research Center Khon Kaen University Khon Kaen, Thailand Mikael Skurnik Department of Bacteriology and Immunology Infection Biology Research Program, Haartman Institute, University of Helsinki Helsinki, Finland and Helsinki University Central Hospital Laboratory Diagnostics Helsinki, Finland
Katsuaki Sugiura Food and Agricultural Materials Inspection Centre Chuo-ku, Saitama-shi Saitama, Japan Antonia Susca Institute of Sciences of Food Production National Research Council (ISPA-CNR) Bari, Italy Isabella Tamagnini Department of Food Science and Microbiology University of Milan Milan, Italy Rogério Tenreiro Universidade de Lisboa Center for Biodiversity Functional and Integrative Genomics (BioFIG) Edifício ICAT, Campus da FCUL, Campo Grande Lisbon, Portugal Herbert Tomaso Friedrich Loeffler Institute Institute of Bacterial Infections and Zoonoses Jena, Germany Sandra Torriani Dipartimento di Scienze, Tecnologie e Mercati della Vite e del Vino Università degli Studi di Verona Verona, Italy
Paweł Sta˛ czek Institute of Microbiology and Immunology University of Łódz´ Łódz´, Poland
Hiroshi Ushijima Aino Health Science Center Aino University Tokyo, Japan
Damien Stark Division of Microbiology, SydPath St. Vincent‘s Hospital Darlinghurst, Australia
Jaco J. Verweij Department of Parasitology Leiden University Medical Center Leiden, the Netherlands
xxv
Contributors
Jan Vinjé Division of Viral Diseases Center for Disease Control (CDC) Atlanta, Georgia
Jae-Ran Yu Department of Environmental and Tropical Medicine Konkuk University School of Medicine Seoul, Korea
Benjamin R. Warren Research, Quality, & Innovation ConAgra Foods, Inc. Omaha, Nebraska
Olga Zaborina Center for Surgical Infection Research and Therapeutics University of Chicago Chicago, Illinois
P. Lewis White NPHS Microbiology Cardiff University Hospital of Wales Cardiff, Wales, United Kingdom Lihua Xiao Division of Parasitic Diseases Centers for Disease Control and Prevention Atlanta, Georgia Guangai Xue Department of Molecular Immunology School of Agricultural and Life Sciences University of Tokyo Bunkyo-ku, Tokyo, Japan Tetsuya Yanagida Department of Parasitology Asahikawa Medical College Asahikawa, Japan Hélène Yera Laboratoire de Parasitologie-Mycologie Hôpital Cochin AP-HP Université Paris Descartes Paris, France
Gianluigi Zanusso Department of Neurological Sciences University of Verona Verona, Italy Wei-Hua Zhao Department of Microbiology and Immunology Showa University School of Medicine Tokyo, Japan Xing-Quan Zhu Laboratory of Parasitology College of Veterinary Medicine South China Agricultural University Guangzhou, Guangdong, People’s Republic of China Qing-Jun Zhuang Laboratory of Parasitology College of Veterinary Medicine South China Agricultural University Guangzhou, Guangdong, People’s Republic of China
Detection: 1 Molecular Principles and Methods Lisa Gorski
United States Department of Agriculture
Andrew Csordas
University of California
Contents 1.1 Introduction........................................................................................................................................................................... 1 1.2 Detection Methods................................................................................................................................................................ 3 1.2.1 Pathogen Detection in Complex Matrices—Sample Preparation.............................................................................. 3 1.2.2 Nucleic Acid Based Detection................................................................................................................................... 3 1.2.2.1 PCR............................................................................................................................................................. 3 1.2.2.2 Isothermal Amplification............................................................................................................................ 7 1.2.2.3 Microarray Detection.................................................................................................................................. 8 1.2.3 Fluorescence in situ Hybridization (FISH)................................................................................................................ 8 1.2.4 Immunological Detection Methods........................................................................................................................... 8 1.2.5 Combined Detection Methods................................................................................................................................... 9 1.2.6 Foodborne Pathogen Typing...................................................................................................................................... 9 1.2.7 Microfabrication and Microfluidics........................................................................................................................... 9 1.2.8 Other Molecular Detection Approaches.................................................................................................................... 9 1.2.9 Assay Design and Data Analysis Software.............................................................................................................. 10 1.3 Detection Targets................................................................................................................................................................. 10 1.3.1 Viral Targets............................................................................................................................................................ 10 1.3.1.1 RNA Targets.............................................................................................................................................. 11 1.3.1.2 Viral Structural Genes.............................................................................................................................. 11 1.3.1.3 Other Viral Targets.................................................................................................................................... 11 1.3.2 Nonviral Targets...................................................................................................................................................... 11 1.3.2.1 Ribosomal RNA Genes . .......................................................................................................................... 11 1.3.2.2 Cytoskeleton Proteins................................................................................................................................ 12 1.3.2.3 Virulence and Toxin Genes....................................................................................................................... 12 1.3.2.4 Unique Genes and Sequences................................................................................................................... 12 1.3.2.5 Insertion Elements..................................................................................................................................... 13 1.3.2.6 Mitochondrial Genes................................................................................................................................. 13 1.3.2.7 Genes for Surface Expressed Markers...................................................................................................... 13 1.3.3 Using Multiple Targets............................................................................................................................................. 14 1.4 Validation............................................................................................................................................................................ 14 1.5 Conclusions.......................................................................................................................................................................... 14 Acknowledgments........................................................................................................................................................................ 15 References.................................................................................................................................................................................... 15
1.1 Introduction While the vast majority of our food supplies are nutritious and safe, illness due to foodborne pathogens still affects millions if not billions of people each year. It is estimated that up to 30% of the population in industrialized nations suffer
from foodborne illness each year.1 In the U.S. there are an estimated 76 million cases each year that result in 325,000 hospitalizations, and 5000 deaths.2 Estimates of the number of cases in developing countries are difficult to obtain due to differences in reporting of cases in different countries; however, the rates of illness are expected to be higher.1,3,4 1
2
Molecular Detection of Foodborne Pathogens
Diarrheal diseases, a high number of which result from foodborne contamination, kill an estimated 1.8 million children worldwide.3 Table 1.1 summarizes the statistics of U.S. foodborne illness outbreaks for the year 2006 broken down by etiology. An outbreak is constituted by more than one person becoming ill by the same strain of an organism. The list displays only outbreaks from known etiologies of bacterial, viral, parasitic, and helminthic origin, and does not take into account outbreaks where an etiology could not be assigned. Nor does it take into account sporadic cases of illness, which far outnumber outbreak cases. Most of these sporadic cases are not reported to any official health tracking agency because they are not severe, or cultures are never obtained.1 An even greater number of people with sporadic cases of foodborne illness do not seek medical attention. Whether an illness is mild or severe, the underlying message from the statistics is that millions or billions of servings of food are contaminated with a pathogen or a toxin each year. Table 1.1 illustrates that the types of foods implicated is broad and comprises meats, dairy, produce, grains, processed foods, and water. While many cases of foodborne illness result from human cross-contamination in restaurants or in the home, a large amount results from foods that arrive
into the kitchen already contaminated. These organisms can contaminate the foods directly by association with feed animals or plants prior to or during processing, through contaminated water used for watering or washing, and through handling by infected people. One of the most difficult and fundamental issues in food safety is the detection of foodborne pathogens. The problem is terribly complex with a multitude of factors and variables with which to contend. With the infectious dose of some of the pathogens as low as <100 cells or particles, sensitivity is essential. In some instances, an enrichment step is necessary to amplify the number of pathogens in the sample simply so that they can be detected. However, enrichment does not work with viruses or toxins, and some organisms with long generation times can take weeks to enrich. Additionally nonprocessed or minimally processed foods are not sterile and native microflora can sometimes mask the presence of the pathogen. Finally the food matrix itself sometimes inhibits detection by affecting the chemistries used in detection methods. While an all-encompassing test that would detect every possible pathogen or toxin would be desirable, the technology does not yet exist. Ideally, the detection of pathogens should be fast and economical. Ultimately a balance between the financial burden of testing and the risk of selling of untested foods must
Table 1.1 Number of Foodborne Outbreaks with Confirmed Etiologies in the U.S. for the Year 2006 Agent
No. of Outbreaks
No. of Cases
Bacterial
Bacillus Brucella Campylobacter Clostridium Escherichia Listeria Salmonella Shigella Staphylococcus Vibrio Subtotal
3 1 22 20 29 3 116 9 12 8 223
35 5 283 745 520 7 2751 183 380 427 5336
Viral
Hepatitis A Norovirus Subtotal
3 333 336
34 10,970 11,004
Parasite
Cryptosporidium Cyclospora Giardia Subtotal
2 3 2 7
16 19 11 46
Helminth
Trichinella Subtotal
1 1
2 2
567
16,388
Total
Suspected Vehicles Produce, rice, meat Cheese Milk, cheese, seafood, produce, meat Produce, seafood, canned food, meat Milk, produce, meat Cheese, salad Meat, dairy, produce, peanut butter Salad, produce, meat Meat, dairy, seafood Seafood
Spring water, unspecified Salads, seafood, meat, produce Unspecified Fruit salad Unspecified Bear meat
Source: Compiled from Centers for Disease Control http://www.cdc.gov.
3
Molecular Detection: Principles and Methods
be met to ensure the safety of consumers and simultaneous profitability for food producers. The following chapters give detailed reviews of the latest methods and targets for detection of specific organisms. However, when reviewing the subject of molecular detection methods, common themes arise. These themes relate to the choices of detection methods and the molecular targets for detection.
1.2 Detection Methods A wide range of foodborne pathogen detection techniques have been developed including culturing methods, nucleic acid methods, immunological methods, microscopy, spectroscopy, and bioluminescence, with varying degrees of cost, specificity, sensitivity, and ease of use. The major considerations of a detection system include the cost of the process, the target for detection, and the specificity and sensitivity of the procedure selected for detection. In recent years painstaking methods of cell culture and microscopic observation have yielded faster, more efficient molecular methods of detection. While traditional microbial detection methods may yield adequate target specificity and sensitivity, the time to results is on the order of days, often relying upon pathogen growth. Numerous molecular techniques have emerged that offer the advantage of speed along with specific and sensitive detection. Molecular methods have also proven advantageous in cases where it is difficult to culture the target of interest, as can be the case with viruses. These methods require a solid understanding of the physiology of the target organism, its close relatives, and those with which it may coexist on a food surface.
1.2.1 Pathogen Detection in Complex Matrices—Sample Preparation Simultaneous advances in detection methods and in sample preparation prior to analysis are needed to ensure a safe food supply.5 Foodborne pathogens have been associated with a wide variety of foods including poultry, beef, shellfish, fruits, vegetables, and drinking water. Without appropriate preparation of a test sample prior to detection, a common potential problem to many detection methods is that the sample background material may drastically decrease the sensitivity of the detection step or even lead to false negative test results. Food derived polymerase chain reaction (PCR) inhibitors include Ca2+, fats, glycogen, and phenolic compounds.6 The presence of proteinases in cheese7 and milk8 may also inhibit PCR. Different approaches have been used to counteract poor PCR performance in difficult backgrounds. Bovine serum albumin has shown success in relieving PCR inhibition in certain cases,9 and the type of DNA polymerase used can greatly affect the outcome of a reaction in the presence of biological samples.10 Additional potential challenges of detecting foodborne pathogens include their nonuniform dispersal and very low concentrations within foods. Therefore, considerable effort is often required to prepare a sample such that it is suitable
for testing with a nucleic acid detection procedure. Methods that have been used for the removal of PCR inhibitors include physical separation techniques such as filtration, DNA extraction, and adsorptive methods such as immunomagnetic separation.11 Lampel et al.12 used filters capable of trapping and lysing microorganisms, then used these filters directly in PCR reactions. The detection limits of Shigella flexneri in artificially contaminated foods using the filter system were greatly improved as compared to unfiltered tests.
1.2.2 Nucleic Acid Based Detection Advances in nucleic acid testing have included rapid amplification techniques and associated automated instrumentation, microarray based technology, and lab-on-a-chip platforms. The relatively low cost and speed of oligonucleotide synthesis, the wide range of 3′ and 5′ oligonucleotide modifications readily available, and powerful software to aid in molecular assay design and data analysis have facilitated the growth of a wide range of nucleic acid based techniques applied to the detection of foodborne pathogens. 1.2.2.1 PCR Nucleic acid amplification techniques have an enormous range of applications and have become an indispensible tool in molecular biology and powerful rapid screening method in the detection of foodborne pathogens. By targeting and amplifying (or making copies of) DNA sequences in vitro, it has been possible to detect the presence of specific DNA sequences with sensitivities down to a single target copy per reaction, and in many cases quantify the results. PCR is a method for the amplification of double or single stranded (ss) DNA sequences in vitro. The reaction proceeds in response to temperature driven steps of double stranded (ds) DNA denaturation, primer or ss oligonucleotide annealing to complementary ss target DNA sequences, and DNA polymerase extension. These steps are repeated, and under appropriate conditions will generate a doubling of the initial number of target copy sequences with each cycle. The primers define the 5′ ends of the discrete products that are subsequently formed. Three step PCRs use three individual temperature steps for denaturation, annealing, and extension, while two step PCRs use a combined annealing and extension step. Reaction reagents typically include a thermostable DNA polymerase, deoxyribonucleoside triphosphates (dNTPs), user selected primers for targeting specific sequences, magnesium chloride, and template or target DNA. The process is rapid, requiring between minutes and hours to generate enough discrete sized target sequences for detection; a single thermal cycle may require as little as a few seconds to complete. The length of time required for a reaction is typically a function of variables such as the length of the target sequence and the heating and cooling rates of the thermal cycler used. However, it is now possible to find PCR systems capable of thermal cycling speeds so fast that decreasing cycle time further would not be worthwhile without first finding a DNA polymerase capable of working faster than those currently
4
Molecular Detection of Foodborne Pathogens
in use.13 While it is possible for PCR to routinely detect low copy numbers in a reaction, many reactions use between 5 and 10 µl sample volumes, yielding a lower detection limit of close to 103 CFU/ml.14 Among the expanding array of nucleic acid amplification techniques, PCR remains the most popular method, presumably as a result of its cost and ease of use,15 and has been used extensively for the detection of foodborne pathogens. By the early 1990s numerous primer sets had been developed for the detection of pathogens and the food industry had gained interest in this powerful method.16 The technique was initially reported in 1985,17 explained in full detail in 1986,18 and has since undergone several significant modifications including the use of a thermostable polymerase19 preventing enzyme destruction at denaturation temperatures, and “hot start” enzymes20 for temperature induced activation control, reducing the possibility of nonspecific product formation. Other major advances have included amplicon formation monitoring without opening the reaction tube,21,22 yielding facile quantification of initial target copy numbers, and the use of melting curve analysis to evaluate product specificity, which in some cases, allows extension of the quantifiable range beyond what is possible with threshold cycle analysis alone.23 In addition to evaluating a reaction’s specificity and detection limit, PCR reaction efficiency is often used to assess performance. The number of target copies generated after n cycles, xn, is a function of the initial target copy number xo and the amplification efficiency ε:
xn = xo(1 + ε)n,
(1.1)
with the amplification efficiency ranging from 0 to 1. Assay parameters that may influence reaction efficiency include primers, annealing temperature, and type of polymerase used. Annealing temperature optimization may be used to balance reaction efficiency and specificity. Approaches to the quantification of real-time PCR products have been described,22,24,25 and techniques typically involve the monitoring of fluorescence accumulation as a function of cycle number through specific or nonspecific dsDNA binding dyes. The threshold cycle, CT, is the fractional cycle at which enough fluorescence has accumulated to rise above the background signal and may be used for quantification. Absolute quantification is possible with unknown samples by running reactions of known template copy numbers to obtain a relationship between the threshold cycle number and the amount of initial template in the reaction. A mathematical model for relative quantification purposes has also been described.26 1.2.2.1.1 Practical Considerations for PCR-based Detection The strength of PCR is its weakness; the assay is incredibly sensitive to the detection of nucleic acids. Since PCR products serve as substrates for subsequent reactions, extremely large numbers of target copies may be generated. As a result
care must be taken in reaction setup and amplicon handling following a reaction to prevent carry-over contamination. Kwok and Higuchi27 list important steps to avoid the occurrence of false positive results, including physically separating the preparation of PCR reagents and the handling of PCR products, as well as frequently changing disposable gloves. While technique is paramount in the ability to generate reproducible results, a brilliant enzymatic approach has also been used to avoid false positive results. Longo et al.28 used a strategy that involved using dUTP in place of dTTP for PCR. All subsequent reactions were treated with uracil DNA glycosylase (UDG), followed by thermal inactivation of this enzyme prior to starting thermal cycling. As a result, any carry-over contaminating DNA would contain uracil and ultimately be rendered unamplifiable through the action of UDG, while simultaneously leaving target DNA intact. Nonspecific amplification arises from primers that bind to unintended targets such as themselves (primer dimers) or other unintended sequences present in the reaction mixture (e.g., DNA sequences from the natural microbiota present in foods). Methods to minimize nonspecific amplification include proper primer design, optimization of assay conditions, and the use of a hotstart DNA polymerase. Wittwer et al.29 studied the influence of annealing time on product specificity. Tests indicated that as annealing time increased, so did the tendency of primer sets to form nonspecific products. Although specificity was generally improved with short annealing times, in some cases there was a tradeoff in the amount of product formed and the specificity of the products formed. Other techniques for optimizing PCR conditions include varying the concentrations of primers and MgCl2, and evaluating two and three step thermal cycling formats. The ultimate test of a primer set’s specificity is in evaluating the performance with target and nontarget DNA sequences. Although it is possible to generate millions of amplicon copies in an hour or less, one complicating factor with PCR testing of food samples is that the level of inhibition is a function of the type of food tested.30 PCR inhibitors may hamper cell lysis, making it difficult to extract DNA, degrade or sequester nucleic acids, or they may act on DNA polymerase.6 In an effort to increase the likelihood of detection when pathogens are present in a sample, separation methods, enrichment procedures, and the extraction of DNA have been used. A negative PCR result could indicate that the target sequence was not present in the reaction or that the reaction itself failed. In order to avoid the uncertainty of such a result in diagnostic PCR, it has been proposed that PCRs contain an internal amplification control.31 Internal amplification controls are nontarget DNA sequences that will be amplified regardless of whether or not the target sequence was present in the reaction. If the internal amplification control is not amplified, then the reaction failed, and it is not possible to know if the target sequence was present in the failed reaction, so the detection step must be repeated.
5
Molecular Detection: Principles and Methods
The amplification of nucleic acids for detection purposes is usually just one step of a procedure that involves assay design and sample preparation prior to amplification, followed by specificity and sensitivity analysis. Some steps prior to and after amplification are shown in Figure 1.1.
using a technique such as agarose gel electrophoresis to compare the mobility of standard DNA ladder to the mobility of the amplified DNA (Figure 1.2). Comparison of the known standards to the PCR products can be used to estimate the size of the products formed. This step may be followed by performing a Southern blot to evaluate sequence specificity. Two potential drawbacks to traditional PCR are that (i) endpoint quantification is challenging and (ii) it is necessary to open the reaction tube to verify reaction product specificity,
1.2.2.1.2 Traditional PCR Traditional PCR techniques involve amplification of a target sequence of interest followed by product size verification
Assay design
Sample preparation
• target selection • software aided oligo design
• enrichment • extraction • separation
Specificity analysis
Target amplification • thermal cycling • isothermal incubation
Quantification • CT analysis
• gel electrophoresis • sequence specific probes – Southern blotting – labeled probes – microarray hybridization • complementary sequence Tm • sequencing
Figure 1.1 Steps used for the detection of nucleic acids by amplification. Quantification is not essential to verify specificity.
Melt, anneal primers
Repeat multiple cycles
Extend
Millions of copies of original template
Traditional PCR with gel
Real-time PCR with nonspecific detection
Real-time PCR with sequence-specific detection TaqMan
Molecular Beacon
Unbound probe with reporter and quencher
PCR products
Probe binds Primer binds
PCR proceeds Probe displaced Fluorescent reporter separated from quencher
DNA ladder
Unbound, unactive SYBR green
ssDNA
Bound, active SYBR green
dsDNA
Unbound molecular beacon Target
Probe binds, Beacon unfolds, Reporter activated Reporter, quenched Quencher Reporter, activated
Figure 1.2 Representation of PCR and detection protocols. The principle of PCR is illustrated in the top part of the figure. On the bottom are detection techniques. These include gel electrophoresis after traditional PCR. Real-time PCR with nonspecific fluorescent dye is shown where the dye only fluoresces when associated with double stranded DNA. Real-time PCR with probe-based detection with TaqMan and Molecular Beacon technologies is illustrated where the fluorescent reporter must be physically separated from the quencher in order to fluoresce.
6
increasing the opportunity for carry-over contamination. Traditional PCR therefore requires separate instrumentation for the amplification and evaluation of dsDNA products. However, provided that PCR products are handled carefully and that real-time quantification is not necessary, traditional PCR techniques can be used with great success for the detection of food pathogens. A single enrichment, thermal cycling protocol, set of PCR reagent components and concentrations were used for the detection of 13 foodborne pathogens by Wang et al.32 Agarose gel electrophoresis on 2% agarose gels stained with ethidium bromide was used for separation of PCR products. The PCR detection limits reported ranged from two cells to 5 × 104 cells for E. coli O157:H7 and Shigella spp., respectively. 1.2.2.1.3 Real-time PCR The ability to monitor amplicon accumulation as a reaction proceeds has drastically improved the field of nucleic acid detection. In addition to facilitating the quantification of initial target copy numbers, real-time PCR allows an operator to evaluate product specificity without opening the reaction chamber, saving time, and reducing carry-over contamination risk. Real-time PCR systems offer a wide range of capabilities. These include the ability to handle thousands of samples per day, perform 35 thermal cycles in under 40 minutes, and detect initial target copy numbers over a range from 10 to 1010.33 The design of real-time PCR assays has been aided by commercially available software packages that can determine optimal primer, probe, and reaction conditions, given a specific sequence of interest. Real-time PCR assays are typically designed to target short DNA fragments using primers specifically selected to avoid the formation of primer dimers. The increase in fluorescence in response to amplicon formation is generally accomplished in one of two ways: through the use of a nonspecific dsDNA binding, or by sequence specific probes that generate a signal only in the presence of the target DNA sequence. Realtime PCR techniques and applications have been reviewed extensively,14,34–37 and experimental comparisons among instrumentation and assay formats have been performed to compare sensitivities.38 1.2.2.1.4 Real-time PCR—Nonspecific Detection Nonspecific dsDNA binding dyes have been used for realtime PCR fluorescence based detection systems for target quantification and specificity evaluation. Over the course of thermal cycling, an increase in the amount of fluorescence generated is recorded. The earlier this increase in fluorescence occurs, the larger the initial target copy number present in the reaction. Following thermal cycling, product specificity is verified by slowly raising the reaction temperature through a broad temperature range that includes the expected product melting temperature, while simultaneously recording fluorescence in order to determine the melting temperature (Tm) of any dsDNA products that have formed (Figure 1.2). The melting temperature of a dsDNA
Molecular Detection of Foodborne Pathogens
product is the temperature at which half of the product has become ss. This melting temperature is a function of the dsDNA length, GC content, solution salt concentration, and dye concentration. Advantages of using nonspecific ds binding dyes as compared to probe based systems include cost and ease of assay design. As a result, this approach may be used as a less expensive alternative for initial testing with a primer set. However, this technique does not provide information regarding the length or sequence of the amplified product, and GC rich regions within a single amplicon may create complex melting profiles with multiple peaks.39 SYBR Green is a nonspecific dsDNA binding dye that is frequently used in real-time PCR assays. This dye binds to the minor grove of dsDNA and does not give strong fluorescence when free in solution. SYBR Green real-time PCR assays have been successfully used for the detection of foodborne pathogens, with specificity verification performed by melting curve analysis.40,41 1.2.2.1.5 Real-time PCR—Sequence Specific Detection A large number of real-time PCR strategies that are based on fluorescene increases in response to sequence specific detection have also been developed. Probe based real-time PCR techniques are advantageous over the use of nonspecific dsDNA binding dyes in that they may not require analysis of PCR amplicon melting temperatures for product specificity—fluorescence generation is a function of the probe binding to a specific sequence of DNA. In the case of real-time PCR development with probe based systems, excitation and emission wavelengths of the fluorophores selected must be kept in consideration.34 Sequence specific chemistries that have been incorporated into real-time PCR assays include those based on a sequence specific probe and DNA polymerase exonuclease activity, molecular beacons, and self-quenched hairpin primers. One real-time PCR chemistry (TaqMan®) that has been used extensively for the detection of foodborne pathogens relies upon the 5′ exonuclease activity of Taq polymerase. A probe containing a reporter and quencher in close proximity to one another binds to a target region between the two primers which define the ends of the discrete fragment ultimately formed. This probe is cleaved by the 5′ exonuclease activity of a DNA polymerase, separating the fluorophore and quencher, generating increases in fluorescence as a direct result of specific probe binding and target fragment extension (Figure 1.2). Numerous assays have been developed with this chemistry.42–45 Molecular beacons are stem and loop oligonucleotide structures used for sequence specific detection. The loop portion contains a sequence that is complementary to a chosen target, while the stem portion contains a short sequence of bases at the 3′ and 5′ ends that are complementary to one another but not the target.46 Fluorescence and quenching moieties are attached to the ends of the beacon. The beacons are designed such that with no loop complementary sequence present the stem structure is stable, but in the presence of a
Molecular Detection: Principles and Methods
complementary target sequence the arms of the stem separate. This separation changes the conformation of the beacon to a more stable structure, allowing simultaneous separation of the fluorophore and quencher, leading to fluorescence generation (Figure 1.2).46 Molecular beacons have been used in numerous applications,47 outside of monitoring specific amplicon formation in real-time PCR. Molecular beacons have been used in multiplex PCR applications for the simultaneous detection of four pathogenic retroviruses48 and four V. cholerae genes.49 Hairpin primers have also been used to monitor product formation as a function of cycle number. Blunt end hairpin primers using fluorophores with no quencher molecules were used with great success in a real-time PCR assay.50 Nazarenko et al.50 also demonstrated that these blunt end hairpin primers reduced the formation of primer dimers without PCR template present, thereby showing the outstanding specificity of the system. Nordgren et al.51 used this type of chemistry to detect norovirus (NV) genogroups I and II. Using hairpin primers it was possible to distinguish between genogroups in a duplex PCR through melting curve analysis. 1.2.2.1.6 Reverse Transcriptase PCR Enrichment procedures have successfully been used for the sensitive detection of viable foodborne pathogens, but this technique is time consuming, as it is a function of the target organisms growth. While PCR is capable of detecting low levels of target DNA, DNA detection does not provide information regarding the viability of a cell; food processing may destroy bacteria while leaving behind DNA and this DNA may be present even if its host cell is no longer alive.52 On the other hand, RNA is easily destroyed, which makes it suitable for determining organism viability.30 Reverse transcriptase PCR of mRNA targets has demonstrated that these molecules are indicators of cell viability.53,54 Following RNA purification and degradation of contaminating DNA from a sample of interest, RNA is reverse transcribed and the synthesized complementary DNA or cDNA may be amplified as is typically done for any DNA target. Reverse transcriptase PCR has been used successfully for the detection of foodborne bacterial pathogens55 and viruses.56 A real-time reverse transcription PCR assay using a TaqMan minor grove binding probe was implemented for the quantitative detection of H5 avian influenza down to 100 target copies.57 1.2.2.1.7 Multiplex PCR The amplification of several target sequences in a single reaction tube can be accomplished by optimized multiplex PCR assays. The motivation for such an approach includes cost efficiency58 and a reduction in laboratory effort and time.59 Conditions such as annealing temperature and reagent concentrations must be adjusted to allow for the simultaneous amplification of more than one target. Multiplex PCR optimization may be complicated, resulting in preferential amplification, poor sensitivity, and poor specificity59 if satisfactory conditions for all primer and template combinations cannot
7
be met. In comparison with single PCR reactions, multiplex PCR assay design considerations include designing long primers with higher melting temperatures and using elevated MgCl2 concentrations.60 Additionally, design considerations should include a method to distinguish between amplicons following thermal cycling. Methods may include designing target sequences of different sizes or melting temperatures for discrimination using gel electrophoresis or dissociation analysis with nonspecific dsDNA binding dyes, respectively. Using real-time PCR probes with different excitation and emission wavelengths may also be used to accomplish this goal. Mutliplex PCR has been used to detect multiple gene targets for speciation and virulence determination in Listeria monocytogenes.61 Other multiplex assays have been aimed at detecting food or waterborne pathogens of differing genera.58,62–65 Lee et al.64 simultaneously amplified sequences from Salmonella enterica, Salmonella typhimurium, Vibrio vulnificus, Vibrio cholerae, and Vibrio parahaemolyticus with multiplex PCR from seeded oyster homogenates. Following enrichment and DNA purification, it was possible to detect each pathogen at a level of 102 cells/g of oyster homogenate. Kong et al.63 were able to simultaneously detect Aeromonas hydrophila, Shigella flexneri, Yersinia enterocolitca, Salmonella typhimurium, Vibrio cholerae, and Vibrio parahaemolyticus in marine water with detection limits ranging from 100 to 102 CFU in a total assay time of less than 12 hours. Molecular beacons were used for the simultaneous detection of four retroviral target molecules in the same reaction tube.48 Using different colored fluorophores with emission maxima separated over the visible range and target sequences less than 130 bp, Vet et al.48 detected as few as ten retroviral genomes. 1.2.2.2 Isothermal Amplification Within the last 20 years, many techniques have been developed that allow for amplification of nucleic acids under isothermal conditions. These techniques include loop mediated amplification (LAMP),66 nucleic acid sequence based amplification (NASBA),67 rolling circle amplification (RCA),68 and strand displacement amplification (SDA).69 Isothermal amplification simplifies hardware requirements as compared to PCR in that they do not require a system for thermal cycling, and may even work with a simple water bath setup. These techniques may use several sets of primers or more than one enzyme to carry out amplification of the target product without thermal cycling. NASBA is an isothermal amplification process developed shortly after PCR began gaining widespread attention.67 NASBA is a sensitive detection method for the detection of RNA or DNA. The reaction typically consists of three enzymes including T7 RNA polymerase, deoxyribonucleoside triphosphates, two specific primers, and buffering reagents and takes place at approximately 40°C. One major advantage of the procedure is that contaminating genomic DNA does not create problems with the assay as it will not be
8
amplified due to the fact that there is no thermal denaturation step involved with the process.67 NASBA has been used for the detection of Hepatitis A virus (HAV) using primers targeting major capsid proteins.70 Jean et al. used Northern blotting and dot blot hybridization to verify the specificity of their reaction and found a detection limit of 0.4 ng RNA/ml as compared to a reverse transcriptase PCR assay used that yielded a detection limit of 4 ng RNA/ml. Other NASBA published methods for the detection of pathogens in foods have been listed by Rodríguez-Lázaro et al.71 Real-time NASBA has also been used to show product formation as a function of time. Molecular beacons were used to generate fluorescence signals with NASBA assays for the detection of Vibrio cholerae72 and HAV.73 LAMP is a procedure using four primers that have a total of six binding sites on the target DNA sequence. The isothermal reaction allows for the generation of 109 target sequences in less than one hour.66 A LAMP assay targeting the invA gene of Salmonella was developed by Wang et al.74 using an amplification time of approximately 60 minutes and run at 65°C. The detection limit of the LAMP assay was 100 fg of DNA per reaction, whereas a PCR approach gave a detection limit of 1 pg of DNA per reaction tube. 1.2.2.3 Microarray Detection In addition to Southern blots, gel electrophoresis, melting temperature analysis with nonspecific dsDNA binding dyes, and probe based amplification detection, microarrays have been used to analyze the specificity of PCR products. DNA microarray technology (aka DNA chips or gene chips) involves the placement of user defined oligonucleotide probes in specific locations on a solid substrate such as glass. Following hybridization of target DNA sequences to probes anchored on a chip’s surface, fluorescence detection can be used to monitor binding events. Depending on the sensitivity required, microarrays can be used with or without upstream amplification steps. Software analysis of large data sets that are generated greatly facilitates the process of data analysis. The advantages and limitations of several microarray software packages have been reviewed.75 Microarrays may be an effective way of distinguishing between nonspecific and target product formation and therefore this detection strategy may allow the use of more primers in a multiplex PCR assay than would normally be possible.76 Amplification methods have been used in combination with microarray technology for the detection of E. coli O157:H7.77 Wilson et al.78 were able to specifically detect 18 pathogenic microorganisms including, prokaryotes, eukaryotes, and viruses using PCR in combination with a microarray containing over 50,000 probes and with a detection limit as low as 10 fg of DNA.
1.2.3 Fluorescence in situ Hybridization (FISH) Fluorescence in situ hybridization (FISH) is a technique for the probe-based identification of nucleic acids without
Molecular Detection of Foodborne Pathogens
amplification. The technique can be used to specifically identify microbial cells in environmental samples and rRNA molecules are frequently targeted.79 Fluorescently labeled probes can be used to generate signals in the presence of specific target sequences, seen with fluorescence microscopy. Typical steps include sample preparation by fixation and permeabilisation, probe binding, removal of unhybridized probes by washing, and flow cytometry or microscopy detection.79 A FISH technique for the detection of Listeria monocytogenes showed specific detection of the target microorganism and detection was possible in sheep milk samples.80
1.2.4 Immunological Detection Methods At the core of all immunological assays is an antibody and antigen interaction. Numerous formats have been used to detect these binding events and immunological assays have been widely used for the detection of foodborne pathogens. Assay specificity and sensitivity is a function of the quality and type of antibodies used in binding to specific antigen epitopes. Many immunoassay formats are based on the enzyme linked immunosorbent assay (ELISA).81 ELISAs are commercially available for the detection of foodborne pathogens, and the method can be used for the detection of antibodies or antigens. The technique involves coating an antibody to a solid support surface, adding a sample of interest and incubating, and washing to remove nonspecific interactions. This step is followed by the addition of a second antibody to create a sandwich structure between the primary bound antibody, the target of interest, and this secondary antibody. The secondary antibody may be conjugated with an enzyme or fluorophore for detection and quantification with a plate reader. In this assay format, the target antigen must have at least two antibody binding sites.82 Muhammad-Tahir and Alocilja83 used a sandwich immunoassay with lateral flow disposable membranes and polyaniline-conjugated antibodies, and conductance measurements yielded detection limits of less that 100 CFU/ml. Other methods for evaluating immunological binding events include fluorescence microscopy and surface plasmon resonance (SPR). Fluorescence microscopy has been used to evaluate antibodies against protozoan parasites Giardia and Cryptosporidium.84 SPR sensors measure refractive index changes that result from surface plasmon excitation at the interface between a thin metal film and a dielectric material.85 SPR is attractive because it is a label-free technique, but has sensitivity limitations in terms of the size range of molecules that can be detected. An SPR system was used to detect Salmonella enteritidis and Listeria monocytogenes using antibodies against the pathogens on a gold sensor surface.86 The lower limit of detection was 106 CFU/ml for the pathogens, and it was noted that this sensitivity was comparable to an ELISA using the same antibodies. Immunoassay sensitivity and potential cross reactivity should be carefully considered in comparing detection methods. Another consideration in using immunoassay based systems is that antibodies must be raised against antigens. As a result, immunological methods typically must be used
9
Molecular Detection: Principles and Methods
with microorganisms that have been sufficiently characterized.87 The long development times associated with monoclonal antibodies and requirement of in vivo generation makes the widespread application of this technology complicated.88 Also, in some cases it may be difficult to confirm the identity of a microorganism through immunological testing alone. On occasion, reference laboratories found that serotyping could not be used to verify the identity of strains that were initially identified as Salmonella sp.89 Additionally, another nucleic acid based technology may be a suitable alternative for a range of molecular targets traditionally detected by antibodies. Aptamers, single stranded ss DNA or RNA that fold into conformations allowing specific binding to targets, have been proposed as alternative recognition molecules to antibodies.88
1.2.5 Combined Detection Methods Due to limitations of individual detection methods, the combination of two or more techniques has been used for verification purposes, ensuring adequate specificity and sensitivity of results. In a study examining 244 stool samples from an outbreak of gastroenteritis, transmission electron microscopy (TEM), PCR, and ELISA formats were used for the detection of NV.90 The results indicated that at least two of the methods should be used in order to increase the level of confidence in the diagnosis. Combining methods has also been used to enhance the performance of individual assays. Immuno PCR (IPCR) was introduced in 199291 and is a method that can dramatically increase the sensitivity of immunoassays such as the commonly used ELISA. IPCR involves the use of an antibody-DNA conjugate to bind specifically to a target antigen. The antibody is bound to DNA that can then be amplified by PCR. The system is designed such that the presence of PCR product in a reaction means that the target antigen has been detected. One advantage of this technique over other types of PCR methods is that the sequence of DNA to be amplified can be entirely selected by the user.92 An overview of IPCR applications, including pathogen protein detection assays, along with detection limits and sensitivity increases compared to ELISA results, is given by Niemeyer et al.92 A real-time IPCR assay to detect NV capsid proteins in food and fecal samples was developed by Tian and Mandrell.93 They found that PCR inhibitors had a minimal impact on the antigen capture and were removed by wash steps. The real-time IPCR system was the first report to detect NV in contaminated foods without virus purification or concentration. Using a tri-antibody system, the results showed a greater than 1000 fold improvement in sensitivity in comparison to an ELISA assay alone.
1.2.6 Foodborne Pathogen Typing Molecular typing can be used to determine variability within a population of closely related microorganisms and has been
valuable in epidemiological investigations. It is especially important when distinguishing between multiple isolates of the same species. Frequently used methods for studying molecular genetics of bacterial pathogens include pulsedfield gel electrophoresis (PFGE), PCR, and PCR-RFLP (restriction fragment length polymorphism).94 Schwartz and Cantor95 developed PFGE for the separation of large DNA fragments on a 1.5% agarose gel. By alternating the direction of the electrical field across a gel in a perpendicular fashion and varying the pulse length of the different field orientations in a nonuniform fashion from 1 to 90 seconds, it was possible to separate fragments as large as 2000 kb. By changing the direction of the electric field across a gel over short time intervals, it was possible to separate much larger fragments of DNA than was originally possible with standard gel electrophoresis. Whole bacterial chromosomes may be cut by rare digestion enzymes, generating a moderate number of DNA fragments suitable for gel analysis, essentially creating a genetic fingerprint of banding patterns for comparison between strains of the same species.94 PFGE is a technique often used for typing of many bacterial foodborne pathogens and the technique has applicability in studying strain population variability. A typing scheme was created by Wong et al.96 using over 500 strains of Vibrio parahaemolyticus collected from 15 countries and 115 PFGE patterns were identified. It was also found that the restriction enzyme SfiI resulted in clearly separated bands, as opposed to the use of other restriction enzymes.
1.2.7 Microfabrication and Microfluidics Advances in microfluidics along with development of integrated lab-on-a-chip or micro total analysis systems (µTAS) have generated platforms capable of small scale sample preparation, fluid transport, and biological detection.97 Advantages of these microsystems over amplifications on larger scales are that reduced reagent volumes are required, and it may be possible to reduce the amount of time required for the reaction to take place.98 Disadvantages of some microsystems include increased nonspecific binding and the reduction of signal intensity.98 Microchip PCR systems offer advantages of low power consumption as well as rapid heating and cooling. Belgrader et al.99 developed the Advanced Nucleic Acid Analyzer using ten silicon reaction chambers, and detection limit ranges between 102 and 104 organisms/ml were achieved. Neuzil et al.100 obtained heating and cooling rates in excess of 100°C/s using a 100 nl PCR volume with a silicon micromachined chip in a system was able to complete 40 cycles in 5 minutes and 40 seconds.
1.2.8 Other Molecular Detection Approaches Manipulation of nanomaterial properties for targeting biomolecules has created the potential for new techniques that are competitive with ELISA and PCR methods.101 The applications of nanostructures in biodiagnostics has been reviewed.101
10
Many silver and gold nanoparticle based methods have been used to detect DNA. A label-free platform using silver nanoparticles and smooth silver films was used for the detection of ssDNA by surface-enhanced Raman scattering (SERS).102 In another system, gold nanoparticles were functionalized with thiolated oligonucleotides to detect DNA hybridization by transmission SPR spectroscopy.103 Aptamers are ss nucleic acids that can be generated by a process known as systematic evolution of ligands by exponential enrichment (SELEX), by using libraries of synthetic nucleic acids.88 After folding into a particular conformation, the resulting nucleic acid ligands are capable of specifically binding to a wide range of targets including proteins, making these molecules a potential alternative to antibody based detection. Aptamers are beginning to emerge as molecules that can contend with antibodies in the fields of diagnostics and therapeutics.104 Specific advantages of aptamers over antibodies include their ability to reform their structure following denaturation, an in vitro as opposed to animal or cell based selection process, and chemical synthesis of the selected sequence, making it possible to produce the selected ligand in a very repeatable fashion.104,105 Electrochemical nucleic acid detection techniques have emerged that are label-free and therefore do not require fluorescent dyes and optical components. A disposable electrode system has been used for sensing fM quantities of specific ssDNA sequences, and it was possible to verify hybridization specificity down to a single base pair mismatch by using melting curves.106 Other electrochemical DNA systems have shown promising results in detecting DNA in blood serum107 and PCR products amplified from the gyrB gene of Salmonella typhimurium.108
1.2.9 Assay Design and Data Analysis Software Nucleic acid based detection techniques have grown at a staggering rate due to the availability of target sequence data, powerful methods for nucleic acid amplification, and the ability to easily design suitable nucleic acid sequences for a particular assay. The design of a sensitive, specific PCR assay includes many considerations, and some of the most important are selecting appropriate primers and target DNA sequences. Computer aided PCR assay design systems began appearing not long after the amplification technique was introduced. One such program provided the ability to evaluate DNA duplex stability, oligonucleotide specificity, and oligonucleotide self-complementarity.109 Significant empirical optimization with poorly designed primers can be costly, time consuming, and may not yield adequate results. PCR assay design software can aid in finding primers that have minimal tendency to form secondary structures, closely match primer melting temperatures, find a suitable amplicon size, and predict its melting temperature, all in less time than it takes to select parameter constraints. Additionally, user defined criteria allow primer sets to be rated in terms of their ability to match desired characteristics. Many packages can
Molecular Detection of Foodborne Pathogens
be found online at no charge by using keywords phrases such as “PCR design software” and range in available features from displaying oligonucleotide secondary structure formation to design aides for multiplex real-time PCR assays.
1.3 Detection Targets Just as important as the selection of a suitable method for detection is the selection of an appropriate target to detect. Targets for detection must be unique to the organism of interest. The ideal target would be a gene or a noncoding region with a unique sequence present only in the organism of interest. While unique genes exist, most detection systems take advantage of sequence variations in genes that are shared by many different organisms. Only by studying these organisms, comparing sequence data, and determining specificity have researchers elucidated targets suitable for detection systems in foods. While specificity is an issue, the target should not be so specific that it fails to detect most strains of a species. The detection sequence should be relatively stable within the species. Genes that undergo high rates of recombination, such as some surface antigens that change often to evade immune systems, are not desirable targets. The most common detection sequences are in genetic regions that share some common traits. These loci are common to most if not all the isolates of a species, and they have a high level of sequence conservation, but enough variability in sequence and/or length to distinguish them from similar loci in other genera and sometimes species within genera. Good candidates are genetic loci that are somewhat constrained in sequence because the gene products encode products of essential function but still display some amount of variability (e.g., ribosomal RNA or cytoskeletal proteins). Technical considerations play a role in the choice of detection targets as well. Some high G + C regions may not have high PCR efficiency. This is something to keep in mind if universal primers are being used in a food with a large amount of natural microflora (such as produce or raw meat) when testing for a pathogen that may be present in low numbers. If the template for detection is present in very low numbers, it could be missed if PCR amplifies competing targets with higher efficiency. This is why targets should be tested in laboratory situations with food samples contaminated with pathogens. This allows for assessment not only of the target but the potential inhibition of PCR by components of the food matrix.
1.3.1 Viral Targets The limited genetic information in viruses in relation to the rest of the organisms discussed in this book necessitates a separate discussion of viral detection targets. Viruses consist of genetic material within a proteinaceous capsid and sometimes a surrounding lipoglycoprotein envelope. They are completely dependent on host cells for the expression of their genetic material, their reproduction, and their assembly. Since they have neither organelle structures nor ribosomes,
11
Molecular Detection: Principles and Methods
protocols using those targets for detection are useless for viruses. They have very small genomes in comparison with other classes of foodborne pathogens, meaning that there is not a lot of variety in genes to choose for detection purposes. While some concepts of viral detection are shared by other pathogens, some detection targets are unique to viruses. 1.3.1.1 RNA Targets Some of the viruses involved in foodborne outbreaks carry their genetic information as RNA, so reverse transcriptasePCR is used for detection of them. Some RNA viruses contain a gene for an RNA dependent RNA polymerase, which is used for duplication of the viral genetic information. The mutation rate in RNA viruses is much higher than in DNA viruses because of the lack of proofreading ability in RNA dependent RNA polymerase.110,111 This makes it difficult to find stable regions of the genome to use as sequence markers. The polymerase gene itself is one of the few regions of the RNA genome that is relatively conserved. It is an example of a gene that serves an essential function to the virus, so broad changes in sequence that may affect its function are not tolerated. It is used as a detection target for some RNA viruses including hepatitis A, Norwalk virus, and others.112–115 DNA viruses lack such an accommodating gene to use for detection. 1.3.1.2 Viral Structural Genes Capsid proteins are the viral components on display to the environment. They are the major antigenic determinants in viruses, and as such are unique to each virus. These sequence differences among structural proteins present in all viruses is probably the most exploited target for viral detection.113 Capsid genes are used for detection of both DNA and RNA viruses. The V2 and V3 capsid genes in hepatitis A116 have been used for detection of the virus in spiked food samples.117,118 Similarly, primers to rotavirus conserved genome region 9, which contains genes for capsid structure have also been used as targets for detection.118 Strain variability among the different strains of the same virus group results in divergence of capsid gene sequences, and in some viruses the capsid gene sequences are highly mutable. As a result some isolates are not detected by some capsid-directed primer targets. This has been reported for different varieties of Norwalk virus and others.119 Therefore, capsid-designed primers work for detection as long as they target conserved regions in the capsid sequence.120,121 1.3.1.3 Other Viral Targets Noncoding regions in viral genomes, as long as they are conserved and therefore usable between different isolates, have also been used as detection targets for several viruses.122–124 This is the case with the 5′ noncoding region of HAV.125 In other cases unique genes, such as hemagglutinin in avian influenza virus,126 are detection targets. Additionally, since viruses have small genomes multiple isolates of the
same virus type can be sequenced to find unique regions shared among them. Whether or not they are coding regions, these unique sequences can then be used for detection targets for that virus. This procedure was used to find detection targets for Astroviruses.127
1.3.2 Nonviral Targets 1.3.2.1 Ribosomal RNA Genes The most common target for molecular detection is the DNA encoding ribosomal RNA (rRNA). All organisms except for viruses contain these loci. These genetic loci are uniquely suited for diagnostic purposes because they have regions that are very highly conserved in sequence, as well as regions that are divergent. Depending on which regions of the rRNA are targeted they can give different levels of identification from kingdom through genus and species, as well as sometimes differentiating strains within a species.128,129 These regions are also desirable for identification purposes because they share similar physical chromosomal structures (Figure 1.3). Ribosomal RNA in both prokaryotes and eukaryotes is synthesized as one precursor molecule which is then processed to make ribosomes. In prokaryotes the 16S, 23S, and 5S rRNAs are transcribed as one unit also containing a tRNA. In eukaryotes the 18S, 5.8S, and 28S rRNAs are also transcribed as a single unit. In both cases mature rRNAs are made by processing of the primary transcript. Because ribosomes perform an exact function in all living cells the sequence diversity among functional areas of rRNA is highly constrained, but some variation is tolerable. On the other hand, the nonfunctional regions of rRNA loci are under minimal selective pressure, and their sequences and lengths can vary greatly. These differences in rRNA sequence have been used to determine evolutionary relationships between organisms.128 Another benefit of rRNA loci is that they are often present in multiple copies since many ribosomes are necessary for the functioning of growing cells. This means multiple copies of the template sequence for amplification. Beyond the sequence variability in the nonfunctional regions of the rRNA, variable regions are contained within each of the rRNA subunits that provide targets for detection
16S
4S
23S
5S
16S–23S spacer region
28S
5.8S
18S (SSU) ITS
ITS
Figure 1.3 Basic physical map of ribosomal DNA loci in prokaryotes (top) and eukaryotes (bottom). ITS, internal transcribed spacer region, SSU, small subunit RNA.
12
of many foodborne pathogens. The 16S, 23S, 18S and 28S subunits have been utilized for detection in most cases. The 16S and 18S RNAs, sometimes referred to as the small subunit RNAs (SSU RNA) in protozoa, have more sequence diversity than the larger subunits (23S and 28S), and as a result the smaller RNAs are used more often for detection.130,131 SSU RNA is a popular target among the protozoa and helminths.132–134 The 16S rRNA sequences have defined bacterial phylogenetic relationships;128 however, for differentiation between species in the same genus the 16S rRNA region is often not discriminating enough because of its low rate of mutation. Even greater diversity in sequence can be obtained by using the spacer regions between the structural subunits. These regions get transcribed as part of the preribosomal RNA, but are cut away later. Since they are not functional RNAs, the spacer regions are not under selective pressure to retain their sequence, but closely related species share similarities in these regions. Because these spacer regions are bound on either side by conserved regions (Figure 1.3), universal primers exist that will bind to the conserved regions and allow their amplification. Specific probes are then used to detect pathogens. Among prokaryotes this spacer region is called the 16S–23S intergenic spacer region (ISR). In eukaryotes, the analogous region is called the internal transcribed spacer region (ITS). ITSs are present in high copy number, and display phylogenetic divergence such that they can show species differentiation.135 The 16S–23S spacer region is widely used to probe for foodborne pathogenic bacteria,131,136 and ITSs are used quite often for detection of fungi and for some helminths.135,137–139 While very useful, sometimes rRNA is not a preferred target. Since all prokaryotes and eukaryotes contain rRNA, primers will amplify regions from many different organisms. If a pathogen is present in low number among normal microflora in foods, then the pathogen target must compete with other templates present in a sample. If the target of interest has a lower PCR efficiency than others present, then the organism of interest may be missed. rRNA has met with mixed results in amplifications from Giardia, for example, because of a high G + C ratio in its 18S rRNA sequence.140 Also, for differentiation of a pathogenic species from nonpathogenic relatives in the same genus, rRNA may not be discriminating enough. 1.3.2.2 Cytoskeleton Proteins Similar to ribosomal DNA, gene sequences for cytoskeletal proteins have been conserved in eukaryotes. These proteins control vital functions such as growth and division of cells, motility, endocytosis, exocytosis, and maintenance of the cell structure. Because these genes arose early in eukaryotic evolution and their sequences have a slow rate of change, they are useful for phylogenetic comparison of species.141,142 These same traits make them useful detection targets, especially if amplification of ITS regions is problematic. Actin and β-tubulin have been used as targets to distinguish between different species in genres of various fungi.143 Giardin, a
Molecular Detection of Foodborne Pathogens
protein associated with the cytoskeleton in Giardia has been used as a detection target.144,145 These proteins, as such, do not exist in prokaryotes, so cytoskeletal targets are limited to detection of eukaryotic pathogens. 1.3.2.3 Virulence and Toxin Genes Among bacteria and fungi there are many cases where a genus consists of pathogenic and nonpathogenic species. Examples are Listeria, Aeromonas, Aspergillus, and Penicillium, to name a few. Often rRNA is not suitable to distinguish between the pathogen and their closely related nonpathogen in the same genus. One way to distinguish them is by assaying for virulence or toxin genes, which are unique to the pathogen genomes. In bacteria, virulence genes are often grouped together on the genome at discrete loci called pathogenicity islands. The altered G + C content of the DNA in many of the pathogenicity islands in relation to the rest of the genome, and repeated sequences on their edges hint that they arrived in these organisms by horizontal transfer.146 Often the pathogens are genetically similar to their sister species except for the pathogenicity islands and other virulence genes. In order to ensure detection of the pathogen in the food sample, and not the innocuous species in the genus, it makes sense to screen directly for the virulence genes or toxins. Virulence gene sequences can be used as specific targets if the gene is unique enough, and the sequence does not vary much between different isolates of a pathogenic species. Hemolysins are a popular target, and they have been used for detection in foods of Shigella, Vibrio, Listeria, Yersinia, Aeromonas, and others.55,147–154 In addition to virulence genes which are involved in the infection process, some organisms produce toxins which are released from the cells. Sometimes these toxins are released as a part of the disease process; however, many organisms release toxins while growing in a food product. Food poisoning is actually caused by reactions to toxins present in food that are made by organisms that grew there. Toxin genes are usually of unique sequence, and so they are used as detection targets. Examples of using toxin genes as detection targets in foods are cereulide, the emetic toxin of Bacillus cereus in rice, botulinum toxin made by Clostridium botulinum in meat and canned corn, enterotoxin made by Staphylococcus aureus in dairy products, and an array of mycotoxins made by fungi such as Alternaria, Aspergillus, Pennicillium, and Fusarium in apples and grains.137,155–162 Other organisms make toxins as part of the disease process once the organism has already grown in the individual, and these types of toxins are also used as detection targets in foods. Examples of these toxins are cytolethal distending toxin in Campylobacter sp. in poultry, and the shiga toxins in Shigella some E. coli strains in meat and dairy products.163–165 1.3.2.4 Unique Genes and Sequences The best detection targets are genes that are absolutely unique to the organism of interest. Failing that, a gene that has unique sequences is desirable. In this section are several examples of unique gene sequences that are neither
Molecular Detection: Principles and Methods
rRNA nor related to virulence and toxicity, but have been found by studies of the physiology of the organisms in question. In Staphylococcus aureus, the nuc gene is a thermostable nuclease.166 While it is not unique to S. aureus, it has sequences in it that will distinguish it from other similar genes. Therefore, it has been used as a detection target for S. aureus.167 The per gene, which encodes perosamine synthetase, has a sequence that is highly conserved among Brucella species, and primers were designed to take advantage of that specificity for detection.168 A unique region in an open reading frame encoding part of the Type III secretion system was utilized as a target to differentiate Burkholderia pseudomallei strains from other bacteria as well as other Burkholderia spp.169 The genus Pseudomonas encompasses a large number of species, some of which are very closely related, so rRNA can be problematic in distinguishing the pathogens from the nonpathogens. The carA gene which encodes carbamoyl phosphate synthase in Pseudomonas sp. was used to distinguish between different species in the genus in meats.170 In order to differentiate between different strains of E. coli sequences in gadA and gadB, which encode glutamate decarboxylase, have been used in artificially contaminated wheat grain.171,172 For the detection of Salmonella in poultry houses the iroB gene, which is absent in the closely related E. coli, was used.173,174 The cpn60 gene (also known as groEL or hsp60), which encodes a heat shock protein in bacteria, contains within it a fragment that has been useful for determining phylogenetic relationships among bacteria. A database of sequences exists to identify organisms found by using this gene as a detection target.175 The rpsU- dnaG- rpoD region is another locus has been used to differentiate between different bacteria. This region encodes proteins involved in the initiations of protein, DNA, and RNA synthesis, and is another example of a locus that has regions that are highly conserved and others that are variable. It has been found to vary between bacteria genera, but to be relatively conserved between species within a genus.176,177 This region was used to distinguish the foodborne pathogen Enterobacter sakazakii from other Enterobacter sp. in infant formula.178 The Toxoplasma B1 gene, which is highly repetitive (35 copies) and highly conserved among various Toxoplasma spp. has been used as a detection target.179,180 The cytoskeletal protein giardin is a major antigenic determinant that is unique Giardia.181 It is also conserved between the different species of Giardia, and as such is a useful detection target. Among the helminths complete genome sequences are not available for many of the genera. However, sequences have been identified by researchers that are unique to some, and these have been used as detection probes. Organisms that have been detected in this fashion include Clonorchis, Opisthorchis, Paragonimus, Taenia, and Fasciola.182–186 1.3.2.5 Insertion Elements In many cases rRNA gene is a fine target for differentiating between genera. However, it is sometimes not discriminating
13
enough for the differentiation of species or subspecies. In the case of Mycobacterium avium subsp. paratuberculosis,187,188 IS900 used. This insertion sequence in the genomes of M. avium subsp. paratuberculosis strains allows discretion down to the subspecies level between different M. avium subspecies.189 If simple detection of genus and species is required for the Mycobacterium genus then 16S rRNA is used. Another insertion sequence, IS711 is used as a species specific detection target for Brucella abortus.190 Primers specific for IS407A have been used to differentiate Burkholderia mallei from B. pseudomallei. 1.3.2.6 Mitochondrial Genes In cases where a whole genome sequence is not available for a eukaryotic organism, mitochondrial genome sequences often are available. These organelles, which are present in almost all eukaryotes, contain genomes on the order of 12–20 kb in length that can provide useful targets for detection. For the most part mitochondrial genomes contain the same complement of genes including those coding for proteins needed for oxidative phosphorylation, rRNA, tRNA, as well as noncoding spacer regions. The mitochondrial genome replicates on its own separate from the nucleus, and the coding regions differ at the rate at which they acquire mutations. The noncoding regions have the most variable sequences. Comparisons of mitochondrial genomes have been used to determine phylogenetic relationships between organisms.191,192 Mitochondrial genes are used often for the molecular detection of helminths and some fungi in foods. The mitochondrial gene COX2, which encodes one of the subunits of cytochrome oxidaise, was used as a target for detection of Saccharomyces cerevisiae.193 Cytochrome oxidase and NADH dehydrogenase genes from the mitochondrial DNA is also a popular target for the detection of helminths such as Clonorchis, Opisthorchis, Fasciola, and Diphyllobothrium.194–196 Mitochondrial sequences can be used to differentiate between closely related species in a genus based on size differences in noncoding regions.195 1.3.2.7 Genes for Surface Expressed Markers Similar to the genes that encode capsid proteins in viruses, genes that encode surface markers in other organisms have been used as detection targets. These surface markers are often antigenic determinants, meaning that their coding regions are sufficiently unique for use in detection. However, a problem with surface markers lies in strain variation. In organisms that change surface markers to evade the immune system, detection based on those markers is not useful. Yet bacterial capsule genes are sometimes used to detect Streptococcus species.197 Streptococcus suis contains an extracellular protein factor encoded by the epf gene that is a specific marker for these strains.198 Among Gram-negative bacteria genes encoding lipopolysaccharide markers were used for detection of E. coli, Salmonella, and Vibrio.199 Flagellar genes in bacteria also fall into this category. Many of the flagellar components are expressed on the surface of the cell. They demonstrate unique signatures, so they are also antigenic. In
14
some instances flagella serve as virulence factors for bacteria when they are involved in attachment to animal host cells. Several bacterial detection target strategies utilize flagellar genes to detect and differentiate species of Campylobacter,200 E. coli.201 The eap gene in Staphylococcus aureus encodes a cell-surface associated protein that allows adherence of the bacterium to host cells. This gene was described as a potential detection target.202 In Brucella the BCSP-31 gene encodes a cell surface antigen specific to Brucella spp. BCSP-31, and other outer membrane protein encoding genes have been used as Brucella-specific detection targets.203,204 The gene for the oncosphere-specific protein tso31 has been used as a detection target for the helminth Taenia.205 The oocyst wall protein gene CpR1 from Cryptosporidium is also a target for food detection systems.134,206,207
1.3.3 Using Multiple Targets The best way to screen for a particular pathogen in foods is to use multiple targets for detection. If a combination of rRNA, virulence, and other relevant target genes are used, then there can be a fair amount of confidence that most or all strains of any pathogen can be detected. The most efficient ways of detecting these multiple targets at the same time would be either with a multiplex procedure or with microarray analysis.60,76,199 Panicker et al.149 used both microarrays and multiplex PCR to detect Vibrio spp. in shellfish. Beyond multiple targets and methods, the chances of detection are enhanced with a pre-enrichment step before molecular analysis. This can take the form of a microbiological enrichment, a capture and concentration with immunomagnetic beads that bind to specific pathogens, or both. Just as multiple targets are used for detection of one pathogen, they are also used to detect several pathogens in one test. Screening for several potential pathogens with one protocol saves both time and money. E. coli, L. monocytogenes, and Salmonella typhimurium were each detected in contaminated wheat in one protocol utilizing a microbiological enrichment step followed by multiplex PCR using primers specific to all three bacteria.171 Multiplex PCR was also used for simultaneous detections of Salmonella and Vibrio in shellfish,62 and Yersinia, Staphylococcus, and Shigella in lettuce.65 A microarray was used to detect the mycotoxin biosynthetic genes of Fusarium, Penicillium, and Aspergillus.137 Wilson et al.78 developed a microarray to detect eighteen prokaryotic, eukaryotic, and viral pathogens at once including Brucella, Clostridium, Staphylococcus, Vibrio, Yersinia, and Fusarium.
1.4 Validation Before widespread use of detection methods, they should be validated to make sure that they will detect most or all isolates of a species. False negatives can lead to disastrous consequences, and false positives can lead to costly, unnecessary recalls by manufacturers. A detection target is not very useful
Molecular Detection of Foodborne Pathogens
if a subset of strains of that organism do not possess it. The best methods have been validated by use in multiple laboratories to make sure they work with different sets of workers. This type of interlaboratory validation is routinely done. For example, 12 laboratories recently validated a Campylobacter detection protocol in spiked chicken carcass rinses,208 and several labs were involved in detection of hepatitis A from spiked food samples.117 Experiments within the food matrix are very important as they will not only assess the detection method within in the presence of potential inhibitors, but also determine how well the target organism competes with natural microbiota in the food. The competition aspect is important to test if an enrichment is involved prior to actual detection. Targets should be screened to make sure they do not react with unwanted organisms. Potential primers and probes should be tested against multiple, closely related species for cross-reactivity. Also during these validations, sensitivity of the method can be determined with known levels of organisms added to foods.
1.5 Conclusions Molecular biology has rapidly revolutionized food diagnostics, driven by biotechnology advances fueled by basic science.209 Numerous molecular detection techniques have emerged that are rapid, sensitive, and specific in detecting nucleic acid sequences of foodborne pathogens. Several factors have led to an explosive growth in methods available for the detection and quantification of foodborne pathogens including the ready availability of synthetic oligonucleotide sequences of approximately 100 bp or less, the ability to modify these sequences at their 3′ or 5′ ends with fluorescence labels or conjugation chemistries, the development of extremely sensitive DNA amplification techniques such as PCR, software tools for molecular assay design and data evaluation, and DNA sequence databases to allow for the search for efficient target sequences. Rapid and simple sample preparation techniques, simplification of data analysis, standardization of molecular testing procedures, and identification of suitable detection targets will lead to the more widespread acceptance of molecular techniques. Additionally, cost effective solutions to pathogen detection and systems for on-site analysis that require minimal operator interface would benefit many industries. Microfabrication, microfluidics, and nanoparticle conjugation chemistries are likely to play significant roles in future systems. The extent to which foodborne pathogen detection solutions will converge upon widely accessible integrated instrumentation solutions that merge preparation, detection, and data interpretation capabilities in a seamless platform remains to be seen. However, molecular detection techniques will likely continue to simplify and increase the speed of detection procedures while simultaneously improving the sensitivity and specificity required for tracking pathogens in environmental, clinical, and food matrices.
Molecular Detection: Principles and Methods
Acknowledgments The authors wish to thank J. Barak, M. Borucki, D. Flaherty, W. Miller and J. Palumbo for helpful discussions and advice.
References
1. WHO, Food safety and foodborne illness, http://www.who. int/mediacentre/factsheets/fs237/en/index.html) 2007. 2. Mead, P.S. et al. Food-related illness and death in the United States. Emerg. Infect. Dis., 5, 607, 1999. 3. Stein, C. et al. The global burden of disease assessments— WHO is responsible? PLoS Neg. Trop. Dis., 1, 1, 2007. 4. Todd, E.C.D. Challenges to global surveillance of disease patterns. Mar. Poll. Bull., 53, 569, 2006. 5. Batt, C.A. Food pathogen detection. Science, 316, 1579, 2007. 6. Wilson, I.G. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol., 63, 3741, 1997. 7. Rossen, L. et al. Inhibition of PCR by components of food samples, microbial diagnostic assays and DNA-extraction solutions. Int. J. Food Microbiol., 17, 37, 1992. 8. Powell, H.A. et al. Proteinase inhibition of the detection of Listeria monocytogenes in milk using the polymerase chain reaction. Lett. Appl. Microbiol., 18, 59, 1994. 9. Kreader, C.A. Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein. Appl. Environ. Microbiol., 62, 1102, 1996. 10. Al-Soud, W.A. and Rådström, P. Capacity of nine thermostable DNA polymerases to mediate DNA amplification in the presence of PCR-inhibiting samples. Appl. Environ. Microbiol., 64, 3748, 1998. 11. Lantz, P.-G., Hahn, H.B. and Rådström, P. Sample preparation methods in PCR-based detection of food pathogens. Trends Food Sci. Technol., 5, 384, 1994. 12. Lampel, K.A., Orlandi, P.A. and Kornegay, L. Improved template preparation for PCR-based assays for detection of foodborne bacterial pathogens. Appl. Environ. Microbiol., 66, 4539, 2000. 13. Csako, G. Present and future of rapid and/or high-throughput methods for nucleic acid testing. Clin. Chim. Acta, 363, 6, 2006. 14. Olsen, J.E. et al. Probes and polymerase chain reaction for detection of food-borne bacterial pathogens. Int. J. Food Microbiol., 28, 1, 1995. 15. Monis, P.T. and Giglio, S. Nucleic acid amplification-based techniques for pathogen detection and identification. Inf. Gen. Evol., 6, 2, 2006. 16. Harris, L.J. and Griffiths, M.W. The detection of foodborne pathogens by the polymerase chain reaction (PCR). Food Res. Int., 25, 457, 1992. 17. Saiki, R.K. et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230, 1350, 1985. 18. Mullis, K. et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol., 51, 263, 1986. 19. Saiki, R.K. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487, 1988. 20. Kellogg, D.E. et al. TaqStart antibody: “Hot Start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques, 16, 1134, 1994.
15 21. Higuchi, R. et al. Simultaneous amplification and detection of specific DNA sequences. Biotechniques, 10, 413, 1992. 22. Higuchi, R. et al. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechniques. 11, 1026, 1993. 23. Ririe, K.M., Rasmussen, R.P. and Wittwer, C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem., 245, 154, 1997. 24. Rutledge, R.G. and Côté, C. Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acid. Res., 31, e93, 2003. 25. Ginzinger, D.G. Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp. Hematol., 30, 503, 2002. 26. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res., 29, 2002, 2001. 27. Kwok, S. and Higuchi, R. Avoiding false positives with PCR. Nature, 339, 237, 1989. 28. Longo, M.C., Berninger, M.S. and Hartley, J.L. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reaction. Gene, 93, 125, 1990. 29. Wittwer, C.T., Reed, G.B. and Ririe, K.M. Rapid cycle DNA amplification. In The Polymerase Chain Reaction, Mullis, K.B., Ferré, F. and Gibbs, R.A. (eds.). Birkhauser, Boston, 1994. 30. Glynn, B. et al. Current and emerging molecular diagnostic technologies applicable to bacterial food safety. Int. J. Dairy Technol., 59, 126, 2006. 31. Hoorfar, J. et al. Diagnostic PCR: making internal amplification control mandatory. J. Appl. Microbiol., 96, 221, 2003. 32. Wang, R.-F., Cao, W.-W. and Cerniglia, C.E. A universal protocol for PCR detection of 13 species of foodborne pathogens in foods. J. Appl. Micorbiol., 83, 727, 1997. 33. Logan, J.M.J. and Edwards, K.J. An overview of real-time PCR platforms. In Real-Time PCR An Essential Guide, Edwards, K., Logan, J. and Saunders, N. (eds.). Horizon Bioscience, London, 2004. 34. Kubista, M. et al. The real-time polymerase chain reaction. Mol. Asp. Med., 27, 97, 2006. 35. Levin, R.E. The application of real-time PCR to food and agricultural systems. A review. Food Biotechnol., 18, 97, 2004. 36. Mackay, I.M. Real-time PCR in the microbiology laboratory. Clin. Microbiol. Infect., 10, 190, 2004. 37. Zhang, T. and Fang, H.H.P. Applications of real-time polymerase chain reaction for quantification of microorganisms in environmental samples. Appl. Microbiol. Biotechnol., 70, 281, 2006. 38. Reynisson, E. et al. Evaluation of probe chemistries and platforms to improve the detection limit of real-time PCR. J. Microbiol. Methods, 66, 2006, 2006. 39. Li, W. et al. Complex DNA melting profiles of small PCR products revealed using SYBR Green I. Biotechniques, 35, 702, 2003. 40. Alarcón, B., Vicedo, B. and Aznar, R. PCR-based procedures for detection and quantification of Staphylococcus aureus and their application in food. J. Appl. Microbiol., 100, 352, 2006. 41. Delibato, E. et al. Development of a SYBR green real-time PCR and a multichannel electrochemical immunosensor for specific detection of Salmonella enterica. Anal. Lett., 39, 1611, 2006.
16 42. Hsu, C.-F., Tsai, T.-Y. and Pan, T.-M. Use of the duplex TaqMan PCR system for detection of shiga-like toxinproducing Escherichia coli O157:H7. J. Clin. Microbiol., 43, 2668, 2005. 43. Liu, Y. et al. Real time PCR using TaqMan and SYBR green for detection of Enterobacter sazakii in infant formula. J. Microbiol. Methods, 65, 21, 2006. 44. Vishnubhatla, A. et al. Rapid 5′-nuclease (TaqMan) assay for detection of virulent strains of Yersinia enterocolitica. Appl. Enviorn. Microbiol., 66, 4131, 2000. 45. Wu, V., Fung, D. and Oberst, R. Evaluation of a 5′-nuclease (TaqMan) assay with the thin layer oxyrase method for the detection of Yersinia enterocolitica in ground pork samples. J. Food Prot., 67, 271, 2004. 46. Tyagi, S. and Kramer, F.R. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol., 14, 303, 1996. 47. Goel, G. et al. Molecular beacon: a multitask probe. J. Appl. Microbiol., 99, 435, 2005. 48. Vet, J.A.M. et al. Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc. Natl. Acad. Sci. USA, 96, 6394, 1999. 49. Gubala, A.J. and Proll, D.F. Molecular-beacon multiplex real-time PCR assay for detection of Vibrio cholerae. Appl. Environ. Microbiol., 72, 6424, 2006. 50. Nazarenko, I. et al. Multiplex quantitative PCR using selfquenched primers labeled with a single fluorophore. Nucleic Acids Res., 30, e37, 2002. 51. Nordgren, J. et al. Novel light-upon-extension real-time PCR assays for detection and quantification of genogroup I and II noroviruses in clinical specimens. J. Clin. Microbiol., 46, 164, 2008. 52. Hanna, S.E., Connor, C.J. and Wang, H.H. Real-time polymerase chain reaction for the food microbiologist: technologies, applications, and limitations. J. Food Sci., 70, R49, 2005. 53. Bleve, G. et al. Development of reverse transcription (RT)-PCR and real-time RT-PCR assays for rapid detection and quantification of viable yeasts and molds contaminating yogurts and pasteurized food products. Appl. Envrion. Microbiol., 69, 4116, 2003. 54. Sheridan, G.E.C. et al. Detection of mRNA by reverse transcription-PCR as an indicator of viability of E. coli cells. Appl. Environ. Microbiol., 64, 1313, 1998. 55. Klein, P.G. and Juneja, V.K. Sensitive detection of viable Listeria monocytogenes by reverse transcription-PCR. Appl. Environ. Microbiol., 63, 4441, 1997. 56. Cliver, D.O. Detection and control of foodborne viruses. Trends Food Sci. Technol., 6, 353, 1995. 57. Lu, Y.Y. et al. Rapid detection of H5 avian influenza virus by TaqMan-MGB real-time RT-PCR. Lett. Appl. Microbiol., 46, 20, 2008. 58. Gilbert, C. et al. Development of a triplex PCR assay for the specific detection of Campylobacter jejuni, Salmonella spp., and Escherichia coli O157:H7. Mol. Cell. Probes, 17, 135, 2003. 59. Markoulatos, P., Siafakas, N. and Moncany, M. Multiplex polymerase chain reaction: a practical approach. J. Clin. Lab. Anal., 16, 47, 2002. 60. Settanni, L. and Corsetti, A. The use of multiplex PCR to detect and differentiate food- and beverage-associated microorganisms: a review. J. Microbiol. Methods, 69, 1, 2007. 61. Liu, D. et al. A multiplex PCR for species- and virulencespecific determination of Listeria monocytogenes. J. Microbiol. Methods, 71, 133, 2007.
Molecular Detection of Foodborne Pathogens 62. Brasher, C.W. et al. Detection of microbial pathogens in shellfish with multiplex PCR. Curr. Microbiol., 37, 101, 1998. 63. Kong, R.Y.C. et al. Rapid detection of six types of bacterial pathogens in marine waters by multiplex PCR. Wat. Res., 36, 2802, 2002. 64. Lee, C.-Y., Panicker, G. and Bej, A.K. Detection of pathogenic bacteria in shellfish using multiplex PCR followed by CovaLinkTM NH microwell plate sandwich hybridization. J. Microbiol. Methods, 53, 199, 2003. 65. Park, S.-H., Kim, H.-J. and Kim, H.-Y. Simultaneous detection of Yersinia enterocolitica, Staphylococcus aureus, and Shigella spp. in lettuce using multiplex PCR method. J. Microbiol. Biotechol., 16, 1301, 2006. 66. Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acid. Res., 28, e63, 2000. 67. Compton, J. Nucleic acid based sequence amplification. Nature, 350, 91, 1991. 68. Fire, A. and Xu, S.-Q., Rolling replication of short DNA circles. Proc. Natl. Acad. Sci. USA, 92, 4641, 1995. 69. Walker, T.G. et al. Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system. Proc. Natl. Acad. Sci. USA, 89, 392, 1992. 70. Jean, J. et al. Detection of hepatitis A virus by the nucleic acid sequence-based amplification technique and comparison with reverse transcription-PCR. Appl. Environ. Microbiol., 67, 5593, 2001. 71. Rodríguez-Lázaro, D. et al. Application of nucleic acid sequence-based amplification for the detection of viable foodborne pathogens: progress and challenges. J. Rapid Methods Auto. Microbiol., 14, 218, 2006. 72. Fyske, E.M. et al. Detection of Vibrio cholerae by real-time nucleic acid sequence-based amplification. Appl. Environ. Microbiol., 73, 1457, 2007. 73. El Galil, K.H.A. et al. Real-time nucleic-acid sequence based amplification assay for detection of hepatitis A virus. Appl Environ Microbiol., 71, 7113, 2005. 74. Wang, L. et al. Specific and rapid detection of foodborne Salmonella by loop-mediated isothermal amplification method. Food Res. Int., 41, 69, 2008. 75. Liu, D.K. et al. Comparative evaluation of microarray analysis software. Mol. Biotech. 26, 225, 2004. 76. Call, D.R., Borucki, M.K. and Loge, F.J. Detection of bacterial sample in environmental samples using DNA microarrays. J. Microbiol. Methods, 53, 235, 2003. 77. Vora, G.J. et al. Nucleic acid amplification strategies for DNA microarray-based pathogen detection. Appl. Environ. Microbiol., 70, 3047, 2004. 78. Wilson, W.J. et al. Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. Mol. Cell. Probes, 16, 119, 2002. 79. Amann, R., Fuchs, B.M. and Behrens, S. The identification of microorganisms by fluorescene in situ hybridization. Curr. Op. Biotechol., 12, 231, 2001. 80. Oliveira, M. et al. Development of a fluorescent in situ hybridization protocol for the rapid detection and enumeration of Listeria monocytogenes in milk. J. Food Safety, 98, 119, 2003. 81. Bonwick, G.A. and Smith, C.J. Immunoassays: their history, development and current place in food science and technology. Int. J. Food Sci. Technol., 39, 817, 2004. 82. Notermans, S. and Wernars, K. Immunological methods for detection of foodborne pathogens and their toxins. Int. J. Food Microbiol., 12, 91, 1991.
Molecular Detection: Principles and Methods 83. Muhammad-Tahir, Z. and Alocilja, E.C., A conductometric biosensor for biosecurity. Biosens. Bioelect., 18, 813, 2003. 84. Rose, J.B. et al. Evaluation of immunofluorescence techniques for detection of Cryptosporidium oocysts and Giardia cysts from environmental samples. Appl. Environ. Microbiol., 55, 3189, 1989. 85. Homola, J. and Piliarik, M. Surface plasmon resonance based sensors. In Springer Series on Chemical Sensors and Biosensors, Homola, J. (ed). Springer-Verlag, Berlin, 2006. 86. Koubová, V. et al. Detection of foodborne pathogens using surface plasmon resonance biosensors. Sensors Actuators B: Chemical, 74, 100, 2001. 87. Veal, D.A. et al. Fluorescence staining and flow cytometry for monitoring microbial cells. J. Immunol. Methods, 243, 191, 2000. 88. Proske, D. et al. Aptamers—basic research, drug development, and clinical applications, Appl. Microbiol. Biotechol., 69, 367, 2005. 89. Hoorfar, J., Baggesen, D.L. and Porting, P.H. A PCR based strategy for simple and rapid identification of rough presumptive Salmonella isolates. J. Microbiol. Methods, 35, 77, 1999. 90. Rabenau, H.F. et al. Laboratory diagnostics of Norovirus: which method is the best? Intervirology, 46, 232, 2003. 91. Sano, T., Smith, C.L. and Cantor, C.R. Immuno-PCR: very sensitive antigen detection by means of specific antibodyDNA conjugates. Science, 258, 120, 1992. 92. Niemeyer, C.M., Adler, M. and Wacker, R. Immuno-PCR: High sensitivity detection of proteins by nucleic acid amplification. Trends Biotechol., 23, 208, 2005. 93. Tian, P. and Mandrell, R. Detection of Norovirus capsid proteins in faecal and food samples by a real-time immuno PCR method. J. Appl. Microbiol., 100, 564, 2006. 94. Lukinmaa, S. et al. Application of molecular genetic methods in diagnostics and epidemiolgoy of food-borne bacterial pathogens. APMIS, 112, 908, 2004. 95. Schwartz, D.C. and Cantor, C.R. Separation of yeast chromosome-sized DNAs by pulsed field gel electrophoresis. Cell, 37, 67, 1984. 96. Wong, H.-C. et al. A pulsed-field gel electrophoresis typing scheme for Vibrio parahaemolyticus isolates from 15 countries. Int. J. Food Microbiol., 114, 280, 2007. 97. Hardt, S. and Schönfeld, F. Microfluidics: fundamentals and engineering concepts. In Microfluidic Technologies for Miniaturized Analysis Systems, Hardt, S. and Schönfeld, F. (eds). Springer, New York, 2007. 98. Münchow, G. and Drese, K.-S. Nucleic acid amplification in microsystems. In Microfluidic Technologies for Miniaturized Analysis Systems, Hardt, S. and Schönfeld, F. (eds). Springer, New York, 2007. 99. Belgrader, P. et al. Rapid pathogen detection using a microchip PCR array instrument. Clin. Chem., 44, 2191, 1998. 100. Neuzil, P. et al. Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes. Nucleic Acid. Res., 34, e77, 2006. 101. Rosi, N.L. and Mirkin, C.A. Nanostructures in biodiagnostics. Chem. Rev., 105, 1547, 2005. 102. Braun, G. et al. Surface-enhanced Raman spectroscopy for DNA detection by nanoparticle assembly onto smooth metal films. J. Am. Chem. Soc., 129, 6378, 2007. 103. Hutter, E. and Pileni, M.-P. Detection of DNA hybridization by gold nanoparticle enhanced transmission surface plasmon resonance spectroscopy. J. Phys. Chem., 107, 6497, 2003.
17 104. Jayasena, S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem., 45, 1628, 1999. 105. Tombelli, S., Minunni, M. and Mascini, M. Aptamers-based assays for diagnostics, environmental and food analysis. Biomol. Eng., 24, 191, 2007. 106. Jenkins, D.M. et al. Hybridization probe for femtomolar quantification of selected nucleic acid sequences on a disposable electrode. Anal. Chem., 78, 2314, 2006. 107. Xiao, Y. et al. Label-free electrochemical detection of DNA in blood serum via target-induced resolution of an electrodebound DNA pseudoknot. J. Am. Chem. Soc.,129, 11896, 2007. 108. Lai, R.Y. et al. Rapid, sequence-specific detection of unpurified PCR amplicons via a reusable, electrochemical sensor. Proc. Natl. Acad. Sci. USA, 103, 4017, 2006. 109. Rychlik, W. and Rhoads, R.E. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing, and in vitro amplification of DNA. Nucleic Acids Res., 17, 8543, 1989. 110. Drake, J.W. and Holland, J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA, 96, 13910, 1999. 111. Elena, S.F. and Sanjuán, R. Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J. Virol., 79, 11555, 2005. 112. Day, J.M., Spackman, E. and Pantin-Jackwood, M. A multiplex RT-PCR test for the differential identification of turkey astrovirus type 1, turkey astrovirus type 2, chicken astrovirus, avian nephritis virus, and avian rotavirus. Avian Dis., 51, 681, 2007. 113. Pina, S. et al. Viral pollution in the environment and in shellfish: human Adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol., 64, 3376, 1998. 114. Jiang, X., Wang, J. and Estes, M.K. Characterization of SRSVs using RT-PCR and a new antigen ELISA. Arch. Virol., 140, 363, 1995. 115. Chan, M.C.W. et al. Sapovirus detection by quantitative realtime RT-PCR in clinical stool specimens. J. Virol. Methods, 134, 146, 2006. 116. Jansen, R.W., Siegl, G. and Lemon, S.M. Molecular epidemiology of human hepatitis A virus defined by an antigencapture polymerase chain reaction method. Proc. Natl. Acad. Sci. USA, 87, 2867, 1990. 117. Papafragkou, E. et al. Rapid and sensitive detection of hepatitis A virus in representative food matrices. J. Virol. Methods, 147, 177, 2008. 118. Jean, J. et al. Simultaneous detection and identification of hepatitis A virus and rotavirus by multiplex nucleic acid sequence-based amplification (NASBA) and microtiter plate hybridization system. J. Virol. Methods, 105, 123, 2002. 119. Saito, H. et al. Application of RT-PCR designed from the sequence of the local SRSV strain to the screening in viral gastroenteritis outbreaks. Microbiol. Immunol., 42, 439, 1998. 120. Jonassen, C.M. et al. Comparison of capsid sequences from human and animal astroviruses. J. Gen. Virol., 82, 1061, 2001. 121. Jiang, B. et al. Sequence conservation and expression of the gene encoding the outer capsid glycoprotein among human group C rotaviruses of global distribution. Arch. Virol., 141, 381, 1996. 122. Atmar, R.L. et al. Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl. Environ. Microbiol., 69, 631, 1993.
18 123. Sánchez, G. et al. Hepatitis A virus. In Methods in Molecular Biology, Spencer, J.F.T. and Ragout de Spencer, A.L. (eds). Humana Press, Inc., Totowa, NJ, 2004. 124. Kämmerer, U., Kunkel, B. and Korn, K. Nested PCR for specific detection and rapid identification of human Picornaviruses. J. Clin. Microbiol., 32, 285, 1994. 125. Rivera, V.M., Welsh, J.D. and Maizel, J.V. Jr. Comparative sequence analysis of the 5′ noncoding region of the Enteroviruses and Rhinoviruses. Virology, 165, 42, 1988. 126. Ng, L.F.P. et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect. Dis., 6, 40, 2006. 127. Royuela, R., Negredo, A. and Sánchez-Fauquier, A. Development of a one step real-time RT-PCR method for sensitive detection of human astrovirus. J. Virol. Methods, 133, 14, 2006. 128. Woese, C. Bacterial evolution. Microbiol. Rev., 51, 221, 1987. 129. Sogin, M.L. and Silberman, J.D. Evolution of the protists and protistan parasites from the perspective of molecular systematics. Int. J. Parasitol., 28, 11, 1998. 130. Rudi, K. et al. Rapid identification and classification of bacteria by 16S rDNA restriction fragment melting curve analyses. Food Microbiol., 24, 474, 2007. 131. Jensen, M.A., Webster, J.A. and Straus, N. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol., 59, 945, 1993. 132. Santín, M., Trout, J.M. and Fayer, R. Prevalence of Enterocytozoon bieneusi in post-weaned dairy calves in the eastern United States. Parasitol. Res., 93, 287, 2004. 133. Dzikowski, R. et al. Use of rDNA polymorphism for identification of Heterophyidae infecting freshwater fishes. Dis. Aquat. Organ., 59, 35, 2004. 134. Gómez-Couso, H. et al. Detection of Cryptosporidium and Giardia in molluscan shellfish by multiplexed nested-PCR. Int. J. Food Microbiol., 91, 279, 2004. 135. Nazar, R.N. et al. Potential use of PCR-amplified ribosomal intergenic sequences in the detection and differentiation of verticillium wilt pathogens. Physiol. Mol. Plant Pathol., 39, 1, 1991. 136. Molander, A. et al. A protocol for polymerase chain reaction detection of Entercoccus faecalis and Enterococcus faecium from the root canal. Int. Endodon. J., 35, 1, 2002. 137. Schmidt-Heydt, M. and Geisen, R. A microarray for monitoring the production of mycotoxins in foods. Int. J. Food Microbiol., 117, 131, 2007. 138. Kusaba, M. and Tsuge, T. Phylogeny of Alternaria fungi known to produce host-specific toxins on the basis of variation in internal transcribed spacers of ribosomal DNA. Curr. Genet., 28, 491, 1995. 139. Zur, G. et al. Detection of Alternaria fungal contamination in cereal grains by a polymerase chain reaction-based assay. J. Food Prot., 65, 1433, 2002. 140. Rochelle, P.A. et al. Comparison of primers and optimization of PCR conditions for detection of Cryptosporidium parvum and Giardia lamblia in water. Appl. Environ. Microbiol., 63, 106, 1997. 141. Fletcher, L.D. et al. Structure, expression and phylogenetic analysis of the gene encoding actin I in Pneumocystic carinii. Genetics, 137, 743, 1994. 142. Schroeder, S. et al. The β-tubulin gene is a useful target for PCR-based detection of an albino Ophiostoma piliferum used in biological control of sapstain. Eur. J. Plant Pathol., 108, 793, 2002.
Molecular Detection of Foodborne Pathogens 143. Morello, L.G. et al. Detection and quantification of Aspergillus westerdijkiae in coffee beans based on selective amplification of β-tubulin gene by using real-time PCR. Int. J. Food Microbiol., 119, 270, 2007. 144. Mahbubani, M.H. et al. Detection of Giardia in environmental waters by immuno-PCR amplification methods. Curr. Microbiol., 36, 107, 1998. 145. Guy, R.A. et al. Real-time PCR for quantification of Giardia and Cryptosporidium in environmental water samples and sewage. Appl. Environ. Microbiol., 69, 5178, 2003. 146. Hacker, J. and Kaper, J.B. Pathogenicity islands and the evolution of microbes. Ann. Rev. Microbiol., 54, 641, 2000. 147. Gasanov, U., Hughes, D. and Hansbro, P.M. Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: a review. FEMS Microbiol. Rev., 29, 851, 2005. 148. Villalobo, E. and Torres, A. PCR for detection of Shigella spp. in mayonnaise. Appl. Environ. Microbiol., 64, 1242, 1998. 149. Panicker, G. et al. Detection of pathogenic Vibrio spp. in shellfish by using multiplex PCR and DNA microarrays. Appl. Environ. Microbiol., 70, 7436, 2004. 150. Panicker, G., Myers, M.L. and Bej, A.K. Rapid detection of Vibrio vulnificus in shellfish and Gulf of Mexico water by real-time PCR. Appl. Environ. Microbiol., 70, 498, 2004. 151. Bej, A.K. et al. Detection of total and hemolysin-producing Vibrio parahaemolyticus in shellfish using multiplex PCR amplification of tl, tdh, and trh. J. Microbiol. Methods, 36, 215, 1999. 152. Kingombe, C.I.B. et al. PCR detection, characterization, and distribution of virulence genes in Aeromonas spp. Appl. Environ. Microbiol., 65, 5293, 1999. 153. Wannet, W.J.B. et al. Detection of pathogenic Yersinia enterocolitica by a rapid and sensitive duplex PCR assay. J. Clin. Microbiol., 39, 4483, 2001. 154. Wang, G. et al. Detection and characterization of the hemoloysin genes in Aeromonas hydrophila and Aeromonas sobria by multiplex PCR. J. Clin. Microbiol., 41, 1048, 2003. 155. Blaiotta, G. et al. PCR detection of staphylococcal enterotoxin genes in Staphylococcus spp. strains isolated from meat and dairy products. Evidence for new variants of seG and seI in S. aureus AB-8802. J. Appl. Microbiol., 97, 719, 2004. 156. Fricker, M. et al. Diagnostic real-time PCR assays for the detection of emetic Bacillus cereus strains in foods and recent foodborne outbreaks. Appl. Environ. Microbiol., 73, 1892, 2007. 157. Yoon, S.-Y. et al. Application of real-time PCR for quantitative detection of Clostridium botulinum type A toxin gene in food. Microbiol. Immunol., 49, 505, 2005. 158. Andersen, B. et al. Real-time PCR quantificaton of the AM-toxin gene and HPLC qualification of toxigenic metabolites from Alternaria species from apples. Int. J. Food Microbiol., 111, 105, 2006. 159. Shapira, R. et al. Detection of aflatoxigenic molds in grains by PCR. Appl. Environ. Microbiol., 62, 3270, 1996. 160. Mayer, Z. et al. Quantification of the copy number of nor-1, a gene of the aflatoxin biosynthetic pathway by real-time PCR, and its correlation to the cfu of Aspergillus flavus in foods. Int. J. Food Microbiol., 82, 143, 2003. 161. Bluhm, B.H., Cousin, M.A. and Woloshuk, C.P. Multiplex real-time PCR detection of fumonisin-producing and trichothecene-producing groups of Fusarium species. J. Food Prot., 67, 536, 2004. 162. Geisen, R. et al. Development of a real time PCR system for detection of Penicillium nordicum and for monitoring ochratoxin A production in foods by targeting the ochratoxin polyketide synthase gene. System. Appl. Microbiol., 27, 501, 2004.
Molecular Detection: Principles and Methods 163. Samosornsuk, W. et al. Evaluation of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the identification of Campylobacter strains isolated from poultry in Thailand. Microbiol. Immunol., 51, 909, 2007. 164. Chen, S. et al. An automated fluorescent PCR method for detection of shiga toxin-producing Escherichia coli in foods. Appl. Environ. Microbiol., 64, 4210, 1998. 165. Cebula, T.A., Payne, W.L. and Feng, P. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. Appl. Environ. Microbiol., 33, 248, 1995. 166. Alarcón, B., Vicedo, B. and Aznar, R. PCR-based procedures for detection and quantification of Staphylococcus aureus and their application in food. J. Appl. Microbiol., 100, 352, 2006. 167. Barkstad, O.G., Aasbakk, K. and Maeland, J.A. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol., 30, 1654, 1992. 168. Bogdanovich, T. et al. Validated 5’ nuclease PCR assay for rapid identification of the genus Brucella. J. Clin. Microbiol., 42, 2261, 2004. 169. Novak, R.T. et al. Development and evaluation of a realtime PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J. Clin. Microbiol., 44, 85, 2006. 170. Ercolini, D. et al. Simultaneous detection of Pseudomonas fragi, P. lundensis, and P. putida from meat by use of a multiplex PCR assay targeting the carA gene. Appl. Environ. Microbiol., 73, 2354, 2007. 171. Kim, J. et al. Simultaneous detection by PCR of Escherichia coli, Listeria monocytogenes, and Salmonella typhimurium in artificially inoculated wheat grain. Int. J. Food Microbiol., 111, 21, 2006. 172. McDaniels, A.E. et al. Confirmational identification of Escherichia coli, a comparison of genotypic and phenotypic assays for glutamate decarboxylase and β-D-glucuronidase. Appl. Environ. Microbiol., 62, 3350, 1996. 173. Bäumler, A.J., Heffron, F. and Reissbrodt, R. Rapid detection of Salmonella enterica with primers specific for iroB. J. Clin. Microbiol., 35, 1224, 1997. 174. Soumet, C. et al. An immunoconcentration-PCR assay to detect Salmonella in the environment of poultry houses. Int. J. Food Microbiol., 48, 221, 1999. 175. Hill, J.E., Town, J.R. and Hemmingsen, S.M. Improved template representation in cpn 60 polymerase chain reaction (PCR) product libraries generated from complex templates by application of a specific mixture of PCR primers. Environ. Microbiol., 8, 741, 2006. 176. Erickson, B.D. et al. Nucleotide sequence of the rpsU-dnaGrpoD operon from Salmonella typhimurium and a comparison of this sequence with the homologous operon of Escherichia coli. Gene, 40, 67, 1985. 177. Versalovic, J. et al. Conservation and evolution of the rpsUdnaG-rpoD macromolecular synthesis operon in bacteria. Mol. Microbiol., 8, 343, 1993. 178. Seo, K.H. and Brackett, R.E. Rapid, specific detection of Enterobacteri sakazakii in infant formular using a real-time PCR assay. J. Food Prot., 68, 59, 2005. 179. Lin, M.-H. et al. Real-time PCR for quantitiative detection of Toxoplasma gondii. J. Clin. Microbiol., 38, 4121, 2000. 180. Burg, J.L. et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol., 27, 1787, 1989.
19 181. Faubert, G. Immune response to Giardia duodenalis. Clin. Microbiol. Rev., 13, 35, 2000. 182. Wonratanacheewin, S. et al. Development of a PCR-based method for the detection of Opisthorchis veverrini in experimentally infected hamsters. Parasitology, 122, 175, 2001. 183. Parvathi, A. et al. Clonorchis sinensis: development and evaluation of a nested polymerase chain reaction (PCR) assay. Exp. Parasitol., 115, 291, 2007. 184. Kaplan, R.M. et al. A repetitive DNA probe for the sensitive detection of Fasciola hepatica in infected snails. Int. J. Parasitol., 25, 601, 1995. 185. Maleewong, W. et al. Detection of Paragonimus heterotremus in experimentally infected cat feces by antigen captureELISA and by DNA hybridization. J. Parasitol., 83, 1075, 1997. 186. González, L.M. et al. Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J. Clin. Microbiol., 38, 737, 2000. 187. Pillai, S.R. and Jayarao, B.M. Application of IS900 PCR for detection of Mycobacterium avium subsp. paratuberculosis directly from raw milk. J. Dairy Sci., 85, 1052, 2002. 188. Ravva, S.V. and Stanker, L. H. Real-time quantitative PCR detection of Mycobacterium avium subsp. paratuberculosis and differentiation from other mycobacteria using SYBR green and TaqMan assays. J. Microbiol. Methods, 63, 305, 2005. 189. Bull, T.J. et al. Characterization of IS900 loci in Mycoba cterium avium subsp. paratuberculosis and development of multiplex PCR typing. Microbiology 146, 2185, 2000. 190. O’Leary, S., Sheahan, M. and Sweeney, T. Brucella abortus detection by PCR assay in blood, milk and lymph tissue of serologically positive cows. Res. Vet. Sci., 81, 170, 2006. 191. Boore, J.L. Animal mitochondrial genomes. Nucleic Acid Res., 27, 1767, 1999. 192. Le, T.H., Blair, D. and McManus, D.P. Mitochondrial DNA sequences of human schistosomes: the current status. Int. J. Parasitol., 30, 283, 2000. 193. López, V. et al. A simplified procedure to analyse mitochondrial DNA from industrial yeasts. Int. J. Food Microbiol., 68, 75, 2001. 194. Le, T.H. et al. Clonorchis sinensis and Opisthorchis viverrini: development of a mitochondiral-based multiplex PCR for their identification and discrimination. Exp. Parasitol., 112, 109, 2006. 195. Kim, K.-H. et al. Characterization of the complete mitochondrial genome of Diphyllobothrium nihonkaiense (Diphyllobothriidae: Cestoda) and development of molecular markers for differentiating fish tapeworms. Mol. Cells, 23, 379, 2007. 196. Cucher, M.A. et al. PCR diagnosis of Fasciola hepatica in field-collected Lymnaea columella and Lymnaea viatrix snails. Vet. Parasitol., 137, 74, 2006. 197. Marois, C. et al. Multiplex PCR assay for detection of Streptococcus suis species serotypes 2 and 1/2 in tonsils of live and dead pigs. J. Clin. Microbiol., 42, 3169, 2004. 198. Wisselink, H.J., Joosten, J.J. and Smith, H.E. Multiplex PCR assays for simultaneous detection of six major serotypes and two virulence-associated phenotypes of Streptococcus suis in tonsillar specimens from pigs. J. Clin. Microbiol., 40, 2922, 2002. 199. Morin, N.J., Gong, Z. and Li, X.-F. Reverse transcription-multiplex PCR assay for simultaneous detection of Escherichia coli O157:H7, Vibro cholerae O1, and Salmonella typhi. Clin. Chem., 50, 2037, 2004.
20 200. Harmon, K.M., Ransom, G.M. and Wesley, I.V. Differentiation of Campylobacter jejuni and Campylobacter coli by polymerase chain reaction. Mol. Cell. Probes, 11, 195, 1997. 201. Gannon, V.P.J. et al. Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterhemorrhagic Escherichia coli strains. J. Clin. Microbiol., 35, 656, 1997. 202. Hussain, M. et al. eap gene as novel target for specific identification of Staphylococcus aureus. J. Clin. Microbiol., 46, 470, 2008. 203. Imaoka, K. et al. Simultaneous detection of the genus Brucella by combinatorial PCR. Jpn. J. Infect. Dis., 60, 137, 2007. 204. Tantillo, G.M., Di Pinto, A. and Buonavoglia, C. Detection of Brucella spp. in soft cheese by semi-nested polymerase chain reaction. J. Dairy Res., 70, 245, 2003.
Molecular Detection of Foodborne Pathogens 205. Mayta, H. et al. Nested PCR for specific diagnosis of Taenia solium taeniasis. J. Clin. Microbiol., 46, 286, 2008. 206. Laberge, I. et al. Detection of Cryptosporidium parvum in raw milk by PCR and oligonucleotide probe hybridization. Appl. Environ. Microbiol., 62, 3259, 1996. 207. Wiedenmann, A., Krüger, P. and Botzenhart, K. PCR detection of Cryptosporidium parvum in environmental samples--a review of published protocols and current developments. J. Ind. Microbiol. Biotechnol., 21, 150, 1998. 208. Josefsen, M.H. et al. Validation of a PCR-based method for detection of food-borne thermotolerany Campylobacters in a multicenter collaborative trial. Appl. Environ. Microbiol., 70, 4379, 2004. 209. Feng, P. Impact of molecular biology on the detection of foodborne pathogens. Mol. Biotechnol., 7, 267, 1997.
Section I Foodborne Viruses
2 Adenoviruses Charles P. Gerba
University of Arizona
Roberto A. Rodríguez
University of North Carolina
Contents 2.1 Introduction......................................................................................................................................................................... 23 2.1.1 Classification and Morphology................................................................................................................................ 23 2.1.2 Biology, Pathogenesis, and Medical Importance..................................................................................................... 24 2.1.2.1 Gastroenteritis........................................................................................................................................... 25 2.1.2.2 Respiratory Infections............................................................................................................................... 25 2.1.2.3 Pharyngoconjunctival Fever (PCF)........................................................................................................... 25 2.1.2.4 Eye Infections............................................................................................................................................ 25 2.1.2.5 Obesity...................................................................................................................................................... 25 2.1.2.6 Morbidity and Mortality............................................................................................................................ 25 2.1.2.7 Impact on the Immunocompromised........................................................................................................ 25 2.1.2.8 Water- and Foodborne Outbreaks............................................................................................................. 25 2.1.2.9 Occurrence in Water................................................................................................................................. 26 2.1.2.10 Occurrence in Shellfish............................................................................................................................. 26 2.1.2.11 Survival in the Environment and Shellfish............................................................................................... 26 2.1.3 Identification and Diagnosis.................................................................................................................................... 27 2.1.3.1 Culture-Based Techniques........................................................................................................................ 27 2.1.3.2 Antibody-Based Methods.......................................................................................................................... 27 2.1.3.3 Nucleic Acid Probes.................................................................................................................................. 27 2.1.3.4 PCR-Based Techniques............................................................................................................................. 27 2.1.3.5 Integrated Techniques............................................................................................................................... 27 2.2 Methods............................................................................................................................................................................... 28 2.2.1 Sample Preparation.................................................................................................................................................. 28 2.2.2 Detection Procedures............................................................................................................................................... 29 2.3 Conclusions and Future Perspectives.................................................................................................................................. 30 References.................................................................................................................................................................................... 31
2.1 Introduction The potential for the transmission of adenoviruses by foods has only recently received attention and has been almost entirely focused on shellfish. Transmission of adenovirus eye and respiratory infections by recreational waters, however, has been well documented. Recent outbreaks have suggested that adenoviruses can also be transmitted by drinking water. Association of adenoviruses with water and food outbreaks is difficult because of the wide variety of illnesses that the viruses can cause, and of large number of asymptomatic cases. This is exacerbated by the fact that being a nonreportable disease, adenovirus infection is often associated with illnesses not considered foodborne (respiratory infections). Still occurrence of these viruses in food and water should be taken as an indication of their potential to be transmitted by
these routes. The application of molecular methods has been key in our understanding of exposure by food and water.
2.1.1 Classification and Morphology The human adenoviruses belong to the genus Mastadenovirus in the family Adenoviridae and consist of at least 51 serotypes. These serotypes are divided into six subgenera labeled A through F. Each serotype is distinguished by its resistance to neutralization by antisera to other known adenovirus serotypes.1 Table 2.1 outlines the current classification scheme for human adenovirus serotypes. Adenoviruses have a nonenveloped, icosahedral virion that consists of a core containing linear double-stranded DNA (26–45 kb) enclosed by a capsid.2 The capsid is composed of 252 capsomers, 240 of which are hexons and 12 of which 23
24
Molecular Detection of Foodborne Pathogens
are pentons. Each penton projects a single fiber that varies in length for each serotype, an exception being the pentons of the enteric adenoviruses (serotypes 40 and 41) that project two fibers.1 Adenoviruses are approximately 70–100 nm in diameter.
2.1.2 Biology, Pathogenesis, and Medical Importance Due to their physical, chemical, and structural properties, adenoviruses may survive extended periods of time outside host cells. They are stable in the presence of many physical and chemical agents, as well as adverse pH conditions. For example, adenoviruses are resistant to lipid solvents due to the lack of lipids within their structure.4 Infectivity is optimal between pH 6.5 and 7.4; however, the viruses can withstand pH ranges between 5.0 and 9.0. Adenoviruses are heat resistant (particularly type 4) and may remain infectious after freezing.5 Table 2.1 Human Adenovirus Serotype Classification Subegenera A B C D E F
Serotypes 12, 18, 31 3, 7, 11, 14, 16, 21, 34, 35, 50 1, 2, 5, 6 8–10, 13, 15, 17, 19, 20, 22–30, 32, 33, 36–39, 42–49, 51 4 40, 41
Source: Adapted from Shenk, T., Adenoviridae: The viruses and their replication. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.), Lippincott Williams and Wilkins, Philadelphia, PA, 2001, and van Regenmortel, M.H.V. et al., Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses, Academic Press, San Diego, CA, 2000.
Routes of infection include the mouth, nasopharynx and the ocular conjunctiva. Less frequently, the virus can become systemic and affect the bladder, liver, pancreas, myocardium or central nervous system.6 Of the 51 currently recognized human serotypes (a serotype 52 has been proposed), only onethird are associated with a specific human disease (Table 2.2). Other infections remain largely asymptomatic. Adenoviruses are associated with a variety of types of clinical illnesses involving almost every human organ system. Illnesses include upper (pharyngitis and tonsillitis) and lower (bronchitis, bronchiolitis, and pneumonia) respiratory illnesses, conjunctivitis, cystitis, and gastroenteritis. Several studies have found that the enteric adenoviruses are second only to rotaviruses as the causative agents of acute gastroenteritis in infants and young children.7,8 Most illnesses caused by adenoviruses are acute and self-limiting. Although the symptomatic phase may be short, all adenoviruses can remain in the gastrointestinal tract and continue to be excreted for an extended period of time. Species within subgenera C may continue to be excreted for months or even years after disease symptoms have resolved. Adenoviruses can remain latent in the body (in tonsils, lymphocytes and adenoidal tissues) for years and be reactivated under certain conditions, such as a change in immune status. The long-term effect of such a latent infection is unknown.5 Adenovirus infections may be accompanied by diarrhea, though the virus can be excreted even if diarrhea is not present.7 A large proportion of infections caused by subgenera A and D tend to be asymptomatic, whereas the species within subgenera B and E tend to result in a higher rate of symptomatic respiratory illnesses. Immunity is species-specific. The presence of pre-existing antibodies resulting from a previous infection is usually protective. It is difficult to confidently link all adenoviruses to specific illnesses because many infections may be asymptomatic, healthy people can shed viruses.5 Occurrence studies comparing infection in healthy and ill people have found
Table 2.2 Common Illnesses Associated with Human Adenoviruses Disease Acute febrile pharyngitis Pharyngoconjunctival fever Acute respiratory disease Pneumonia Epidemic keratoconjunctivitis Follicular conjunctivitis Gastroenteritis/diarrhea Urinary tract Colon Hepatitis
Individual at Risk Infants, young children School-aged children Military recruits Infants, young children, military recruits Any Infants, young children Infants, young children Bone marrow, liver or kidney transplant recipients, AIDS victims or immunosuppressed
Serotypes 1–3, 5–7 3, 7, 14 3, 4, 7, 14, 16, 21 1–3, 4, 6, 7, 14, 16 8–11,13, 15, 17, 19, 20, 22–29, 37 3, 7 18, 31, 40, 41 34,35 42–49 1, 2, 5
Source: Adapted from Horwitz, M.S., Adenoviruses. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.), Lippincott, Williams and Wilkins, Philadelphia, PA, 2001; and Enriquez, C.E., Adenoviruses. In Encyclopedia of Environmental Microbiology, Bitton, G. (Ed.), John Wiley and Sons, New York, 2002.
Adenoviruses
25
between 0 and 20% of asymptomatic people can shed adenovirus.
complete recovery. Ad3 and Ad7 are the most commonly isolated species.6
2.1.2.1 Gastroenteritis Estimates of the incidence of adenovirus gastroenteritis in the world have ranged from 1.5 to 12%. Enteric adenoviruses are second only to rotaviruses as the leading causes of childhood gastroenteritis.7,9 Diarrhea is usually associated with fever and can last for up to two weeks. Though diarrhea can occur during infection by any type of adenovirus, Ad40 and Ad41 of subgenus F specifically cause gastroenteritis and diarrhea. Adenovirus type 31 (Ad31) is also suspected of causing infantile gastroenteritis. Some estimate that Ad40/41 contribute from 5 to 20% of hospitalizations for diarrhea in developed countries.10
2.1.2.5 Obesity There is accumulating evidence that several viruses may be involved in obesity in animals and humans.14 Studies in chickens, mice and nonhuman primates indicate that Ad36 can cause obesity.15 Obese humans have a higher prevalence of serum antibodies to Ad36 than lean humans.16 Other adenoviruses are capable of causing obesity in animals, but no correlation with antibodies has been demonstrated.16 The metabolic and molecular mechanisms of how adenovirus infections cause obesity are not precisely understood; however, increases in food intake alone cannot explain the observed increases in adiposity (tendency to store fat), suggesting that Ad36 induces metabolic changes.17 One mechanism appears to be that Ad36 influences the differentiation of preadipocyte.17
2.1.2.2 Respiratory Infections Over 5% of respiratory illnesses in children younger than 5 years of age are due to adenovirus infections.11 The initial transmission of adenoviruses is through the nasopharynx. Secondary transmission in households can be as high as 50% due to fecal-oral transmission from children shedding virus in the feces. Adenoviruses can be recovered from the throat or stool of an infected child for up to three weeks.6 Adenovirus respiratory infections are also well documented in adults. 2.1.2.3 Pharyngoconjunctival Fever (PCF) Pharyngoconjunctival fever (PCF) refers to a syndrome of pharyngitis, conjunctivitis, and spiking fever.5 Symptoms of this syndrome include unilateral or bilateral conjunctivitis, mild throat tenderness, and fever. The illness usually lasts from 5 to 7 days, with no permanent eye damage.4 The most commonly isolated adenovirus serotype is 3, although 7 and 14 have also been associated.6 The disease is best known for centering on summer camps, pools, and small lakes.12,13 Transmission of the agent appears to require direct contact with the water, allowing the virus direct contact with the eyes or upper respiratory tract. Secondary spread is common, although adults contracting the disease tend to have milder symptoms, usually only conjunctivitis. 2.1.2.4 Eye Infections Epidemic keratoconjunctivitis (EKC) is a syndrome which causes inflammation of the conjunctiva and cornea. EKC was once referred to as “Shipyard Eye,” as it was first described in shipyard workers.6 EKC is considered highly contagious and begins with edema of the eyelids, pain, shedding tears, and photophobia. Serotypes 8, 11, 19, and 37 can cause EKC. Transmission occurs through direct contact with eye secretions from an infected person as well as through contact with contaminated surfaces, eye instruments, ophthalmic solutions, towels, or hands of medical personnel. Outbreaks have involved mostly adults. Follicular conjunctivitis is often contracted by swimming in inadequately chlorinated swimming pools or in lakes during the summer.6 Most cases result in only mild illness and
2.1.2.6 Morbidity and Mortality Since adenovirus is not a reportable disease agent, there are no national or population-based morbidity and mortality figures available; most of the epidemiological data come from the study of select populations who appear to be most affected by adenovirus exposure. These include children in institutions such as hospitals and daycare centers, military recruits, immunocompromised individuals, and groups of families. Enteric infection in children results in disease 50% of the time. This percentage is greater when the infection is centered in the respiratory tract.5 Attack rates for waterborne outbreaks have been as high as 67% in children, with secondary attack rates (person-to-person transmission) of 19% for adults and 63% for children.5 2.1.2.7 Impact on the Immunocompromised Although adenovirus infection may result in mild or asymptomatic infections in the immuno competent in the immunocompromised, the virus can disseminate into any body system and cause pneumonitis, meningoencephalitis, hepatitis (especially in liver and bone marrow transplant patients), and hemorrhagic cystitis (especially in kidney transplant patients).5 According to Hierholzer18 over 11% of transplant recipients become infected with adenoviruses, with an 18% case fatality rate. The enteric adenoviruses are rarely isolated from immunocompromised patients with gastroenteritis or diarrhea and are generally not associated with serious illness in the immunocompromised. 2.1.2.8 Water- and Foodborne Outbreaks Although adenoviruses have been detected in shellfish no foodborne outbreaks have been documented to date. This may be a simple reflection that the virus is never considered a cause and thus no testing is perform to assess if adenoviruses could be involved. However, contact with recreational water has been associated with numerous adenovirus outbreaks over the years. Adenoviruses are the most reported cause of swimming pool outbreaks associated with viruses. Many outbreaks of PCF from nonenteric adenoviruses have come from people
26
swimming in pools and lakes. Ad3, Ad4, Ad7, and Ad14 have been associated with outbreaks in swimming pools19,20 and the adenoviruses have been detected in pool waters after outbreaks.12 It is clear that nondisinfected or inadequately disinfected recreational water is a source of adenovirus infection in swimmers. A routine monitoring of chlorinated swimming pools in South Africa demonstrated the presence of adenovirus by polymerase chain reaction (PCR) in 26 of 93 (15.4%) samples.20 While the detection method did not assess virus viability, it did demonstrate the widespread occurrence of adenoviruses in swimming pools. There have been three drinking water outbreaks reported in Europe in which enteric adenoviruses may have been a cause of gastroenteritis.21–23 Multiple viral agents were involved and the water had not been adequately disinfected. 2.1.2.9 Occurrence in Water Limited data has been available on the occurrences of adenoviruses in water. Only since the development of molecular methods for the direct detection of adenoviruses in water with confirmation tests performed in cell culture has data become available. Adenoviruses have been isolated from wastewater and river water, often more frequently and at higher concentrations than the enteroviruses.24–27 Adenoviruses have also been detected in sewage, rivers, oceans, swimming pools. Adenoviruses are commonly detected in raw and nondisinfected secondary sewage discharges, although little published data is available for the U.S. In Spain, monthly samples of raw sewage, effluent, river water, and seawater were tested using nested PCR amplification. Adenovirus was detected in 14 of 15 sewage, two of three effluent, 15 of 23 river water, and seven of nine seawater samples. Samples that were positive for enterovirus or hepatitis A were also positive for adenovirus, but there was no correlation between the fecal coliform level and adenovirus occurrence.26 In Greece, 36 samples of sewage effluent were tested over a 15-month period using cell culture. Adenovirus was detected in all samples with concentrations ranging from 70 to 3200 cytopathic units (CPU)/l. In Australia,24 raw sewage, primary effluent, and secondary effluent were sampled over a year using cell culture; 25 of 26 raw sewage, 23 of 26 primary effluent and 23 of 26 secondary effluent samples were positive for adenovirus.28 The mean concentrations in sewage, primary effluent, and secondary effluent were 1950, 1350, and 250 infectious units (IU)/l, respectively. Enteroviruses were removed to a greater extent than adenoviruses by activated sludge treatment.24 Both respiratory and enteric adenoviruses have been isolated from surface waters worldwide. Nevertheless, survey data is limited in the U.S. An evaluation of 29 surface water samples in the U.S. yielded 38% positive for infectious Ad40 and Ad41.29 The concentration of Ad40/41 ranged from 1.03 to 3.23 per 100 l. In this study, adenoviruses were more common in surface waters than enteroviruses and astroviruses. Likewise, when comparative studies have been conducted, adenoviruses usually outnumber enteroviruses in surface waters. Infectious adenoviruses have been detected in conventionally treated and disinfected drinking water in Africa and Asia
Molecular Detection of Foodborne Pathogens
using genome detection with PCR in cell culture.30,31 In both of these studies, adenoviruses were commonly detected in the raw, untreated surface water. In one study, adenoviruses were found in 4.4% of the finished drinking water samples that met the current acceptable bacteriological standards. In the other study, adenoviruses were detected at concentrations ranging from 0 to 0.9 most probable number (MPN)/100 l. In the van Heerden et al. study it was noted that none of the adenoviruses growing in cell culture produced cytopathic effects (CPE). 2.1.2.10 Occurrence in Shellfish Interest in the occurrence of adenoviruses in shellfish largely stems from their potential as indicators of other enteric viruses and fecal pollution.26 As with sewage and surface waters adenoviruses appear to be in greater numbers or at least isolated more commonly in shellfish than other enteric viruses, which may be a reflection of their greater stability in the environment.32 In addition, being a DNA virus eliminates the added steps for detection enteric RNA viruses needed for reverse transcription-PCR (RT-PCR). Although cell culture has been used to a limited degree PCR has been the method of choice, because of the long incubation times required for production of cytopathogenic effects in cell culture required for adenoviruses. Adenoviruses have been reported from every continent where shellfish are harvested. In Spain reported that of the mussels and oysters tested 47% contained adenoviruses, 19% enteroviruses, and 24% hepatitis A virus.33 In a multilaboratory study of virus contamination of shellfish in Europe human adenoviruses detected by PCR where found to correlate with the presence of other human enteric viruses and suggested they could be useful as a molecular index of viral contamination of shellfish.34 In a study in Korea adenoviruses was detected in 89% of the oysters collected from several locations.35 In India adenoviruses were detected in 17% of the oysters and 27% of clam samples, but noroviruses and hepatitis A virus were detected.36 However, enteroviruses were isolated with a greater frequency, 37% for oysters and 46% for clams. 2.1.2.11 Survival in the Environment and Shellfish Limited data suggests that adenoviruses survive longer in water than enteroviruses and hepatitis A virus.37 Adenoviruses also exhibit greater thermal stability than enteroviruses. This may explain their longer survival in water. They are capable of surviving for months in water, especially at low temperatures. The double-stranded DNA that comprises the genome of the virus may provide more stability in the environment. In addition, adenoviruses may use host cell repair enzymes to repair damaged DNA. This may also prolong their survival in the environment and enhance their resistance to inactivation by ultraviolet light. Qualitative PCR analyses of adenovirus DNA in oysters and mussels demonstrated that Ad35 could be detected for 6–8 weeks.38 In contrast the virus was detected in cell culture for 4–6 weeks.
Adenoviruses
2.1.3 Identification and Diagnosis 2.1.3.1 Culture-Based Techniques Adenovirus subgenera A through E can be cultured in human cell lines, albeit slowly,39,40 and thus may be overgrown by other faster growing viruses. They also require more than one passage in cell culture for expression of CPE. For this reason usually TCID50 or MPN methods are used for their quantification in environmental samples27 Guanidine can be added to cultures to selectively suppress enteroviruses while allowing adenoviruses to grow.25 A variety of cell lines have been used to grow and/or detect adenovirus such as HeLa cells,24,41 HEp-2 cells,28,41 293 cells,42 Chang conjunctival cells,43 CaCo-2 cells,44 and PLC/PRF/5 cells.43 Hurst et al.25 found that the number of infectious adenoviruses obtained by observing CPE in the 293 cell line was five-fold greater than the number detected via CPE in HEp-2 cells with sewage samples. Based on these findings and those of Takiff et al.45 they suggested that HEp-2 cells might not be as appropriate for detecting Ad40 and Ad41 as 293 cells. The use of HEp-2 cells might miss the enteric adenoviruses that may constitute up to 80% of the adenoviruses found in raw sewage. This might explain the findings of Tani et al.41 who, unlike other researchers, detected adenoviruses at much lower numbers than the enteroviruses in sewage, but relied on the use of the HeLa and HEp-2 cell lines. Grabow et al.43 determined that the PLC/PRF/5 liver cell line was more sensitive for detecting Ad41 and also exhibited CPE earlier than 293 cells and Chang conjunctival cells; however, while Ad40 may be grown using the PLC/PRF/5 cell line, CPE is not observed.43 This cell line has been used to study the survival and recovery, respectively, of Ad40 and Ad41 in water.19,37 also reported that the PLC/PRF/5 cell line was at least as sensitive as the HEp-2 cell line for isolating the lower-numbered serotypes (i.e., Ad1, Ad2, Ad3, Ad5, Ad6, and Ad7). Although BGM is the most common cell line used for isolation of enteric viruses from environmental samples adenoviruses will not produce CPE in this cell line although they can be detected by ICC-PCR.27,35 2.1.3.2 Antibody-Based Methods Antibody-based techniques have been developed for detecting and identifying adenoviruses in clinical samples, but have rarely been used with environmental samples. Both groupspecific techniques (e.g., detecting all human or primate adenoviruses only) and species-specific techniques (e.g., detecting Ad40 or Ad41 only) have been developed. A group-specific indirect immunofluorescence technique has been used to observe nongrowing (do not replicate or produce CPE) adenoviruses obtained from stool samples in tissue cultures.46 Only two studies have used antibody techniques for adenovirus detection in environmental samples. One used a group-specific immunofluorescence assay to detect adenoviruses in primary sludge from wastewater treatment plants.47 The viruses were visualized in HEp-2 cell cultures in which primary sludge concentrate had been added. The second study compared cell
27
culture, immunofluorescence, and in situ DNA hybridization methods for the detection of the enteric adenoviruses in raw sewage.25 While one of the cell-culture methods (using HEp-2 cells) and the immunofluorescence method (using groupspecific antibodies) yielded nearly equivalent results, the average levels detected using the in situ DNA hybridization technique were approximately 40% greater. 2.1.3.3 Nucleic Acid Probes Gene probes have been developed to detect enteric adenoviruses in clinical and environmental samples, but have thus far seen limited use because they are not as sensitive or as easy to use as PCR methods. Genthe et al.48 used Ad40 and Ad41 specific digoxigenin (DIG)-labeled DNA probes for enteric adenovirus detection in both raw and treated water. Nevertheless, the viability of the adenoviruses detected using this method was questionable since they were still detectable after exposure to 20 mg/l chlorine. 2.1.3.4 PCR-Based Techniques The advent of PCR techniques has provided faster, more sensitive and more specific methods to detect adenoviruses in both clinical and environmental samples. These techniques do not demonstrate infectivity, however. Allard et al.49,50 used PCR to detect adenoviruses in untreated domestic sewage via nested PCR. Puig et al.39 compared cell culture, one-step PCR and nested PCR using sewage and river water samples. Nested PCR was found to be the most sensitive technique, allowing for the detection of < 10 particles. This is 100–1000 times more sensitive than traditional cell culture-based detection methods. Using similar techniques, Pina et al.26 were able to detect human adenoviruses in sewage, river water, seawater, and shellfish. They suggested that the detection of human adenoviruses by PCR be used as an indicator of human viral contamination of the environment. A nested multiplex PCR for detection of human enteric adenoviruses, hepatitis A virus and enteroviruses in sewage and shellfish was reported by Formiga-Cruz et al.51 The limit of detection was approximately one genome copy for adenovirus and ten copies for enterovirus and hepatitis A virus per PCR reaction using cell cultured viruses. The lower detection of enteroviruses may reflect the addition steps to perform RT-PCR for the detection of the RNA viruses. 2.1.3.5 Integrated Techniques A combination of cell culture and PCR has been used as a method to assess the viability of viruses and to increase the speed of identification (i.e., reduce the need for another passage in cell culture). In such methods, PCR is used to detect the presence of viruses growing in cell culture.51 Chapron et al.29 employed this method to detect Ad40 and Ad41 in surface water samples in BGM cells. The viruses did not produce CPE, yet could be detected by PCR. Ko et al.52 developed an RT-PCR method for the detection of Ad2 and Ad41 mRNA in cell culture. Only infectious adenoviruses are detected using this method because only viable viruses are able to produce mRNA during replication in cell culture.
28
Choo and Kim35 compared the detection of adenoviruses in oysters by ICC-PCR in BGM and human lung epithelial cells (A549) along with direct detection in the oyster samples by PCR. They found 23.6%, 50.9%, and 89.1% of all oysters positive by cell culture, ICC-PCR, and direct PCR, respectively. This suggests that not all of the adenoviruses in the oysters were viable. Rigotto et al.53 also reported the greater sensitivity of nested PCR over IC-PCR. Nested PCR was capable of detecting 1.2 plaque forming units (PFU) of Ad5 per gram of tissue vs. 120 CFU/g by ICC-PCR.
2.2 Methods Virus detection in foods usually involves an extraction step followed by a concentration step. To date the only published methods for adenovirus detection in foods have been aimed at its isolation from shellfish. Shellfish extracts and concentrates can be toxic to cell cultures used in virus detection and may have more substances than other foods which may interfere with detection by molecular methods (PCR). No method for the extract/concentration or molecular detection is 100% efficient and should not be expected to be so because of variability in the individual genomes resistance to reagents used in extraction and processing. Another issue is that the volume of the extract may be large relative to the volumes used in the molecular assay limiting the sensitivity of the assay. All of these factors should be taken into consideration when reporting results.
2.2.1 Sample Preparation Due to the low number of viruses found in most surface and ground water samples, viruses are first concentrated from volumes ranging from 10 to 1000 l. Methods commonly used are adsorption to positively or negatively charged microporous filters in a pleated cartridge format, adsorption to positively charged glass wool and ultrafiltration. Viruses are then desorbed or eluted in small volumes of liquid. Fields and Metcalf54 first reported the concentration of adenoviruses using negatively charged filters. Enriquez and Gerba19 demonstrated the use of positively and negatively charged filters for the concentration of Ad40 from tap, sea and waste waters. Jiang and Chu55 used ultrafiltration to concentrate adenoviruses from surface waters and Van Heerden et al.30 used positively charged glass wool to isolate adenoviruses from conventionally treated drinking water. Methods have only been developed for the detection of adenoviruses from shellfish. This usually involves an extraction step from the shellfish, a concentration step and then preparation for PCR. These methods are identical to what is used for other enteric viruses. Methods for used isolating enteroviruses from other foods would likely be useful for adenoviruses.56 The only consideration is that adenoviruses tend to be more sensitive to inactivation at pH levels above 9 than enteroviruses. After shucking usually several shellfish are pooled for processing. Sometimes certain organs such as the gills, digestive gland, or versa are extracted and then pooled. Since viruses may occur in the shellfish meat usually the shellfish
Molecular Detection of Foodborne Pathogens
are processed whole after removal from the shell. The shellfish meat is them homogenized in a blender or stomacher. This is followed by centrifugation to pellet the solids and virus. The supernatant is then discarded. Ultracentifugation can be used to ensure pelleting of the virus26 or the pH lowered to 5.0 and conductivity adjusted to ensure adsorption of the virus to the tissue.57 The virus is then eluted from the homogenized tissues by addition of glycine buffer at pH 9.5–10.0 or with glycine buffer at pH 7.5 and the salt concentration increased to 8000 mg/l and the solids discarded. The eluate is then concentrated further by ultracentrifugation, ultrafiltration, or acid precipitation at pH 4.5. The method reported by Pina et al.26 involving glycine buffer elution and ultracentrifugation or minor modifications appears to be the most commonly used method at present for adenoviruses.33,34,51 The following methods described the processing of shellfish sample prior the analysis by PCR for the detection of adenovirus. This method consists of the use of an alkaline glycine solution (0.25 M pH 10.00) to promote the detachment of viruses from meat. Then the sample is clarified by centrifugation and the viruses are concentrated from the elution solution by polyethylene glycol (PEG) precipitation (8% PEG and 0.3 M of NaCl). The elution of the viruses from shell fish meet was described by Formiga-Cruz et al.34 and Pina et al.26 The conditions for PEG precipitation were described by Lewis and Metcalf.58 Materials: (1) Blender (2) 500 ml Erlenmeyer flask (3) 0.25 M glycine solution: for 1 l distilled water, add 18.75 g of glycine and adjust the pH to 10.00 with 1 N NaOH (4) 250 ml conical centrifuge bottle (5) PEG 6000 (6) Sodium chloride (7) Floor swing bucked refrigerated centrifuge (8) Horizontal shaker (9) 1 N HCl solution (10) 1 N NaOH solution Virus extraction procedure: (1) Homogenize 33 g of shell fish meat with 167 ml of 0.25 M glycine solution in a blender at maximum speed for 30 sec (2) Decant the homogenize solution in a 500 ml Erlenmeyer flask and stir for 15 min (3) Adjust the pH of the solution to 7.3 with 1 N HCl solution (4) Centrifuge at 2500 × g for 30 min (5) Keep the supernatant. Measure the volume of the solution Concentration of virus by PEG precipitation: (1) For 200 ml of eluted sample, add 16 g of polyethylene glycol, and 3.5 g of NaCl (2) Decant the solution in a 250 ml conical bottle
29
Adenoviruses
(3) Put the bottle horizontally in the orbital shaker, shake at 100 revolutions/min overnight at 4°C (4) Centrifuge at 4200 rpm for 1 h (5) Add 5 ml of phosphate buffer, using the pipette, break the pellet and agitate the bottle with a voltex for 1 min (6) Measure the volume on the reconstituted concentrated sample (7) Store the sample at –20°C until further analysis
2.2.2 Detection Procedures For the nucleic acids extraction, we describe a modification of the guanidine thiocianated extraction method described by Boom et al.59 However, any commercial kit for the DNA extraction from plasma or stool sample would work. The described nested-PCR is specific for the hexon gene for all human adenovirus which includes the groups A through F. These set of primers were previously described by Avellon et al.67 Nested PCR consists of two rounds of amplification: the first amplifies the target region from the viral genome and the second round amplifies a smaller region inside the product of the first round amplification. The PCR products are analyzed by agarose gel electrophoresis. Materials: (1) Guanidine lysis buffer: 120 g guanidine thiocyanate in 100 ml TE buffer, 11 ml of 5 M NaCl, 11 ml 3 M sodium acetate (NaOAc) pH 5.5, and 3.5 ml of poplyadenylic acid 5′ potassium salt (1 mg/ml) (2) 100% proof ethanol (3) 70% ethanol solution (4) Sterile nuclease free water (5) Silica spin minicolumns (high-bind RNA minicolumns, Promega Biotek, others manufacturers columns such as Qiagen will work) (6) 2 ml collection tubes (7) 1.5 ml microcentrifuge tubes (8) 5 U/µl hot start taq polymerase (qiagen hotstart or Applied Biosystems gold Taq) (9) 10 × PCR buffer (provided with Taq polymerase) (10) 25 mM MgCl2 (provided with the Taq polymerase) (11) 25 pmoles/µl stock primers (12) 2.5 mM each dNTPs solution (10 mM total) (13) Sterile nuclease free water (14) Micropipets (0.5–10 µl, 10–100 µl, 100–1000 µl sizes) (15) Barrier sterile tips (16) 10% bleach solution (50 ml commercial bleach solution, 450 ml of water) (17) First round PCR primers are: ADHEX1F 5′-AACACCTAYGASTACATGAAC-3′ ADHEX2R 5′-KATGGGGTARAGCATGTT-3′ Fragment size of 473 bp (18) Second round PCR primers are: ADHEX2F 5′-CCCMTTYAACCACCACCG-3′ ADHEX1R 5′-ACATCCTTBCKGAAGTTCCA-3′ Fragment size of 168 bp
Nucleic acid extraction: (1) Add 100 µl of lysis buffer to a 1.5 ml microcentrifuge tubes (2) Add 100 µl of sample to the tubes and mix then with a voltex for 15 sec (3) Incubate at room temperature for 10 min (4) Remove the drops from the lip by a brief centrifugation (5) Add 200 µl of 100% proof ethanol (6) Mix with a voltex for 15 sec (7) Load the 400 µl of sample mixture into the silica minicolumns (8) Centrifuge for 1 min at 16000 × g (9) Place the column in a new collection tube (10) Add 500 µl of 70% ethanol and centrifuge at max speed for 1 min (11) Repeat the wash steps 9 and 10 one more time (12) Place the column in a collection tube. Dry the column by centrifugation at 16000 × g for 1 min (13) Put the column in a sterile 1.5-ml tube (14) Add 50 µl of sterile nuclease free water in the center of the column without touching the walls (15) Let incubate for 1 min and then centrifuge 16000 × g for 1 min (16) Keep the flow through store at –20°C for future PCR analysis Nested PCR procedure: (1) Prepare first round PCR mixture (50 µl) consisting of 1 × PCR buffer, 2.0 mM of MgCl2, 200 µM of each dNTP, 25 pmoles of each primers (ADHEX1F and ADHEX2R) for the first PCR, 1.5 U of Taq polymerase, 2 µl extracted virus DNA, and nuclease free water for a final volume of 50 µl. Prepare a master mixture for multiple reactions and adjust by increasing the volume 5% (to consider the lost of mixture during handling). Specifically, the following calculation is for a master mixture for ten reactions: (i) In a sterile 1.5 ml Eppendolf tube add: 52.5 µl of 10 × PCR buffer 42 µl of 25 mM MgCl2 solution 10.5 µl of Primer F (ADHEX1F) 10.5 µl of Primer R (ADHEX2R) 2.1 µl of Taq polymerase 260 µl of water (ii) Aliquot 40 µl of PCR mixture into each PCR tube and add 10 µl of sample (2) Conduct PCR amplification in a thermal cycler using the following program: one cycle of 94°C for 10 min; 35 cycles of 94°C for 30 sec, 50°C for 30 sec, and 72°C for 30 sec; one cycle of 72°C for 10 min. Use the heated lip option. (Note: If this option is not available then add a drop of mineral oil to the reaction to avoid the vaporization.) (3) Prepare second round PCR mixture (50 µl) consisting of 1 × PCR buffer, 2.0 mM MgCl2, 200 µM of each dNTP, 0.5 µM each primers (ADHEX2F
30
and ADHEX1R) for the second round of PCR, 1.5 U of Taq polymerase, 2 µl of first round PCR, and nuclease free water for a final volume of 50 µl. Specifically, the following calculation is for a master mixture for ten reactions: (i) In a sterile 1.5 ml eppendolf tube add: 52.5 µl of 10 × PCR buffer 42 µl of 25 mM MgCl2 solution 10.5 µl of nested Primer F (ADHEX2F) 10.5 µl of nested Primer R (ADHEX1R) 2.1 µl of Taq polymerase 328 µl of sterile nuclease free water (ii) Aliquot 48 µl of PCR mixture into each PCR tube and add 2 µl of first round PCR product. The cycling conditions of the second round PCR are the same used for first round PCR. (4) Agarose gel electrophoresis (i) Prepare a 2% agarose gel in 0.5 × TBE in a 250-ml Erlenmeyer flask adding 2 g agarose and 100 ml 0.5 × TBE buffer (ii) Heat the gel in a microwave oven until the agarose dissolves. Add 5 µl of 10 mg/ml ethidium bromide stock solution (50 µg/ml working solution) after the agarose cools down (~45°C) and before pouring. (iii) Pour the gel slowly, trying to reduce the formation of bubbles. Put the well comb in its correct position. Let the gel stand for at least 30 min. (iv) Locate the gel wells in the negative side of the electrophoresis chamber. Add 0.5 × TBE buffer until the lever reaches more than 2 mm above the gel. (v) Mix 10 µl of the sample with 2 µl of 6 × loading buffer. (vi) Using a pipette with a fine tip, load the sample into the well. Load at step DNA ladder every six samples (amount recommended by manufacturer). (vii) Check that the polarity is in the correct orientation (well in the negative side, running to positive side). (viii) Applied as follows: 5 V per cm gel length. (ix) Stop the electrophoresis when it reached 70% of the gel length. Use as reference the faster dye of the loading buffer. (x) Visualize the PCR products using a UV transilluminator. (xi) The PCR product size is estimated by comparing it with the step ladder and with the positive control. The 100 bp step ladder has step increases from 100 bp to 1000 bp. A positive sample for adenovirus should show a band between 100 bp and 200 bp with 168 bp. Also, a positive sample should have the same running distance as the positive control.
Molecular Detection of Foodborne Pathogens
Comment on quality control: (1) All the areas for the analysis should be separate in different rooms: one room exclusive for mixing PCR reagents, one room for handling the samples, one for the nested PCR, and another for gel electrophoresis. (2) We recommend using a different PCR workstation/ hood with UV lamp for preparing the master mix and another for the addition of the first round PCR product to the second round PCR mixture. Use a biological hood type 2 for handling the samples. Before and after uses, the hoods should be cleaned with 10% bleach solution and turn on the UV light for 30 min. The bleach can be inactivated with 2% sodium thiosulfate solution and washed with water. (3) Open the reagents only inside the workstation, and the samples and PCR products are only opened in their respective workstation. (4) Keep the equipment in each respective room and not used then in other areas (i.e., pipets, tips, and different lab coats are exclusively used in each room). (5) The PCR product is only opened in the workstation for samples and in the electrophoresis room (negative pressure from the main laboratory).
2.3 Conclusions and Future Perspectives Adenoviruses, like the enteroviruses, cause a wide range of illness many of which are not thought of as being food or waterborne. This, combined with the long time needed to produce cytopathogenic effects in cell culture previously resulted in few studies on their occurrence in the environment and role in food and waterborne diseases. While waterborne transmission is well documented, the role of food in their transmission is unknown. Certainly documenting their presence in food, especially shellfish suggests foodborne transmission is possible. Human adenoviruses are more common in sewage contaminated waters and it has been suggested by several groups of investigators that they may be useful indicators of other enteric viruses in water and shellfish. Adenoviruses also have the added advantage of unlike most human enteric viruses, they have a DNA genome, eliminating the need for RT-PCR. However, recent research on the occurrence of adenoviruses in areas remote from human sewage contamination suggests that other sources besides humans or exceptionally long survival times in the environment.61 Clearly additional research is needed to assess the usefulness of human adenoviruses as indicators of human viral contamination. The application of PCR makes possible for the first time low cost and simple methods for the detection of adenoviruses in food and water. This will help us better understand the role of these vehicles in their transmission. Currently all molecular methods suffer from inability to determine viability without the use of cell culture, small assay volumes, quantification at low numbers of genome copies, interference with substances in concentrates, and the loss of virus during sample processing. These are major challenges that need to
Adenoviruses
be overcome to take full advance of molecular approaches for virus detection in foods.
References
1. Shenk, T. Adenoviridae: the viruses and their replication. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.). pp. 2265– 2300. Lippincott Williams and Wilkins, Philadelphia, PA, 2001. 2. Enriquez, C.E. Adenoviruses. In Encyclopedia of Environ mental Microbiology. Bitton, G., (Ed.). Vol. 1, pp. 92–100. John Wiley and Sons, New York, 2002. 3. van Regenmortel, M.H.V. et al. Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses. pp. 227–238. Academic Press, San Diego, CA, 2000. 4. Liu, C. Adenoviruses. In Textbook of Human Virology, 2nd edn. Belshe, R.B. (Ed.). pp.791–803. Mosby Year Book, St. Louis, MO, 1991. 5. Foy, H.M. Adenoviruses. In Viral Infections of Humans: Epidemiology and Control, 4th edn. Evans, A.S. and Kaslow, R.A. (Eds.). pp. 119–138. Plenum Publishing Corporation, New York, NY, 1997. 6. Horwitz, M.S. Adenoviruses. In Fields Virology, 4th edn. Knipe, D.M. et al. (Eds.). pp. 2301–2326. Lippincott, Williams and Wilkins, Philadelphia, PA, 2001. 7. Wadell, G. Molecular epidemiology of human adenoviruses. Curr. Top. Microbiol. Immunol., 110, 191, 1994. 8. Scott-Taylor, T.H., and Hammond, G.W. 1995. Local succession of adenovirus strains in pediatric gastroenteritis. J. Med. Virol. 45, 331–338. 9. Shinozaki, T. et al. Epidemiology of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children in the Tokyo area. Scand. J. Infect. Dis., 23, 543, 1991. 10. LeBaron, C.W. et al. Viral agents of gastroenteritis. Public health importance and outbreak management. MMWR, 39, 1, 1990. 11. Brandt, C.D., Kim, H.W. and Vargosdo, A.J. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. Am. J. Epidemiol., 90, 484, 1972. 12. D’Angelo, L.J. et al. Pharyngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. J. Infect. Dis., 140, 42, 1979. 13. Harley, D. et al. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Commun. Dis. Intell., 25, 9, 2001. 14. Jaworowska, A. and Barylak, G. Obesity development associated with viral infections. Postepy. Hig. Med. Dosw., 60, 227, 2006. 15. Atkinson, R.L. et al. Human adenovirus -36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes., 29, 281, 2005. 16. Greenway, F. Virus-induced obesity. Am. J. Physiol. Regul. Comp. Physiol., 290, R188, 2006. 17. Vangipuram, S.D. et al. A human adenovirus enhances preadiocytes differentiation, Obes. Res., 12, 77, 2004. 18. Hierholzer, J.C. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev., 5, 262, 1992. 19. Gerba, C.P. and Enriquez, C.E. Virus-associated outbreaks in swimming pools. Proceedings of the 1st Annual Chemistry Symposium. pp. 31–45. National Spa and Pool Institute, National Spa and Pool Institute, Alexandria, VA, 1997. 20. Van Heerden, J., Ehlers, M.M. and Grabow, W.O.K. Detection and risk assessment of adenoviruses in swimming pool water. J. Appl. Microbiol., 99, 1256, 2005. 21. Kukkula, M. et al. Waterborne outbreak of viral gastroenteritis. Scand. J. Infect. Dis., 29, 415, 1997.
31 22. Villena, C. et al. A large infantile gastroenteritis outbreak in Albania caused by multiple emerging rotavirus genotypes. Epidemiol. Infect., 131, 1105, 2003. 23. Divizia, M. et al. Waterborne gastroenteritis outbreak in Albania. Water Sci. Technol., 50, 57, 2004. 24. Irving, L.G. and Smith, F.A. One-year survey of enteroviruses, adenoviruses, and reoviruses isolated from effluent at an activated-sludge purification plant. Appl. Environ. Microbiol., 41, 51, 1981. 25. Hurst, C.J., McClellan, K.A. and Benton, W.H. Comparison of cytopathogenicity, immunofluorescence and in situ DNA hybridization as methods for the detection of adenoviruses. Water Res., 22, 1547, 1988. 26. Pina S. et al. Viral pollution in the environment and in shellfish: human adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol., 64, 3376, 1998. 27. Rodriguez, R.A., Gundy, P.M. and Gerba, C.P. Comparison of BGM and PLC/PRC/5 cell lines for total culturable viral assay of treated sewage. Appl. Environ. Microbiol., 74, 2583, 2008. 28. Krikelis, V. et al. Seasonal distribution of enteroviruses and adenoviruses in domestic sewage. Can. J. Microbiol., 31, 24, 1985. 29. Chapron, C.D. et al. Detection of astroviruses, enteroviruses, and adenovirus types 40 and 41 in surface water collected and evaluated by the information collection rule and an integrated cell culture-nested PCR procedure. Appl. Environ. Microbiol., 66, 2529, 2000. 30. Van Heerden, J. et al. Incidence of adenoviruses in raw and treated water. Water Res., 37, 3704, 2003. 31. Lee, H.K. and Jeong, Y.S. Comparison of total culturable virus assay and multiplex integrated cell culture-PCR for reliability of waterborne virus detection. Appl. Environ. Microbiol., 70, 3632, 2004. 32. Enriquez, C.E. and Gerba, C.P. Concentration of enteric adenovirus 40 from tap, sea, and waster water. Water Res., 95, 2554, 1995. 33. Munianin-Mujika, I. et al. Comparative analysis of viral pathogens and potential indicators in shellfish. Int. J. Food Microbiol., 83, 75, 2003. 34. Formiga-Cruz, M. et al. Distribution of human virus contamination in shellfish from different growing areas in Greece, Spain, Sweden, and the United Kingdom. Appl. Environ. Microbiol., 68, 5990, 2002. 35. Choo, Y.J. and Kim, S.J. Detection of human adenoviruses and Enteroviruses in Korean oysters using cell culture, integrated cell culture-PCR, and direct PCR. J. Microbiol., 44, 1662, 2006. 36. Umesha, K.R. et al. Prevalence of human pathogenic enteric viruses in bivalue molluscan shellfish and cultured shrimp in south west coast of India. Int. J. Food Microbiol., 122, 279, 2008. 37. Enriquez, C. E., Hurst, C.J. and Gerba, C.P. Survival of the enteric adenoviruses 40 and 41 in tap, sea, and waste water. Water Res., 29, 2548, 1995. 38. Hernroth, B. and Allard, A. The persistence of infectious adenovirus (type 35) in mussels (Mytilus edulis) and oysters (Ostrea edulis). Int. J. Food Microbiol., 113, 296, 2007. 39. Puig, M. et al. Detection of adenoviruses and enteroviruses in polluted waters by nested PCR amplification. Appl. Environ. Microbiol., 60, 2963, 1994. 40. Echavarria, M. et al. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virusinfected individuals. J. Clin. Microbiol., 36, 3323, 1998.
32 41. Tani, N. et al. Seasonal distribution of adenoviruses, enteroviruses and reoviruses in urban river water. Microbiol. Immunol., 39, 577, 1995. 42. Brown, M. Laboratory identification of adenoviruses associated with gastroenteritis in Canada from 1983 to 1986. J. Clin. Microbiol., 28, 1525, 1990. 43. Grabow, W.O., Puttergill, D.L. and Bosch, A. Propagation of adenovirus types 40 and 41 in the PCL/PRF/5 primary liver carcinoma cell line. J. Virol. Methods, 37, 201, 1992. 44. Pintó, R.M. et al. Detection of fastidious infectious enteric viruses in water. Environ. Sci. Technol., 29, 2636, 1995. 45. Takiff, H.E., Straus, S.E. and Garon, C.F. Propagation and in vitro studies of previously non-culturable enteral adenoviruses in 293 cells. Lancet, 2, 832, 1981. 46. Retter, M. et al. Enteric adenoviruses: detection, replication and significance. J. Clin. Microbiol., 10, 574, 1979. 47. Williams, F.P. and Hurst, C.J. Detection of environmental viruses in sludge: enhancement of enterovirus plaque assay titers with 5-iodo-2′-deoxyuridine and comparison to adenovirus and coliphage titers. Water Res., 22, 847, 1988. 48. Genthe, B. et al. Detection of enteric adenoviruses in South African water using gene probes. Water Sci. Technol., 31, 345, 1995. 49. Allard, A. et al. Polymerase chain reaction for detection of adenovirus in stool samples. .J Clin. Microbiol., 28, 2659, 1990. 50. Formiga-Cruz, M. et al. Nested multiplex PCR assay for detection of human enteric viruses in shellfish and sewage. J. Virol. Methods, 125, 111, 2005. 51. Reynolds, K.A., Gerba, C.P. and Pepper, I.L. Detection of infectious enteroviruses by an intergrated cell culture-PCR procedure. Appl. Environ. Microbiol., 62, 1424, 1996.
Molecular Detection of Foodborne Pathogens 52. Ko, G., Cromeans, T.L. and Sobsey, M.D. UV inactivation of adenovirus type 41 measured by cell culture mRNA RT-PCR. Water Res., 39, 3643, 2005. 53. Rigotto, C. et al. Detection of adenoviruses in shellfish by means of conventional-PCR, nested-PCR, and integrated cell culture PCR (ICC/PCR). Water Res., 39, 297, 2005. 54. Fields, H.A., and Metcalf, T.G. Concentration of adenovirus from seawater. Water Res., 9, 357, 1975. 55. Jiang, S., and Chu, W. PCR detention of pathogenic viruses in southern California urban rivers. J. Appl. Microbiol., 97, 17, 2004. 56. Goyal, S.M. Methods of virus detection in foods. In Viruses in Foods, Goyal, S.M. (Ed.). pp. 101–119. Springer, New York, NY, 2006. 57. Sobsey, M.D., Carrick, R.J. and Jensen, H.R. Improved methods enteric viruses in oysters. Appl. Environ. Mirobiol., 36, 121, 1978. 58. Lewis G.D. and Metcalf, T.G. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol., 54:1983, 1988. 59. Boom, R., C.J.A. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28, 495, 1990. 60. Avellón, A.P. et al. Rapid and sensitive diagnosis of human adenovirus infections by a generic polymerase chain reaction. J. Virol. Methods, 92, 113, 2001. 61. Lipp, E.R., Futch, J.C. and Griffin, D.W. Analysis of multiple enteric viral targets as sewage markers in coral reefs. Mar. Pollut. Bull., 54, 1897, 2007.
3 Astroviruses
Edina Meleg and Ferenc Jakab University of Pécs
Contents 3.1 Introduction......................................................................................................................................................................... 33 3.1.1 History, Virion Structure and Classification............................................................................................................ 33 3.1.1.1 History....................................................................................................................................................... 33 3.1.1.2 Genome Structure..................................................................................................................................... 34 3.1.1.3 Classification............................................................................................................................................. 35 3.1.2 Pathogenesis and Pathology..................................................................................................................................... 35 3.1.2.1 Physical Features....................................................................................................................................... 35 3.1.2.2 Propagation of Human Astroviruses......................................................................................................... 35 3.1.2.3 Propagation of Animal Astroviruses........................................................................................................ 36 3.1.2.4 Transmission............................................................................................................................................. 36 3.1.2.5 Pathogenesis.............................................................................................................................................. 36 3.1.3 Clinical Features . ................................................................................................................................................... 36 3.1.3.1 Characteristics of Human Illness.............................................................................................................. 36 3.1.3.2 Role in Immunocompromised Hosts......................................................................................................... 37 3.1.3.3 Immunity................................................................................................................................................... 37 3.1.4 Epidemiology........................................................................................................................................................... 38 3.1.4.1 Role in Disease.......................................................................................................................................... 38 3.1.4.2 Antibody Acquisition and Prevalence....................................................................................................... 38 3.1.5 Laboratory Diagnosis............................................................................................................................................... 38 3.1.6 Treatment and Prevention........................................................................................................................................ 40 3.2 Methods............................................................................................................................................................................... 40 3.2.1 Sample Preparation ................................................................................................................................................. 40 3.2.3 Detection Procedures............................................................................................................................................... 40 3.3 Conclusions and Future Perspectives.................................................................................................................................. 43 References.................................................................................................................................................................................... 44
3.1 Introduction
3.1.1 History, Virion Structure and Classification
Astroviruses are the members of Astroviridae family, which include both human and animal nonenveloped viruses possessing a plus-sense, ssRNA genome. In humans, astroviruses mainly produce gastroenteritis together with a broad spectrum of symptoms such as malaise, vomiting, diarrhea, fever and abdominal pain. Besides being one of the most common causes of viral gastroenteritis in young children in developed countries, astrovirus is the culprit for viral diarrhea in young children in some other parts of the world.1 Although foodborne illness resulting from viral infections is a large and growing public health problem, most countries do not have good reporting systems; therefore realistic estimation of the true burden of foodborne diseases is difficult. Based on a recent study, astroviruses account for less than 1% of foodborne illnesses in the United States.2
3.1.1.1 History Astroviruses were first identified by Madeley and Cosgrove in 1975 in the feces of hospitalized infants with diarrhea.3 Based on direct electron microscopy (EM) studies of fecal samples, astroviruses were observed as 28–30 nm particles in diameter with a distinctive five-six pointed star-like surface (Figure 3.1). This morphology distinguished astroviruses from other small, round viruses with similar size, such as picornaviruses and caliciviruses. In some preparations, bridging structures, which may be surface extensions of the virus, have been observed between adjacent astrovirus particles.4 The term “astrovirus” was named after the star morphology (astron = star; Greek), although this surface structure can only be identified in approximately 10% of the particles by EM. Interestingly, particles isolated from infected rhesus
33
34
Molecular Detection of Foodborne Pathogens
5´UTR Non-structural proteins
3´UTR
?
A(n) Structural proteins ORF 1a
ORF 1b
ORF 2
Frameshift site
Figure 3.2 Genome arrangement of astroviruses. www.tulane. edu/~dmsander/WWW/335/Diarrhoea1.gif 50 nm
Figure 3.1 Image of human astroviruses by electron microscopy. http://www.virology.net/Big_Virology/BVRNAastro.html
monkey kidney epithelial (LLCMK2) cells lack the star-like morphology, but it can be induced by a brief exposure to pH = 10 environment. Later, based on high-resolution EM5 and electron cryomicroscopy studies astroviruses seemed to be icosahedral particles with spikes or knob-like projections, and 41–43 nm in total diameter. Studies on purified cell culture-adopted HAstV-1 particles evaluated by cryo-electron microscopy and image analysis revealed a rippled solid capsid shell structure (330 Å in diameter) decorated with 30 dimeric spikes extending 50 Å from the virion surface.6 These particles, however, have not been characterized by protein composition, which is a key factor for the virus-specific infectivity and may have an effect on virion structure.7,8 A few months before naming astroviruses, in 1975 Appleton and Higgins9 reported an outbreak of mild diarrhea and vomiting among infants in a maternity ward. In their study, astroviruses particles were 29–30 nm in diameter, and did not display the special surface features, however by EM these viruses were distinct in size and morphology from the previously identified Norwalk viruses and rotaviruses. One year later specific immunologic reagents proved that these viruses were really astroviruses.10 Subsequently, viral particles, that were similar size and had the star-like surface features, were observed in gastroenteritis cases in several young mammals and birds, including mice,11 kittens,12 dogs,13,14 lambs,15 calves,16 deer,17 piglets,18 minks19 as well as turkeys.20 Gough et al.21 observed fatal hepatitis in ducklings due to astrovirus infection, and virus particles were found in liver of these animals in addition to feces. Astrovirus appears to cause species-specific infections.22 In 1981, Lee and Kurtz23 published the successful isolation of human astroviruses in the presence of trypsin in human embryonic kidney (HEK) cells and passage in LLCMK2 cells, which definitely distinguished them from noncultivatable small, round viruses, such as caliciviruses. In the late 1980s, Herrmann et al.24,25 developed an enzyme immunoassay (EIA) that detects viral antigen. Although, the virus was well known since 1975, the real medical importance was only recognized in 1991.26 Reverse-transcription polymerase chain reaction (RT-PCR) assays were first use in 1995 to detect human astroviruses. These techniques contributed
to more detailed characterization of astrovirus strains by the analysis of nucleotide sequence information.27–29 In the past few years spreading of RT-PCR technique could be observed in studies of the prevalence of astrovirus among children with diarrhea to detect and genotype strains. 3.1.1.2 Genome Structure Astroviruses have a plus-sense, single-stranded RNA genome, which is approximately 6800 nucleotides (nt) (varies from 6.4 to 7.3 kb) in length. It is polyadenylated at the 3′ end, and surrounded by an isocahedral capsid. The genomial RNA includes 5′ and 3′ nontranslated region (UTR), and three open reading frames (ORFs), each encoding polyprotein that is proteolytically processed to yield smaller proteins (Figure 3.2). The two ORF located toward the 5′ end of the genome, designated ORF 1a (~2700 nt) and ORF 1b (~1550 nt), encode nonstructural proteins, such as an RNAdependent RNA polymerase and a 3C-like serine protease that are involved in RNA transcription and replication. ORF 1a also encodes overlapping immunogenic epitopes that are recognized by antibodies produced to intact astroviruses.30 An overlap of 60–70 nt is found between ORF 1a and ORF 1b of mammalian astroviruses (this region is only 12–45 nt long in avian viruses). This overlapping region contains signals which are essential for translation of the viral RNA polymerase through a frameshift mechanism.31,32 This region is completely conserved among human and animal astroviruses in two characteristics: a heptameric AAAAAAC sequence, and the potential to form a downstream stem-loop structure. These features are critical for the ribosomal-1 frameshifting event during the translation of the genome.31,32 The third ORF is located at the 3′ one-third of the genome, designated ORF 2, which has the greatest sequence variability in the astrovirus genome, and encodes the 90 kDa protein that is the precursor of the three capsid proteins that have been described for human astroviruses.33,34 Structural proteins encoded by ORF 2 are translated from the so-called subgenomic (sg) RNA.33,34 The more conserved amino-terminal region of the astrovirus capsid protein has an important function in assembly of the capsid core, while the hypervariable carboxy-terminal form the spikes of the virion and participate in the early interactions between the virus and the host cells.35 ORF 1b and ORF 2 overlap in eight nt. The 3′ UTR of HAstV genome, which is located between ORF 2 and the polyA tail is 80–85 nt long (this sequence can be longer [130–305 nt] in avian viruses).36
35
Astroviruses
The final 19 nt of ORF 2 and the 3′ UTR are thought to be important for interacting with the viral RNA replicase and cellular proteins. These regions are highly conserved among all known HAstV serotypes.37 During infection of susceptible cells, two RNA species have been observed: the full-length genomic RNA (gRNA), and an sgRNA (~2.4 kb in length).38,39 Both RNA species are initially observed at 12 hours postinfection in LLCMK2 cells.39 Synthesis of the negative-sense RNA of astrovirus has not been well studied. By all means, the gRNA is probably a template to synthesize the full-length negative-sense RNA, which is a template to produce both the full-length gRNA and the sgRNA. The synthesis of sgRNA probably requires an internal sequence in the full-length negative sense RNA to serve as promoter for the virus transcriptase. However, the identity of this promoter in astrovirus has not been defined; it is thought that about 120 nt of the ORF 2 region might be an important sequence of the promoter.40 Part of this region includes the sequence AUUUGGAGNGGNACCNAAN5-8 AUGNC (the ORF 2 start codon is underlined; N can be any of the four nucleotides), which is highly conserved among all members of Astroviridae.41 After astrovirus entry, the gRNA is used as a template to synthesize the virus nonstructural proteins. The primary protein product coded by ORF 2 is observed abundantly 12 hours after infection39 (nonstructural proteins are initially detected 6 hours postinfection42). 3.1.1.3 Classification Genome arrangement of astroviruses is similar to the genome of Picornaviridae and Caliciviridae,43 but the size, number, and processing of polyproteins, the lack of an RNA-helicase domain in astroviruses, and the use of a ribosomal frameshifting mechanism distinguish them from similar viruses. Therefore astroviruses are classified into a separate family, the Astroviridae.44 Astroviruses have been isolated from both humans and several animal species. According to the origin of the virus and the genome structure, two genera have been distinguished within the family: mamastrovirus (infect mammals) and avastrovirus (including viruses from avian species). Viruses in the genus mamastrovirus are more closely related to each other than those viruses within the avastrovirus genus.36,45 Serologic relatedness between viruses isolated from different species, even within the same genus has not been identified.46,47 Human astroviruses have been grouped into eight serotypes (HAstV-1 to HAstV-8) according to immunfluorescence and neutralization assays, as well as immunelectron microscopy that use hyperimmune sera to raise different culture adapted strains.23,48–52 Common epitopes of the capsid protein in cases of all known HAstV serotypes were identified. These epitopes are widely used in many different diagnostic assays.24,25 Recently, more sensitive molecular methods are used, that enabled the classification of human astroviruses on the basis of the sequence similarity of specific genome regions. Nowadays, different regions of the genome, obtained
by RT-PCR, have been widely used to group HAstVs into different genotypes; though depending on the specific region of the analyzed genome (ORF 1a, 1b or ORF 2), strains can be grouped differently.53 Several animal serotypes of astroviruses have been identified. At least two, but probably three serotypes are found among bovine astroviruses (BAstVs) based on the crossreactivity to specific sera. Two serotypes have been identified among turkey (TAstVs)36 and chicken astroviruses (CAstVs).46 Many serotypes of astroviruses have been identified in consequence of different serological studies, suggesting that additional types of astrovirus might exist.47,54
3.1.2 Pathogenesis and Pathology 3.1.2.1 Physical Features Astroviruses are one of the most resistant viruses. They show resistance against different physical and chemical agents, such as chloroform, a variety of nonionic, anionic as well as zwitterionic detergents, even lipid solvents; they are able to maintain their infectivity at 60°C for 5 min (HAstV)5,22 or 10 min (TAstV), and at ultralow temperature (–70 to –85°) for 6–10 years, but repeated freezing and thawing is detrimental55 to them, particles are resistant to treatment from pH 3 to 10.5,22 The extreme stability of astroviruses against environmental factors suggests that traditional pasteurization procedures cannot completely inactivate them. Furthermore, astroviruses are able to persist under severe environmental conditions, they endure on inanimate surfaces, on human hands, in dried human and animal fecal materials, in water, on kitchen surfaces, food preparation areas, hospital as well as cruise ship cafeterias, on carpets and hospital lockers.56 There is a lack of information on the survival of astrovirus on foods. Information is also lacking on the efficiency of current washing and decontamination procedures for the removal of astrovirus. It was already demonstrated that traditional disinfection procedures do not eliminate astroviruses by water treatment. 3.1.2.2 Propagation of Human Astroviruses Serial passage of astrovirus in HEK cells requires incorporation of 10 μg/ml trypsin in the serum-free growth media.23 Higher levels of typsin do not improve the viral yield, while lower levels (for example the 0.5 μg/ml necessary for rotavirus growth) are not sufficient to maintain astrovirus in cell culture. After several passages of HEK-293 cells, viruses were able to grow in primary baboon kidney (PBK) cells and in a continuous cell line of LLCMK2 cells. Attempts to establish serial passage by direct inoculation of PBK or LLCMK2 cells with fecally derived astrovirus were unsuccessful. Willcocks et al.57 could propagate the virus in a continuous cell line of human colon adenocarcinoma (CaCo-2) cells using 5 μg/ml trypsin in the culture medium. With this method, the first cytopathic effect (CPE) appeared after 2 days of infection. Nowadays, this cell line is commonly used to grow wild-type astrovirus strains.
36
However, adenocarcinoma cell lines (CaCo-2, T-84, HT-29, SK-CO-1 cells) are the most efficient cells to isolate HAstV, the virus are also able to grow in human liver hepatoma cells (PLC/PRF/5) and in monkey kidney-derived (MA104, Cos-1, vero) cells as well.52,58–60 CaCo-2, T-84 and PLC/PRF/5 cell lines are the most efficient to directly isolate HAstV strains from fecal suspensions.52,58–60 Adaptation of field HAstV strains to grow in cell culture has low efficiency because different astrovirus strains have different susceptibility to trypsin. Although, 10 μg/ml of trypsin has been regularly used to activate virus infectivity; recent isolation of HAstV type-8 in CaCo-2 cells required much higher (200–400 μg/ml) trypsin concentration.8 In consequence, the optimal concentration of trypsin to obtain completely activated virus can depend on the HAstV strain. 3.1.2.3 Propagation of Animal Astroviruses To date bovine,61 porcine62 and avian astroviruses have been propagated in cell culture. Bovine astrovirus was isolated by Aroonprasert et al. in primary neonatal bovine kidney (NBK) cells in the presence of 50 μg/ml trypsin. This amount of trypsin in the culture media was necessary both for direct isolation from fecal samples and for serial passage of the virus in NBK cells. Primary bovine embryo kidney (BEK) cells were also efficient in growing bovine astroviruses using feces and cell culture adopted viruses as the starting material.61 A porcine astrovirus was isolated in embryonic swine kidney cells using 50 μg/ml trypsin in the culture medium. Fecal samples from infected pigs were filtrated and used directly for infection. However, maximal CPE was evident 4–5 days after inoculation of cell monolayers, the CPE was not formed if trypsin was removed from the medium or if the virus inoculum was mixed with convalescent phase serum.62 Chicken astroviruses were successfully adapted to both chicken embryo liver (CEL) and chicken hepatocellular carcinoma (LMH) cells. Tracheal swabs, lymphocytes, and intestine homogenates from infected chickens were particularly used as a source of the virus. Duck astroviruses were also adapted to these cells (CEL and LMH) without the addition of trypsin to the medium.46 Adaptation of turkey astrovirus to avian (as turkey and chicken embryo-derived cells) and mammalian (e.g. CaCo-2, vero) cell lines was unsuccessful, although they could be replicated in turkey embrionated eggs.63–65 Astroviruses from other vertebrates, like lambs,15 red deer,17 cats26 and dogs13,14 have also been isolated in cell cultures, but serial passage of the virus has not been performed. 3.1.2.4 Transmission Astrovirus can be transmitted through the fecal-oral route, by person-to-person contact, from fecally contaminated fingers to foods or to work surfaces and door handles. There is a significant risk of contamination from field workers who do not have adequate on-site toilet and hand-washing facilities.56 Astroviruses can be disseminated over a wide area in aerosol droplets (produced by vomiting), which is a particular hazard for exposed food or surfaces with subsequent transfer to foods.
Molecular Detection of Foodborne Pathogens
Astroviruses can be transferred with contaminated food and water from different origins.52,66–70 Sequence analysis of HAstV strains detected from both clinical samples and water supplies verified that water could be an important source for HAstV contamination, because virus strains from both origins were identical, at least in the specific genome region analyzed.69 It was shown, that poliovirus can infiltrate into the roots and body of plants from the soil,71 and consequently it is probable, that astroviruses also have the same feature. 3.1.2.5 Pathogenesis Pathogenesis of human astrovirus infections has been extensively studied. Recent histopathologic examinations show that astrovirus infects the mature epithelial cells of the small intestine, especially in the jejunum and in the duodenum.72 Severe diarrhea caused by villus atrophy in the intestine suggests that the inflammatory response does not play an important role in the pathogenesis of astrovirus.72 Other mammalian astroviruses can infect epithelial cells (OAstV, BAstV), subepithelial macrophages (OAstV), as well as M cells (BAstV) of the small intestine.73,74 OAstV particles were also observed in vacuoles of the enterocytes.73 OAstV infection was characterized by transient villus atrophy and crypt hypertrophy, which resulted in severe diarrhea after 2–4 days of infection. BAstV was unable to induce diarrhea in gnotobiotic animals, nevertheless, inflammatory mononuclear cells above the dome villi were observed on infection with this virus.74 In addition, the lamina propria was infiltrated with neutrophils and cells with degenerate nuclei were present. Lymphoid cell depletion was noted in the central region of germinal centers beneath the infected dome villi. In the case of turkey astrovirus 2 (TAstV-2) infection, mild crypt hyperplasia was observed after 1 day of infection in the proximal jejunum, while after 3–5 days of infection the same manifestation was observed in the distal jejunum and ileum, as well as in the duodenum.75 Electron microscopy studies revealed intracytoplasmic astrovirus aggregates in enterocytes on the sides and base of villi in the ileum and distal jejunum on day 3 postinfection. Astrovirus infection do not cause inflammation in humans72 and turkeys,65 but induce apoptosis in cultured cells,76 which suggest that this form of programmed cell death, could contribute to diarrhea in some species. Several other mechanisms could also contribute to the gastroenteritis due to astroviruses.
3.1.3 Clinical Features 3.1.3.1 Characteristics of Human Illness HAstV are the causative agents of viral gastroenteritis worldwide mainly in children (under the age of 5). Within the four childhood gastroenteritis virus (rotavirus, enteric adenovirus, astrovirus and calicivirus) HAstV is the second most common viral agent that causes diarrhea in young children evaluated in outpatient settings.26 Astrovirus infections have also been recognized in elderly, institutionalized patients77,78 and
37
Astroviruses
immunocompromised individuals. HAstV type 1 has been detected as the predominant strain in most countries.22,51 However, the incubation period in most HAstV infections is 3–4 days; a shorter incubation time of 24–36 hours was also documented during an outbreak of gastroenteritis in a Japanese kindergarten.79–81 Generally, human astroviruses induce a mild, watery diarrhea that typically lasts for 2–3 days, associated primarily with vomiting, fever, anorexia, abdominal pain and a variety of constitutional symptoms lasting no more than 4 days.22,82 Dehydration also can occur in patients with underlying gastrointestinal disease, poor nutritional status, or mixed infections83 (Table 3.1). Prolonged lactose intolerance and sensitivity to cow’s milk have been described.84,85 Persistent gastroenteritis due to astrovirus has been associated with serotype 3.86 Deaths related to astrovirus infection are extremely rare, although have been reported.87 Severe intussusception caused by HAstV infection was also documented in a child hospitalized with gastroenteritiss.88 In an Argentinean outpatient study with children under 36 months of age, astrovirus was associated with 12.4% of the diarrhea episodes; fever was present in 41.6%, and 16.7% of the patients required hospitalization.89 In Egypt among children under the age of 3 years, the total incidence of diarrhea due to astrovirus was equal to rotavirus; and severe dehydration arose out of 17% of astrovirus infected patients.90 Astroviruses cause infection at relatively low doses in humans, and appear in food which are usually obtainable in easy-to-use form, and therefore are not subjected to cooking conditions that kill them. Infected food workers may shed virus for longer periods of time, and for that reason may remain infectious even after full recovery.92 In children it may be difficult to distinguish diarrhea caused by astrovirus from that caused by rotavirus on clinical grounds alone.22,26 However, in general astrovirus diarrhea is less severe when compared to symptomatic rotavirus infection, as it does not cause significant dehydration and patients are less likely to require hospitalization.26,45,85 3.1.3.2 Role in Immunocompromised Hosts HAstVs cause chronic diarrhea among immunosuppressed patients in all age groups. HAstVs cause infection more frequently in patients with several immune diseases, such as chronic lymphocytic leukemia, congenital T-cell immunodeficiency, human immunodeficiency, combined immunodeficiency, Waldenstrom’s macroglobulinaemia and immunodeficiency polyendocrinopathy.93–96 Depletion of CD4 + T-cells by disease or iatrogenic means (for example chemotherapy) develops prolonged astrovirus diarrhea.93,97,98 Among HIV-infected patients, several viruses (for example astroviruses, adenoviruses, picobirnaviruses) were found more often in the stools of those with diarrhea (n = 65) than those without diarrhea (n = 65).95 HAstVs have been associated with outbreaks in bone marrow transplant patients.99 Chronic astrovirus diarrhea has been published in a child, who received a bone marrow transplant for combined immunodeficiency.22 The infection persisted until the child’s death, but no antibodies to astroviruses were detected in the serum.
Table 3.1 Clinical Symptoms Associated with Human Astrovirus Infection Diarrhea
Incidence 72–100% Duration 2–3 days (average) Maximum number of stools 4/24 hours Incidence of bloody diarrhea 0% Abdominal pain Incidence 50% Vomiting Incidence 20–70% Duration 1 day (average) Maximum number of vomiting 1/24 hours Fever Incidence 20–25% Maximum 37.9°C Dehydration Incidence to a degree 24–30% Incidence of severe dehydration 0–5% Hospitalization Incidence 6% Duration 6 days (average) Bronchiolitis Incidence 33% Otitis Incidence 13% Severity score (1–20)* 5 (average) Admission diagnosis of gastroenteritis 18.7–48% Source: Adopted from Walter, J.E., Mitchell, D.K., Curr. Opin. Infect. Dis., 16, 247, 2003. *20 points scoring system according to Ruuska and Vesikari.91
3.1.3.3 Immunity At present the determining factors of immunity to astrovirus are not well understood. Astroviruses primarily infect two age groups (young children and the elderly) and institutionalized patients. The age distribution of symptomatic infection suggests that antibodies to astrovirus acquired in childhood provide a certain protection from illness through adult life and that immunity decreases late in life. Studies revealed that in volunteers with detectable serum astrovirus antibody, diarrhea did not manifest clinically after virus challenge.79 Indirect evidence suggests that astrovirus-specific antibodies play a role in limiting infection in the host. Gamma globulin pools in the USA and Japan contain antibodies to human astroviruses, suggesting that astrovirus infection is common.81,100 Studies in the UK have shown that antibodies to astrovirus are acquired in early childhood; 70% have antibody by school age, 75% by 10 years of age, and 77% by early adulthood.101 The normal mucosal immune system is important in the protection of individuals from repeated human astrovirus infections.102 CD4 + T-cells that recognize human astrovirus antigens in a human leukocyte antigen (HLA)-restricted manner have been found in the lamina propria of intestinal tissue of healthy adults.102 Upon activation, these human astrovirus CD4 + T-cells may play a role in preventing repeated astrovirus infections by production of helper T-cell subtype 1-type cytokines, interferon gamma and tumor necrosis factor, providing a defense barrier at the portal of entry.
38
The role of the humoral immune response in animals to restrict astrovirus infection is not clear. It was demonstrated, that virus replication in small turkeys infected with TAstV was limited, however the infection did not induce significant adaptive immune response. No protection was observed against TAstV on secondary challenge; and the restricted virus replication was attributed to an inherent response, cured by production of nitric oxide.103
3.1.4 Epidemiology Human astrovirus infections have been detected worldwide, principally in young children suffering from diarrhea.9,77,95,104,105 Human astroviruses cause disease in (i) infants and young children, (ii) elderly institutionalized patients, (iii) immunocompromised hosts, and (iv) otherwise healthy individuals that come into contact with astrovirus-contaminated food or water. Studies in Australia,106 Thailand26 and Guatemala83 have revealed HAstV as the second most common cause of gastroenteritis in children, after rotavirus, with incidences varying from 4.2% to 8.6%. Large outbreaks caused by astroviruses through contaminated food, which affect thousands of persons in Japan, have been reported among otherwise normal school-age children and adults.107,108 Age distribution of HAstV can vary. In a Spanish study, 80% of children under 3 years of age were infected with astroviruses.109 In Egypt age-specific HAstV and rotavirus incidences were similar (0.38 for infants under 6 months, 0.40 for infants between 6 and 11 months, and 0.16 for children 12–23 months).90 Astrovirus infections occur primarily in the winter months in temperate regions and in the rainy seasons in more tropical climates.45,83 HAstV type 1 has been detected as the predominant strain in most countries,48,69,106,110 and the circulation of other types in a given period is probably less frequent throughout the year in any single geographic area, but the most common serotype can vary with time and location. Hence, in the UK 72% of the community-acquired astroviruses, detected between 1975 and 1987 were serotype 1,22 while in Australia serotypes 1, 3, and 4 were most frequently found in an 18-year period.111 In Mexico, astrovirus type 2 was the predominant strain (35%).112 Although in a study in 2004, where samples were analyzed from different regions of Mexico, types 1, 2, 3, 4, 6, 7, and 8 were found, and in a region, frequency of serotype 8 and type 1 was the same.113 Both community-acquired26,85 and nosocomial9,84 infections have been described. 3.1.4.1 Role in Disease Until recently it was complicated to determine the real incidence of astrovirus infection and its role in disease, partly due to the frequency of coinfections with other pathogens.45 Development of more sensitive detection methods has clarified their role in gastroenteritis in different populations. Astroviruses frequently cause outbreaks of diarrhea in child care centers, and children less than 36 months of age attending child care settings are at the greatest risk of developing
Molecular Detection of Foodborne Pathogens
diarrhea.114 In several parts of the world astroviruses are known to be the main cause of viral diarrhea in young children.1 Astroviruses were identified as a foodborne pathogen only within the last 30 years, though they have probably been causing foodborne infections for centuries. Astroviruses are estimated to participate in less than 1% of all foodborne illness, similar to rotaviruses,2 which mean 39000 cases per year out of 3.9 million total cases due to viruses.2 Although, weaknesses and variations in foodborne disease surveillance systems (where such programmes exist at all), make the global estimation of foodborne diseases difficult. Symptoms of astroviral foodborne infection range from mild gastroenteritis to severe life-threatening syndromes. The seriousness of foodborne illness caused by astroviruses is dependant on the number of infective virus particles, moreover the age, genetic background, and general immune, health and nutrition status of the infected person, as well as the efficiency of sanitation systems. Thus foodborne diseases most seriously affect children, pregnant women, the elderly, and people already suffering from other diseases causing severe illness. Any food that has been handled manually and not at all or insufficiently heated is a possible source of astrovirus infection.115 Contamination of fresh produce by the astrovirus-containing fecal material frequently causes foodborne illnesses. The source of this contamination can vary from an infected person that has contact with food, to an entire harvesting area subjected to inefficiently or even untreated sewage or sludge (which is commonly used as fertilizer), and polluted water for irrigation.56 Bivalve molluscan shellfish can concentrate astroviruses from large volumes of water, allowing accumulation of virus from fecally contaminated water. 3.1.4.2 Antibody Acquisition and Prevalence Antibodies to astrovirus are generally acquired in early childhood. In 1978, an examination of 87 children under 10 years of age in the Oxford region of the UK demonstrated a rapid increase in antibody prevalence from 7% in 6–12-month-old babies, to 70% by school age.101 Astrovirus antibodies could be detected in 75% of the 10-year-old children. Young adults were also examined, and 77% had antibodies to astrovirus. In this study HAstV antibodies were detected by immunofluorescence of astrovirus infected cells; consequently, the prevalence of astrovirus in the population was likely underestimated. In a seroprevalence study among hospitalized children in the UK rates of 86% for serotype 1, 1% for type 2, 8% for serotype 3, and 6% for serotype 4 were reported.116
3.1.5 Laboratory Diagnosis Table 3.2 summarizes the current diagnostic methods for astroviruses. Most studies of astrovirus detection in food have focused on shellfish. Different protocols have been developed for the detection of astroviruses from foodstuffs; and comparative studies are needed to determine which assays should be recommended.117 The detection of astroviruses from any type of food sample without an effective concentration
39
Astroviruses
Table 3.2 The Current Diagnostic Techniques for Astroviruses Method Electron microscopy (EM)
Specimen
Sensitivity
Reagents
Negative stained fecal 106 to 107 virus specimens particles per gram of feces119 105 to 106 particles per gram of stool
• Organic solvents, resin, • Aqueous (or alcoholic) solutions of heavy metal stains
Enzyme immunoassay (EIA)
Clinical samples25
Molecular techniques (molecular probes, reverse transcriptionpolymerase chain reaction/RT-PCR/)
Both clinical and environmental samples69,118,120–125
• A group reactive monoclonal antibody (8E7) • Viral antigen • A polyclonal antiserum as the detector antibody • Commercial kit is available (DAKO Corporation,Carpenteria, CA) • Probe (fragment of astrovirus genome) in the case of molecular probes • Extracted astrovirus nucleic acid • Primers (oligonucleitodes from different regions of the genome)29,53,126,127 • Deoxinucleotides • Reverse transcriptase • Polymerase
Cell culturing
Both clinical and environmental samples
Immunoelectron microscopy (IEM)
Comparable sensitivity (91%) and specificity (98%) to IEM (105 to 106 particles per gram of stool)
• Molecular probes: 105 to 106 particles per gram of stool119 • RT-PCR: ten to 100 particles per gram of feces119
Media, trypsin
Limitations/Requirements • A lack of specific antibodies to every serotype119 • Experienced microscopist • Only 10% of the astroviral particles in a given specimen display the distinctive surface star-like structure54 • Cannot be used for looking for the lower concentration of virus particles present in contaminated food or water
• Knowledge of human astrovirus genomes • The high variability in the genomic sequence does not allow the use of universal primers for all members of the family, Astroviridae36 • Fail to distinguish between infectious and noninfectious virus particles • Diagnostic methods for the detection of astroviruses or viral RNA in food and water have not been adopted to routine laboratories in most parts of the world • Naturally occurring inhibitors can hamper the PCR reaction. Therefore, the incorporation of an internal nucleic acid standard into each RT-PCR tube is important to identify inhibitors and eliminate false negatives • Requires the extraction of the viral RNA from the sample (e.g. with borate buffer, glycine solution, saline beef, proteinase K digestion, washing of food samples with guanidinium thiocyanate, adding PBS to the food sample, then extract with Freon) • More sensitive real-time RT-PCR has been developed • Have also been used to confirm the presence of astrovirus in EIA-positive samples28,95,104. Good correlation between EIA and RT-PCR has been observed, although it was demonstrated that in some cases RT-PCR has a higher sensitivity than EIA in detecting astrovirus28 • Have also been used to detect astrovirus genome in animals, such as minks128 and turkeys129 • Time-consuming, unreliable, expensive • Requires trypsin for isolation from primary specimens • Polluted water and shellfish samples are usually toxic for cell cultures
40
procedure and appropriate virus detection method is difficult and frequently unsuccessful. Several concentration methods have been developed in recent years. Concentration and purification of virions from shellfish rely on physicochemical procedures,118 such as polyethylene glycol (PEG) 6000 or 8000 precipitation, organic flocculation, or application of positively-charged virosorb filters. In addition, many different viral detection techniques have been used, ranging from tissue culture methods to nucleic acid hybridization. It is important to apply a method, which is flexible, inexpensive and can be used without extensive pH treatment or use of multiple reagents. Furthermore, it can be used in a minimally equipped laboratory and by staff with a minimal level of training. The traditional technique for detection of astroviruses is to isolate them in tissue culture. The isolation of astroviruses from food samples is not an easy task. Bacterial contaminations from shellfish also create difficulties in virus propagation in cell cultures. Treating samples with large amounts of antibiotics or chloroform might be effective, but toxic effects cannot be excluded. Therefore, at present, molecular techniques (such RT-PCR, real-time PCR, or immunomagnetic beads-PCR) offer the best alternative to develop sensitive and specific methods for the detection of astroviruses from environmental samples.130 Unfortunately, molecular techniques fail to distinguish between infectious and noninfectious virus particles, which may be a critical point in environmental virology and infection control.131 Although, the RNA genome does not remain intact without the protective capsid in an RNase-rich environment; therefore, if the genomic RNA could be detected by amplification, there is a good reason to suppose that viruses are infective. Virus detection in other foods, such as lettuce, strawberry, deli meats (ham, turkey, and roast beef), and green onion is not general.132
3.1.6 Treatment and Prevention Astrovirus gastroenteritis is generally characterized as a mild, self-limiting diarrhea with or without nausea and vomiting. The infection can strike down the individual for a few days, but does not require specific therapy. Although, more severe disease can develop in patients who have other medical problems, such as underlying gastrointestinal disease, malnutrition, immunodeficiency, coinfection with other pathogens(s) or prolonged illness. In addition, dehydration in young children may demand oral or intravenous fluid resuscitation. Intravenous immunoglobulin may be a beneficial adjunct in patients with severe immunodeficiency who have no response to conservative therapies,93 however, subsequent studies are required to determine effectiveness and to ascertain indications. Determinant of prevention of astrovirus infection is to break transmission, particularly in hospitals and other institutions, day-care centers, and families where person-to-person transmission is probable. Immunization against astroviruses is the ideal solution to prevent outbreaks, considering that
Molecular Detection of Foodborne Pathogens
astrovirus is a medically important pathogen.26,83 Vaccine development is not current, because the actual importance of astroviruses, as well as key factors of immunity are not well understood. Nevertheless, a prophylactic vaccine can play a remarkable role in reducing the incidence of food- and waterborne infections caused by astrovirus. Until then, general hygienic procedures, such as hand washing, disinfection of probably contaminated areas, surfaces (associated with feces or vomits containing astrovirus) with chlorine-based detergents, wearing of gloves for all points in the food chain where foodstuffs are handled manually, and appropriate treatment of potable water can prevent foodborne outbreaks and diseases due to astroviruses. It is also essential to not grow or wash foodstuffs in fecally contaminated water. Moreover, pasteurization procedures, disease control in animals, better regulation of shellfish beads, improvement in the safety of animals own feed and water supply, and protection from manure can prevent outbreaks; primarily because general hygienic procedures are not always sufficient to reduce astroviral infections and contamination.
3.2 Methods 3.2.1 Sample Preparation Frequently used virus concentration methods are summarized in Table 3.3, and general sample preparation and detection procedures of astroviruses from food samples are shown in Table 3.4. Food samples are usually obtained from cafeterias, coastal waters, as well as shellfish growing areas, and stored at 4°C, for a maximum of 24 hours until further processing. Generally, cold storage temperatures (2–8°C) delay senescence, product browning and growth of microorganisms in minimally processed fruits as well as vegetables, however promote the survival of astroviruses. Although, most studies of astrovirus detection in food have focused on shellfish. Shellfish are generally shucked, and the stomach and digestive verticula are removed by dissection, and frozen (–20°C) until analysis. For analysis, 20–25 g tissues need to be thawed on ice, then homogenized (e.g. in tryptose phosphate broth (TPB)-glycine buffer) and—in some cases—sonicated before virus concentration and nucleic acid extraction. In order to prevent cross-contamination, it is recommended to sterilize the homogenizing part of the blender with ethanol (70%) and to heat for 1 min after each sample. Some detailed sample preparation procedures are introduced in Section 3.2.3. Here we provide three step-wise protocols (Figures 3.3 through 3.5) for preparation of mussel, food and shellfish for RT-PCR detection of astroviruses.
3.2.3 Detection Procedures (i) Extraction of viral RNA: Viral RNA is prepared with one of the methods outlined in Figures 3.3 through 3.5. (ii) RT-PCR: The type-common primer pair Mon2/ PRBEG (Mon2, 5′ GCT TCT GAT TAA ATC AAT
41
Astroviruses
Table 3.3 Frequently used Virus Concentration Techniques from Foods Method
Reagents and Equipment
Underlying Priniciples
Hydroextraction
Homogenized sample in dialysis bag surrounded by polyethylene glycol
Viruses remain inside the bag, at 4°C, complete within 18–24 hours
Ultracentrifugation
Homogenized sample
Ultrafiltration
Homogenized sample, membrane
Adsorption to membrane filters Precipitation
Homogenized sample, positive/ negative filter Homogenized sample, PEG
Centrifuge at speeds above 50000 rpm Sample is driven through a membrane by applying pressure, viruses and macromolecules are retained Membrane filters retain viruses Add 8% PEG
Advantages/Disadvantages –Low recovery –Viruses are sometimes adsorbed to the dialysis membrane, –Toxic substances present in food may inactivate viruses during the 24-hour incubation period –Ultracentrifuge is very expensive –Good recovery, –Clogging of the filter
–Clogging, –Membrane coating components –Simple, cheap, –Good recovery
Table 3.4 General Sample Preparation and Detection Procedures of Astroviruses from Food Samples Concentration Homogenization, centrifugation Homogenization, sonification, centrifugation Homogenization in 1:7 (wt/vol) 10% TPB-0.05 M glycine (pH 9), centrifugation Homogenization, ultracentrifugation
Viral extraction or elution PEG 6000 centrifugation Freon TF centrifugation
Viral nucleic acid extraction Proteinase K, phenol-chloroform extraction, ethanol precipitation Mix of glass powder matrix and guanidine isothiocyanate
Detection
Reference
RT-PCR, hybridization
124
Nested RT-PCR
133
Chloroform extraction, PEG 6000 precipitation
Proteinase K digestion , phenolchloroform extraction, ethanol precipitation
RT-PCR, cell culture
33
Glycine buffer, PBS, centrifugation,
Guanidinium thiocyanate-silica particles
(nested) RT-PCR
134
TTT 3′; PRBEG, 5′ ACC GTG TAA CCC TCC TCT C 3′) targeting the hypervariable 3′ end of ORF2 region of astrovirus types 1–3 to 5–8, as well as Mon2/JWT4 (JWT4, 5′ GCA GAG AGC TTG TTA TTA AC 3′) for HAstV-4 are used for detection of HAstV by RT-PCR. These primers yield amplicons from 296 to 332 bp depending on the different HAstV types.136 (1) Prepare reverse transcription mixture (25 μl per tube) containing 0.1% bovine serum albumin, 0.4 mM dNTP mix (Promega, Madison, WI), 2 U AMV-RT (avian myeloblastosis virus RT, Promega, Madison, WI), 4 U RNasine (RNase inhibitor, Promega, Madison, WI), 0.05 μM dithiothreitol (Promega, Madison, WI), 2 μM
negative-strand primer (Mon2) and 5 μl RNA suspension in the reaction buffer (10 mM Tris, 50 mM KCl, 3 mM MgCl2, pH 8.3). (2) Incubate the tubes for 1 hour at 42°C. (3) Prepare PCR mixture (25 μl per tube) containing 10% dimethyl sulfoxide (Sigma, St. Louis, MO), Taq polymerase and 1 μM positive-strand primer (PRBEG, JWT4 or DM4 [DM4, 5′ CTA CAG TTC ACT CAA ATG AA 3′]) in the reaction buffer (same as the RT). (4) Transfer the total volume (25 μl) of cDNA from step 2 into each tube containing 25 μl PCR mixture. Perform PCR amplification with an initial denaturation at 94°C for 3 min, followed by 40 cycles of amplification; denaturation at 94°C for
42
Molecular Detection of Foodborne Pathogens
Homogenize (1 min, 9,500 rpm), then stir on magnetic stirrer (15 min) Sonicate (1 min, 100 W), centrifuge (10,000 × g, 90 min, 4°C)
Virus extraction
Grind the mussel tissue (3 min, 10,000 rpm), then add 100 ml 1 M borate-3% beef extract buffer pH 9
Adjust the pH to 7.3, then supplement the extract with 10% (final concentration) PEG 6000
Centrifuge (10,000 × g, 90 min, 4°C) Resuspend the pellet in 12 ml Na2HPO4 (pH 9) with vigorous magnetic stirring
Concentration
Incubate overnight at 4°C
Centrifuge (1,500 × g, 20 min, 4°C), then adjust the pH to 7.2 Extract RNA (RNA-PLUS purification kit; Bioprobe Systems, Montreuil, France or phenolchloroform extraction), resuspend the RNA pellet in 25 µl diethyl pyrocarbonate-treated water RT-PCR
Figure 3.3 Protocol I: preparation of mussel sample for RT-PCR detection of astroviruses (based on Traore et al., Appl. Environ. Microbiol., 64, 3118, 1998.) Wash the food (20–40 g) 3× with 40 ml PBS, mix for 5 min Freon extract (add 70 ml Freon, for 5 min, centrifugation [5,000 × g, 10 min, 4°C]) PEG precipitate (add 10% PEG 6000 and 0.3 M NaCl, incubate: 2 h, 4°C; centrifugation [7000 × g, 30 min, 4°C]) Extract the pellet with 8 ml TRIzol Clarification (centrifugation [8000 x g, 20 min, 4°C] Phenol/chlorophorm extract (add 1.6 ml chloroform to the aqueous phase, mix for 15 sec; incubation: 3 min, room temperature; centrifugation: 8000 × g, 20 min, 4°C; mix the aqueous layer with 4 ml isopropanol for 30 sec; incubation: 10 min, room temperature; centrifugation: 8000 × g, 20 min, 4°C) Precipitate viral RNA (wash the pellet with 8 ml 70 % ethanol; centrifugation: 7000 × g, 5 min, 4°C; air dry the pellet; suspend in 100 µl RNase-free water; store at –80°C RT-PCR amplification
Figure 3.4 Protocol II: preparation of food sample for RT-PCR detection of astroviruses (according to Schwab et al., Appl. Environ. Microbiol., 66, 213, 2000.) Homogenize 25 g shellfish in TPB-0.05 M glycine (pH 9.0–9.5) (5 min), then sonicate (2 min, 100 W) Concentration: centrifugation (3000 × g, 30 min, 4°C), adjust supernatants pH to 7.2–7.4 add PEG 6000 (8%;wt/vol), stir: 2 h, 4°C, then repeat centrifugation Detoxification: resuspend pellet in 5 ml 0.15 M Na2HPO4 (pH 9.0–9.5), sonicate 2 times (30 sec, 100 W) centrifugation (10000 × g, 30 min, 4°C), adjust supernatants pH to 7.4 Purification: add PBS to 15 ml final volume, then extract 5 times with Freon TF centrifugation (3000 × g, overnight, 4°C) over membrane filter Nucleic acid extraction: lyse with 6.6 M guanidine isothiocyanate, bind nucleic acid to silica particles, wash with guanidine isothiocyanate, ethanol and acetone Elution: TE buffer at 56°C, ethanol precipitate: add 0.1 vol. sodium acetate and 2 volume ethanol, leave at –70°C, 30 min, centrifuge at 20000 × g, 20 min, 4°C RT-PCR assay
Figure 3.5 Protocol III: preparation of shellfish for RT-PCR detection of astroviruses (based on Lees et al., Appl. Environ. Microbiol., 60, 2999, 1994.)
Astroviruses
1 min, annealing at 50°C for 1 min, and elongation at 72°C for 1 min. The final extension is at 72°C for 10 min. (5) Separate PCR products by agarose gel (3%) electrophoresis in Tris–boric acid EDTA buffer, pH 8.0, containing ethidium bromide (0.5 μg/ml), and visualize amplicons by UV-transillumination at 320 nm. (iii) Sequencing and phylogenetic analysis: The amplicons from the 3′ end of ORF2 obtained above are cloned into pGEM-T vector (Promega, Madison, WI) following the manufacturer’s instructions. Two different clones of the same RT-PCR amplicon are sequenced using fluorescein-labeled primers and commercial sequencing kit (SequiTerm EXCEL II Long-Read DNA Sequencing Kit-ALF, Epicentre Technologies, Madison, WI) on an automated sequencer (ABI 310, Applied Biosystems, Foster City, CA) following the manufacturer’s recommendations. Basic sequence manipulation and verification are performed using OMIGA software (v.2.0 Accelrys Co., San Diego, CA). Nucleotide sequences of the Hungarian strains are compared to available reference strains and a genotype is assigned based upon similarity scores. Viruses with 97–100% nucleotide identity in the 3’ end of ORF2 region of the genome are considered the same strain. In order to obtain a more accurate and reliable comparison, phylogenetic analysis is performed on representative strains using a longer, approximately 1.2-kb region (Mon2/DM4) of the 3’ end of ORF2. ClustalW v1.7 (http://evolution.genetics.washington.edu) is used to create multiple alignments of the amino acid sequences of the selected partial capsid sequences. The nucleotide sequences are added and aligned by GeneDoc v2.3 (http://www.psc. edu/biomed/genedoc) using the corresponding amino acid sequences as template, resulting in a consensus length of 1183 nucleotides terminating at the 3’ end of ORF2. A phylogenetic tree is constructed from the nucleotide sequence alignment using the maximum-likelihood algorithm in the program DNAML of PHYLIP v3.52c (http://evolution.genetics.washington.edu/phylip) running in a UNIX environment. The global rearrangement option is invoked and the order of the sequence input is randomized 50 times. The analysis is performed unrooted.
3.3 Conclusions and Future Perspectives Since astrovirus is one of the main four viruses that cause foodborne infections, studies are needed to estimate the burden and cost of illness caused by foodborne astroviral infections, especially among susceptible individuals. Therefore, better surveillance systems are required. Molecular investigation of astroviruses throughout the whole food chain and through populations is also essential. The burden of
43
foodborne illnesses due to astrovirus is highest in the elderly, and as a result of aging populations it will probably increase in the following years.137 The extreme stability of astroviruses in the environment and their highly infectious nature contribute to the ease of foodborne transmission. Infected foodhandlers play a well known role in transmission of astrovirus. Nevertheless, virus contamination may occur anywhere in the food chain, consequently the role of the infected agricultural laborer should be taken into consideration. The use of sludge as fertilizer and wastewater for irrigation increase the risk for viral contamination. There is a need to develop quick and simple molecular methods for detection of astroviruses from foodstuffs, and to urge rapid exchange of typing information between food laboratories and countries. New methods should be comparable and need to be standardized. Further studies are needed to evaluate the applicability of these methods in food microbiology.137 Molecular methods may play an important role to better understand foodborne astroviral outbreaks. Further studies are needed both to evaluate the mechanism of emergence of epidemic strains and the plausible link with animal astrovirus infections. There is a need for international cooperation as well as a well-organized public health system with the involvement of researchers to find solutions for foodborne astroviral outbreaks. Development of rapid detection methods to combine epidemiological and virological information is also necessary in the limitation of foodborne outbreaks. Contaminated products usually have a normal look, smell and taste, which present difficulties in the identification of astrovirus. Also, appropriate astrovirus detection methods are in general, not routinely available in food microbiology laboratories. While routine cell culture methods isolate astroviruses easily from blood or other sterile sites, specific methods are necessary to identify them from foodstuffs. A primary obstacle of linking epidemic outbreaks with foods is to detect the small amount of viruses that may be present in foodstuffs. In addition, by the time the infection is clinically manifest, the food under discussion has been consumed or discarded. In most countries the surveillance infrastructure for foodborne diseases of microbiological (or chemical) etiology, is weak or nonexistent. Moreover, in many countries, principally in the developing world, laboratory resources and skills to identify astroviruses are inadequate, and etiology-specific surveillance is often not possible. Even in the developed countries, laboratory-based surveillance is not well advanced. Absence of a simple and reliable diagnostic test to detect astroviruses in food makes surveillance difficult. Currently available routine monitoring systems focus on bacterial pathogens. Nowadays, directives establish no specific microbiological criteria concerning the presence of enteric viruses in food or water; nonetheless it has clearly been shown, that no correlation between the presence of HAstVs and indicators of fecal pollution was found. Further investigations are needed to establish possible correlations between fecal contamination and HAstVs as viral
44
contaminants.138 Nevertheless, the shortcomings of standard indicator organisms: fecal coliform bacteria, Escherichia coli, and Salmonellae as generally accepted indicators of fecal contamination of food, have been highlighted in several studies,139,140 and this has led to calls for a reassessment of quality guidelines based on these indicator organisms. The food industry and the scientific community should work together to develop an integrated plan of action to address foodborne astroviral infections.
References
1. Matsui, S.M., Greenberg, H.B. Astroviruses. In: Field’s Virology, 4th ed. Knipe, D.M. and Howley, P.M. (eds.). Lippincott Williams & Wilkins, Philadelphia, PA, 875–894, 2001. 2. Mead, P.S., Slutsker, L., Dietz, V., McCaig, L.F., Bresee, J.S., Shapiro, C., Griffin, P.M., Tauxe, R.V. Food-related illness and death in the United States. Emerg. Infect. Dis. 5, 607, 1999. 3. Madeley, C.R., Cosgrove, B.P. 28 nm particles in faeces in infantile gastroenteritis. Lancet 2, 451, 1975. 4. Madeley, C.R. Comparison of the features of astroviruses and caliciviruses seen in samples of feces by electron microscopy. J. Infect. Dis. 139, 519, 1979. 5. Risco, C., Carrascosa, J.L., Pedregosa, A.M., Humphrey, C.D., Sánchez-Fauquier, A. Ultrastructure of human astrovirus serotype 2. J. Gen. Virol. 76(Pt 8), 2075, 1995. 6. Matsui, S.M., Kiang, D., Ginzton, N., Chew, T., GeigenmüllerGnirke, U. Molecular biology of astroviruses: selected highlights. Novartis Found Symp. 238, 219, 2001. 7. Bass, D.M., Qiu, S. Protelolytic processing of the astrovirus capsid. J. Virol. 74, 1810, 2000. 8. Méndez, E., Fernandez-Luna, T., Lopez, S., Méndez-Toss, M., Arias, C.F. Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein. J. Virol. 76, 7996, 2002. 9. Appleton, H., Higgins, P.G. Viruses and gastroenteritis in infants. Lancet 1, 1297, 1975. 10. Caul, E.O., Appleton, H. The electron microscopical and physical characteristics of small round human fecal viruses: an interim scheme for classification. J. Med. Virol. 9, 257, 1982. 11. Kjeldsberg, E., Hem, A. Detection of astroviruses in gut contents of nude and normal mice. Arch. Virol. 84, 135, 1985. 12. Hoshino, Y., Zimmer, J.F., Moise, N.S, Scott, F.W. Detection of astroviruses in faeces of a cat with diarrhoea. Arch. Virol. 70, 373, 1981. 13. Marshall, J.A., Healey D.S., Studdert, M.J., Scott, P.C., Kennett, M.L., Ward, B.K., Gust, I.D. Viruses and viruslike particles in the faeces of dogs with and without diarrhea. Aust. Vet. J. 61, 33, 1984. 14. Williams, F.P. Jr. Astrovirus-like, coronavirus-like, and parvovirus-like particles detected in the diarrheal stools of beagle pups. Arch. Virol. 66, 216, 1980. 15. Snodgrass, D.R., Gray, E.W. Detection and transmission of 30 nm virus particles (astroviruses) in faeces of lambs with diarrhoea. Arch. Virol. 55, 287, 1977. 16. Woode, G.N., Bridger, J.C. Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves. J. Med. Microbiol. 11, 441, 1978. 17. Tzipori, S., Menzies, J.D., Gray, E.W. Detection of astroviruses in the faeces of red deer. Vet. Rec. 108, 286, 1981.
Molecular Detection of Foodborne Pathogens 18. Bridger, J.C. Detection by electron microscope of caliciviruses, astroviruses and rotavirus-like particles in the faeces of piglets with diarrhoea. Vet. Rec. 107, 532, 1980. 19. Englund, L., Chriel, M., Dietz. H.H., Hedlund, K.O. Astrovirus epidemiologically linked to pre-weaning diarrhoea in mink. Vet. Microbiol. 85, 1, 2002. 20. McNulty, M.S., Curran, W.L., McFerran, J.B. Detection of astroviruses in turkey faeces by direct electron microscopy. Vet. Rec. 106, 561, 1980. 21. Gough, R.E., Collins, M.S., Borland, E., Keymer, I.F. Astrovirus-like particles associated with hepatitis in ducklings. Vet. Rec. 114, 279, 1984. 22. Kurtz, J.B., Lee, T.W. Astroviruses: human and animal. In: Novel Diarrhoea Viruses. Bock, G., Whelan, J. (eds.). Ciba Foundation Symposium. Wiley, Chichester, UK, 92–107, 1987. 23. Lee, T.W., Kurtz, J.B. Serial propagation of astrovirus in tissue culture with the aid of trypsin. J. Gen. Virol. 57, 421, 1981. 24. Herrmann, J.E., Hudson, R.W., Perron-Henry, D.M., Kurtz, J.B., Blacklow, N.R. Antigenic characterization of cell cultivated astrovirus serotypes and development of astrovirus-specific monoclonal antibodies. J. Infect. Dis. 158, 182, 1988. 25. Herrmann, J.E., Nowak, N.A., Perron-Henry, D.M., Hudson, R.W., Cubitt, W.D., Blacklow, N.R. Diagnosis of astrovirus gastroenteritis by antigen detection with monoclonal antibodies. J. Infect. Dis. 161, 226, 1990. 26. Herrmann J.E., Taylor, D.N., Echeverria, P., Blacklow, N.R. Astroviruses as a cause of gastroenteritis in children. N. Engl. J. Med. 324, 1757, 1991. 27. Jonassen, T.O., Monceyron, C., Lee, T.W., Kurtz, J.B., Grinde, B. Detection of all serotypes of human astrovirus by the polymerase chain reaction. J. Virol. Methods 52, 327, 1995. 28. Mitchell, D.K., Monroe, S.S., Jiang, X., Matson, D.O., Glass, R.I., Pickering, L.K. Virologic features of an astrovirus diarrhea outbreak in a day care center revealed by reverse transcriptase-polymerase chain reaction. J. Infect. Dis. 172, 1437, 1995. 29. Saito, K., Ushijima, H., Nishio, O., Oseto, M., Motohiro, H., Ueda, Y., Takagi, M., Nakaya, S., Ando, T., Glass, R. Detection of astroviruses from stool samples in Japan using reverse transcription and polymerase chain reaction amplification. Microbiol. Immunol. 39, 825, 1995. 30. Matsui, S.M., Kim, J.P., Greenberg, H.B., Young, L.M., Smith, L.S., Lewis, T.L., Herrmann, J.E., Blacklow, N.R., Dupuis, K., Reyes, G.R. Cloning and characterization of human astrovirus immunoreactive epitopes. J. Virol. 67, 1712, 1993. 31. Lewis, T.L., Matsui, S.M. Astroviral ribosomal frameshifting in an infection-transfection transient expression system. J. Virol. 70, 2869, 1996. 32. Lewis, T.L., Matsui, S.M. Studies of the astrovirus signal that induces (-1) ribosomal frameshifting. Adv. Exp. Med. Biol. 412, 323, 1997. 33. Monroe, S.S., Jiang, B., Stine, S.E., Koopmans, M., Glass, R.I. Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses. J. Virol. 67, 3611, 1993. 34. Willcocks, M.M., Carter, M.J. Identification and sequence determination of the capsid protein genojme of human astrovirus serotype 1. FEMS Microbiol. Lett. 114, 1, 1993. 35. Krishna, N.K. Identification of structural domains involved in astrovirus capsid biology. Viral Immunol. 18, 17, 2005. 36. Koci, M.D., Schultz-Cherry, S. Avian astroviruses. Avian Pathol. 31, 213, 2002.
Astroviruses 37. Monceyron, C., Grinde, B., Jonassen, T.O. Moleculrar characterisation of the 3’-end of the astrovirus genome. Arch. Virol. 142, 699, 1997. 38. Koci, M.D., Seal, B.S., Schultz-Cherry, S. Molecular characterization of an avian astrovirus. J. Virol. 74, 6173, 2000. 39. Monroe, S.S., Stine, S.E., Gorelkin, L., Herrmann, J.E., Blacklow, N.R., Glass, R.I. Temporal synthesis of proteins and RNAs during human astrovirus infection of cultured cells. J. Virol. 65, 641, 1991. 40. Walter, J.E., Briggs, J., Guerrero, M.L., Matson, D.O., Pickering, L.K., Ruiz-Palacios, G., Berke, T., Mitchell, D.K. Molecular characterization of a novel recombinant strain of human astrovirus associated with gastroenteritis in children. Arch. Virol. 146, 2357, 2001. 41. Jonassen, C.M., Jonassen, T.T.Ø, Sveen, T.M., Grinde, B. Complete genomic sequences of astroviruses from sheep and turkey: comparison with related viruses. Virus Res. 91, 195, 2003. 42. Guix, S., Caballero, S., Bosch, A., Pintó, R.M. C-terminal nsP1a protein of human astrovirus colocalizes with the endoplasmic reticulum and viral RNA. J. Virol. 78, 13627, 2004. 43. Green, K.Y., Ando, T., Balayan, M.S., Berke, T., Clarke, I.N., Estes, M.K., Matson, D.O., Nakata, S., Neill, J.D., Studdert, M.J., Thiel, H.J. Taxonomy of the caliciviruses. J. Infect. Dis. 181(suppl 2), S322, 2000. 44. Monroe, S.S., Carter, M.J., Herrmann, J.E., Kurtz, J.B., Matsui, S.M. Family Astroviridae. In: Virus Taxonomy: Classification and Nomenclature of Viruses. Murphy, F.A., Fauquet, C.M., Bishop, D.H.L., Ghabrial, S.A., Jarvis, A.W., Martelli, G.P., Mayo, M.A., Summers, M.D. (eds). SpringerVerlag, Vienna, Austria, 364, 1995. 45. Walter, J.E., Mitchell, D.K. Astrovirus infection in children. Curr. Opin. Infect. Dis. 16, 247, 2003. 46. Baxendale, W., Mebatsion, T. The isolation and characterisation of astroviruses from chickens. Avian Pathol. 33, 364, 2004. 47. Woode, G.N., Gourley, N.E., Pohlenz, I.F., Liebler, E.M., Mathews, S.L., Hutchinson, M.P. Serotypes of bovine astrovirus. J. Clin. Microbiol. 22, 668, 1985. 48. Koopmans, M.P., Bijen, M.H., Monroe, S.S., Vinje, J. Agestratified seroprevalence of neutralizing antibodies to astrovirus types 1 to 7 in humans in The Netherlands. Clin. Diagn. Lab. Immunol. 5(1), 33, 1998. 49. Kurtz, J.B., Lee, T.W. Human astrovirus serotypes Lancet 2(8416), 1405, 1984. 50. Lee, T.W., Kurtz, J.B. Human astrovirus serotypes. J. Hyg. (Camb.) 89, 539, 1982. 51. Lee, T.W., Kurtz, J.B. Prevalence of human astrovirus serotypes in the Oxford region 1976–92, with evidence for two new serotypes. Epidemiol. Infect. 112, 187, 1994. 52. Taylor, M.B., Cox, N., Vrey, M.A., Grabow, W.O. The occurrence of hepatitis A and astroviruses inselected river and dam waters in South Africa. Water Res. 35, 2653, 2001. 53. Belliot, G., Laveran, H., Monroe, S.S. Detection and genetic differentiation of human astroviruses: phylogenetic grouping varies by coding region. Arch. Virol. 142, 1323, 1997. 54. Monroe, S.S. Molecular epidemiology of human astroviruses. In: Perpectives in Medical Virology. Viral Gastroenteritis. Desselberger, U., Gray, J.J. (eds.). Elsevier, Amsterdam, The Netherlands, 607–616, 2003.
45 55. Williams, F.P. Jr. Electron microscopy of stool-shed viruses: retention of characteristic morphologies after long-term storage at ultralow temperatures. J. Med. Virol. 29, 192, 1989. 56. Seymour, I.J., Appleton, H. Foodborne viruses and fresh produce. J. Appl. Microbiol. 91, 759, 2001. 57. Willcocks, M.M., Carter, M.J., Laidler, F.R., Madeley, C.R. Growth and characterisation of human faecal astrovirus in continuous cell line. Arch. Virol. 113, 73, 1990. 58. Brinker, J.P., Blacklow, N.R., Herrmann, J.E. Human astrovirus isolation and propagation in multiple cell lines. Arch. Virol. 145, 1847, 2000. 59. Taylor, M.B., Grabow, W.O., Cubitt, W.D. Propagation of human astrovirus in the PLC/PRF5 hepatoma cell line. J. Virol. Methods 67, 13, 1997. 60. Taylor, M.B., Marx, F.E., Grabow, W.O. Rotavirus, astrovirus and adenovirus associated with an outbreak of gastroenteritis in a South African child care centre. Epidemiol. Infect. 119, 227, 1997. 61. Aroonprasert, D., Fagerland, J.A., Kelso, N.E., Zheng, S., Woode, G.N. Cultivation and partial characterization of bovine astrovirus. Vet. Microbiol. 19, 113, 1989. 62. Shimizu, M., Shirai, J., Narita, M., Yamane, T. Cytopathic astrovirus isolated from porcine acute gastroenteritis in an established cell line derived from porcine embryonic kidney. J. Clin. Microbiol. 28, 201, 1990. 63. Guy, J.S., Miles, A.M., Smith, L., Fuller, F.J., Schultz-Cherry, S. Antigenic and genomic characterization of turkey enteroviruslike virus (North Carolina, 1988 isolate): identification of the virus as turkey astrovirus 2. Avian Dis. 48, 206, 2004. 64. Koci, M.D., Kelley, L.A., Larsen, D., Schultz-Cherry, S. Astrovirus induced synthesis of nitric oxide contributes to virus control during infection. J. Virol. 78, 1564, 2004. 65. Koci, M.D., Moser, L.A., Kelley, L.A., Larsen, D., Brown, C.C., Schultz-Cherry, S. Astrovirus induces diarrhea in the absence of inflammation and cell death. J. Virol. 77, 11798, 2003. 66. Appleton, H. Small round viruses: Classification and role in food-borne infections. In: Novel Diarrhoea Viruses. Bock, G., Whelan, J. (eds.). Ciba Foundation Symposium 128. Wiley, Chichester, UK, 108–125, 1987. 67. Le Cann, P., Ranarijaona, S., Monpoeho, S., Le Guyader, F., Ferré, V. Quantification of human astroviruses in sewage using real-time RT-PCR. Res. Microbiol. 155, 11, 2004. 68. Maunula, L., Kalso, S., Von Bonsdorff C.H., Pönkä, A. Wading pool water contaminated with both noroviruses and astroviruses as the source of gastroenteritis outbreak. Epidemiol. Infect. 132, 737, 2004. 69. Nadan, S., Walter, J.E., Grabow, W.O., Mitchell, D.K., Taylor, M.B. Molecular characterization of astroviruses by reverse transcriptase PCR and sequence analysis: comparison of clinical and environmental isolates from South Africa. Appl. Environ. Microbiol. 69, 747, 2003. 70. Push, D., Oh, D.Y., Wolf, S., Dumke, R., Schröter-Bobsin, U., Höhne, M., Röske, I., Schreier, E. Detection of enteric viruses and bacterial indicators in German environmental waters. Arch. Virol. 150, 929, 2005. 71. Oron, G., Goemans, M., Manor, Y., Feyen, J. Poliovirus distribution in the soil-plant system under reuse of secondary wastewater. Water Res. 29, 1069, 1995. 72. Sebire, N.J., Malone, M., Shah, N., Anderson G, Gaspar HB, Cubitt WD. Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J. Clin. Pathol. 57, 1001, 2004.
46 73. Snodgrass, D.R., Angus, K.W., Gray, E.W., Menzies, J.D., Paul, G. Pathogenesis of diarrhoea caused by astrovirus infections in lambs. Arch. Virol. 60(3–4), 217, 1979. 74. Woode, G.N., Pohlenz, J.F., Gourley, N.E., Fagerland, J.A. Astrovirus and Breda virus infections of dome cell epithelium of bovine ileum. J. Clin. Microbiol. 19, 623, 1984. 75. Thounevelle, M.L., Haynes, J.S., Reynolds, D.L. Astrovirus infection in hatchling turkeys: histologic, morphometric, and ultrastructural, findings. Avian Dis. 39, 328, 1995. 76. Guix, S., Bosch, A., Ribes, E., Dora Martínez, L., Pintó, R.M. Apoptosis in astrovirus-infected CaCo-2 cells. Virology 319, 249, 2004. 77. Gray, J.J., Wreghitt, T.G., Cubitt, W.D., Elliott, P.R. An outbreak of gastroenteritis in a home for the elderly associated with astrovirus type 1 and human calicivirus. J. Med. Virol. 23, 377, 1987. 78. Lewis, D.C., Lightfoot, N.F., Cubitt, W.D., Wilson, S.A. Outbreaks of astrovirus type 1 and rotavirus gastroenteritis in a geriatric in-patient population. J. Hosp. Infect. 14, 9, 1989. 79. Kurtz, J.B., Lee, T.W., Craig, J.W., Reed, S.E. Astrovirus infection in volunteers. J. Med. Virol. 3, 221, 1979. 80. Midthun, K., Greenberg, H.B., Kurtz, J.B., Gary, G. W., Lin, F. C., Kapikian, A.Z. Characterization and seroepidemiology of a type 5 astrovirus associated with an outbreak of gastroenteritis in Marin County, California. J. Clin. Microbiol. 31, 955, 1993. 81. Konno, T., Suzuki, H., Ishida, N, Chiba, R., Mochizuki, K., Tsunoda, A. Astrovirus-associated epidemic gastroenteritis in Japan. J. Med. Virol. 9, 11, 1982. 82. Greenberg, H.B., Matsui, S.M. Astroviruses and caliciviruses: emerging enteric pathogens. Infect. Agents Dis. 1, 71, 1992. 83. Cruz, J.R., Bartlett, A.V., Herrmann, J.E., Cáceres, P., Blacklow, N.R., Cano, F. Astrovirus-associated diarrhea among Guatemalan ambulantory rural children. J. Clin. Microbiol. 30, 1140, 1992. 84. Esahli, H., Breback, K., Bennet, R., Ehrnst, A., Eriksson, M., Hedlund, K-O. Astroviruses as a cause of nosocomial outbreaks of infant diarrhea. Pediatr. Infect. Dis. 10, 511, 1991. 85. Nazer, H., Rice, S., Walker-Smith, J.A. Clininal associations of stool astrovirus in childhood. J. Pediatr. Gastroenterol. Nutr. 1, 555, 1982. 86. Caballero, S., Guix, S., El-Senousy, W.M., Calicó, I., Pintó, R.M., Bosch, A. Persistent gastroenteritis in children infected with astrovirus: association with serotype-3 strains. J. Med. Virol. 71, 245, 2003. 87. Singh, P.B., Sreenivasan, M.A., Pavri, K.M. Viruses in acute gastroenteritis in children in Pune, India. Epidemiol. Infect. 102, 345, 1989. 88. Jakab, F., Péterfai, J., Verebély, T., Meleg, E., Bányai, K., Mitchell, D.K., Szücs, G. Human astrovirus infection associated with childhood intussusception. Pediatr. Inter. 49, 103, 2007. 89. Giordano, M.O., Martinez, L.C., Isa, M.B., Paez Rearte, M., Nates, S.V. Childhood astrovirus-associated diarrhea in the ambulantory setting in a Public Hospital in Cordoba city, Argentina. Rev. Inst. Med. Trop. Sao Paulo 46, 93, 2004. 90. Naficy, A.B., Rao, M.R., Holmes, J.L., Abu-Elyazeed, R., Savarion, R., Wierzba, T.F., Frenck, R.W., Monroe, S.S., Glass, R.I., Clemens, J.D. Astrovirus diarrhea in Egyptian children. J. Infec. Dis. 182, 685, 2000.
Molecular Detection of Foodborne Pathogens 91. Ruuska, T., Vesikari, T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand. J. Infect. Dis. 22, 259, 1990. 92. Parashar, U.D., Dow, L., Fankhauser, R.L., Humphrey, C.D., Miller, J., Ando, T., Williams, K.S., Eddy, C.R., Noel, J.S., Ingram, T., Bresee, J.S., Monroe, S.S., Glass, R.I. An outbreak of viral gastroenteritis associated with consumption of sandwiches: implications for the control of transmission by food handlers. Epidemiol. Infect. 121, 615, 1998. 93. Björkholm, M., Celsing, F., Runarsson, G., Waldenström, J. Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenstrom’s macroglobulinemia. Int. J. Hematol. 62, 117, 1995. 94. Gallimore, C.I., Taylor, C., Gennery, A.R., Cant, A.J., Galloway, A., Lewis, D., Gray, J.J. Use of a heminested reverse transcriptase PCR assay for detection of astrovirus in environmental swabs from an outbreak of gastroenteritis in a pediatric primary immunodeficiency unit. J. Clin. Microbiol. 43, 3890, 2005. 95. Grohmann, G.S., Glass, R.I., Pereira, H.G., Monroe, S.S., Hightower, A.W., Weber, R., Bryan, R.T. Enteric viruses and diarrhea in HIV-infected patiens. Enteric Opportunistic Infections Working Group. N. Engl. J. Med. 329, 14, 1993. 96. Wood, D.J., David, T.J., Chrystie, I.L., Totterdell, B. Chronic enteric infection in two T-cell immunodeficient children. J. Med. Virol. 24, 435, 1988. 97. Bergmann, L., Fencehl, K., Jahn, B., Mitrou, P.S., Hoelzer, D. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann. Oncol. 4, 371, 1993. 98. Coppo, P., Scieux, C., Ferchal, F., Clauvel, J-P., Lassoued, K. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate. Ann. Hematol. 79, 43, 2000. 99. Cubitt, W.D., Mitchell, D.K., Carter, M.J., Willcocks, M.M., Holzel, H. Application of electronmicroscopy, enzyme immunoassay, and RT-PCR to monitor an outbreak of astrovirus type 1 in a paediatric bone marrow transplant unit. J. Med. Virol. 57, 313, 1999. 100. LeBaron, C.W., Furutan N.P., Lew, J.F., Allen, J.R., Gouvea, V., Moe, C., Monroe, S.S. Viral agents of gastroenteritis. Morbid. Mortal. Wkly. Rept. 39(RR-5), 1, 1990. 101. Kurtz, J.B., Lee, T.W. Astrovirus gastroenteritis age distribution of antibody. Med. Microbiol. Immunol. 166(1–4), 227, 1978. 102. Molberg, Ø., Nilsen, E.M., Sollid, L.M., Scott, H., Brandtzaeg, P., Thorsby, E., Lundin, K.E.A. CD4 + T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology 114, 115, 1998. 103. Mendez, E., Arias, C.F. Astroviruses. In: Field’s Virology, 5th ed. Knipe, D.M. and Howley, P.M. (eds.). Lippincott Williams & Wilkins, Philadelphia, PA, 981–1000, 2007. 104. Cox, G.J., Matsui, S.M., Lo, R.S., Hinds, M., Bowden, R.A., Hackman, R.C., Meyer, W.G., Mori, M., Tarr, P.I., Oshiro, L.S., Ludert, J.E., Meyers, J.D., McDonald, G.B. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 107, 1398, 1994. 105. Moe, C.L., Allen, J.R., Monroe, S.S., Gary, Jr., H.E., Humphrey, C.D., Herrmann, J.E., Blacklow, N.R., Carcamo, C., Koch, M., Kim, K-H., Glass, R.I. Detection of astrovirus in pediatric stool samples by immunoassay and RNA probe. J. Clin. Microbiol. 29, 2390, 1991.
Astroviruses 106. Palombo, E.A., Bishop, R.F. Annual incidence, serotype distribution, and genetic diversity of human astrovirus isolates from hospitalized children in Melbourne, Australia. J. Clin. Microbiol. 34, 1750, 1996. 107. Oishi, I., Yamazaki, K., Kimoto, T., Minekawa, Y., Utagawa, E., Yamazaki, S., Inouye, S., Grohmann, G.S., Monroe, S.S., Stine, S.E., et al. A large outbreak of acute gastroenteritis associated with astrovirus among students and teachers in Osaka, Japan. J. Infect. Dis. 170, 439, 1994. 108. Utagawa, E.T., Nishizawa, S., Sekine, S., Hayashi, Y., Ishihara, Y., Oishi, I., Iwasaki, A., Yamashita, I., Miyamura, K., Yamazaki, S., Inouye, S., Glass, R.I. Astrovirus as a cause of gastroenteritis in Japan. J. Clin. Microbiol. 32, 1841, 1994. 109. Guix, S., Caballero, S., Villena, C., Bartolome, R., Latorre, C., Rabella, N., Simo, M., Bosch, A., Pintó, R.M. Molecular epidemiology of astrovirus infection is Spain, Barcelona. J. Clin. Microbiol. 40, 133, 2002. 110. Mitchell, D.K., Matson, D.O., Cubitt, W.D., Jackson, L.J., Willcocks, M.M., Pickering, L.K., Carter, M.J. Prevalence of antibodies to astrovirus types 1 and 3 in children and adolescents in Norfolk, Virginia. Pediatr. Infect. Dis. J. 18, 249, 1999. 111. Schnagl, R.D., Belfrage, K., Farrington, R., Hutchinson, K., Lewis, V., Erlich, J., Morey, F. Incidence of human astrovirus in central Australia (1995 to 1998) and comparison of deduced serotypes detected from 1981 to 1998. J. Clin. Microbiol. 40, 4114, 2002. 112. Guerrero, M.L., Noel, J.S., Mitchell, D.K., Calva, J.J., Morrow, A.L., Martinez, J., Rosales. G., Velázquez, F.R., Monroe, S.S., Glass, R.I., Pickering, L.K., RuizPalacios, G.M. A prospective study of astrovirus diarrhea of infancy in Mexico City. Pediatr. Infect. Dis. J. 17, 723, 1998. 113. Méndez-Toss, M., Griffin, D.D., Calva, J., Contreras, J.F., Puerto, F.I., Mota, F., Guiscafré, H., Cedillo, R., Muñoz, O., Herrera, I., López, S., Arias, C.F. Prevalence and genetic diversity of human astroviruses in Mexican children with symptomatic and asymptomatic infections. J. Clin. Microbiol. 42, 151, 2004. 114. Mitchell, D.K., Van, R., Morrow, A.L., Monroe S.S., Glass, R.I., Pickering, L.K. Outbreaks of astrovirus gastroenteritis in day care centers. J. Pediatr. 123, 725, 1993. 115. Djuretic, T., Wall, P.G., Ryan, M., Evans, H.S., Adak, G.K., Cowden, J.M. General outbreaks of infectious intestinal disease in England and Wales 1992 to 1994. CDR Rev. 6, R57, 1996. 116. Noel, J., Cubitt, D. Identification of astrovirus serotypes from children treated at the Hospitals for Sick Children, London 1981–1993. Epidemiol. Infect. 113, 153, 1994. 117. Lees, D. Viruses and bivalve shellfish. Int. J. Food Microbiol. 59, 81, 2000. 118. Traore, O., Arnal, C., Mignotte, B., Maul, A., Laveran, H., Billaudel, S., Schwartzbrod, L. Reverse transcriptase PCR detection of astrovirus, hepatitis A virus, and poliovirus in experimentally contaminated mussels: comparison of several extraction and concentration methods. Appl. Environ. Microbiol. 64, 3118, 1998. 119. Glass, R.I., Noel, J., Mitchell, D., Herrmann, J.E., Blacklow, N.R., Pickering, L.K., Dennehy, P., Ruiz-Palacios, G., De Guerrero, M.L., Monroe, S.S. The changing epidemiology of astrovirus-associated gastroenteritis: a review. Arch. Virol. (Suppl.) 12, 287, 1996.
47 120. Chapron, C.D., Ballester, N.A., Fontaine, J.H., Frades, C.N., Margolin, A.B. Detection of astroviruses, enteroviruses, and adenovirus types 40 and 41 in surface waters collected and evaluated by the information collection rule and an integrated cell culture-nested PCR procedure. Appl. Environ. Microbiol. 66, 2520, 2000. 121. Elamri, D.E., Aouni, M., Parnaudeau, S., Le Guyader, F.S. Detection of human enteric viruses in shellfish collected in Tunisia. Lett. App. Microbiol. 43, 399, 2006. 122. Gabrieli, R., Macaluso, A., Lanni, L., Di Giamberardino, F., Cencioni, B., Petrinca, A.R., Divizia, M. Enteric viruses in molluscan shellfish. New Microbiol. 30, 471, 2007. 123. Grimm, A.C., Cashdollar, J.L., Williams, F.P., Fout, G.S. Development of an astrovirus RT-PCR detection assay for use with conventional real-time, and integrated cell culture/ RT-PCR. Can. J. Microbiol. 50, 269, 2004. 124. Le Guyader, F., Haugarreau, L., Miossec, L., Dubois, E. and Pommepuy, M. Three-year study to assess human enteric viruses in shellfish. Appl. Environ. Microbiol. 66, 3241, 2000. 125. Pintó, R.M., Villena, C., Le Guyader, F., Guix, S., Caballero, S., Pommepuy, M., Bosch, A. Astrovirus detection in wastewater samples. Water Sci. Technol. 43, 73, 2001. 126. Noel, J.S., Lee, T.W., Kurtz, J.B., Glass, R.I., Monroe, S.S. Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J. Clin. Microbiol. 33, 797, 1995. 127. Walter, J.E., Mitchell, D.K., Guerrero, M.L., Berke, T., Matson, D.O., Monroe, S.S., Pickering, L.K., Ruiz-Palacios, G. Molecular epidemiology of human astrovirus diarrhea among children from a periurban community of Mexico City. J. Infect. Dis. 183, 681, 2001. 128. Mittelholzer, C., Englund, L., Hedlund, K.O., Dietz, H.H., Svensson, L. Detection and sequence analysis of Danish and Swedish strains of mink astrovirus. J. Clin. Microbiol. 41, 5192, 2003. 129. Koci, M.D., Seal, B.S., Schultz-Cherry, S. Development of an RT-PCR diagnostic test for avian astrovirus. J. Virol. Methods 90, 79, 2000. 130. Tsai, Y-L., Tran, B., Sangermano, L.R. and Palmer, C.J. Detection of poliovirus, hepatitis A virus, and rotavirus from sewage and ocean water by triplex reverse transcriptase PCR. Appl. Environ. Microbiol. 60, 2400, 1994. 131. Abad, F. X., Pintó, R. M., Villena, C., Gajardo, R. and Bosch, A. Astrovirus survival in drinking water. Appl. Environ. Microbiol. 63, 3119, 1997. 132. Schwab, K.J, Neill, F.H., Fankhauser, R.L., Daniels, N.A, Monroe, S.S., Bergmire-Sweat, D.A., Estes, M.K., Atmar, L.R. Development of methods to detect “norwalk-like viruses” (NLVs) and hepatitis A virus in delicatessen foods: application to a food-borne NLV outbreak. Appl. Environ. Microbiol. 66, 213, 2000. 133. Green, J., Henshilwood, K., Gallimore, C.I., Brown, D.W.G., Lees, D.N. A nested reverse transcriptase PCR assay for detection of small round-structured viruses in environmentally contaminated molluscan shellfish. Appl. Environ. Microbiol. 64, 858, 1998. 134. Pina, S., Puig, M., Lucena, F., Jofre, J., Girones, R. Viral pollution in the environment and in shellfish: human adenovirus detection by PCR as an index of human viruses. Appl. Environ. Microbiol. 64, 3376, 1998. 135. Lees, D.N., Henshilwood, K., Doré, W.J. Development of a method for detection of enteroviruses in shellfish by PCR with poliovirus as a model. Appl. Environ. Microbiol. 60, 2999, 1994.
48 136. Meleg, E., Jakab, F., Kocsis, B., Bányai, K., Melegh, B., Szücs, Gy. Human astroviruses in raw sewage samples in Hungary. J. Appl. Microbiol. 101, 1123, 2006. 137. Koopmans, M., von Bonsdorff, C-H., Vinjé, J., de Medici, D., Monroe, S. Foodborne viruses. FEMS Microbiol. Rev. 26, 187, 2002. 138. Macaluso, A., Gabieli, R., Lanni, L., Saccares, S., Pana, A., Divizia, M. Enteric viruses and bacteriological parameters in molluscs. Ann Ig. 16(1–2), 237, 2004.
Molecular Detection of Foodborne Pathogens 139. Croci, L., De Medici, D., Scalfaro, C., Fiore, A., Divizia, M., Donia, D., Cosentino, A.M., Moretti, P., Costantini, G. Determination of enterovirus, hepatitis A virus; bacteriophages and E. coli in Adriatic sea mussels. J. Appl. Microbiol. 88, 293, 2000. 140. Le Guyader, F., Apaire-Marchais, V., Brillet, J., Billaudel, S. Use of genomic probes to detect hepatitis A virus and enterovirus RNA in wild shellfish and relationships of viral contamination and bacterial contamination. Appl. Environ. Microbiol. 59, 3963, 1993.
4 Avian Influenza Virus Giovanni Cattoli and Isabella Monne
Istituto Zooprofilattico Sperimentale delle Venezie
Contents 4.1 Introduction......................................................................................................................................................................... 49 4.1.1 Classification of AI Virus........................................................................................................................................ 49 4.1.2 Biology and Pathogenesis........................................................................................................................................ 50 4.1.3 Medical Importance and Zoonotic Implication of AI Viruses................................................................................ 50 4.1.4 Diagnosis of AI Viruses........................................................................................................................................... 51 4.1.4.1 Virus and Antigen Detection..................................................................................................................... 51 4.1.4.2 Serology for AI Diagnosis......................................................................................................................... 52 4.1.4.3 Molecular Tests......................................................................................................................................... 52 4.2 Methods............................................................................................................................................................................... 55 4.2.1 Sample Collection and Handling............................................................................................................................. 55 4.2.1.1 Selection of Samples to be Collected........................................................................................................ 55 4.2.1.2 Transportation and Storage of Specimens................................................................................................. 55 4.2.1.3 Handling of Specimens............................................................................................................................. 56 4.2.2 Samples Preparation for PCR Testing..................................................................................................................... 56 4.2.3 Detection Procedures............................................................................................................................................... 56 4.2.3.1 One Step RT-PCR for the Detection of Type A Influenza Viruses........................................................... 56 4.2.3.2 One Step RT-PCR for the Detection of AI Viruses Belonging to the H5 Subtype................................... 57 4.2.3.3 Two Step RT-PCR for the Subtype Specific Detection of H7 AI Virus.................................................... 57 4.2.3.4 Detection of Type A Influenza Virus by Qualitative Real Time PCR (M gene)...................................... 58 4.2.3.5 Detection of Type A Influenza Viruses of H5 HA Subtype by Qualitative One Step Real Time RT-PCR..................................................................................................................................................... 58 4.2.3.6 Detection of Type A Influenza Viruses of H7 HA Subtype by Qualitative Real Time PCR......................................................................................................................................... 59 4.3 Conclusions and Future Perspectives.................................................................................................................................. 59 References.................................................................................................................................................................................... 60
4.1 Introduction Recent outbreaks of avian influenza (AI) in birds occurring in Europe, in the Americas, Asia, and Africa, have provided field evidence of how challenging could it be to control this infection, particularly in densely populated poultry areas or in areas where free-range rural village poultry and backyard flocks are present.1–3 The early detection of AI in domestic and wild bird populations as well as in poultry commodities has been recognized as crucial to the implementation of timely and adequate prevention and control strategies. In the last decade, an increasing number of novel molecular technologies have become available to aid diagnosis of infectious diseases of animals and many of these have been applied to improve and accelerate the diagnosis of AI. In addition, more traditional diagnostic protocols, mainly based on classical viral culture methods and
i mmuno-enzymatic assays, have been revisited or improved in the recent years. The increased availability of diagnostic tests in conjunction with improved knowledge on the epidemiology and the pathogenesis of AI, is resulting in a modified approach to surveillance and diagnosis of this infection, with a wider application of the molecular-based technologies.4
4.1.1 Classification of AI Virus Influenza viruses have segmented, negative sense, single strand RNA genomes. The viruses are classified in the family Orthomyxoviridae. At present the Orthomyxoviridae family consists of five genera, only viruses of the Influenzavirus A genus are known to infect birds. Influenza A viruses are subdivided into subtypes based on the antigenic relationships in the surface glycoproteins, hemagglutinin (HA), and neuraminidase (NA). At present, 16 HA subtypes have been recognized
49
50
(H1–H16) and nine NA subtypes (N1–N9).5 Each virus has one type of HA and one type of NA antigen, apparently in any combination.
4.1.2 Biology and Pathogenesis Type A AI viruses are very widespread in nature; up to now they have been detected in more than 105 different species of wild birds from 26 families.6 Wild aquatic birds are natural reservoirs of these viruses and they can become infected by viruses of all HA and NA subtypes without showing signs of disease. In domesticated poultry AI viruses can be grouped in two pathotypes based on the clinical signs they may cause mainly in gallinaceous species: low pathogenic AI (LPAI) viruses and highly pathogenic AI (HPAI) viruses. LPAI viruses mostly cause infections of the respiratory and the enteric tract and the infection is subclinical in most avian species. Infections may be characterized by mild respiratory signs, some depression and reduced egg production. HPAI viruses not only replicate in the respiratory and enteric tract but also in endothelial cells throughout the body with spillover to adjacent parenchymal cells. Disease signs involve the respiratory and enteric tracts and many other organ systems, such as the central nervous system. Lesions are characterized by multiple haemorrhages in visceral organs and the skin, and mortality rates approach 100%. Infection with HPAI viruses thus leads to wide dissemination in the body and virus presence in many organs and edible tissues.7 To date, only viruses of H5 and H7 subtype have been shown to cause HPAI in susceptible species, but not all H5 and H7 viruses can be classified as HPAI. It appears that H5 and H7 HPAI viruses arise by mutation after an AI virus precursor of low pathogenicity (LPAI) has been introduced into poultry. It follows that all HPAI viruses should have a LPAI progenitor, although the latter have only been identified in a limited number of cases.8 For all influenza A viruses the HA glycoprotein is produced as a precursor, HA0, which requires post translational cleavage by host proteases before it is functional and virus particles are infectious.9 The HA0 precursor proteins of AI viruses of low virulence for poultry (LPAI viruses) have a single arginine at the cleavage site and another basic amino acid at position -3 or -4 from the cleavage site. These viruses are limited to cleavage by extracellular host proteases such as trypsin-like enzymes and thus restricted to replication at sites in the host where such enzymes are found, i.e., the respiratory and intestinal tracts. HPAI viruses possess multiple basic amino acids (arginine and lysine) at their HA0 cleavage sites, either as a result of apparent insertion or apparent substitution, and appear to be cleavable by an intracellular ubiquitous proteases. HPAI viruses are able to replicate throughout the bird, damaging vital organs and tissues, which results in disease and death.10,11 The factors that bring about mutation from LPAI to HPAI are not known. In some instances mutation seems to have taken place rapidly (at the primary site) after introduction in
Molecular Detection of Foodborne Pathogens
poultry possibly through the wild birds,12,13 in others the LPAI virus has circulated in poultry for months before mutating.14 Therefore, it is impossible to predict if and when this mutation will occur. However, it can be reasonably assumed that the wider the circulation of LPAI in poultry, the higher the chance that mutation to HPAI will occur. HPAI viruses are not necessarily virulent for all species of birds and the severity of the clinical signs may vary with bird species, age of the host and virus strain.15,16 In particular, ducks rarely show clinical signs as a result of HPAI infections although there are reports that some of the Asian H5N1 viruses have caused disease and the HPAI viruses A/duck/Italy/2000 H7N1 and A/chicken/Germany/34 (H7N1) have been reported to cause disease and death in naturally and experimentally infected waterfowl.15,17 Bird to bird transmission of AI viruses is complex and it largely depends on the virus strain, host species and environmental factors.18 LPAI viruses are mainly excreted with feces, through the cloaca. Viral shedding through the respiratory tract is also considered important, at least for some species or some strains, as the Asian HPAI H5N1. For this virus, and similarly for other HPAI viruses, transmission from poultry to humans is supposed to occur primarily through direct contact with secretions of the upper respiratory tract, infected feces, feathers, organs, and blood of infected animals. Inhalation of contaminated dust or droplets can be an alternative transmission route.19
4.1.3 Medical Importance and Zoonotic Implication of AI Viruses Until recently, direct infection of humans with AI viruses had not been considered significant. Human cases were sporadically reported between 1959 and 1996 with only three documented cases, two in the USA (HPAI and LPAI H7N7) and one, likely to be of laboratory exposure-origin, in Australia (HPAI H7N7). In all cases the patients recovered and the main clinical sign was characterized by self-limiting conjunctivitis.3,8 However, starting from 1996, a series of events has raised the concerns on the zoonotic potential of AI infections. With some exceptions, since 1996 almost all the reported cases of AI virus infection in humans have been caused by HPAI viruses belonging to the H5 or H7 subtypes directly transmitted from infected birds to humans. Among the LPAI viruses, the first documented case of avian to human transmission was described in 1996 and caused by a LPAI H7N7 virus. The virus was isolated in England from the eye of a woman suffering from conjunctivitis. This person had ducks and the virus was shown to be genetically 100% of avian origin.20,21 In 1999, LPAI viruses belonging to the H9N2 subtype were isolated from two young girls in Hong Kong.22 They were suffering from an influenza-like syndrome and fortunately they recovered with no serious consequences. Subsequently, isolation of H9N2 viruses in human beings was reported in the Peoples Republic of China on five occasions during 1998.23 In 2003, LPAI H7N2 was isolated from a patient with respiratory symptoms in the US. Also in this case, the patient recovered.3
Avian Influenza Virus
In two other circumstances, evidence of contacts between LPAI viruses and humans were only detected serologically. A serological survey in human beings potentially at risk of exposure during the 2002–2003 LPAI H7N3 epidemic in Italy revealed the presence of specific antibodies in 3.8% of serum samples collected in poultry workers.24 Serological prevalence with regard to H9N2 was also revealed by the hemagglutination inhibition test in the human population at risk of exposure in Iran.25 However, this latter finding needs confirmation by means of other serological tests. Certainly, more significant and severe are the human infections caused by HPAI viruses. The first documented evidence on how serious could be the consequences of avian to human transmission of HPAI viruses occurred in 1997 in Hong Kong. In that year, the HPAI H5N1 circulating in the domestic poultry was capable of infecting 18 people, causing the death of six of them.26 Viruses belonging to the same antigenic subtype, H5N1, and genetically related to the 1997 viruses re-emerged in Hong Kong in 2003.27 In that year, this HPAI virus circulating in poultry in South East China began to spread westward among wild and domestic birds throughout Asia, reaching Europe and Africa in 2005 and 2006. Since then, the continued infections of humans and other mammals, such as felines, caused by this virus have caused great concern over the capabilities of H5N1 to cross the species barrier and to potentially become easily transmissible among humans. To date (2nd February 2009), a total of 404 confirmed cases of HPAI H5N1 infections in humans and 254 human deaths have been reported to the World Health Organization (WHO) (available at http://www.who.int/csr/disease/avian_influenza/ country/cases_table_2008_04_17/en/index.html). Other HPAI viruses belonging to the H7 subtype were reported as etiological agents of severe human infections to a minor extent compared to HPAI H5N1. During the 2003 outbreak caused by the H7N7 HPAI virus in poultry in The Netherlands, 82 cases were reported in humans. Generally, symptoms were described as influenza-like illness and/or conjunctivitis, but one fatality also occurred.28 In Canada, persons involved in outbreaks management suffered from conjunctivitis, headache, and flu-like syndrome. The H7N3 HPAI virus, responsible for the outbreak in poultry, was confirmed to be the causative agent of the disease. Fortunately, no fatal cases occurred.29 While such human infections generally result from direct and intensive contact with infected or diseased poultry, other routes of infection such as consumption of edible tissues from infected avians or contact with contaminated water have been suggested as possible sources of infection.
4.1.4 Diagnosis of AI Viruses Surveillance and monitoring programmes have been implemented in many countries around the world as a result of the global spread of AI viruses and of the subsequent implications on public perception and animal health issues. These programmes are mainly targeting the wild birds—considered as the main reservoirs—and the poultry population. The main aims of these
51
programmes are to detect and control AI viruses in the poultry compartment, thus preventing their spread to human beings. Therefore, nowadays laboratory testing is mainly applied to trace viral circulation in a given area or in a susceptible population in order to implement an early warning system, in addition to diagnose the presence of the virus in a diseased flock or animal or in poultry derived products. This implies the use of rapid, sensitive and, possibly, cost-effective laboratory tests adaptable to very high throughputs.4 4.1.4.1 Virus and Antigen Detection Traditionally, laboratory protocols for the detection and the identification of AI viruses were based on virus isolation (VI) in SPF eggs or in cell cultures. The application of these methods of laboratory investigation is mainly limited by the fact that they are not flexible to a sudden increase in demand, are not cost-effective and often require a long processing time. In fact, these methods are time-consuming and require a minimum of 12 days before a negative result may be issued. Office International des Epizooties (OIE) and EU official methods require two blind passages in eggs of 6 days, before the sample is considered negative.30,31 At present, there seems to be only limited space for improving the time-efficiency of these methods. What appears to be a major bottleneck is the obtainment of suitable substrates for VI. The primary cell cultures and the continuous cell lines tested so far provide variable results, mainly strain to strain dependant and, in general, they are less sensitive than SPF eggs. These are expensive and not always easily available. The use of eggs derived from AI and Newcastle disease virus (NDV) specific antibody negative (SAN) parent stocks are considered as an alternative method in the OIE manual30 and, more recently, in the EU manual.31 VI implies the replication in laboratory of viable viral particles to a significant concentration thus, biosafety, and biocontainment should be regarded as a priority for laboratories in which AI VI is performed. Despite these major difficulties, VI in fowl’s eggs still remains the gold standard for AI virus detection. Its sensitivity is equal or often superior to many alternative tests. In addition, genetic or antigenic variation of the viruses, as well as the presence of contaminants or PCR inhibitors in the samples, can impair the efficiency of molecular and immunoassays, but they have minor impact on VI. Under certain circumstances, it might be desirable to test a certain number of samples in a short period of time. In this case, antigen capture immunoassays can be considered a very useful diagnostic tool. They are very easy to use, do not require sophisticated or expensive equipment and, in many instances, they can be applied on-site, thus avoiding the time-consuming and delicate phase of sample preparation and shipment. In many cases, test results can be available within minutes. To date, most of the antigen capture tests available on the market target the type A influenza virus nucleoprotein (NP), thus detecting any type A influenza virus. With the exception of one H5 subtype specific test for veterinary use, this kind of
52
Molecular Detection of Foodborne Pathogens
assay does not provide any indication on the subtype involved. Furthermore, no indication on the pathotype (i.e., HPAI vs LPAI) can be obtained. Their main limitations consist in the unsatisfactory sensitivity compared to VI and molecular tests, and their unit cost.32,33 Due to their low sensitivity, sampling numbers should be increased before the presence of viral circulation in a given population can be ruled out. For the same reason, excessive dilution of the samples by pooling of swabs should be avoided. These features make this kind of assay unsuitable for monitoring and early detection programmes, where large number of samples must be cost-effectively screened with sensitive testing procedures. 4.1.4.2 Serology for AI Diagnosis Serology represents a relatively inexpensive and practical methodology to assess the circulation and the prevalence of influenza viruses in poultry. It does not provide direct evidence on the presence of the virus but, in the framework of a surveillance effort in domesticated birds, serological diagnosis is considered a suitable approach to monitor the AI-free status of a given region or farm. On the contrary, the application of the serological methods available today in wild bird surveillance may generate information of very limited use, particularly for HPAI surveillance.34 In fact, serology does not provide information concerning the pathotype and wild birds, specifically wild waterfowl, which are commonly infected by LPAI viruses, therefore serologically positive. During monitoring or surveillance programmes, large numbers of animals have to be tested in order to guarantee acceptable statistical significance. In recent times the agar gel immuno-diffusion (AGID) test has been superseded by commercial ELISA tests. Both systems detect antibodies to
the group antigen of influenza A viruses, and therefore are unable to give any indication on the virus subtype causing infection. These tests find their primary application in monitoring poultry flocks, although most of them lack validation data for minor species (ducks, geese, quails etc). In addition, AGID is not suitable for testing sera of waterfowl as the latter do not produce precipitating antibodies.35 The hemagglutination inhibition test is a simple, robust, and fully validated test that generates qualitative and quantitative information on antibodies that are a result of vaccination or of infection in most avian species. It is more labor-intensive than ELISA or AGID tests, but it yields information that under certain circumstances is more valuable and useful for managing field situations. 4.1.4.3 Molecular Tests In implementation of surveillance and monitoring programmes for AI, cost-effective testing procedures capable of facing high and constant workflows are necessary. During AI outbreaks the main problems encountered by a diagnostic laboratory are represented by a sudden increase in sample testing and an increased pressure for faster turn-around-time (TAT), both combined with high quality test performances and cost effectiveness.36 In this respect, the possibility of diagnosing AI by using molecular methods offers important advantages compared to other protocols, such as VI and ELISA. For this reason, in the recent past there has been a significant increase in the development and application of testing procedures for the detection of AI viral RNA. Several RT-PCR and real time PCR protocols have been published in scientific journals (see Table 4.1 for references) and the most recent methodologies such as NASBA,37,38 LAMP-PCR39,40 and pyrosequencing41,42
Table 4.1 Main Representative PCR-Based Protocols for the Detection of AI Viruses Published Since 2000 in International Scientific Journals Target End point RT-PCR Type A influenza virus Type A influenza virus, H5 and H7 subtypes Type A influenza virus, H5 and H7 subtypes Type A influenza virus and Newcastle Disease virus Type A influenza virus, avian pneumovirus and Newcastle Disease virus Type A influenza virus, H5, H7, H9 subtypes Type A influenza virus, H5, H7 and H9 H5 AI subtypes H7 AI subtypes H5 and H7 subtypes
Assay
One step RT-PCR Two step RT-PCR
Notes
Reference
82 83
One step RT-PCR-ELISA Two step duplex RT-PCR
Positive samples confirmed by dot-blot hybridisation. Emi-nested PCR for H7 subtype. Laboratory evaluation. Partially validated on Eurasian lineage. Validated assay.
One step multiplex RT-PCR
Laboratory evaluation.
85
One step type A RT-PCR and one step multiplex RT-PCR (H5, H7, H9) Two step, multiplex RT-PCR One step RT-PCR Two step RT-PCR One step multiplex RT-PCR
Laboratory evaluation.
86
Laboratory evaluation. Ring test evaluation on Eurasian strains. Ring test evaluation on Eurasian strains. Limited clinical validation.
87 56 56 88
44 84
(Continued)
53
Avian Influenza Virus
Table 4.1 (Continued) Target
Assay
Notes
H5 subtype of the H5N1 HPAI virus H1-H16 AI subtypes H1-H16 AI subtypes H1-H15
One step RT-PCR RT-PCR and sequencing RT-PCR and sequencing RT-PCR and sequencing
Limited clinical validation. Limited validation. Laboratory evaluation. Laboratory evaluation.
Real time RT-PCR (rRT-PCR) Type A influenza virus
One step rRT-PCR
Type A influenza virus Type A influenza virus
One step rRT-PCR One step rRT-PCR
Type A influenza virus
Two step rRT-PCR
Type A influenza virus, H5 and N1 Type A influenza virus, H5 and H9
One step multiplex rRT-PCR One step multiplex rRT-PCR
Type A influenza virus, H9 and N2
One step multiplex rRT-PCR
Type A and B influenza virus, H5
One step multiplex rRT-PCR
Type A and B influenza virus, H5 and N1
One step multiplex rRT-PCR
H5, H7, H9 AI subtypes
One step rRT-PCR
H5 and H7 subtypes
One step multiplex rRT-PCR
H5 AI subtypes
One step rRT-PCR
H5N1 HPAI virus of the Qinghai lineage
One step rRT-PCR
H5 subtype of the H5N1 HPAI virus
Two step rRT-PCR
H5 subtype of the H5N1 HPAI virus
Two step multiplex rRT-PCR
H5 subtype of the H5N1 HPAI virus
One step rRT-PCR
N1 subtype
One step rRT-PCR
Hydrolysis probe. Validated assay. MGB-hydrolysis probe. Laboratory evaluation. Light upon extension fluorogenic primers. Laboratory evaluation. SybrGreen chemistry. Limited field evaluation. MGB-hydrolysis probes. Laboratory evaluation. Hydrolysis probe. Laboratory evaluation. SybrGreen 1 dye. Validated assay Discrimination between type A and B not possible. Laboratory evaluation. Hydrolysis probes. Limited clinical validation on human specimens. Hydrolysis probes. Validated assay for Eurasian lineage. Hydrolysis probe. Validated assay for American lineage. Hydrolysis probes. Validated assay for Eurasian lineage. Hydrolysis probe. Validated assay. MGB-hydrolysis probes. Laboratory evaluation on one human specimen. Hydrolysis probes targeting two distinct regions of the HA molecule. Validated on human specimens of Hong Kong and Vietnam origin. Hydrolysis probe. Limited clinical validation on human specimens. MGB-hydrolysis probes. Validated assay on N1 subtypes pf the Eurasian lineage
have been applied, in many cases successfully, for the detection and typing of AI viruses. However, the use of these latter techniques is limited to research purposes at the moment. With reference to the application of nucleic acid amplification protocols, sample processing appears less cold-chain dependant, as the preservation of cellular integrity and virus viability is not essential for these assays. The possibility to detect AI viral RNA in samples containing inactivated viral particles due to prolonged storage or shipment, or in samples treated to eliminate viral infectivity increases the chances to diagnose the disease in specimens collected in remote area of the world and addresses the biosafety issues. Reagents are also available to better preserve the integrity of a fragile molecule as the RNA at environmental temperatures.43 Thus,
Reference 89 61 60 59
45, 56 90 91 92 93 94 95 96 97 46 45 54 57 98 99
42 100
unlike VI, molecular techniques can also be applied in small laboratories, providing that the basic equipment is available. This can contribute to the extension of a diagnostic laboratory network in the affected area and to the reduction of the TAT by avoiding the submission of the samples to a distant central and fully equipped laboratory of virology. In terms of analytical and diagnostic sensitivity and specificity, the data available concerning the molecular tests for AI can be considered as optimal for their application in large scale diagnosis during an outbreak, showing values of diagnostic sensitivity, and specificity close to or above 90%.32,44,45 An excellent agreement with the VI was reported during a LPAI outbreak investigation32 and in clinical validation of real time protocols.46 Data derived from experimental study32
54
indicate that RT-PCR based methods are capable of revealing viral RNA in tracheal swabs of experimentally infected birds for 10–15 days after challenge, similarly to VI. This period of time covers the first 7–10 days post-infection, when serology is not of diagnostic aid due to an undetectable immune response. Similarly, other studies provided experimental evidence of the usefulness of PCR-based techniques as an alternative to qualiquantitative VI methodologies.47,48 Molecular techniques can provide a variety of data useful for surveillance, monitoring, and outbreak investigation. Once the RNA is extracted, it is possible to gain information not only concerning the presence of virus in the clinical specimen, but also about the HA and NA gene segments, the pathotype (LPAI vs HPAI virus) and other genomic sequencing data that can be used for molecular epidemiology. Most importantly, expensive, and time consuming in vivo tests for pathogenicity can be avoided, preserving animal welfare. However, the recent and extensive applications of these kinds of molecular assays in the field of AI diagnosis have highlighted some drawbacks. The costs related to the equipment and reagents needed for PCR and real time PCR testing are still significant, although they decreased in recent times, mainly as a result of the widespread use of these technologies and the subsequent marketing competition. Nucleic acids amplification methodologies are generally extremely sensitive assays, making them prone to easily reveal cross contamination of samples, leading to false positive results. Mishandling of the extracted RNA, improper use of reagents or use of nonsterile, non RNAse-free disposables, or inadequate reference controls, may result in false negative test response. AI viruses exhibit a significant degree of genetic variability, particularly in certain important regions of the genome, as for segment 4 (HA) and 6 (NA). This might lead to diagnostic failures of some molecular tests based on primers and probes targeting these hyper variable regions when applied on mutated or new emerging viruses. A recent example for this is the PCR detection failure of viruses belonging to the H7 subtypes occurred during wild bird surveillance program in the US. In this case, a few nucleotides mismatches in the PCR probe targeting the HA molecule were the likely cause of failure.49 Consequently, the recent initiatives concerning AI sequence data sharing50 are crucial in the understanding of viral evolution and in updating probes and other molecular diagnostic tools as long as the viruses mutate. Considering the extreme sensitivity of many nucleic acid amplification assays, some samples tested positive by a given molecular test might not be confirmed by any other test applied on the same sample, including VI.51 Therefore, the adoption of fully validated protocols and harmonized test is mandatory. Examples of unexpected false positive results may indeed occur after extensive field application.52 Since AI is now threatening almost every continent, these considerations should seriously be taken into account when planning official guidelines and diagnostic protocols. Public institutions and private biotechnology companies are currently investing resources in research and development of
Molecular Detection of Foodborne Pathogens
more stabilized PCR reagents, robust molecular protocols and easy-to use, flock-side molecular tests.53 Currently, the most common types of molecular tests used for AI detection are RT-PCR or real time RT-PCR (rRT-PCR)based protocols (Table 4.1). Schematically, these can be further subdivided in protocols for the so-called “generic” detection of type A influenza viruses and protocols for the detection and identification of specific type A influenza virus subtypes. The common genomic targets of the first type of molecular tests are well conserved segments of the viral genome located in the genes encoding for the matrix proteins (M1 and 2) or the NP. Since these proteins are antigenically and genetically conserved regardless of the virus subtype, these types of tests are virtually capable of detecting type A influenza viruses belonging to subtypes H1–H16. Based on the available literature, these protocols exhibit high sensitivity and specificity, with higher performances of the rRT-PCR tests compared to the RT-PCR tests. For these reasons, these type A influenza tests are used as screening tests to evaluate the infectious status of an animal, flock or area (see Table 4.1 for references). Infections caused by AI viruses belonging to the H5 and H7 subtype are of major concern for public health and economic impact. Regardless of their pathogenicity, which may vary, they are notifiable diseases of animals, according to the current international legislation for animal health.30 Therefore, their occurrence must be detected promptly and immediately reported to the national and international veterinary authorities. As a consequence, all the samples tested positive in the screening for type A influenza virus should be PCR tested for the identification of these two subtypes and/or immediately submitted for VI attempts.31,36 Several protocols have been described for the specific PCR detection of H5 and H7 directly in clinical specimens (Table 4.1) and some of them properly validated.45,46,54 Phylogenetic studies55 demonstrated that H5 and H7 sequences could be divided into two major groups, related to the geographical origin of the viruses. Thus, so called “American” and “Eurasian” lineages were described among avian H5 and H7 viruses. These groups reflect the genetic variation observed in the targeted genes and this has also influence in the development and application of specific diagnostic assays. In fact, molecular tests designed on viruses belonging to the American lineage generally exhibit poor performances, in term of sensitivity, when applied on the Eurasian strains and vice versa.45,56 The major public health and veterinary concern raised by the spread of the Asian H5N1 HPAI also contributed to the development of several molecular tests specifically targeting this dangerous virus (Table 4.1). In many instances, these protocols are duplex RT-PCR or rRT-PCR tests targeting the H5 and the N1 gene segments of this specific virus, but sometimes they result in poor performances when applied on different H5 strains. One protocol has been described targeting one specific H5N1 HPAI genetic sublineage.57 LPAI viruses belonging to the H9 subtype are also of major interest for the economic losses they can cause to the
Avian Influenza Virus
poultry industries58 in addition to their sporadic capabilities to be transmitted to humans, fortunately without serious consequences.22 These reasons have also led to the development of rapid molecular tests for its detection in clinical specimens (see Table 4.1 for references). In some instances, there is the need to determine the specific subtype of type A PCR positive samples, once the involvement of the H5, H7, and H9 subtypes has been ruled out. RT-PCR protocols designed on conserved regions of the HA molecule were developed and subsequent sequence analysis of the PCR product should enable the identification of the H1–H16 subtype.59,60,61 These protocols are useful for rapid subtyping of viral isolates, but the lower sensitivity of these methods may represent a limit for their direct application on clinical specimens. Currently, none of the published molecular tests have been specifically validated for AI detection in poultry-derived products such as meat, feathers, etc. Recently, a protocol describing the RNA extraction procedure and the subsequent RT-PCR protocol for the detection of AI RNA from manure has been described.62
4.2 Methods 4.2.1 Sample Collection and Handling 4.2.1.1 Selection of Samples to be Collected Protocols concerning sample collection for AI are mainly focused on the detection of the virus in holdings suspected to be infected, thus, in living, moribund or recently dead birds. As a reference, the EU diagnostic manual for AI, adopted in 2006 by the EU31 or the OIE Manual for Diagnostic Tests and Vaccines for Terrestrial Animals30 provide concise but practical guidelines concerning sample collection and transportation. For molecular testing, viable viruses are not requested. However, the target RNA molecule is extremely fragile and its degradation due to improper sample handling and storage may result in false negative results. The targeted replication sites of LPAI viruses are the respiratory (mainly trachea and lungs) and the digestive (intestines) tract. HPAI viruses are disseminated throughout the whole body tissues. Both, LPAI and HPAI viruses, are shed via the upper respiratory tract and feces but the quantity of shed viral particles and the duration of shedding may vary according to host species, host immune status, and virus strains.63,64 Thus, tissue specimens from trachea, lungs, and intestines or oropharyngeal, tracheal, or cloacal swabs are suitable samples for AI detection in carcasses and/or living birds. In addition, for HPAI viruses, specimens from brain and other internal organs, such as spleen, heart and kidney, can be collected. Intestinal contents of fresh feces also may contain high viral loads.65–67 However, presence of potential PCR inhibitors, bacterial or fungal contaminations and proteases impose particular attention when dealing with this type of material as false PCR results (positives or negatives) may occur. In case of HPAI infections, the virus causes viremia and therefore can be present also in the blood of recently infected birds.68–70 Data on the duration and intensity of the
55
viremic period are scarce and these parameters can vary greatly according to the virus strain, its pathotype or the host involved. For example, virus titres in experimentally infected chickens varied from 101.4 EID50/ml for H5N2 HPAI69 to 108 EID50/ml for H5N1 HPAI.68 In another study, ducks experimentally inoculated with A/H5N1 HPAI revealed virus titers in blood ranging from 100.7 EID50/ml to 102.3 EID50/ml.71 For LPAI viruses, replication occurs at the epithelial surfaces of the respiratory and intestinal tracts; therefore viremia is not expected for this pathotype. However, in a few occasions H9 or H7 LPAI virus genomes have been detected in blood and viable viruses were isolated.72,73 Based on the above mentioned data, blood does not represent an ideal sample for AI detection but it can be considered as a potential source of environmental contamination during handling and processing of blood samples collected from suspected HPAI infected animals or during slaughtering of poultry in the pre-clinical phase of the disease. Viremia and viral replication in endothelial cells occurring in HPAI infections contribute to the colonization of muscles and other edible tissues (i.e., liver) in infected birds. Muscles and meat of domestic birds were found to be HPAI infected during field investigations on imported poultry products74 as well as experimental infections.69,75 Incomplete evisceration or contamination from lungs and intestine during slaughtering procedures may lead to LPAI or HPAI contaminated meat or carcasses, as recently demonstrated.76 Therefore, muscles (particularly breast and tight muscles) or respiratory and intestinal tissues still present in poultry carcasses represent suitable specimens for the detection of both HPAI and LPAI viruses. 4.2.1.2 Transportation and Storage of Specimens Swabs, tissue specimens, or feces should be immediately submitted to the laboratory for testing. Soon after their collection, samples should be refrigerated on ice or with frozen gel packs. In case a submission delay (>24 h) to the laboratory is expected, samples should be frozen in dry ice, liquid nitrogen or -80°C. Repeated cycles of freezing and thawing must be avoided to prevent reduction of the viral load, cell lysis, and consequent RNA degradation. Storage of allantoic fluids of eggs inoculated with H5 and H7 HPAI, and LPAI viruses in the guanidine-based lysis buffer included in two commercial RNA extraction kits preserved the suitability of the original RNA template for real time PCR amplification up to 7 days at + 4°C; ambient temperature and at + 37°C.77 Importantly, the same lysis buffers were able to inactivate both the HPAI and LPAI viruses tested after 4 h, thus increasing the biosafety of the handled specimens. In one other investigation,78 end point RT-PCR amplification was still possible after 2 weeks storage at ambient temperature of bird fecal samples spiked with influenza A viruses using guanidine buffer, commercial preservative or alcohols (ethanol or isopropanol) as preservatives. PCR products up to 521 bp were obtained in samples preserved with guanidine or commercial buffers and up to 206 bp in samples
56
preserved with alcohols. Obviously, all these procedures will make parallel VI attempts impossible. In case VI is necessary to confirm results of molecular testing or to assess viral infectivity, viral transport medium (VTM) should be used. VTM are generally based on phosphate saline buffered solutions (PBS, pH 7.0–7.4) or protein-based media, such as brain heart infusion (BHI) or tris-buffered tryptose bacteriological media supplemented with antibiotics and/or antifungals.31 VTM supplementation with glycerol (10–20%) contributes to better preserve sample stability and integrity, particularly during prolonged storage at low temperatures. 4.2.1.3 Handling of Specimens Probably only one documented case of human infection caused by an AI virus following laboratory exposure has been reported so far in the scientific literature.79 The case occurred in Australia and consisted of conjunctivitis caused by an H7N7 HPAI virus. In contrast, several cases of conjunctivitis, influenza-like illness and one fatal case of acute lung infection were reported during the H7N7 HPAI poultry outbreaks in 2003 in The Netherlands.28 People confirmed to be infected were somehow involved in the outbreak management. Adequate protective measures should therefore be adopted during collection and handling of samples suspected to contain AI viruses, at the farm level, at the slaughterhouse and within the laboratory. Personal protective items (PPI), such as lab-coats, goggles, disposable gloves, should be properly worn during necropsies and collection of samples from animals suspected to be AI-infected. Orthomyxoviruses are identified as biological agents of biohazard class 2.80,81 According to the WHO recommen dations,81 they should be manipulated in a BSL2 laboratory, adopting BSL3 work practices. Good laboratory practices should be applied during the whole process of sample testing at laboratory level. Useful and practical guidelines and comprehensive information on biosafety-related issues in the laboratory can be found in the EU manual for AI and on the WHO website.31,80,81
4.2.2 Samples Preparation for PCR Testing The following procedures for sample preparation can be followed prior to submitting the specimen for RNA extraction and subsequent RT-PCR amplification. Organs and tissues (brain, trachea, lungs, intestine): extract the RNA from tissue homogenate. Using sterile scissors or surgical blades, cut small blocks (approximately 2–5 mm × 2–5 mm) of tissues. If possible, tissues blocks should be frozen in liquid nitrogen to better preserve RNA integrity and to facilitate tissue disruption. Animal tissues can then be disrupted simply by sterile pestle and mortar. Fiber-rich tissues (e.g., lung and trachea) may require the addition of sterile quartz powder or sand to better disrupt tissue cells. To facilitate the disruption and the homogenization process, 300–500 µl of sterile PBS can be added. This will make also possible the preparation of aliquots for other types of test (i.e., VI),
Molecular Detection of Foodborne Pathogens
starting exactly from the same homogenate. Homogenization is carried out simply using a syringe and needle. Alternatively, a commercially available, automatic homogenizer can be used. Add the requested amount of this suspension to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. Cloacal swabs, tracheal, or oro-pharyngeal swabs: dilute swabs in PBS (max 1 ml) and extract the RNA from this suspension. It is possible to pool the samples (up to ten tracheal swabs/pool or five cloacal swabs/pool). Vortex briefly. Add the requested amount of this suspension to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. Feces: a suspension is prepared by adding one volume of feces to four volumes of sterile PBS. Add the requested amount of this suspension to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. Allantoic fluid: simply add the requested amount of sample (allantoic fluid) to the lysis buffer of the RNA extraction kit according to the manufacturer’s instructions. RNA extraction: several methods for the manual or robotic extraction of the RNA exist. Many commercial kits are available, some of them developed and optimized for the extraction of the nucleic acids on specific matrixes, such as tissues, blood, and stool. However, to facilitate the organization of sample processing within the laboratory and make it more cost-effective and practical, only some kits are presented in this chapter, which can be used on different matrixes with satisfactory results. The kits listed should be considered as examples, representatives of the most common types used in different laboratories or described in several scientific journals. They have been evaluated in many laboratories working on AI. The use of other kits not included in the list is possible, providing their performances are methodically evaluated. Kits widely used for RNA extraction: NucleoSpin® RNA II (Macherey-Nagel GmbH & Co., Germany); RNeasy® MiniKit (Qiagen Gmbh, Germany); High pure RNA isolation kit (Roche Applied Science, Germany), not recommended for feces; MagMax (Ambion/Applied Biosystems), for swabs or other liquid matrix. Not recommended for tissues and organs. Useful for robotic extractions. Extraction protocol follows the manufacturer’s instructions.
4.2.3 Detection Procedures 4.2.3.1 One Step RT-PCR for the Detection of Type A Influenza Viruses This protocol is a modification of the method developed and described by Fouchier et al.82 for the detection of type A influenza viruses in samples of human and animal origin, including birds. According to previous field investigation on swabs of avian origin, the relative sensitivity was 95.6% (CI95 = 93.1–98.0) and the relative specificity was 96.3% (CI95 = 94.4–98.1) when compared to VI.32 In one other study on experimentally infected ducks48 the protocol provided 100% of relative sensitivity and 94% of
57
Avian Influenza Virus
relative specificity. In some cases, unspecific bands can be visualized on gel.52 Careful examination of the gel and use of proper controls and size-markers are therefore extremely important. Target: M gene Sample: RNA 5 µl in 25 µl of total reaction volume Reagents: One step RT-PCR (Applied Biosystems GeneAmp® Gold RNA PCR Core Kit Part No 4308207) Primers:82 Forward M52 C: 5′-CTT CTA ACC GAG GTC GAA ACG-3′ Reverse M253 R: 5′-AGG GCA TTT TGG ACA AAG/T CGT CTA-3′
a given thermocycler. The protocol has been tested mainly on H5 AI viruses belonging to the “Eurasian” lineage. Target: HA gene Sample: RNA 5 µl in 50 µl of total reaction volume Reagents: One step RT-PCR (Qiagen OneStep RT-PCR Kit cat # 210212) Primers:56 H5-kha-1: CCT CCA GAR TAT GCM TAY AAA ATT GTC H5-kha-3: TAC CAA CCG TCT ACC ATK CCY TG Note the inclusion of degenerate nucleotides indicated above in bold.
Reagent (Conc. Stock Solution)
Reagent
Final Concentration
Volume Required for one Reaction
/
4.7 µl
RNase-free water PCR buffer 5 × MgCl2 25 mM
1 × 2.5 mM
5 µl 2.5 µl
dNTPs mix 10 mM
1 mM
2.5 µl
DTT 100 mM
10 mM
2.5 µl
Primer M52 C 10 mM
0.3 mM
0.75 µl
Primer M253 R 10 mM
0.3 mM 10 U
0.75µl
Reverse transcriptase 50 U/µl
15 U
0.3 µl
Ampli Taq GOLD 5 U/µl Total volume Vortex the mix for few seconds. Aliquote 20 µl in 0.2-ml PCR tubes. RNA
2.5 U
0.5 µl
RNase inhibitor 20 U/µl
Final reaction volume
}
0.5 µl
20 µl 5 µl
RNase-free water PCR buffer 5 × from Qiagen OneStep RT-PCR Kit dNTPs mix 10 mM each (from Qiagen Kit)
Final Concentration
Volume Required for one Reaction (50 µl)
/
28.8 µl
1 ×
10 µl
0.4 mM each
2 µl
Primer H5-kha-1: 50 pmol/µl (50 µM)
1 µM
1 µl
Primer H5-kha-3: 50 pmol/µl (50 µM)
1 µM
1 µl
RNase inhibitor 40 U/µl (Promega) One Step RT-PCR Enzyme Mix (Qiagen Kit) Volume minus target
8U
0.2 µl 2 µl 45 µl
Volume extracted RNA
5 µl
Final reaction volume
50 µl
25 µl
Cycling conditions: One cycle of 42°C for 20 min; one cycle of 95°C for 5 min; 40 cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 1 min; one cycle of 72°C for 10 min. Detection: Agarose gel 2 % or silver stained SDSPAGE 7% Expected amplified fragment: 244 bp.
Cycling conditions: One cycle of 50°C for 30 min; one cycle of 94°C for 15 min; 40 cycles of 94°C for 30 sec, 58°C for 1 min, and 68°C for 2 min; one cycle of 68°C for 7 min. Detection: Agarose gel 2 % or silver stained SDSPAGE 7% Expected amplified fragment: 300–320 bp.
4.2.3.2 One Step RT-PCR for the Detection of AI Viruses Belonging to the H5 Subtype This one step RT-PCR protocol has been partially validated in two consecutive ring trials performed in the EU and the results were published.56 According to the ring trials results, the protocol appears to be sensitive and useful for H5 AI virus detection in clinical specimens. Since the targeted region encompass the cleavage site segment of the HA gene segment, the subsequent sequence of the resulted amplified products will allow the determination of the pathotype. However, some results have revealed possible specificity problems. These include false positives with non-H5 AI specimens and/or multiple bands of similar size to the predicted amplicon. This may relate to the precise cycling conditions which are employed on
4.2.3.3 Two Step RT-PCR for the Subtype Specific Detection of H7 AI Virus This protocol consists in a two step RT-PCR first developed in The Netherlands and then selected for its good results among different tests during the AVIFLU European project.56 By this protocol, amplicon is detected conventionally by agarose gel electrophoresis with ethidium bromide staining or by SDS-PAGE with silver staining. The amplicon span the HA cleavage site so sequencing can provide pathotyping information, i.e., LPAI or HPAI. Target: HA gene Sample: RNA 5 µl in 50 µl of total reaction volume Primers:56 GK 7.3 5′-ATG TCC GAG ATA TGT TAA GCA-3′ GK 7.4 5′-TTT GTA ATC TGC AGC AGT TC-3′
58
Molecular Detection of Foodborne Pathogens
Step 1. Preparation of cDNA
Reagent
Final Concentration
RNA
/
Volume Required for one Reaction 10 µl
Primer GK 7.3 50 µM 2.5 µM 1 µl Heat to 95°C for 2 min and put the mix immediately on ice; then add the following reagents: RNase-free water / 3 µl
1 ×
M-MLV RT Buffer 5 × dNTPs mix 10 mM
0.5 mM each
RNase inhibitor 40 U/µl MMLV-RT 200 U/µl Final reaction volume
Probe:45 FAM M + 64 : FAM-5′-tca ggc ccc ctc aaa GCC GA-3′-TAMRA
Final Concentration
Volume Required for one Reaction
Probe FAM M + 64 1 µM
100 nM
2.5 µl
2 × QuantiTect Multiplex RT-PCR Master Mix
1 ×
12.5 µl
Reagent
4 µl
Primer M + 25F 5 µM
300 nM
1.5 µl
1 µl
Primer M-124R 5 µM QuantiTect Multiplex RT Mix
300 nM
1.5 µl
/
0.2 µl
/
1.8 µl
20 U
0.5 µl
100 U
0.5 µl 20 µl
Reverse transcriptase thermal parameters: 15 min at 37°C; 45 min at 42°C.
RNase-free water Total volume Vortex the mix for few seconds. Aliquote 20 µl per tube RNA Final reaction volume
Step 2. cDNA PCR amplification This protocol has been evaluated using the reagents contained in the AB Gene Kit cat#AB-0575/DC/LD/A:
Final Concentration
Volume Required for one Reaction
/
18 µl
1 ×
25 µl
Primer GK 7.3 50 µM
1 µM
1 µl
Primer GK 7.4 50 µM Total volume
1 µM
1 µl
Reagent RNase-free water 2 × Reddy Mix PCR Master Mix with dNTPs
cDNA Final reaction volume
}
45 µl 5 µl 50 µl
Cycling conditions: one cycle of 94°C for 30 min; 35 cycles of 94°C for 30 sec, 52°C for 30 sec, 72°C for 45 sec; one cycle of 72°C for 4.15 min. Detection: agarose gel 2% or silver stained SDSPAGE 7% Expected amplified fragment: 200–220 bp. 4.2.3.4 Detection of Type A Influenza Virus by Qualitative Real Time PCR (M gene) The protocol uses the probe-primer set previously evaluated by Spackman et al.45 The basic procedure has been previously evaluated by different authors.45,56 In the one step rRT-PCR protocol described below the QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643) has been adopted. Reagents: QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643) Primers:45 Forward M + 25: AGA TGA GTC TTC TAA CCG AGG TCG Reverse M-124: TGC AAA AAC ATC TTC AAG TCT CTG
}
20 µl 5 µl 25 µl
Cycling conditions: This protocol was developed on AB7300 (Applied Biosystems) and Rotorgene 6000 (Corbett) real time platforms. Other laboratories using different instrumentation platforms should first critically and carefully examine these cycling conditions as they may not perform optimally on other instruments. Hence cycling temperatures, times and ramp speeds may all need to be modified. Thermal parameters: one cycle of 50°C for 20 min; one cycle of 95°C for15 min; 40 cycles of 94°C for 45 sec, 60°C for 45 sec. 4.2.3.5 Detection of Type A Influenza Viruses of H5 HA Subtype by Qualitative One Step Real Time RT-PCR Similarly to the H7 real time PCR protocol (Section 4.2.3.6), this protocol has been developed and properly validated recently.46 The procedure can be coupled with H7 detection within the same real time PCR run, providing a fast and sensitive method for the detection of notifiable AI subtypes in poultry. The protocol has been validated on a wide variety of H5/H7 isolates of the Eurasian lineage, including the recent H5/H7 LPAI viruses circulating in poultry and wild birds as well as the H5N1 HPAI viruses circulating in Eastern and Central Asia, Middle East, Europe and Africa. The protocol was developed using the QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643). Reagents: QuantiTect Multiplex RT-PCR Kit (Qiagen Cod. 204643). Primers:46 Forward H5 F : TTA TTC AAC AGT GGC GAG Reverse H5 R: CCA KAA AGA TAG ACC AGC Note degenerate nucleotides indicated in bold. Probe:46 FAM H5: FAM-5′-ccc tag cac tgg caa tca tg-3′-TAMRA
59
Avian Influenza Virus
Reagent (Conc. Stock Solution)
Final Concentration
Probe FAM H5 1 µM
150 nM
2 × QuantiTect Multiplex RT-PCR Master Mix
1 ×
Volume Required for one Reaction 3.75 µl 12.5 µl
Primer H5F 5 µM
300 nM
1.5 µl
Primer H5Rnew 5 µM QuantiTect Multiplex RT Mix
300 nM
1.5 µl
RNase-free water Total volume Vortex the mix for few seconds. Aliquote 20 µl per tube RNA
0.2 µl /
}
0.55 µl 20 µl 5 µl 25 µl
Final reaction volume
Cycling conditions: This protocol was evaluated on AB7300 (Applied Biosystems) and Rotorgene 6000 (Corbett) real time platforms. Other laboratories using different instrumentation platforms should first critically and carefully examine these cycling conditions as they may not perform optimally on other instruments. Hence cycling temperatures, times and ramp speeds may all need to be modified. Thermal parameters: one cycle of 50°C for 20 min; one cycle of 95°C for 15 min; 40 cycles of 94°C for 45 sec, 54°C for 45 sec. 4.2.3.6 Detection of Type A Influenza Viruses of H7 HA Subtype by Qualitative Real Time PCR 46 Primers: Forward H7 F: TTT GGT TTA GCT TCG GG Reverse H7 R: GAA GAM AAG GCY CAT TG Note degenerate nucleotides indicated in bold. Probe:46 VIC H7: VIC-5′-CAT CAT GTT TCA TAC TTC TGG CCA T-3 ′-TAMRA
Reagent Probe VIC H7 1 µM 2 × QuantiTect Multiplex RT-PCR Master Mix
Final Concentration
Volume Required for one Reaction
150 nM
3.75 µl
1 ×
12.5 µl
Primer H7F 10 µM
300 nM
0.75 µl
Primer H7R 10 µM QuantiTect Multiplex RT Mix
900 nM
2.25 µl
/
0.55 µl
RNase-free water Total volume Vortex the mix for few seconds. Aliquote 20 µl per tube RNA Final reaction volume
real time platforms. Other laboratories using different instrumentation platforms should first critically and carefully examine these cycling conditions as they may not perform optimally on other instruments. Hence cycling temperatures, times and ramp speeds may all need to be modified. Thermal parameters: one cycle of 50°C for 20 min; one cycle of 95°C for 15 min; 40 cycles of 94°C for 45 sec, 54°C for 45 sec.
0.2 µl
}
20 µl 5 µl 25 µl
Cycling conditions: This protocol was evaluated on AB7300 (Applied Biosystems) and Rotorgene 6000 (Corbett)
4.3 Conclusions and Future Perspectives The increasing importance of AI viruses for the veterinary and medical sciences in the last decade has contributed to a tremendous increase in actions related to this infection with the aim to better understand the pathogenicity and virulence mechanisms of these viruses and to develop better diagnostic tools for their detection. Taking advantages of the new technologies available nowadays for the diagnosis of infectious diseases, an impressive number of scientific papers has been published describing the application of technologies, such as NASBA, LAMP-PCR, or microarrays, to the detection of the viruses. Further, well established technologies, such as RT-PCR or real time PCR have been improved and applied for this infection. As for many other infectious and contagious diseases, it has been realized that rapidity in the detection and characterization of the responsible microorganism is essential for the disease control. The key issues related to the major changes in the field of AI diagnosis in the last 10–15 years, can be summarized into two main points: improved rapidity and flexibility. If compared to the classical VI and typing methods, molecular technologies have probably not improved significantly the diagnostic sensitivity or specificity. Rather, they have allowed the detection of the causative agent, in association with its typing, subtyping, and with the characterization of its molecular determinant of pathogenicity in a more time-effective and flexible manner. Importantly, the molecular tests have made the screening of large susceptible populations, such as poultry or wild birds, sustainable and cost-effective for many countries. Many molecular protocols are currently available for AI testing, but only few of these have been fully and properly validated at present. Provision and harmonization of molecular test validation procedures is therefore necessary to expand the number of validated protocols, getting to more standardized laboratory results. With very few exceptions, the vast majority of the available protocols have been developed and tested for the detection of AI viruses in clinical specimens, from alive or dead animals. To better perform epidemiological investigations, as well as to better address public health and food safety issues, it would be desirable to expand the application of the molecular tests to environmental specimens, such as water, soil, surfaces, etc., and to poultry-derived products such as meat, feathers, and eggs. Thus, the development of new protocols or the validation of the existing testing procedures on these materials appears to be necessary.
60
References
1. Perroncito, E. Epizoozia tifoide nei gallinacei. Ann. Accad. Agric. Torino, 21, 87, 126, 1878. 2. Capua, I. and Marangon S. Control of avian influenza in poultry. Emerg. Infect. Dis., 12, 1319, 2006. 3. Perdue, M.L. and Swayne, D.E. Public health risk from avian influenza viruses. Avian Dis., 49, 317, 2005. 4. Cattoli, G. and Terregino, C. New perspectives in avian influenza diagnosis. Zoonoses Public Health, 55, 24, 2008. 5. Fouchier, R.A.M. et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from blackheaded gulls. J. Virol., 79, 2814, 2005. 6. Olsen, B. et al. Global patterns of influenza A virus in wild birds. Science, 312, 384, 2006. 7. EFSA (European Food Safety Authority), Scientific report of the scientific panel on biological hazards on “Food as a possible source of infection with highly pathogenic avian influenza viruses for humans and other mammals”.. EFSA J., 74, 1, 2006. Also available online at www.efsa.eu.int 8. Capua, I. and Alexander, D.J. Human implications of avian influenza viruses and Paramyxoviruses. Eur. J. Clin. Microbiol. Infect. Dis., 23, 1, 2004. 9. Rott, R. The pathogenic determinant of influenza virus. Vet. Microbiol., 33, 303, 1992. 10. Vey, M. et al. Haemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the recognition motif R-X-R/K-R. Virology, 188, 408, 1992. 11. Senne D.A. et al. Survey of the haemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the cleavage site as a marker of pathogenicity potential. Avian Dis., 40, 425, 1996. 12. Suarez, D.L. et al. Recombination resulting in virulence shift in avian influenza outbreak. Emerg. Infect. Dis., 10, 1, 2004. 13. Pasick, J., Handel, K. and Robinson, J. Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J. Gen. Virol., 86, 727, 2005. 14. Banks, J. et al. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch. Virol., 146, 963, 2001. 15. Alexander, D.J. et al. The pathogenicity of four avian influenza viruses for chickens, turkeys and ducks. Res. Vet. Sci., 24, 242, 1978. 16. Alexander, D.J., Parsons, G. and Manvell, R.J. Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtype for chickens, turkeys, ducks and quails. Avian Pathol., 15, 647, 1986. 17. Capua, I. and Mutinelli, F. Mortality in Muscovy ducks and domestic geese associated with natural infection with a highly pathogenic avian influenza virus of H7N1 subtype. Avian Pathol., 30, 179, 2001. 18. Alexander, D.J. An overview of the epidemiology of avian influenza. Vaccine, 25, 5637, 2007. 19. Mumford, E. et al. Avian influenza H5N1: risks at the humananimal interface. Food Nutr. Bull., 28, 357, 2007. 20. Kurtz, J., Manvell, R.J. and Banks, J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet, 348, 901, 1996. 21. Banks, J. et al. Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses. Arch. Virol., 145, 1047, 2000. 22. Peiris, M. Human infection with influenza H9N2. Lancet, 354, 916, 1999.
Molecular Detection of Foodborne Pathogens 23. Guo, Y., Li, J. and Cheng, X. Discovery of men infected by avian influenza A (H9N2) virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 13, 105, 1999. 24. Puzelli, S. et al. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J. Infect. Dis., 192, 1318, 2005. 25. Hosseini, M. et al. Seroprevalence of H9N2 antibody in poultry farm and slaughter house workers of Iran using HI test. Proceedings of the 13th World Association of Veterinary Diagnosticians Symposium, 11–14 November 2007, Melbourne, Australia. 26. Subbarao, K. et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279, 393, 1998. 27. Peiris, J.S et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet, 21, 363, 617, 2004. 28. Koopmans, M. et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet, 363, 587, 2004. 29. Tweed, S.A. et al. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis., 10, 2196, 2004. 30. OIE (World Organization for Animal Health), Highly pathogenic avian influenza. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th Edition. Office International des Epizooties, Paris, France, 258, 2004. 31. EC (European Commission), Commission Decision 2006/437/ EC of 4 August 2006 approving a diagnostic manual for avian influenza as provided for in Council Directive 2005/94/EC [notified under document number C (2006) 3477], 2006. Available at: http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/l_237/ l_23720060831en00010027.pdf 32. Cattoli, G. et al. Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds. Avian Pathol., 33, 432, 2004. 33. Woolcock, P.R. and Cardona, C.J. Commercial immunoassay kits for the detection of influenza virus type A: evaluation of their use with poultry. Avian Dis., 49, 477, 2005. 34. Cattoli, G. and Capua, I. Diagnosing avian influenza in the framework of wildlife surveillance efforts and environmental samples. J. Wildlife Dis., 43, S35, 2007. 35. Higgins, D.A. Precipitating antibodies of the duck (Anas plathyrhyncos). Comp. Biochem. Physiol., 93B, 135, 1989. 36. Cattoli, G. and Capua, I. Molecular diagnosis of avian influenza during an outbreak. Dev. Biol. (Basel), 124, 99, 2006. 37. Collins, R.A. et al. A NASBA method to detect high- and lowpathogenicity H5 avian influenza viruses. Avian Dis., 47, 1069, 2003. 38. Lau, L.T. et al. Nucleic acid sequence-based amplification methods to detect avian influenza virus. Biochem. Biophys. Res. Commun., 313, 336, 2004. 39. Imai, M. et al. Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection. Vaccine, 24, 6679, 2006. 40. Jayawardena, S. et al. Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg. Infect. Dis., 13, 899, 2007. 41. Pourmand, N. et al. Rapid and highly informative diagnostic assay for H5N1 influenza viruses. PLoS One, 20,1e95, 2006. 42. Ellis, J.S. et al. Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J. Clin. Microbiol., 45, 1535, 2007.
Avian Influenza Virus 43. Forster, J.L. et al. The effect of sample type, temperature and RNAlater trade mark on the stability of avian influenza virus RNA. J. Virol. Methods, 149, 190, 2008. 44. Dybkaer, K., et al. Application and evaluation of RT-PCRELISA for the nucleoprotein and RT-PCR for detection of low-pathogenic H5 and H7 subtypes of avian influenza virus. J. Vet. Diagn. Invest., 16, 51, 2004. 45. Spackman, E. et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol., 40, 3256, 2002. 46. Monne, I. et al. Development and validation of a one step real time PCR assay for the simultaneous detection of H5, H7 and H9 subtype avian influenza viruses. J. Clin. Microbiol., 46, 1769, 2008. 47. Lee, C.W. and Suarez, D.L. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J. Virol. Methods, 119, 151, 2004. 48. Foni, E. et al. Detection of influenza A virus by RT-PCR and standard methods in experimental infection of Ducks. New Microbiol., 28, 31, 2005. 49. Xing, Z. et al. Realtime RT-PCR assay unable to detect H7 subtype avian influenza viruses isolated from wild birds. J. Clin. Microbiol., 46,1844, 2008. 50. Bogner, P. et al. A global initiative on sharing avian flu data. Nature, 442, 981, 2006. 51. OIE (World Organization for Animal Health). Quality Standard and Guidelines for Veterinary Laboratories: Infectious Diseases, 2nd Edition. Office International des Epizooties, Paris, France, 2008, Available online at http://www.oie.int. 52. Martì, N.B. et al. False positive results obtained by following a commonly used reverse transcription-PCR protocol for detection of Influenza A virus. J. Clin. Microbiol., 44, 3845, 2006. 53. Das, A. et al. Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real time reverse transcription-PCR with lyophilized reagents. J. Clin. Microbiol., 44, 3065, 2006. 54. Slomka, M.J. et al. Validated real time reverse transcriptasepolymerase chain reaction and its application in H5N1 outbreaks in 2005–2006. Avian Dis., 50, 373, 2007. 55. Suarez, D.L. Evolution of avian influenza viruses. Vet. Microbiol., 74, 15, 2000. 56. Slomka, M.J. et al. Identification of sensitive and specific avian influenza polymerase chain reaction methods through blind ring trials organized in the European Union. Avian Dis., 51, 227, 2007. 57. Hoffmann, B. et al. Rapid and highly sensitive pathotyping of avian influenza A H5N1 virus by using real-time reverse transcription-PCR. J. Clin. Microbiol., 45, 600, 2007. 58. Banks, J. et al. Phylogenetic analysis of influenza A viruses of H9 haemagglutinin subtype. Avian Pathol., 29, 353, 2000. 59. Lee, M-S. et al. Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J. Virol. Methods, 97, 13, 2001. 60. Phipps, L.P., Essen, S.C. and Brown, I.H. Genetic subtyping of influenza A viruses using RT-PCR with a single set of primers based on conserved sequences within the HA2 coding region. J. Virol. Methods, 122, 119, 2004. 61. Wang, R. et al. Examining the hemagglutinin subtype diversity among wild duck-origin influenza A viruses using ethanol-fixed cloacal swabs and a novel RT-PCR method. Virology, 375, 182, 2008.
61 62. Guan, J. et al. Development of methods for detection and quantification of avian influenza and newcastle disease viruses in compost by real-time reverse transcription polymerase chain reaction and virus isolation. Poultry Sci., 87, 838, 2008. 63. Capua, I. et al. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathol., 33, 158, 2004. 64. Keawcharoen, J. et al. Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis., 14, 600, 2008. 65. Webster, R.G., et al. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology, 84, 268, 1978. 66. Tian, G. et al. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology, 341, 153, 2005. 67. Rimmelzwaan, G.F., Osterhaus, A.D. and Kuiken, T. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol., 168, 176, 2006. 68. Mase, M. et al. Experimental assessment of the pathogenicity of H5N1 influenza A viruses isolated in Japan. Avian Dis., 49, 582, 2005. 69. Swayne, D.E. and Beck, J.R. Experimental study to determine if low-pathogenicity and high-pathogenicity avian influenza viruses can be present in chicken breast and thigh meat following intranasal virus inoculation. Avian Dis., 49, 81, 2005. 70. Muramoto, Y. et al. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiol. Immunol., 50, 73, 2006. 71. Kishida, N. et al. Pathogenicity of H5 influenza viruses for ducks. Arch. Virol., 150, 1383, 2005. 72. Kishida, N. et al. Co-infection of Staphylococcus aureus or Haemophilus paragallinarum exacerbates H9N2 influenza A virus infection in chickens. Arch. Virol., 149, 2095, 2004. 73. Toffan, A. et al. Conventional inactivated bivalent H5/H7 vaccine prevents viral localisation in muscles of turkeys infected experimentally with LPAI and HPAI H7N1 isolates. Avian Pathol., 37, 407, 2008. 74. Tumpey, T.M. et al. Characterization of highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J. Virol., 76, 6344, 2002. 75. Beato, M.S. et al. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine, 25, 4064, 2007. 76. Beato, M.S. et al. Isolation and characterization of an H10N7 avian influenza virus from poultry carcasses smuggled from China into Italy. Avian Pathol., 35, 400, 2006. 77. Beato, M.S. et al. Inactivation of avian influenza viruses by nucleic acid extraction reagents. Proceedings of the 13th World Association of Veterinary Diagnosticians Symposium, 11–14 November 2007, Melbourne, Australia. 78. Evers, D.L., Slemons, R.D. and Taubenberger, J.K. Effect of preservative on recoverable RT-PCR amplicon length from influenza A virus in bird feces. Avian Dis., 51, 965, 2007. 79. Taylor, H.R. and Turner A.J. A case report of fowl plague keraconjunctivitis. Brit. J. Ophthalmol., 61, 86, 1977. 80. WHO Laboratory Biosafety Manual, 3rd Edition, 2004. Available online at http://www.who.int/csr/resources/ publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/. 81. WHO Laboratory Biosafety Guidelines for Handling Specimens Suspected of Containing Avian Influenza A Virus, 2005. Available online at http://www.who.int/csr/disease/ avian_influenza/guidelines/handlingspecimens/en/.
62 82. Fouchier, R.A.M. et al. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol., 38, 4096, 2000. 83. Starick, E., Römer-Oberdörfer, A. and Werner, O. Type- and subtype-specific RT-PCR assays for avian influenza A viruses (AIV). J. Vet. Med. B. Infect. Dis. Vet. Public Health, 47, 295, 2000. 84. Farkas, T. et al. Rapid and simultaneous detection of avian influenza and newcastle disease viruses by duplex polymerase chain reaction assay. Zoonoses Public Health., 54, 38, 2007. 85. Malik, Y.S., Patnayak, D.P. and Goyal, S.M. Detection of three avian respiratory viruses by single-tube multiplex reverse transcription-polymerase chain reaction assay. J. Vet. Diagn. Invest., 16, 244, 2004. 86. Chaharaein, B. et al. Detection of H5, H7 and H9 subtypes of avian influenza viruses by multiplex reverse transcriptionpolymerase chain reaction. Microbiol. Res., doi:10.1016/j. micres.2007.01.001. 87. Xie, Z. et al. A multiplex RT-PCR for detection of type A influenza virus and differentiation of avian H5, H7, and H9 hemagglutinin subtypes. Mol. Cell. Probes, 20, 245, 2006. 88. Thontiravong, A. et al. The single-step multiplex reverse transcription- polymerase chain reaction assay for detecting H5 and H7 avian influenza A viruses, Tohoku. J. Exp. Med., 211, 75, 2007. 89. Ng, L.F. et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect. Dis., 2, 6, 2006. 90. Di Trani, L. et al. A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control. BMC Infect. Dis., 6, 87, 2006.
Molecular Detection of Foodborne Pathogens 91. Kiss, I. et al. Application of real-time RT-PCR utilising lux (light upon extension) fluorogenic primer for the rapid detection of avian influenza viruses. Acta Vet. Hung., 54, 525, 2006. 92. Karlsson, M. et al. A real-time PCR assay for the monitoring of influenza A virus in wild birds. J. Virol. Methods, 144, 27, 2007. 93. Payungporn, S. et al. Single step multiplex real-time RT-PCR for H5N1 influenza A virus detection. J. Virol. Methods, 131, 143, 2006. 94. Li, P.Q. et al. Development of a multiplex real-time polymerase chain reaction for the detection of influenza virus type A including H5 and H9 subtypes. Diagn. Microbiol. Infect. Dis., 61, 192, 2008. 95. Ong, W.T. et al. Development of a multiplex real-time PCR assay using SYBR Green 1 chemistry for simultaneous detection and subtyping of H9N2 influenza virus type A. J. Virol. Methods, 144, 57, 2007. 96. Rossi, J., Cramer, S. and Laue, T. Sensitive and specific detection of influenza virus A subtype H5 with real-time PCR. Avian Dis., 51, 387, 2007. 97. Wu, C. et al. A multiplex real-time RT-PCR for detection and identification of influenza virus types A and B and subtypes H5 and N1. J. Virol. Methods, 148, 81, 2008. 98. Lu, Y.Y et al. Rapid detection of H5 avian influenza virus by TaqMan-MGB real-time RT-PCR. Lett. Appl. Microbiol., 46, 20, 2008. 99. Ng, K.O.E., et al. Influenza A H5N1 detection. Emerg. Infect. Dis., 11, 1303, 2005. 100. Agüero, M. et al. A real-time TaqMan RT-PCR method for neuraminidase type 1 (N1) gene detection of H5N1 Eurasian strains of avian influenza virus. Avian Dis., 51 (Suppl 1), 378, 2007.
5 Hepatitis A and E Viruses Hiroshi Ushijima, Pattara Khamrin Aino University
Niwat Maneekarn
Chiang Mai University
Contents 5.1 Introduction ........................................................................................................................................................................ 63 5.1.1 Hepatitis A Virus (HAV)......................................................................................................................................... 63 5.1.1.1 Overview of Hepatitis A Virus Infection and Pathogenesis..................................................................... 63 5.1.1.2 Hepatitis A Virion, Genome Organization, and Proteins......................................................................... 63 5.1.1.3 HAV Classification and Genetic Diversity................................................................................................ 64 5.1.1.4 Foodborne and Waterborne HAV.............................................................................................................. 64 5.1.1.5 Diagnosis of HAV..................................................................................................................................... 64 5.1.2 Hepatitis E Virus (HEV)......................................................................................................................................... 65 5.1.2.1 Overview of Hepatitis E Virus Infection and Pathogenesis...................................................................... 65 5.1.2.2 Hepatitis E Virion, Genome Organization, and Proteins.......................................................................... 66 5.1.2.3 HEV Classification and Genetic Diversity................................................................................................ 66 5.1.2.4 Foodborne and Waterborne HEV............................................................................................................. 66 5.1.2.5 Diagnosis of HEV..................................................................................................................................... 66 5.2 Methods............................................................................................................................................................................... 67 5.2.1 Reagents and Equipments........................................................................................................................................ 67 5.2.2 Sample Collection and Preparation ........................................................................................................................ 68 5.2.2.1 HAV Specimen Collection and RNA Extraction ..................................................................................... 68 5.2.2.2 HEV Specimen Collection and RNA Extraction ..................................................................................... 68 5.2.3 Detection Procedures . ............................................................................................................................................ 68 5.2.3.1 Detection of HAV . ................................................................................................................................... 68 5.2.3.2 Detection of HEV . ................................................................................................................................... 70 5.3 Conclusions and Future Perspectives.................................................................................................................................. 71 References.................................................................................................................................................................................... 71
5.1 Introduction 5.1.1 Hepatitis A Virus (HAV) 5.1.1.1 Overview of Hepatitis A Virus Infection and Pathogenesis Viral hepatitis is a major health concern worldwide with higher incidence in developing countries than in the developed countries.1,2 Hepatitis A virus (HAV) is one of the etiologic agents of acute viral hepatitis. Most infection occur in children and generally are self-limiting.1 Transmission of HAV is primarily via the fecal-oral route, either by contact with an infected person or by ingestion of contaminated food and water.1 In the industrialized countries, due to improvements of public health and socioeconomic conditions, there has been a shift of HAV infection toward a higher age with an increase of hospitalized and severe cases associated with outbreaks.3 The illness severity is age-dependent. Generally,
HAV infection in children is asymptomatic and rarely develops jaundice, whereas in older children and adults are symptomatic infection with a wide range of clinical manifestations from mild and anicteric infection to severe and fulminant hepatic failure (FHF).1 Infected people can excrete HAV in feces for about 3 months or longer, and viremia is detectable by reverse transcription-polymerase chain reaction (RT-PCR) in the majority of patients at the onset of symptoms and can persist for several weeks after aminotransferase peak.4 Viral replication occurs primarily within hepatocytes, and then the viruses are secreted into bile through the bile ducts which results in large amount of virus being shed in the feces.5 5.1.1.2 Hepatitis A Virion, Genome Organization, and Proteins HAV is classified as the only member of the genus Hepatovirus within the Picornaviridae family.6,7 It is a 63
64
spherical, icosahedral symmetry, nonenveloped RNA virus. The virus particle is 27–32 nm in diameter with a positive single-stranded RNA genome of 7.5 kb.1 The viral genome composed of 5′ nontranslated region (NTR), structural protein regions, nonstructural protein regions, 3′ NTR, and followed by a short poly(A) tail.8 A single large open reading frame (ORF) of HAV genome can be divided into three distinct functional protein-encoded regions termed P1, P2, and P3. The P1 region encodes the capsid polypeptides VP1–VP4. The P2 and P3 regions encode the nonstructural polypeptides which are necessary for virus replication.8 5.1.1.3 HAV Classification and Genetic Diversity The HAV strains isolated from various parts of the world constitute a single serotype. However, genetic variability between strains allows the classification of HAV into six different genotypes based on phylogenetic analysis of nucleotide sequences in the VP1/P2A region.9,10 Based on this region, the HAV strains that differ from each other at least 15% of nucleotide sequences are considered to be different genotypes, while the strains that their nucleotide sequence differ over 7–7.5% belong to different HAV subgenotypes.9 Of six HAV genotypes, genotype I, II, and III are associated with human infections, and are further divided into subgenotype IA, IB, IIA, IIB, IIIA, and IIIB, respectively. The remaining three genotypes IV, V, and VI are represented by strains of simian HAV.9,10 From the epidemiological data, HAV genotypes I and III are the vast majority of human strains which comprise more than 80% of strains circulating worldwide.1,9,11 5.1.1.4 Foodborne and Waterborne HAV Foodborne and waterborne viral infections are increasingly recognized as the causes of illness in humans. HAV is one of the leading causes of foodborne and waterborne viral infections. It can be transmitted from person-to-person, or indirectly via food and water contaminated with virus-containing feces. HAV has previously been isolated directly from food or environmental sources. Salad vegetables, soft fruits, green onion, strawberry, lettuce, clam, shellfish, and oyster samples have been reported to be the sources of HAV infections.12–17 A large epidemic outbreak of HAV, reported in 1988, was attributed to the ingestion of raw clams and caused illness in 300,000 persons in Shanghai, China.18 Moreover, waterborne outbreaks of HAV associated with HAV contamination in water supply have also been reported from several countries. HAV has also been detected in river, canal, ground/tap water and sewage.12,16,19–21 5.1.1.5 Diagnosis of HAV For the detection of HAV genomic RNA, several genome segments have been amplified by different sets of primer pairs. The genomic regions which have been used widely to detect
Molecular Detection of Foodborne Pathogens
and to define HAV genotypes, included the junction of VP3/ VP1 region.17,22–25 the junction of VP1/P2A region,4,24–28 the entire VP1 region,29 and the junction of 3C/3D region.30 The primers used for the detection of HAV are summarized in Table 5.1. Currently, the genomic region that most commonly used for the detection and identification of HAV genotypes is the VP1/P2A junction region. To facilitate the molecular analysis of HAV, the amplification of their genomic RNA and sequencing of DNA amplicon should be performed and HAV genotypes are identified based on sequence analysis. Sequence variation within the VP1/P2A junction has defined six HAV genotypes and two subtypes within genotypes I, II, and III.9–11 In contrast to most picornaviruses, HAV of human origin replicates poorly in cell cultures with a relatively low concentration of viruses and viral antigen being produced into the cultured supernatant. For these reasons, development of a number of RT-PCR-based assays that enable the rapid and specific detection of small amount of viral nucleic acid in environmental sources, food samples, and clinical specimens have been developed recently. Several kinds of clinical samples have been used for the detection of HAV genome, including stool, serum, saliva, and liver suspension.9,26,31 In addition, HAV has also been detected by other sensitive molecular techniques such as restriction fragment length polymorphism (RFLP),32 Southern blotting,33 real-time RT-PCR,34 and reverse transcription loop-mediated isothermal amplification assay (RT-LAMP).35 Currently, the amplification of viral RNA by RT-PCR is the most sensitive and widely used method for the detection of foodborne HAV RNA.15,16,21,25,36 The efficiency of the extraction methods for HAV RNA from clinical specimens is of great important for molecular diagnosis. Therefore, choosing appropriate RNA extraction methods is a critical step for a successful and valid use of PCR amplification of viral genome in clinical samples. Traditionally, proteinase K digestion and guanidinium isothiocyanate (GTC)-phenol-chloroform extraction method followed by ethanol precipitation has been widely used to extract RNA from serum or stool samples.37 Recently, numerous protocols for RNA extraction, i.e., GTC-silica method, antigen-capture method, and magnetic beads coated with anti-HAV have been used for the isolation of HAV RNA and to separate viral genome from the potential inhibitors of RT-PCR reaction that might exist in the clinical samples.9,22,31,37–41 The total genomic RNA of HAV can also be easily isolated from clinical samples with high sensitivity and reproducibility by using commercially available RNA extraction kits, i.e., Trizol LS® Reagent (Invitrogen Life Technology, Carlsbad, CA)30,41 or QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany).27,31,35,42 Recently, the use of the QIAamp Viral RNA Mini Kit (Qiagen) has been reported to be an efficient method for extraction of HAV genomic RNA with a detection limit of 6 × 103 copies/ml in clinical samples.31
65
Hepatitis A and E Viruses
Table 5.1 Oligonucleotide Primers for the Detection and Sequencing of HAV from Clinical Specimens Primer Name
Region
Sequence 5′–3′
Position
Sense
VP1-4
VP3/VP1
First PCR
CGT TGC TTC CCA TGT CAG AG
2115–2135
+
VP1-5
VP3/VP1
First PCR
GAC CTT CCC ATA AAC TTG TAG
2483–2462
–
VP1-2
VP3/VP1
Second PCR
GTT TTG CTC CTC TTT ATC ATG CTA TG
2168–2194
+
VP1-1
VP3/VP1
Second PCR
GGA AAT GTC TCA GGT ACT TTC TTT G
2415–2390
–
BR-5
VP1/P2A
First PCR
TTG TCT GTC ACA GAA CAA TCA G
2950–2972
+
BR-9
VP1/P2A
First PCR
AGT CAC ACC TCT CCA GGA AAA CTT
3310–3286
–
RJ-3
VP1/P2A
Second PCR
TCC CAG AGC TCC ATT GAA
2984–3002
+
BR-6
VP1/P2A
Second PCR
AGG AGG TGG AAG CAC TTC ATT TGA
3217–3193
–
–
VP3/VP1
First PCR
GTG AAT GTT TAT CTT TCA GCA AT
2133–2155
+
–
VP3/VP1
First PCR
GAT CTG ATG TAT GTC TGG ATT CT
2429–2451
–
–
VP3/VP1
Second PCR
GCT CCT CTT TAT CAT GCT ATG GAT
2172–2195
+
–
VP3/VP1
Second PCR
CAG GAA ATG TCT CAG GTA CTT TCT
2392–2415
–
–
VP1/P2A
First PCR
GAC AGA TTC TAC ATT TGG ATT GGT
2870–2893
+
–
VP1/P2A
First PCR
CCA TTT CAA GAG TCC ACA CAC T
3360–3381
–
–
VP1/P2A
Second PCR
CTA TTC AGA TTG CAA ATT ACA AT
2896–2981
+
–
VP1/P2A
Second PCR
AAC TTC ATT ATT TCA TGC TCC T
3268–3289
–
+2897
VP1/P2A
First PCR
CTA TTC AGA TTG CAA ATT AYA AT
2897–2819
+
–3288
VP1/P2A
First PCR
AAY TTC ATY ATT TCA TGC TCC T
3267–3288
–
+2949
VP1/P2A
Second PCR
TAT TTG TCT GTY ACA GAA CAA TCA G
2949–2973
+
–3192
VP1/P2A
Second PCR
AGG RGG TGG AAG YAC TTC ATT TGA
3169–3192
–
A
VP3/VP1
First PCR
GTT TTG CTC CTC TTT ATC ATG CTA TG
2167–2192
+
B
VP3/VP1
First PCR
GGA AAT GTC TCA GGT ACT TTC TTT G
2389–2414
–
A
VP3/VP1
Second PCR
GTT TTG CTC CTC TTT ATC ATG CTA TG
2167–2192
+
C
VP3/VP1
Second PCR
TCC TCA ATT GTT GTG ATA GC
2358–2377
–
HA027
3C/3D
First PCR
TTT GGW GTT GGD GAG AAR AAT GG
5318–5340
+
HA030
3C/3D
First PCR
AAG CGT TTT GGA GAC YAC ATT C
5969–5989
–
HA028
3C/3D
Second PCR
GTG TKA GRT GGG TYA TGA ATG C
5343–5364
+
HA029
3C/3D
Second PCR
GAC YAC ATT CAT TGA ACA YTG AG
5955–5977
–
5.1.2 Hepatitis E Virus (HEV) 5.1.2.1 Overview of Hepatitis E Virus Infection and Pathogenesis HEV is widely spread in many tropical and subtropical countries where sanitary infrastructure remains inadequate.43 Clinical manifestations of HEV infection are similar to those of HAV infection and encompass a wide spectrum of symptoms. Typical HEV symptoms include jaundice, hepatomegaly, dark- or tea-colored urine, anorexia, diarrhea, vomiting, and fever.44,45 The illness is usually self-limiting and typically lasts for about 1–4 weeks and infection does not progress to chronicity. The disease is slightly more severe than HAV infection, but still has a low mortality in the general population with the rate of about 1–4%.44,46 However, a few patients develop a prolonged clinical illness
PCR Product
Reference
369 bp
24
247 bp
24
360 bp
24, 26, 27
234 bp
24, 26, 27
319 bp
25
244 bp
25
512 bp
25
394 bp
25
392 bp
4, 28
244 bp
9, 28
248 bp
23
211 bp
23
672 bp
30
635 bp
30
24 24
24, 26, 27 24, 26, 27
25 25
25 25
4, 28 9, 28
23 23
30 30
and severe complications with a high mortality rate associated with infection of pregnant women (15–20%), particularly in the third trimester of pregnancy. Causes of death among pregnant women with HEV infection include hepatic encephalopathy and disseminated intravascular coagulation.43,47–50 Incubation period of HEV infection ranges from 15 to 60 days.51–53 HEV antigen first appears in the liver and this is typically followed by viremia.54 Virus accumulates at a relatively high concentration in bile and is subsequently shed in the feces. Viremia and fecal shedding are detected prior to liver abnormalities. Liver function tests are indicative of hepatic inflammation. Laboratory tests of enzyme level abnormalities including, high peak of alanine aminotransferase (ALT), aspartate aminotransferase (AST), gammaglutamyl aminotransferase (GGT), and serum alkaline phosphatase (SAP). Experimental studies
66
of HEV infections in human volunteers demonstrated that liver enzyme elevations occurred at 4–5 weeks after oral ingestion and persisted for 3–13 weeks.51,53 Virus excretions in feces occurred approximately at 2–4 weeks. In addition, HEV RNA could be detected in serum around the first 2–3 weeks after exposure. Antibodies to HEV were first detected at about 6 weeks after infection and remained detectable up to 2 years.51,53 The HEV pathogenesis is not well understood. Several studies demonstrated that HEV is transmitted through fecal-oral contact or consumption of contaminated food or water.43,55–57 The site of the primary replication has not been identified, but it is presumed to be in the intestinal tract. The route and mechanism by which the virus reaches the liver from the intestinal tract after consumption of the virus remain unclear. However, possible mechanism of HEV associated disease may be due to (i) liver cell injury caused by either an immunologic mechanism and/or direct cytopathic effects of the virus on the liver cells, and (ii) viral antigenantibody complex mediated vasculitis/glomerulonephritis.47 HEV particle is almost certainly resistant to the change of pH between alkaline and acidic. Therefore, it can survive in the gastrointestinal tract and cause infection, but does not seem to tolerate exposure to high salt concentration, including cesium chloride. Since the main mode of transmission of HEV is the fecal-oral route, prevention of HEV infection, therefore, relies primarily on the provision of clean drinking water, improving personal hygiene, and avoiding consumption of raw, uncooked meat, and vegetables. Study of thermal stability of HEV suggests that it is less stable than HAV.58 5.1.2.2 Hepatitis E Virion, Genome Organization, and Proteins Initially, HEV had been classified as a member of the Picornaviridae family. Later, it was shown that HEV was antigenically and biophysically unrelated to the picornaviruses. For these reasons, HEV has been reclassified as the only member of the genus Hepevirus in the new family Hepeviridae.43 HEV has been characterized as a nonenveloped 27–34 nm particle with a positive sense single-stranded RNA genome. Its genome is approximately 7.2 kb in length, and contains a short 5′ NTR, three ORFs (ORF1, ORF2, ORF3), 3′ NTR, and followed by a poly(A) tail.59–61 ORF1 is the largest among the three ORFs and encodes a nonstructural protein containing methyltransferase, helicase, and replicase domains. ORF2 encodes the major capsid protein of the virus, while ORF3 encodes a small protein that appears to serve as a viral regulatory protein rather than a structural protein.43,62,63 5.1.2.3 HEV Classification and Genetic Diversity Only a single known serotype of HEV is recognized to date. However, based on sequence analysis, several HEV isolates
Molecular Detection of Foodborne Pathogens
identified from different parts of the world have been classified into five genotypes.43,64,65 Of these, genotypes 1–4 are found in humans, genotypes 3 and 4 are restricted mainly in pigs, whereas genotype 5 has been isolated from chickens in the US.65 Data of global distribution of HEV in humans demonstrated that genotype 1 has been circulated in the developing countries in Asia and Africa, and is responsible mainly for waterborne outbreaks in these areas. Genotype 2 has been reported from outbreaks of HEV in Mexico and Nigeria. On the other hand, genotypes 3 and 4 are sometimes found to be associated with zoonotic infection and have been reported from sporadic cases of an acute HEV infection and/or domestic pigs in America, Europe, and Asia.43,47 5.1.2.4 Foodborne and Waterborne HEV HEV is spread mainly through the fecal-oral route via fecal contamination in water and food products. The growing data on the epidemiological studies of HEV indicated that HEV may be a zoonotic virus. Detections of HEV RNA from feces and anti-HEV from sera of swine have recently been documented.66–68 In addition, a number of studies reported the evidence of zoonotic foodborne transmission of HEV from animals to humans, such as, detection of HEV from pig livers sold in Japan and the US.57,69 Direct evidence for zoonotic foodborne transmission of HEV has also been confirmed in Japan where consumption of uncooked deer and wild-boar meat resulted in HEV infection in humans.70,71 In addition, waterborne outbreaks of HEV disease have been reported in association with contaminated water supply in several countries worldwide.72–76 5.1.2.5 Diagnosis of HEV For diagnosis of HEV infection, several methods are available. These include immune electron microscopy (IEM), enzyme immunoassay (EIA), immunochromatography (IC), RT-PCR, real-time PCR, and nucleic acid sequence analysis. Among these methods, RT-PCR and nucleic acid sequence analysis are widely used methods for the detection and genotype identification of foodborne HEV (food/water contaminations) and zoonotic HEV infections.77–80 These techniques have replaced the traditional immunological tests and become the gold standard for diagnosis of HEV infection. Recently, molecular techniques based on RT-PCR for the detection of viral genomic RNA have been developed for both epidemiological study and diagnosis of HEV infection. The most reliable marker for diagnosis of HEV infection is the presence of HEV RNA in serum or fecal samples. Therefore, several protocols of nested RT-PCR have been reported for direct detection of HEV from clinical specimens.77,81–88 The oligonucleotide primers used for the detection of HEV from clinical specimens are summarized in Table 5.2.
67
Hepatitis A and E Viruses
Table 5.2 Oligonucleotide Primers for the Detection and Sequencing of HEV From Clinical Specimens Primer Name
Region
Sequence 5′–3′
Position
Sense
HE361 HE364 HE366 HE363
ORF2/3 ORF2/3 ORF2/3 ORF2/3
First PCR First PCR Second PCR Second PCR
GCR GTG GTT TCT GGG GTG AC CTG GGM YTG GTC DCG CCA AG GYT GAT TCT CAG CCC TTC GC GYM TGG TCD CGC CAA GHG GA
5302–5321 5446–5465 5325–5344 5442–5461
+ – + –
ConsORF2-s1 ConsORF2-a1 ConsORF2-s2 ConsORF2-a2
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
GAC AGA ATT RAT TTC GTC GGC TGG CTT GTT CRT GYT GGT TRT CAT AAT C GTY GTC TCR GCC AAT GGC GAG C GTT CRT GYT GGT TRT CAT AAT CCT G
6298–6321 6470–6494 6347–6368 6467–6491
+ – + –
E1 E5 E2 E4-1
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
CTG TTT AAY CTT GCT GAC AC WGA RAG CCA AAG CAC ATC GAC AGA ATT GAT TTC GTC G TGY TGG TTR TCR TAA TC
6260–6279 6551–6568 6298–6316 6467–6486
+ – + –
F1 R1 F2 R2
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
GCC GAG TAT GAC CAG TCC A ACA ACT CCC GAG TTT TAC CC AAT GTT GCG ACC GGC GCG C TAA GGC GCT GAA GCT CAG C
6577–6595 7107–7127 6649–6668 7079–7098
+ – + –
Forward (ex) Backward (ex) Forward (in) Backward (in)
ORF1 ORF1 ORF1 ORF1
First PCR First PCR Second PCR Second PCR
CAT GGT CGA GAA GGG CCA GG GCG GAA GTC ATA ACA GTG GG ATG ACT TTG CTG AGT TTG ACT CAT ATT CCA GAC AGT ATT CC
4089–4108 4631–4650 4403–4423 4601–4620
+ – + –
3156N 3157N 3158N 3159N
ORF2 ORF2 ORF2 ORF2
First PCR First PCR Second PCR Second PCR
AAT TAT GCY CAG TAY CGR GTT G CCC TTR TCY TGC TGM GCA TTC TC GTW ATG CTY TGC ATW CAT GGC T AGC CGA CGA AAT CAA TTC TGT C
5711–5732 6419–6441 5996–6017 6322–6343
+ – + –
PCR Product
Reference 77 77 77 77
164 bp 137 bp
82 82 82 82
197 bp 145 bp
88 88 88 88
309 bp 189 bp
84 84 84 84
551 bp 450 bp
86 86 86 86
562 bp 218 bp
85 85 85 85
731 bp 348 bp
5.2 Methods 5.2.1 Reagents and Equipments Reagents DEPC-treated water Ethanol Phosphate buffered saline (PBS), pH 7.4 Chloroform Isopropanol TRIzol® LS reagent QIAamp Viral RNA Mini Kit 5× First-Strand RT Buffer DTT Deoxynucleotide triphosphate (dNTP) Mix (2.5 and 10 mM) SuperScript III Reverse Transcriptase (200 units/µl) Random primer (1 µg/µl) RNase Inhibitor (40 units//µl) Mineral oil 5× Colorless GoTaq PCR buffer
Supplies and Equipments 0.2, 0.5, 1.5-ml tubes (RNase-free) Micropipetters and aerosol barrier filter tips (10, 100, 1000 µl) Disposable protective gloves Appropriate tube racks Suitable containers for ice Disposable plastic pipets Freezer –20, –80°C High speed microcentrifuge Class II biological safety cabinet Speed-vacuum Heat box Vortex mixer PCR thermal cycler Laboratory balances Agarose gel electrophoresis apparatus Timers (Continued)
68
Molecular Detection of Foodborne Pathogens
Reagents
Supplies and Equipments
Specific primers for HAV and HEV GoTaq DNA polymerase (5 units/µl) TAE (Tris-acetate-EDTA) buffer Agaro Loading dye 100 bp DNA ladder marker Ethidium bromide Wizard SV Gel and PCR Clean-Up System or QIAquick PCR purification kit BigDye Terminator v3.1 Cycle Sequencing Kit
5.2.2 Sample Collection and Preparation 5.2.2.1 HAV Specimen Collection and RNA Extraction Although feces, serum, saliva, and liver suspension can be used for diagnosis of foodborne HAV infection, the specimens of choice are feces and serum. The fecal specimen should be collected within 1 week after the onset of dark urine and stored at –20°C until tested.89 The 10% stool suspension is prepared in phosphate-buffered saline (pH 7.4) and clarified by centrifugation at 4,800 × g for 15 min to eliminate larger debris. Serum sample should be collected during the first month after presentation of clinical signs or symptoms (jaundice, dark urine, or the level of serum ALT/AST are higher than 20 UI/L) The obtained serum should be stored at –20°C or below until use for RNA extraction. For the TRIzol® LS extraction method, 100 µl of serum or 10% (w/v) fecal supernatant is mixed with 800 µl of TRIzol® LS reagent and 200 µl of chloroform. After centrifugation at 8,000 × g for 20 min at 4°C, the upper phase is precipitated with 600 µl of isopropanol at –20°C for 18–24 h. Then, follows by centrifugation, and the pellet is washed with 70% ethanol, air dry, and finally resuspended in 10 µl of DEPCtreated water. For QIAamp Viral RNA Mini Kit, the RNA is extracted from the fecal supernatant or serum according to the manufacturer’s instructions. Briefly, 140 µl of 10% (w/v) fecal supernatant or serum is mixed with 560 µl of AVL viral lysis buffer. The mixture is incubated at room temperature for 10 min and 560 µl of ethanol is added. Then, the mixture is applied onto the spin column, centrifuge at 6000 × g for 1 min, and 500 µl of AW1 buffer is added. The column is centrifuged at 6,000 × g for 1 min to remove unbound materials, and washed by addition of 500 µl of AW2 buffer. Then, the column is centrifuged at full-speed for 3 min, and placed into a new 1.5-ml microcentrifuge tube. Finally, 60 µl of AVE buffer is added directly onto the column to elute HAV genomic RNA. After incubation at room temperature for 1 min, the column is centrifuged at 6,000 × g for 1 min. The obtained RNA is used as a template for PCR amplification. The genomic RNA can be stored at –80°C until nested RT-PCR assay is performed. 5.2.2.2 HEV Specimen Collection and RNA Extraction The specimens of choice for the diagnosis of HEV infection are serum and stool samples. Specimens should be collected
Ultraviolet transilluminator Syringe and needle Sterile Pasteur piptes DNA sequencer (ABI 3100 Applied Biosystems)
in an early acute phase of the disease and stored at –20°C until tested. Long-term storage should be kept at –70°C. Several methods have been used for the extraction of HEV RNA from clinical specimens prior to RT-PCR. These include the use of glass powder RNA extraction, antigencapture method by the use of anti-HEV antibody to capture the virus particle, microspin columns for HEV RNA extraction, and conventional RNA separation by using GTCphenol-chloroform extraction method.90–92 Recently, highly sensitive and reproducible RNA extraction kits, which are commercially available, have been introduced and widely used for HEV genomic RNA isolation, including Trizol LS® Reagent (Invitrogen Life Technology) and QIAamp Viral RNA Mini Kit (Qiagen).77,80–83 The details of specimen collection and RNA extraction methods are similar to those of the protocols described above for HAV detection.
5.2.3 Detection Procedures 5.2.3.1 Detection of HAV (i) Reverse-transcription PCR (RT-PCR): The following RT-PCR protocol has been modified from previously published reports.24,26,27 The RT reaction is carried out in a total volume of 15 µl. Note: Vortex and spin down all microcentrifuge tubes of RT-PCR components before use. (1) Prepare the reverse transcription mix (RT-mix) as follows (volumes indicated as per specimen): Component DEPC-treated water 5× First-strand buffer 0.1 M DTT dNTP mix (10 mM) SuperScript III reverse transcriptase Random primer (hexa-deoxyribonucleotide mixture; 1 µg/µl) RNase inhibitor Total
Volume (µl) 3.3 3.0 0.8 0.8 0.8 0.8 0.5 10.0
(2) Add 10 µl RT-mix to each 0.5 ml tube followed by addition of 5.0 µl of individual RNA sample. (3) Spin the tubes briefly to ensure that no reagent droplets remain on the side of the tubes. (4) Overlay the reaction mixture with one drop of mineral oil to prevent evaporation during the RT process.
69
Hepatitis A and E Viruses
(5) Transfer the reaction tubes to a 50°C heat box for 1 h, and then increase temperature to 95°C for 5 min. (6) Rapidly chill the tubes on ice for 5 min. (7) The cDNA can be used directly in the PCR, or stored at –20°C for future use. (ii) Nested PCR for HAV detection: For nested PCR amplification, two different PCR reactions (first and second PCR) are performed separately in a total volume of 25 µl. The cDNA is amplified for the detection of HAV genome. A forward primer BR-5 is used in combination with a reverse primer BR-9 (Table 5.1) to specifically generate a PCR amplicon of 360 bp.24 (1) Remove all aliquots of PCR reagents (DEPCtreated water, 5 × Colorless GoTaq PCR buffer, 2.5 mM dNTP mix, primers, GoTaq DNA polymerase) from the –20°C freezer. Vortex and spin down all reagents before opening the tubes. (2) Prepare the first PCR reaction mix as follows (volumes indicated as per specimen) : Component
Volume (µl)
DEPC-treated water
13.9 5.0
5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM) Primer BR-5 (20 pmol/µl)
2.0 0.5
Primer BR-9 (20 pmol/µl)
0.5 0.1
GoTaq DNA polymerase (5 units/µl) Total
22.0
(3) Add 22.0 µl of first PCR mix and 3.0 µl of cDNA into a 0.2-ml PCR tube. (4) Turn on a thermocycler and preheat the block to 93°C. (5) Spin the sample tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature. (6) Place the sample tubes in the thermal cycler for 30 cycles of 93°C for 30 sec, 55°C for 30 sec, 72°C for 50 sec; and one cycle of 72°C for 10 min. (7) Following amplification, pulse-spin the reaction tubes to pull down the condensation droplets at the inner wall of the tubes. The samples are now ready for the second PCR or stored frozen at –20°C. (8) The second PCR is conducted using the first PCR product as a template. Prepare the second PCR reaction mix as follows (volumes indicated as per specimen): Component DEPC-treated water 5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM)
(9) Add 23.0 µl of second PCR mix and 2.0 µl of first PCR product to a 0.2-ml PCR tube. (10) Then, the PCR is carried out under the same thermal cycling conditions as the first amplification. The expected size of the second PCR product is 234 bp in length. (11) Analyze the PCR products by agarose gel electrophoresis through 2% agarose gel in TAE buffer at 100 volts for 30 min. (12) The gel is stained with ethidium bromide and then visualized under ultraviolet light source. Note: negative control is also concurrently included along with the test samples in order to monitor any possible contamination that might be occur during the PCR procedure. (iii) HAV sequence analysis and genotype identification: To characterize HAV genotypes, a phylogenetic analysis should be carried out by direct sequencing of the nucleotide sequence of VP1/P2A junction. A key step in all sequencing methods is the careful preparation of the template with adequate concentration and purity. Prior to sequencing reaction, the unincorporated nucleotide and primers remaining after the PCR amplification must be removed. This step can be done simply by using a commercial spin column kits (Wizard SV Gel and PCR Clean-Up System; Promega, Madison, WI or QIAquick PCR purification kit; Qiagen). The amount of purified PCR product is once more estimated by electrophoresis through 2% agarose gel in parallel with standard DNA and the purified product is used as a template in cycle sequencing reaction. Nucleotide sequencing is performed using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) according to the manufacturer protocol. (1) For each sequencing reaction, mix the following reagents in a labeled tube Component Terminator ready reaction mix (v3.1) 5 × Sequencing buffer Purified PCR product (~100 ng) Sequencing primer (BR-6; 5 pmol/µl) DEPC-treated water Total
Volume (µl) 14.9 5.0
Primer RJ-3 (20 pmol/µl)
2.0 0.5
Primer BR-6 (20 pmol/µl)
0.5
GoTaq DNA polymerase (5 units/µl) Total
0.1 23.0
Volume (µl) 4.0 4.0 1.0 1.0 10.0 20.0
(2) Spin the samples tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature. (3) Place the sample tubes in a thermocycler for a total of 25 cycles of 96°C for 10 sec, 50°C for 5 sec, and 60°C for 4 min. (4) Then, the DNA sequencing product is purified by ethanol-EDTA precipitation, washed with 70% ethanol, and dry the pellet in a vacuum centrifuge. (5) Finally, analyze the nucleotide sequence of the DNA product using an automated DNA sequencer ABI 3100 Applied Biosystems.
70
Molecular Detection of Foodborne Pathogens
Note: having obtained good-quality sequence data, it is necessary to compare the sequence data with other published sequences. Therefore, the HAV nucleotide sequences of VP1/P2A junction should be compared with those of the reference strains available in the NCBI (National Center for Biotechnology Information) GenBank database, EMBL (The European Molecular Biology Laboratory), or DDBJ (DNA Data Bank of Japan). Phylogenetic and molecular evolutionary analyses are conducted using MEGA version 4.93 The authors strongly recommend that the new sequences obtained should be submitted for deposition in one of the databases mentioned above, in order to make them available to the scientific community. Most journals do not accept manuscripts before deposition of the sequence data in one of those databases. 5.2.3.2 Detection of HEV (i) RT-PCR: The protocols that are routinely used for the detection and genotyping of HEV from clinical specimens have been modified from References 77 and 81. RNA is reverse-transcribed in the presence of random primers and the RT is carried out under the same conditions as those described above for HAV detection. (ii) Nested PCR for HEV detection: To detect the HEV RNA, a part of ORF2/3 is amplified by nested PCR. The oligonucleotide primers for the detection of HEV are described previously by Inoue et al. (Table 5.2).77 The reaction mixture for the first round amplification is similar to that of HAV except for the primers used. (1) Remove all aliquots of PCR reagents (DEPCtreated water, 5 × Colorless GoTaq PCR buffer, 2.5 mM dNTP mix, primers, GoTaq DNA polymerase) from the –20°C freezer. Vortex and spin down all reagents before open the tubes. (2) Prepare the first PCR reaction mix as follow (volumes indicated as per specimen): Component DEPC-treated water 5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM)
13.9 5.0
Primer HE361 (20 pmol/µl)
2.0 0.5
Primer HE364 (20 pmol/µl)
0.5
GoTaq DNA polymerase (5 units/µl) Total
Volume (µl)
0.1 22.0
(3) Add 22.0 µl of first PCR mix and 3.0 µl of cDNA into a 0.2-ml PCR tube. (4) Turn on a thermal cycler and preheat the block to 94°C. (5) Spin the sample tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature.
(6) Place the sample tubes in the thermocycler for a total of 35 cycles of 94°C for 30 sec, 58°C for 30 sec, and 72°C for 30 sec; and one cycle of 72°C for 10 min. (7) Following amplification, pulse-spin the reaction tubes to pull down all the solution that may attach to the inner wall of the tubes. The samples are ready for second PCR or stored frozen at –20°C. (8) Then, nested PCR is performed in a total volume of 25 µl with 2 µl of amplification product from the first round PCR. Prepare the second PCR reaction mix as follows (volumes indicated as per specimen): Component DEPC-treated water 5 × Colorless GoTaq PCR buffer (containing MgCl2) dNTP mix (2.5 mM)
Volume (µl) 14.9 5.0
Primer HE366 (20 pmol/µl)
2.0 0.5
Primer HE363 (20 pmol/µl)
0.5
GoTaq DNA polymerase (5 units/µl) Total
0.1 23.0
(9) Add 23.0 µl of second PCR mix and 2.0 µl of first PCR product to a 0.2-ml PCR tube. (10) Then, the nested PCR is carried out under the same thermal cycling conditions as the first amplification. The expected sizes of the amplification products are 164 bp and 137 bp for the first and second round PCR, respectively. (11) The PCR product sizes are determined by electrophoresis through 3% agarose gel in TAE buffer at 100 volts for 30 min. (12) The gel is stained with ethidium bromide and then visualized under ultraviolet light source. Note: negative control is also concurrently included along with the test samples in order to monitor any possible contamination that might occur during the PCR procedure. (iii) HEV sequence analysis and genotype identification: For the detection of genetic variation and genotype identification of HEV, genome sequence and phylogenetic analyses should be performed at least one part of the gene by direct sequencing of PCR products. HEV PCR product purification and sequencing protocol are similar to those described above for the HAV sequence analysis except for sequencing primer HE363 is used. (1) For each sequencing reaction, mix the following reagents in a labeled tube Component Terminator ready reaction mix (v3.1) 5 × Sequencing buffer Purified PCR product (~100 ng) Sequencing primer (HE363; 5 pmol/µl) DEPC-treated water Total
Volume (µl) 4.0 4.0 1.0 1.0 10.0 20.0
71
Hepatitis A and E Viruses
(2) Spin the samples tubes in a microcentrifuge at 14,000 × g for 30 sec at room temperature. (3) Place the sample tubes in a thermocycler for 25 cycles of 96°C for 10 sec, 50°C for 5 sec, and 60°C for 4 min. (4) Then, the DNA sequencing product is purified by ethanol-EDTA precipitation, washed with 70% ethanol, and the pellet is dried in a vacuum centrifuge. (5) Finally, the nucleotide sequence of the DNA product is analyzed using an automated DNA sequencer ABI 3100 Applied Biosystems.
5.3 Conclusions and Future Perspectives Acute viral hepatitis is an important disease caused by a variety of hepatitis viruses. Among them, HAV, and HEV contribute a significant role on the disease. Both are enteric viruses and transmitted by fecal-oral contact or consumption of contaminated food or water. HAV is responsible for acute viral hepatitis, which represents a significant public health problem in many countries due to the persistent circulation of the viruses in the environment. HEV epidemics have also been reported in some developing countries and are associated frequently with contaminated drinking water. In addition, it causes substantial morbidity and mortality, particularly among pregnant women. Recently, the determination and analysis of molecular biomarkers (e.g., nucleic acid sequencing or phylogenetic analysis) have been used to detect and to determine the relatedness of the viruses circulating worldwide. Molecular epidemiology has become a particularly powerful tool for investigation of foodborne and waterborne outbreaks of the diseases. In addition, the availability of a large and growing database of HAV and HEV sequences has allowed the identification of the source of virus contamination and may help to accelerate the public health concern and immediate response to the outbreaks. Although single round PCR is the most familiar molecular assay for the detection and genotyping of pathogens in clinical microbiology, the multiplex PCR assay is also getting much attention and has been developed and widely used to serve these purposes in several viruses. However, multiplex PCR has some inherited limitations, particularly the sensitivity of the method. For future perspective, a more highly sensitive, reliable, and inexpensive method needs to be developed for the detection and genotyping of pathogens. Most recently, DNA microarray technology has been developed and widely applicable in several aspects of infectious diseases, particularly for the detection and identification of infecting pathogens. In some cases, the detection limit of microarray was found to be as little as 10 fg of pathogenic DNA, which is far below the detection limits of other existing technologies. Conceivably, DNA microarray is an ideal tool that needs to be developed for the detection and identification, as well as genotyping and characterizing of HAV and HEV in the future.
References
1. Hollinger, F.B., and Emerson S.U., Hepatitis A Virus. In: Knipe, D.M, and Howley, P.M., (ed.), Fields Virology, 5th ed. pp. 911–947. Lippintcott Williams & Wilkins, Philadelphia, PA, 2007. 2. Acharya, S.K. et al. Viral hepatitis in India. Natl. Med. J. India., 19, 203, 2006. 3. Shapiro, C.N., and Margolis, H.S. Worldwide epidemiology of hepatitis A virus infection. J. Hepatol., 2, 11, 1993. 4. Bower, W.A. et al. Duration of viremia in hepatitis A virus infection. J. Infect. Dis., 182, 12, 2000. 5. Robertson, B. Hepatitis A and E. In: Mahy, B.W.J, and ter Meulen, V. (ed.), Topley & Wilson’s Microbiology & Microbial Infection, 10th ed. pp. 1160–1187. Edward Arnold, London. 6. Minor, P.D. et al. Picornaviridae. Classification and nomenclature of viruses: the fifth report of the international committee on taxonomy of viruses. Arch. Virol. (Suppl.), 2, 320, 1991. 7. Melnick, J.L. Properties and classification of hepatitis A virus. Vaccine, 10, 24, 1992. 8. Cohen, J.I. et al. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J. Virol., 61, 50, 1987. 9. Robertson, B.H. et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol., 73, 1365, 1992. 10. Lu, L. et al. Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate). J. Gen. Virol., 85, 2943, 2004. 11. Costa-Mattioli, M. et al. Genetic analysis of hepatitis A virus outbreak in France confirms the co-circulation of subgenotypes Ia, Ib and reveals a new genetic lineage. J. Med. Virol., 65, 233, 2001. 12. Dubois, E. et al. Detection and quantification by real-time RT-PCR of hepatitis A virus from inoculated tap waters, salad vegetables, and soft fruits: characterization of the method performances. Int. J. Food. Microbiol., 30, 141, 2007. 13. Chancellor, D.D. et al. Green onions: potential mechanism for hepatitis A contamination. J. Food. Prot., 69, 1468, 2006. 14. Bidawid, S., Farber, J.M., and Sattar, S.A. Rapid concentration and detection of hepatitis A virus from lettuce and strawberries. J. Virol. Methods, 88, 175, 2000. 15. Suñén, E. et al. Comparison of two methods for the detection of hepatitis A virus in clam samples (Tapes spp.) by reverse transcription-nested PCR. Int. J. Food. Microbiol., 91, 147, 2004. 16. Formiga-Cruz, M. et al. Nested multiplex PCR assay for detection of human enteric viruses in shellfish and sewage. J. Virol. Methods, 125, 111, 2005. 17. Sincero, T.C. et al. Detection of hepatitis A virus (HAV) in oysters (Crassostrea gigas). Water. Res., 40, 895, 2006. 18. Halliday, M.L. et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J. Infect. Dis., 164, 852, 1991. 19. de Paula, V.S. et al. Hepatitis A virus in environmental water samples from the Amazon Basin. Water. Res., 41, 1169, 2007. 20. Venter, J.M. et al. Hepatitis A virus in surface water in South Africa: what are the risks? J. Water. Health., 5, 229, 2007. 21. Kittigul, L. et al. Detection and characterization of hepatitis A virus in water samples in Thailand. J. Appl. Microbiol., 100, 1318, 2006. 22. Arnal, C. et al. Comparison of seven RNA extraction methods on stool and shellfish samples prior to hepatitis A virus amplification. J. Virol. Methods, 77, 17, 1999.
72 23. Apaire-Marchais, V. et al. Development of RT-semi-nested PCR for detection of hepatitis A virus in stool in epidemic conditions. Mol. Cell. Probes, 8, 117, 1994. 24. Bruisten, S.M. et al. Molecular epidemiology of hepatitis A virus in Amsterdam, the Netherlands. J. Med. Virol., 63, 88, 2001. 25. Chironna, M. et al. Genetic analysis of HAV strains recovered from patients with acute hepatitis from Southern Italy. J. Med. Virol., 70, 343, 2003. 26. Poovorawan, Y. et al. Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand. J. Clin. Virol., 32, 24, 2005. 27. Rodrigues, L. et al. Molecular epidemiology of hepatitis A virus in a group of Portuguese citizens living in Lisbon area. J. Med. Virol., 79, 483, 2007. 28. de Paula, V.S. et al. Detection of hepatitis A virus RNA in serum during the window period of infection. J. Clin. Virol., 29, 254, 2004. 29. Costa-Mattioli, M. et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol., 76, 9516, 2002. 30. Endo, K. et al. Analysis of the full-length genome of a subgenotype IIIB hepatitis A virus isolate: primers for broadly reactive PCR and genotypic analysis. J. Med. Virol., 79, 8, 2007. 31. Amado, L.A. et al. Comparison between serum and saliva for the detection of hepatitis A virus RNA. J. Virol. Methods, 148, 74, 2008. 32. Goswami, B.B., Burkhardt, W., and Cebula, T.A. Identification of genetic variants of hepatitis A virus. J. Virol. Methods, 65, 95, 1997. 33. Buti, M. et al. Assessment of the PCR-Southern blot technique for the analysis of viremia in patients with acute hepatitis A. Gastroenterol. Hepatol., 24, 1, 2001. 34. Shan, X.C., Wolffs, P., and Griffiths, M.W. Rapid and quantitative detection of hepatitis A virus from green onion and strawberry rinses by use of real-time reverse transcriptionPCR. Appl. Environ. Microbiol., 71, 5624, 2005. 35. Yoneyama, T. et al. Rapid and real-time detection of hepatitis A virus by reverse transcription loop-mediated isothermal amplification assay. J. Virol. Methods, 145, 162, 2007. 36. Papafragkou, E. et al. Rapid and sensitive detection of hepatitis A virus in representative food matrices. J. Virol. Methods, 147, 177, 2008. 37. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156, 1987. 38. Boom, R. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28, 495, 1990. 39. Deng, M.Y., Day, S.P., and Cliver, D.O. Detection of hepatitis A virus in environmental samples by antigen-capture PCR. Appl. Environ. Microbiol., 60, 1927, 1994. 40. Jothikumar, N., Cliver, D.O., and Mariam, T.W. Immuno magnetic capture PCR for rapid concentration and detection of hepatitis A virus from environmental samples. Appl. Environ. Microbiol., 64, 504, 1998. 41. de Paula, V.S. et al. Comparison of four extraction methods to detect hepatitis A virus RNA in serum and stool samples. Braz. J. Infect. Dis., 7, 135, 2003. 42. Phan, T.G. et al. A novel RT-multiplex PCR for enteroviruses, hepatitis A and E viruses and influenza A virus among infants and children with diarrhea in Vietnam. Arch. Virol., 150, 1175, 2005. 43. Emerson, S.U., and Purcell R.H. Hepatitis E Virus. In: Knipe, D.M, Howley, P.M., (ed.), Fields Virology, 5th ed. pp. 3047– 3058. Lippintcott Williams & Wilkins, Philadelphia, PA, 2007.
Molecular Detection of Foodborne Pathogens 44. Aggarwal, R., and Krawczynski, K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J. Gastroenterol. Hepatol., 15, 9, 2000. 45. Emerson, S.U., and Purcell, R.H. Hepatitis E virus. Rev. Med. Virol., 13, 145, 2003. 46. Krawczynski, K. Hepatitis E. Hepatology, 17, 932, 1993. 47. Mushahwar, I.K. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J. Med. Virol., 80, 646, 2008. 48. Jilani, N. et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol., 22, 676, 2007. 49. Tsega, E. et al. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin. Infect. Dis., 14, 961, 1992. 50. Khuroo, M.S. and Kamili, S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J. Viral. Hepatol., 10, 61, 2003. 51. Chauhan, A. et al. Hepatitis E virus transmission to a volunteer. Lancet, 16, 149, 1993. 52. Tsarev, S.A. et al. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. USA, 15, 559, 1992. 53. Balayan, M.S. et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 20, 23, 1983. 54. Purcell, R.H. and Emerson, S.U. Animal models of hepatitis A and E. ILAR. J., 42, 161, 2001. 55. Okamoto, H., Takahashi, M., and Nishizawa, T. Features of hepatitis E virus infection in Japan. Intern. Med., 42, 1065, 2003. 56. Divizia, M. et al. Waterborne gastroenteritis outbreak in Albania. Water. Sci. Technol., 50, 57, 2004. 57. Yazaki, Y. et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol., 84, 2351, 2003. 58. Emerson, S.U., Arankalle, V.A., and Purcell, R.H. Thermal stability of hepatitis E virus. J. Infect. Dis., 192, 930, 2005. 59. Reyes, G.R. et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science, 247, 1335, 1990. 60. Tam, A.W. et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology, 185, 120, 1991. 61. Wang, Y. et al. The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. J. Gen. Virol., 81, 1675, 2000. 62. Koonin, E.V. et al. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA, 89, 8259, 1992. 63. Surjit, M., Jameel, S., and Lal, S.K. The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA. J. Virol., 78, 320, 2004. 64. Emerson, S.U., and Purcell, R.H. Hepatitis E. Pediatr. Infect. Dis. J., 26, 1147, 2007. 65. Purcell, R.H., and Emerson, S.U. Hepatitis E: an emerging awareness of an old disease. J. Hepatol., 48, 494, 2008. 66. Clayson, E.T. et al. Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal. Am. J. Trop. Med. Hyg., 53, 228, 1995. 67. Arankalle, V.A. et al. Human and swine hepatitis E viruses from Western India belong to different genotypes. J. Hepatol., 36, 417, 2002.
Hepatitis A and E Viruses 68. Fernández-Barredo, S. et al. Prevalence and genetic characterization of hepatitis E virus in paired samples of feces and serum from naturally infected pigs. Can. J. Vet. Res., 71, 236, 2007. 69. Feagins, A.R. et al. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J. Gen. Virol., 88, 912, 2007. 70. Tei, S. et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J. Med. Virol., 74, 67, 2004. 71. Masuda, J. et al. Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol. Res., 31, 178, 2005. 72. Rab, M.A. et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am. J. Trop. Med. Hyg., 57, 151, 1997. 73. Sarguna, P., Rao, A., and Sudha Ramana, K.N. Outbreak of acute viral hepatitis due to hepatitis E virus in Hyderabad, India. J. Med. Microbiol., 25, 378, 2007. 74. Maila, H.T., Bowyer, S.M., and Swanepoel, R. Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995. J. Gen. Virol., 85, 89, 2004. 75. Bile, K. et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am. J. Trop. Med. Hyg., 51, 466, 1994. 76. Panda, S.K., Thakral, D., and Rehman, S. Hepatitis E virus. Rev. Med. Virol., 17, 151, 2007. 77. Inoue, J. et al. Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J. Virol. Methods, 137, 325, 2006. 78. Jothikumar, N. et al. Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction. Appl. Environ. Microbiol., 59, 2558, 1993. 79. Huang, F.F. et al. Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J. Clin. Microbiol., 40, 1326, 2002. 80. Garkavenko, O. et al. Detection and characterisation of swine hepatitis E virus in New Zealand. J. Med. Virol., 65, 525, 2001.
73 81. Takahashi, M. et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J. Clin. Microbiol., 45, 3671, 2007. 82. Zhao, C. et al. Comparison of real-time fluorescent RT-PCR and conventional RT-PCR for the detection of hepatitis E virus genotypes prevalent in China. J. Med. Virol., 79, 1966, 2007. 83. Mizuo, H. et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J. Clin. Microbiol., 40, 3209, 2002. 84. He, J. Molecular detection and sequence analysis of a new hepatitis E virus isolate from Pakistan. J. Viral. Hepatol., 13, 840, 2006. 85. Cooper, K. et al. Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J. Clin. Microbiol., 43, 1684, 2005. 86. Zhao, Z.Y. et al. Detection of hepatitis E virus RNA in sera of patients with hepatitis E by polymerase chain reaction. Hepatobiliary Pancreat. Dis. Int., 6, 38, 2007. 87. Aggarwal, R. et al. Genetic variability of hepatitis E virus within and between three epidemics in India. Virus. Res., 59, 35, 1999. 88. Zhang, F. et al. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J. Med. Virol., 78, 1441, 2006. 89. Coulepis, A.G. et al. Detection of hepatitis A virus in the feces of patients with naturally acquired infections. J. Infect. Dis., 141, 151, 1980. 90. McCaustland, K.A. et al. Application of two RNA extraction methods prior to amplification of hepatitis E virus nucleic acid by the polymerase chain reaction. J. Virol. Methods, 35, 331, 1991. 91. Ray, R. et al. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet, 338, 783, 1991. 92. Aggarwal, R., and McCaustland, K.A. Hepatitis E virus RNA detection in serum and feces specimens with the use of microspin columns. J. Virol. Methods, 74, 209, 1998. 93. Tamura, K. et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 24, 1596, 2007.
6 Noroviruses Anna Charlotte Schultz
Technical University of Denmark (DTU)
Jan Vinjé
Center for Disease Control (CDC)
Birgit Nørrung
University of Copenhagen
Contents 6.1 Introduction......................................................................................................................................................................... 75 6.1.1 Background and Classification................................................................................................................................ 75 6.1.2 Biology..................................................................................................................................................................... 76 6.1.3 Pathogenesis............................................................................................................................................................. 76 6.1.4 Epidemiology........................................................................................................................................................... 76 6.1.5 Diagnosis.................................................................................................................................................................. 77 6.1.5.1 Issues Concerning Sample Processing...................................................................................................... 77 6.1.5.2 Issues Concerning Amplification, Detection, and Quality Assurance (QA)............................................. 80 6.2 Methods............................................................................................................................................................................... 82 6.2.1 Reagents and Equipment.......................................................................................................................................... 82 6.2.2 Sample Preparation.................................................................................................................................................. 82 6.2.3 Detection of Noroviruses by Real-time RT-PCR.................................................................................................... 85 6.3 Conclusion and Future Perspectives.................................................................................................................................... 85 Acknowledgments........................................................................................................................................................................ 85 References.................................................................................................................................................................................... 85
6.1 Introduction
6.1.1 Background and Classification
Noroviruses (NoVs) have emerged as a major cause of foodborne illness causing an estimated 30–50% of all foodborne outbreaks in the U.S. Because these viruses are highly contagious, have a low infectious dose, and are persistent in the environment, they are classified as group B biodefense pathogens. The source of most foodborne outbreaks is contaminated bivalve shellfish, which are often eaten raw, or infected food handlers. Foods that have been implicated in outbreaks include ready-to-eat (RTE) foods such as salads, celery, melon, sandwiches, lettuce, cold cooked ham, and fresh or frozen raspberries. Detection of NoV in food is limited to molecular methods as the virus cannot be grown in routine cell culture. This chapter describes the history, classification, and biology of NoVs and provides an overview of the published methods for the molecular detection in various food items. Detailed laboratory protocols for the rapid concentration, extraction, and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) detection in bivalve molluscan shellfish and raspberries are provided.
Although outbreaks of nonbacterial gastroenteritis have been recognized as early as the 1930s, a causative viral agent was not discovered until 1972 when 27 nm sized virus particles were detected by immune electron microscopy (EM) in stool samples of human volunteers who had been fed with a bacterial-free filtrate from an individual that was involved in an outbreak of acute gastroenteritis in an elementary school in Norwalk, Ohio in 1968.63 The virus was named Norwalk virus (NV) and this virus has been established as the prototype virus for the group of viruses now called NoVs, but in the literature also referred to as “Norwalk-like viruses” or small round structured viruses (SRSVs) based on the characteristic surface morphology of the virus particles. The classification of NoVs as members of the family Caliciviridae was established after the cloning and sequencing of the complete genome of NV58 and Southampton virus.72 To date, these viruses are grouped into a separate genus Norovirus. Other genera include Sapovirus, Lagovirus, and Vesivirus41,100 and a new fifth genus is pending. Below the genus level naming of NoVs has not been agreed upon and therefore NoV strains 75
76
are often named after the geographic location where the outbreaks first occurred such as Hawaii virus, Snow mountain virus, Bristol virus, and Minerva virus. A more formal naming system similar to influenza has been proposed with: species infected/virus genus/genogroup/virus name/strain designation/year of detection/country.4
6.1.2 Biology NoVs are a group of 27–35 nm nonenveloped viruses with an icosahedral capsid enclosing a single stranded positive sense RNA genome of approximately 7.5–7.7 nucleotides (nt). The NoV genome contains three open reading frames (ORFs) with ORF1 at the 5′-end of the genome which encodes a polyprotein of six nonstructural proteins including p48, NTPase, p22, VPg (binds to 5′ end to initiate translation), 3CLpro (protease), and RdRp (RNA dependent RNA polymerase). ORF2 and ORF3 code for two structural proteins: a major (VP1) and a minor (VP2) capsid protein.40 NoVs are a genetically diverse group of viruses which are currently classified into five genetic groups or genogroups.40,148 Strains that infect humans belong to genogroups I, II, and IV.148 Genogroup II includes also strains that have been detected uniquely in swine whereas viruses belonging to genogroup III and V infect cattle or mice, respectively. These five genogroups can be further divided into genotypes or genoclusters (eight in genogroup I, 19 in genogroup II, two in genogroup III, one in genogroup IV, and one in genogroup V).148 Subgenomic RNA, rather than genomic RNA, is used as the template for the production of the capsid proteins.8 Additionally, the 5′ end of the subgenomic and genomic RNAs contains a highly conserved nucleotide motif up-stream from the first AUG start codon and is therefore thought to be a site for the initiation of transcription.67 Using cryo-immune EM the structure of the NV has been resolved.111 Virus particles are assembled from 90 dimers of VP1 and a few VP2 molecules and form a T=3 icosahedral capsid.111 The exact role of VP2 is not completely known although this protein may be important in the stability of the overall viral capsid (capsid–RNA complex).8 VP1 folds into a shell domain (S) and a protruding domain (P) linked by an amino acid hinge.111 The relatively conserved S domain is essential for the formation of the icosahedral structure of the virion, while the P domain stabilizes the capsid by a dimeric interaction and forms the characteristic protrusions on the virion.46 The P domain is further subdivided into the P1 and P2 subdomains with the P2 subdomain containing both immune and cellular recognition sites.16,89,133
6.1.3 Pathogenesis After an incubation period between 24 and 48 hours but sometimes as short as 15 hours,38 clinical symptoms include acute projectile vomiting, nonbloody diarrhea, abdominal cramps, nausea, chills, myalgia, and headache.64 Fever is rarely reported. In human volunteers, NV has been shown to
Molecular Detection of Foodborne Pathogens
affect epithelial cells of the small intestine resulting in broadening and flattening of the villi. NoVs do not appear to infect the cells of the large intestine.29,120,127 During acute illness, the inflammation of the mucosa of the small intestine reduces the adsorptive capacity of the villi and produce intestinal fluid contributing to diarrhea while vomiting is likely due to delayed gastric emptying and disrupted motility.101 However, the precise mechanism of virus-induced diarrhea and vomiting is currently unknown.135 The disease in healthy individuals is usually mild and resolved after 1–3 days.64,65 However, severe illness has been reported in young children, the elderly, cardiovascular or renal disease patients,98 transplant recipients, and other immunosuppressed patients,55 in which case fluid replacement or additional supportive care may be needed.145 Rates of asymptomatic virus shedding of 32% have been reported in both clinical outbreak studies and studies in human volunteers experimentally infected with NV.38
6.1.4 Epidemiology NoVs are transmitted primarily through the fecal-oral route, either directly from person-to-person via contaminated hands, or indirectly via contaminated food or water. The virus can also persist for several days to weeks on surfaces and fomites which can act as a source of continuing infection during outbreaks. Importantly, airborne droplets of vomitus are infectious and have been strongly implicated in contaminating the environment and in direct transmission of NoV within semiclosed communities such as cruise ships, hospitals, the military and long-term care facilities.97 Human NoVs are estimated to be responsible for up to 95% of nonbacterial epidemic gastroenteritis worldwide in humans of all age groups.40 Recent studies indicate that NoV disease is also associated with a significant number of sporadic cases of gastroenteritis.42,56,94 Most outbreaks throughout the world are caused by strains that belong to GII, whereas <5% of the outbreaks are caused by GI and GIV outbreaks are very rare. In most years, viruses of different genotypes cocirculate but in 1996, 2002, and 2006, viruses of genetic cluster GII.4 were associated with the majority of the outbreaks globally. Molecular analysis of these GII.4 strains demonstrated that older GII.4 strains are being replaced by new GII.4 subtypes every 2–3 years coinciding with an increase in the number of outbreaks. These findings are somewhat similar to the evolution of influenza viruses and it has been hypothesized that herd immunity may contribute to a proposed epochal evolution model for GII.4 NoVs88,126 although there are other possible explanations that could describe these observations (e.g., natural fluctuation). NoVs bind to human histoblood group antigens (HBGAs),52,53,57,87,96,131,132 which are complex carbohydrates present on the surfaces of red blood cells as well as on the mucosal epithelium and in body fluids with important biological functions.95,112 The recognition of HBGAs by the capsid protein of NoVs appear to be highly strain specific,
Noroviruses
and eight distinct receptor-binding patterns have been iden tified.47,48,54 The binding of NV and other NoV genotypes to certain HBGA molecules has also been strongly linked with clinical infection.57,87,113 Recent studies have shown that HBGAs and in particular secretor status controlled by the 1,2-fucosyltransferase FUT2 gene determine susceptibility to NoV infections, with nonsecretors (FUT2−/−), representing 20% of Europeans, being highly resistant to symptomatic infections with major strains of NoV such as GII.4.73,134 Due to the different HBGA specificities of the capsid protein from distinct strains, a host–pathogen coevolution driven by carbohydrate–protein interactions has been suggested. For a comprehensive overview on HBGAs and susceptibility to NoV infection, the reader is referred to a review of LePendu et al.83 NoV outbreaks are often linked to food handlers who infect foods that are eaten raw or not further processed (RTE foods) prior to consumption.138,146 Other sources of NoV contamination are shellfish growing waters (e.g., oysters) and irrigation water (e.g., soft fruits and vegetables). NoVs have also been associated with outbreaks after exposure to contaminated drinking water.50,74,99 The NoVs are very stable in the environment, which greatly contributes to viral spread and disease.40 Studies in human volunteers in the 1970s showed that NV particles remained infectious after the virus had been exposed to pH 2.7 for 3 hours or incubated at 60°C for 30 min.40
6.1.5 Diagnosis Despite numerous attempts, NoV can still not be grown in cell culture32 and although successful passage of NoV in a 3-D cell culture system has been reported,128 this work has not been confirmed by others.139 After the discovery of NV by EM, this method was used for the next 20 years by many research laboratories for the detection of SRSV or NoVs in human fecal samples. Performing EM, however, requires expensive equipment and is a relative insensitive method as it requires at least 106 particles/ml).40 Further developments allowed the visualization of the NoVs by using immune transmission EM63,65,66 or viral antigens by ELISA. Although these refinements in diagnostic procedures increased the sensitivity, broadly reactive antibodies are not widely available.69,123 The cloning and sequencing of several complete NoV genomes (Norwalk and Southampton) followed by numerous reports on partial sequences from other SRSV strains allowed for the development of the first generation of broadly reactive primers to detect NoVs by RT-PCR.2,59,141 These assays allowed detection of NoVs in human fecal samples and using different primer combinations in a nested-PCR format,39 also detection in food matrices such as shellfish. However, since most food matrices contain RT-PCR inhibitors which are coextracted with viral RNA, a critical step in the detection of low-copy number of NoV in foods is the removal of these inhibitors using multi-step elution, concentration, and extraction procedures.6 Over the last 10 years, significant progress
77
has been made in the development of protocols for the improved detection of enteric viruses in shellfish.6,12,23,27,77,125 While different protocols have successfully detected NoVs in other food matrices,69,80 rigorous evaluation of these protocols is needed before standardized protocols can be implemented in laboratories performing routine detection of NoVs in foods. After the initial sampling, most methods for the detection of viruses in food include the following three steps: (1) elution and concentration of the virus particles from the foodstuff, (2) nucleic acid extraction and, (3) detection and confirmation of viral RNA (4). Various strategies for each step have been described15,30,35,86,117,119 and an overview of these methods and their performance characteristics is summarized in Table 6.1. 6.1.5.1 Issues Concerning Sample Processing Sample collection. When salads, soft fruits or whole shellfish are analyzed, generally 10–50 g of sample is analyzed. Since shellfish accumulate viruses in their digestive tissue,103,115 and NV has been shown to bind specifically to carbohydrate structures on this tissue, a number of methods analyzing only this part of shellfish have been published. This approach allows processing of only 1.5–2 g of digestive tissue which has been demonstrated to be sufficient for the recovery and detection of NoV RNA43,77,85 and requires less processing time.6 However, while the dissection of digestive tissue has several advantages for larger shellfish species like oysters and large mussels, this method is technically difficult for small species, such as clams or cockles. As the number of virus particles in each shellfish will often vary, it is important that the sample to be analyzed will represent a number of different shellfish individuals. Elution and concentration of NoV from foods. Elution and concentration of virus particles from the food matrix are the most critical steps of sample processing before RT-PCR detection of viral RNA. Although efforts are aimed to develop horizontal methods applicable to a wide variety of food matrices such as bivalve shellfish, salads, and soft fruits, some specific adjustments of the method may be required to enhance virus elution from a given foodstuff. Therefore, the elution step of virus from food matrices depends on the type of food being analyzed, as well as its state (e.g., fresh, frozen, etc.). In addition, the selection of an elution step needs to be based upon the differences in surface morphology and hydrophobic interactions, internal tissue composition (i.e., RT-PCR inhibitory substances, pH, etc.), whether the virus is present inside (e.g., shellfish flesh) or at the surface of the food (e.g., salads and soft fruit and RTE foods) and conditions of processing to which the food matrix has been subjected previously.1,21,26,45,71 Some methods for shellfish have used acidic adsorption prior to virus elution, but most methods have performed virus elution using a large volume of buffer (two to five times the sample weight). Glycine buffers containing proteins such as beef extract at an alkaline pH (range 8.5–10) have been most commonly used for this purpose. Moreover, when analyzing acidic and pectin containing raspberries or strawberries, the
20 (0.3 g)
8 (0.12 g)
1.5c
1.5c 1.5c 1.5c 1.5c 2c 10c 5c
GuSCN Alkaline
6
4 (0.32 g)
10
50
8
Lettuce
1 (2.5 g) 5 (1.25 g) 5 (0.07 g)
Alkaline Gycine Chlorof-but, CatFloc
Glycine, chlorof Chlorof-but, CatFloc
50 25 1.5c
Glycine, cat-Floc Glycine Glycine Glycine Threonineb Glycine Glycine
Gycine-threonine Chlorof-but, CatFloc Chlorof-but, CatFloc Zirconia beads Proteinase K Trizol ProteinaseK
Clams
20 (1.5 g) 5 (0.1 g)
1 (1 g) 8 (0.8 g)
0.2 (0.04 g)
Viral Elution
Chlorof-but, CatFloc
Glycine Waterb Glycine Sonication Glycine b
20 50 100 10 25 25c 2c
6 (0.1 g) 6 (0.09 g) 0.5 (0.01 g) 0.8 (0.08 g) 1 (0.05 g)
2 (0.4 g)
2 (0.5 g) 1 (0.5 g) 5 (1 g)
Final % Analyzed
25 50 18 50 25
Sample Size (g)
Mussels
Oysters
Food Sample(s)
PEG
Absorbtion to hydroxyapatite PEG
Ultracentrifugation PEG
Ag capture PEG Ultracentrifugation PEG PEG Ultracentrifugation Ultracentrifugation
PEG PEG Ultracentrifugation
PEG
PEG PEG Ultracentrifugation PEG PEG
Concentration
Table 6.1 Selected Methods Used for Virus Detection in Shellfish, Vegetables and Berries
Trizol QIAshedder™ homogeneiser RNEasy kit
CTAB
Poly A Nucleospin RNAkit RNEasy kit
QIAamp Guanidium, CsCl GuSCN RNEasy kit GuSCN Tryzol + Boom GuSCN
GuSCN+ QIAamp Prot. K, CTAB QIAamp kit RNEasy kit GuSCN GuSCN High Pure Viral NA kit
Prot. K, CTAB
QIAamp Boiling GuSCN GuSCN Tri-reagent
RNA Extraction
50 RT-PCRU NoV 10 PFU HAV 10 RT-PCRU NoV
1.2 TCID50/g HAV 600 PCRU/g HAV
102–103 RT-PCRU NoV
<102 genome copies
22 RT-PCR50U NoV 27 PFU HAV 100 RT-PCRU NoV 100 PFU HAV
1.2 PFU/g EV
Detection Limit(s) (Per Quantity of Analyzed Product)
82
119
37
36 129 22
84 24 110 18 105 107 49
9 122 108 91 60 12 43
6
125 19 106 39 68
Reference
78 Molecular Detection of Foodborne Pathogens
25
Vegetables
15
Raspberries Strawberries Blueberries
20 (3 g)
4 (2.4–3.6 g) Tris-glycine. beef extract
Alkaline Sodium bicarbonate+Soya protein Ultra-filtration
Ultracentrifugation
PEG
Ultracentrifugation
PEG
PEG
Immunomagnetic separation, positively charged filters filtration
Immunomagnetic separation
Magnetic capture
PEG
Filtration
PEG
QIAampa (or miniMAGb)
QIAamp
RNEasy Kit
QIAamp
RNEasy kit
Prot. K, Phenolchlorof CTAB
TrizolTM
QIAamp
Trizol-chlorofpoly(dT) magneticbeads
54 RT-PCRU NoV 12 RT-PCRU HAV 26a or 0b RT-PCRU RV
103–104 RT-PCRU or 102-103 TCID50 HAV
102 RT-PCR U NoV
10% recovery
102 RT-PCRU NoV
10 PFU HAV
0.5 PFU HAV
10-2-102 PFU or 10-105 RT-PCRU HAV
13
118
7
117
7
80
10
123
109
31 30
1.2 × 103 PCRU NoV 50 TCID50 HAV
44
50 PFU HAV
1 RT-PCRU NoV 1 TCID50 HAV
Source: Modified from Le Guyader, F.S., and Atmar, R.L., In Human Viruses in Water, Volume 17: Perspectives in Medical Virology, 1st ed., Bosch, A. (Ed.), Elsevier Science. Amsterdam, 2007. a Detection limit in infectious viruses was calculated taking into account the infectious titer of the HAV stock given by ATCC. b Elution performed after acidic adsorption. c Only digestive tissues analyzed Abbreviations: Glycine, glycine buffer; Chlorof, chloroform; but, butanol; PEG, polyethylene glycol precipitation; ultracentri, ultracentrifugation; prot. K, proteinase K; GuSCN, guanidinium thiocyanate; EV: enterovirus, NoV: norovirus, HAV: hepatitis A virus.
60–90
Alkaline Tris glycine beef-extract
50
Raspberries Strawberries
Alkaline
Gycine Chlorof-but, CatFloc
60
2 (0.2 g)
PBS
PBS
Alkaline glycine
Alkaline
PBS
Alkaline Tryptose phosphate-glycine
Alkaline Tris-glycine-beef extract
10
Raspberries
10
0.4 (0.1 g)
10 (2.5 g)
16 (4 g)
50
One piece of food
25
Green onion Strawberry rinses
Lettuce Strawberries
25
Lettuce Green onions Raspberries
100
25
Green onions
Noroviruses 79
80
release of viruses may be favored by the addition of Tris to the elution buffer, hence increasing the buffer capacity followed by pH neutralization and incubation with pectinase in order to prevent jelly formation.13,30,117,118 After elution of viruses from the food matrix, clarification of the water-phase by extracting with a chloroform-butanol mixture is a rapid step before concentrating the viruses using polyethylene glycol (PEG) precipitation,30 ultracentrifugation,117 or ultrafiltration.13 However, analyzing the digestive tissues of shellfish by direct lysis of the virus particles by proteinase K, or Trizol of the shellfish tissues or by beating with Zirconia beads in the presence of denaturing buffer are elution strategies that have been used successfully.43,60,85,92 A disadvantage of this direct lysis approach is that it often limits the quantity of shellfish tissues that can be analyzed and therefore reduces the chances to recover low amounts of the viral RNA. On the other hand, since small amounts of viruses can still be successfully recovered in relatively smaller amount of digested shellfish, it may be due to the simultaneously decrease in amount of inhibitor which are known to interfere with virus recovery in many concentration methods. There is often an inverse relationship between the recovery of NoV from shellfish tissue and the increasing complexity of the recovery method.43 RNA extraction. Based on the type of food, a variety of methods to extract viral RNA while concurrently reducing the level of PCR inhibitors have been reported4,43 and they are all dependant on the characteristics of the priory concentrated virus suspension. Lysis of the concentrated viruses pellet by proteinase K, followed by purification of nucleic acid using phenol-chloroform and cethyl trimethyl ammonium bromide (CTAB) precipitation was one of the first successful methods described for detection of NoV in shellfish.5 Although this method is quite labor-intensive the efficiency to detect viruses in shellfish has been confirmed in several studies.6,77,78 However, most methods today are based on guanidium extraction either using a variation of the method described by Boom et al.11 or using commercially available kits, based on similar chemistry (QIAamp or RNeasy kit by Qiagen®, or NucliSens magnetic kit by bio-Mérieux). All these RNA extraction methods have proven to be successful for NoV detection in naturally contaminated shellfish, berries, and other food matrices.13,60,80,81,90,114,116 6.1.5.2 Issues Concerning Amplification, Detection, and Quality Assurance (QA) Amplification and detection. The first generation of NoV primers104,144 were not broadly reactive due to the limited knowledge of the tremendous genetic diversity among NoVs. With the availability of more NoV sequences, broadlyreactive RT-PCR assays were designed based on a highly conserved region (region A) within the RdRp.3,12,28,34,76,77,107,141 Although sequences obtained from these assays can be used to distinguish NoV strains, far more reliable genotyping is achieved by amplifying partial regions of the 5′-end of ORF2 (region C) or 3′-end (region D).70,140 While most of the above mentioned RT-PCR assays utilize a virus-specific primer in the RT reaction, random hexamers have also been used successfully to generate cDNA.17,20,39,60 Although nested PCR
Molecular Detection of Foodborne Pathogens
or boosted PCR protocols can increase the sensitivity up to 10–1,000 times12,28,34,39,75,107 extreme care needs to be taken for performing such assays on a routine basis because of the high risk of cross-contamination. Although most RT-PCR assays to detect NoV RNA have been successfully used, no assay which detects all strains has been reported. As a consequence multiplex approaches involving several primer sets and probes are required to address the diversity of these viruses, and no single assay stands out as the best by all criteria.4,143 For example, several outbreak investigations report the use of different primer sets targeting different areas of the genome to be able to amplify the strain in both clinical or environmental samples.79,81,124 Confirmation of RT-PCR amplicons. Although still used in some laboratories, detection of RT-PCR products in ethidium bromide stained agarose gels (i.e., a band having a similar size to that of the positive control) is not considered as an appropriate method for the confirmation of conventional RT-PCR assay results.4 Either probe hybridization assays including dot blot hybridization, liquid hybridization, and Southern blot hybridization have been used for confirmation but the limitation is the genetic variability of NoVs which makes it difficult to select a panel of probes to detect most if not all possible NoV strains.76,78 To resolve this and also to attempt to genotype strains, reverse line blot (RLB) assays have been developed for the confirmation of NoV amplicons derived from the polymerase region142 and capsid region.102 These methods are very useful in large-scale epidemiological studies for the initial NoV confirmation of amplicons. To date, most laboratories use TaqMan realtime RT-PCR assay for the detection and confirmation of NoV (see below) and sequencing of region C or region D amplicons is used to determine the genotype or to link geographical different clusters of NoV illness to the same source (e.g., batch of contaminated oysters). Based on analyzing the complete genomic sequence of 18 NoV strains,67 the ORF1–ORF2 junction region has been identified as the most conserved region of the NoV genome. Consequently, GI, and GII specific real-time (Q)RT-PCR assays targeting this region have been developed.61,130,136 These assays have been refined and have been shown to detect NoV in both clinical and environmental samples robustly.25,60,93,108 A selection of primers and probes and different combinations in which they have been used are shown in Table 6.2. Compared to conventional RT-PCR assays, Q-RT-PCR assays is more sensitive, faster, and quantitative if RT-PCR inhibitors are not present in the sample.93 Q-RT-PCR assays also avoid post RT-PCR confirmation steps, such as gel electrophoresis and hybridization or sequencing because positive products can be confirmed by melting curve analysis (in SYBR green Q-RT-PCR) or by probes (in Taqman Q-RT-PCR). In one study, broadly reactive NoV GI and GII TaqMan RT-PCR assays were developed and evaluated on a panel of 84 archived stool samples representing 19 different NoV genotypes and on cDNA from 38 naturally contaminated shellfish samples.60 The sensitivity of these assays is <10 copies of viral genome per reaction. Replacing the degenerated
81
Noroviruses
Table 6.2 Selected Real-Time RT-PCR Primers and Probes Targeting the ORF1-ORF2 Junction for the Detection of Noroviruses in Foods NoV Genogroup NoV GI
NoV GII
NoV IV
a b c
d e
Primers and Probea
Sequence (5’–3’)b
Positionc
Reference
QNIF4 (+) NV1LCR (–) NVGG1p (+)
CGCTGGATGCGNTTCCAT ccttagacgccatcatcatttac FAM-TGGACAGGAGAYCGCRATCT-TAMRAd
5291–5308 5354–5376 5321–5340
25 130
COG1F (+) COG1R (–) Ring 1(a)-TP (–) Ring 1(b)-TP (–)
CGYTGGATGCGNTTYCATGA CTTAGACGCCATCATCATTYAC FAM-AGATYGCGATCYCCTGTCCA-TAMRAd FAM-AGATCGCGGTCTCCTGTCCA-TAMRAd
5291–5310 5354–5375 5321–5340 5321–5340
61
JJV1F (+) JJV1R (–) JJV1P (+)
GCC ATG TTC CGI TGG ATG TCC TTA GAC GCC ATC ATC AT FAM-TGT GGA CAG GAG ATC GCA ATC TC-BHQ
5282–5299 5377–5358 5319–5341
60
Cog 1F (+) Cog 1R (–) Ring 1A (–) Ring 1B (-)
cgYtggatgcglttYcatga cttagacgccatcatcattYac FAM-agatYgcgatcYcctgtcca-BHQe FAM-agatcgcggtctcctgtcca-BHQe
5291–5310 5354–5375 5321–5340 5321–5340
136
QNIF2 (+) COG2R (–) QNIFs (+)
ATGTTCAGRTGGATGAGRTTCTCWGA TCGACGCCATCTTCATTCACA FAM-AGCACGTGGGAGGGCGATCG-TAMRAd
5012–5037 5080–5100 5042–5061
93 61
COG2F (+) COG2R (–) RING2-TP (+)
CARGARBCNATGTTYAGRTGGATGAG TCGACGCCATCTTCATTCACA FAM-TGGGAGGGCGATCGCAATCT-TAMRAd
5003–5028 5080–5100 5048–5067
61
NV2LCF (+) NV2LCR (–) NV2LCpr (+)
GARYCIATGTTYAGRTGGATG TCGACGCCATCTTCATTCAC FAM-TGGGAGGGSGATCGCRATCT-TAMRAd
5006–5026 5081–5100 5048–5067
130
COG2Fex (+) COG2R (–) RING2(a)+RING2 (b) (+)
MRSTGGATGMGRTTYTCWGA TCGACGCCATCTTCATTCACA FAM-TGGGAGGGYGATCGCAATCT (15 pmol)+ TGGGAGGGGGATCGCGATCT (5 pmol)-TAMRAd
5018–5037 5080–5100 5048–5067
62
COG2F (+) NV117 (–) TM3probe (+)
CAR GAR BCN ATG TTY AGR TGG ATG AG TCG ACG CCA TCT TCA TTC AC FAM -TGG GAG GGC GAT CGC AAT CTG GC-TAMRAd
5003–5028 5081–5100 5048–5070
61 51
JJV2F (+) COG2R (-) RING2-TP (+)
CAAGAGTCAATGTTTAGGTGGATGAG TCGACGCCATCTTCATTCACA FAM-AGCACGTGGGAGGGCGATCG-TAMRAd
5003–5028 5080–5100 5048–5067
60
Mon 4F (+) Mon 4R (–) Ring 4 (+)
tttgagtcYatgtacaagtggatgc tcgacgccatcttcattcaca FAM-tgggagggggatcgcgatct-BHQe
718–742 795–815 763–783
136
+, virus sense; −, antivirus sense. Mixed bases in degenerate primers and probes are as follows: Y = C or T; R = A or G; M = A or C; W = A or T; S = C or G; B = not A; I = inosine; N = any. Nucleotide position are based on the Norwalk (GI); accession number M87661, Camberwell virus (GII); accession number AF145896 and the Fort Lauderdale virus (GIV); accession number AF414426. TAMRA, 6-carboxytetramethylrhodamine quencher dye; FAM, 6-carboxyfluorescein reporter dye. BHQ, black hole quencher dye; FAM, 6-carboxyfluorescein reporter dye.
forward primer61 with a nondegenerated primer made this assay significantly more sensitive and at least as sensitive as the nested PCR.60 In another study, a one-step real-time RT-PCR assay was developed for GII and evaluated with the previously described
GI assay61 on an archived panel of 150 naturally contaminated shellfish samples.93 While the GII assay allowed detection of a large range of different strains circulating in France since 1995, the GI strains were detected infrequently. The detection limit as determined on artificially contaminated oysters
82
were found to be 70 and seven RT-PCR detectable units of GI and GII reference NoV strains, respectively.93 Quality assurance (QA)/quality control (QC). QA/QC measures include the use of positive and negative controls to identify false negative or false positive results, respectively. Most false negative results are a consequence of inefficient virus and/or nucleic acid extraction or the presence of inhibitors. Most false positives results are due to crosscontamination. Process extraction controls. Although numerous methods for the detection of viruses in shellfish have been published, it is difficult to compare assay performance between methods. Reasons for this include the use of different virus strains, different foods or species of shellfish, different RT-PCR methods, and the absence of reports of direct comparisons of different methods. The different methods described in Table 6.1 accomplish inhibitor removal to varying degrees, although no systematic evaluation of the efficiency of inhibitor removal has been performed. In order to facilitate the comparison of methods, a universal standard is needed. For this purpose, Costafreda et al.22 proposed the use of Mengo virus as an extraction control to evaluate virus concentration and nucleic acid extraction efficiency. With the accumulating knowledge of the recent cultivable Murine NoV showing similar environmental and chemical resistance as human NoV14 this could be a well suited and perhaps better candidate to be used as an extraction control for NoV. RT-PCR internal controls (IC). Since the concentration of RT-PCR inhibitors varies depending on the type of samples (e.g., species of shellfish, season of harvesting),125 the addition of an internal control like a viral RNA sequence in NoV RT-PCR reactions is critical to realize false negative results as well as providing data on the extraction efficiency of the assay.6,121 Known quantities of RNA transcripts have been spiked into nucleic acid extracts to allow quantitative22,43 or qualitative81,121 assessment of amplification efficiency. Dilution of the viral RNA is another approach to minimize and assess the potential problem of inhibitors.93 However, this approach also affects the assay sensitivity since a smaller amount of shellfish tissue is analyzed. Amplification inhibition seems to be caused by an imbalance between the amount of inhibitors, the amount of virus present in the sample, and the efficiency of the RNA extraction method coupled with its ability to remove inhibitors. Different IC have been used to generate a PCR product with a different size than the target product making it possible to distinguish between the two during gel electrophoresis. However limitations are often the lack of versatility due to amplification by primers that are not broadly reactive. An internal standard was created by cloning a 319 nt sequence of the polymerase gene containing a 156 nt cDNA insert, resulting in a 475 nt RT-PCR product that was amplified by the broadly reactive primer-pair 289/290 that can detect both NoV and sapovirus strains.33 In another study, synthetic short RNA fragments corresponding to the real-time RT-PCR sequence of the primers and probes targeting the ORF1-ORF junction were created based on NoV GI and GII
Molecular Detection of Foodborne Pathogens
reference strains. In each RNA sequence, a restriction site (BamHI) was included to discriminate the sequence from sample RNA if contamination was suspected.25 When using a competitive IC RNA, there are three possible outcomes of RT-PCR assays: (i) no product (the assay has failed, inhibition may be present); (ii) the IC RNA, but not the virus fragment is obtained (the assay has worked, and the sample is most likely negative or viral RNA is below the detection limit); (iii) the virus fragment, with or without the IC RNA fragment, is obtained (the assay has worked, and the sample is positive). EU legislation requires the inclusion of virus controls in standardized methods for the detection of viruses in foods. To harmonize this aspect, efforts are made within the CEN/ TC275/WG6/TAG4 (virus detection in foods) to develop standardized viral RNA extraction and detection protocols, However it becomes essential to gain more information about the practical application of this method to product safety assessment within the EU.
6.2 Methods 6.2.1 Reagents and Equipment Reagents and equipments for the sample preparation and RNA extraction are listed in Table 6.3. Reagents for real-time RT-PCR are listed in Table 6.4 and reactions can be carried out in a MX3000 Real-time PCR thermal cycler (Stratagene, France), or equivalent equipment.
6.2.2 Sample Preparation Based on epidemiological outbreak investigation, food items that have most often been associated with NoV outbreaks include bivalve molluscs especially oysters, mussels, and clams, salad crops such as lettuce and green onions and soft fruits such as raspberries, strawberries, and blackberries. All these food have been implicated in foodborne outbreaks and should be considered as primary targets for virological analysis. A positive result of such analysis may prevent the outbreak to continue by helping the risk management during outbreak investigations to take the proper action which may be immobilization or withdrawal of food stocks, or prohibition of harvest. However, RTE foods served in restaurants or institutions and subsequently implicated in outbreaks due to improper care during handling are less meaningful to be analyzed for viruses as they are often not well preserved and most often the causative agent cannot be identified. A comprehensive epidemiological investigation may be able to find the risk food and possible actions may include a recall of a certain batch of foods. Although bottled mineral water never has been identified as the source of NoV infection, contamination of mineral water with pathogenic bacteria has been reported.137,147 As mentioned in the introduction of this chapter, virus detection in food includes the following steps: sampling, viral elution, concentration, viral RNA amplification, and
83
Noroviruses
Table 6.3 Reagents and Equipments Used for Sample Preparation RNA Extraction of Shellfish and Soft Fruits Matrix Soft fruit
Reagent, Equipment and Consumables
Composition and Concentration of Reagent/Supplier
Elution buffer 1
Glycine, Tris, 1% [wt/vol] beef extract pH 9.5±0.2.
HCL Pectinase Elution buffer 2
Pectinex/Sigma. Glycine, Tris, 1% [wt/vol] beef extract pH 7.0±0.2.
Shellfish
Proteinase K solution
3 U/ml; add 20 mg proteinase K (30 U/mg) to 200 ml molecular grade water and shake to mix/Finnzymes, cat no. F-202S.
Soft fruits and shellfish
Lysis buffer Magnetic extraction reagents Magnetic silica
NucliSens/Bio-Mérieux, cat no. 200292, 280134. NucliSens/Bio-Mérieux, cat no. 200293. NucliSens/Bio-Mérieux, cat no. 280133; magnetic silica is included in the magnetic extraction reagents (cat no. 200293). However, additional silica will be needed due to the increased amount (250 µl per sample) used in this method.
Soft fruit
Falcon tube containing a nylon cell strainer of 40-µm pore size
BD Falcon.
Centricon Plus-70 centrifugal filter device
100K NMWL; Millipore.
Shellfish
Sterile shucking knife and heavy duty safety glove Scissors and forceps Pipettes and pipette tips Sterile petri dishes and sterile razor blades Centrifuge tubes (15 ml)
For the opening of shellfish. For the dissection of shellfish.
Soft fruits and shellfish
Centrifuge NucliSens miniMAG instrument Thermoshaker Waterbath Aspirator or equivalent apparatus Shaking incubator or equivalent Vortex mixer (or pulse vortexer) Micro-tubes (1.5 ml) Eppendorf tubes (1.5 ml) or equivalent
For the chopping of digestive tissue.
Bio-Mérieux, cat no. 200305. Operating at 60°C, 1,400 rpm. Operating at 65°C. For removal of supernatant Operating at 37°C. Bio-Mérieux, cat no. 200294.
Source: Butot, S., Putallaz, T., and Sanchez, G., Appl. Environ. Microbiol., 73, 186, 2007; Greening, G.E. and Hewitt, J., Food Anal. Methods, 1, 109, 2008; and Jothikumar, N. et al., Appl. Environ. Microbiol., 71, 1870, 2005.
detection. Since there is no standard horizontal method to detect NoV in food matrices, we describe here a method for shellfish and a method for soft fruits. For shellfish, sample preparation is based on analyzing the digestive glands which after carefully chopping into very small pieces are subsequently lysed in a proteinase K solution to digest the tissue and release the viral RNA from the virus particles.60 This procedure has been used successfully to detect NoV in many shellfish samples epidemiologically linked to outbreaks and can also be used to quantitatively determine the virus concentration in oysters within a working day.43 For soft fruits, the sample preparation is based on elution of viruses from the fruits by alkaline buffer followed by virus concentration by ultra-filtration.13 The procedure can be applied for different types of vegetables, herbs, and fresh or frozen berries. Evaluation of two commercially available kits (Viral RNA minikit and NucliSens magnetic kit) for viral RNA extraction from the soft fruit concentrate showed
similar recoveries.11 Since the NucliSens magnetic kit has also been demonstrated to work well for RNA extraction on the proteinase K suspension of shellfish, this kit is used here for both matrices. For detection of NoV RNA, two monoplex RT-PCR assays using specific primers and probes targeting the ORF1–ORF2 junction region have been used successfully.25,93 Both assays have been evaluated on a comprehensive panel of stool samples and have been applied effectively to detect NoV GI or GII in naturally contaminated water or shellfish samples.25,93 The overall sample processing scheme is outlined in Figure 6.1. For each sample preparation set-up, it is crucial to include a suitable internal extraction control in order to assure that no cross-contamination has occurred and to monitor the efficiency of the extraction. As a negative control water can be used, while a positive control should be an aliquot of an RNA virus with known concentration and which can be detected by real-time RT-PCR.
84
Molecular Detection of Foodborne Pathogens
Table 6.4 TaqMan Real-Time Protocol for Detection of NoV GI and GII in Shellfish and Soft Fruits Reagent UltraSense reaction mix* UltraSense enzymes mix* ROX* RNase inhibitor QNIF4 GI forward primer NV1LCR GI reverse primer NV1LCpr GI probe QNIF2d GII forward primer COG2R GII reverse primer QNIFS GII probe PCR qualified water Total volume/reaction before RNA addition
Concentration/Reaction
Concentration Stock Solution
Volume/Reaction (µl)
1× – 1× – 500 nM 900 nM 250 nM 500 nM 900 nM 250 nM – –
5× – 50× – 50 µM 50 µM 50 µM 50 µM 50 µM 50 µM – –
5.00 1.25 0.50 2U 0.25 0.45 0.13 0.25 0.45 0.13 12.42 20
Source: da Silva, A.K. et al., Appl. Environ. Microbiol., 73, 7891, 2007; and Loisy, F. et al., J. Virol. Methods, 123, 1, 2005. * RNA UltraSense™ One-Step Quantitative RT-PCR System. Invitrogen, cat. no. 11732927.
15 g of soft fruit or vegetables
1.5 g of chopped digestive gland representing at least six shellfish
Lyse with 2 ml proteinase K at 37˚C for 60 min with shaking
Elute by agitating for 15 min in 60 ml elution buffer (50 mM Glycine, 100 mM Tris, 1% (w/v) beef extract pH 9.5) Filtrate through cell stainer Pectinase treatment at neutral pH (for pectin containing berries only)
Centrifugation at 10,000 × g for 10 min
Centrifugation at 3500 × g for 15 min
Ultra-filtration of supernatant at 3500 × g for 15–45 min
Lyse viral capsid and remaining tissue by transferring the entire virus suspension to 4 ml lysis buffer.
Viral RNA extraction using magnetic silica NoV RNA detection by TaqMan real-time RT-PCR
Figure 6.1 Flow chart of norovirus detection in soft fruits and shelfish. (From Butot, S., Putallaz, T., and Sanchez, G., Appl. Environ. Microbiol., 73, 186, 2007; da Silva, A.K. et al., Appl. Environ. Microbiol., 73, 7891, 2007; Jothikumar, N. et al., Appl. Environ. Microbiol., 71, 1870, 2005; Loisy, F. et al., J. Virol. Methods, 123, 1, 2005; Svraka, S. et al., J. Clin. Microbiol., 45, 1389, 2007.)
Soft fruits.13 Weight 15 g of soft fruits into a stomacher bag and add 60 ml of elution buffer 1 (Table 6.3). Shake gently for 15 min at room temperature (Figure 6.1). Transfer the eluate to a Falcon tube containing a nylon cell strainer (Table 6.3) to remove particulate debris. Rinse the berries and the cell strainer with 6 ml and 2 ml of elution buffer 1,
respectively. Adjust the pH of the transferred eluate to pH 7.0 with 9.5 M HCl and add 300 µl of pectinase. Incubate while gently shaking for 30 min at room temperature. Centrifuge the extract at 3,500 × g for 15 min. and transfer the supernatant to a Centricon Plus-70 centrifugal filter device (Table 6.3) and centrifuge at 3,500 × g to concentrate
85
Noroviruses
the virus particles to ca. 400 µl. The centrifugal filter device is subsequently rinsed with 200 µl of elution buffer 2 (Table 6.3 and Figure 6.1). Shellfish. 43,60 Select a suitable number (preferably a minimum of six) of live oysters or mussels. Wash off any mud from the shell and open the shellfish with a clean shucking knife. Ensure the hand holding the shellfish is protected with a heavy duty safety glove. Dissect out the digestive glands using scissors and forceps (or equivalent tools). Transfer the glands to a clean petri dish and chop finely with a razor blade. During preparation the shellfish must be placed on ice. Transfer a 1.5 g portion of chopped glands into a 15 ml centrifuge tube. Add 2 ml of proteinase K solution (Table 6.3) and mix well. Incubate at 37°C in a shaking incubator (or equivalent) for 60 min. Transfer the tube to a water bath at 65°C for 15 min as a second incubation. Centrifuge at 10,000 × g for 10 min, decant the supernatant, measure, and record the volume and retain the sample (supernatant) for nucleic acid extraction. RNA extraction. Add the entire sample obtained from the shellfish (proteinase K suspension) or soft fruits (ultrafiltrate) sample preparation to a tube containing 4.5 ml of NucliSens lysis buffer and vortex briefly. Continue the procedure according to the manufactures instructions except for using 250 µl of well-mixed magnetic silica solution. Resuspend the extracted RNA in 100 µl elution buffer and use this for real-time RT-PCR.
6.2.3 Detection of Noroviruses by Real-time RT-PCR Amplification and inhibition controls. A negative amplification control (water) and positive amplification controls (e.g., GI and GII reference RNA in low copy numbers) should be included in each amplification series in order to monitor for cross contamination, and amplification efficiencies. In addition the inhibitor removal during the nucleic acid extraction and potential amplification inhibition should be assessed by e.g., testing each sample in duplicates of undiluted and 1/10 diluted RNA. Mastermix and RT-PCR conditions. The mastermixes for real-time RT-PCR should be prepared fresh immediately prior to use. A separate mastermix should be prepared for each of the NoV genogroups. Add the ingredients in the order listed in Table 6.4 and prepare enough mastermix for at least one reaction more than required. Dispense 20 µl mastermix to each well plus 5µl of the RNA sample to be tested (giving a total volume of 25 µl in each well). RT should be carried out for 30 min at 50°C, and denaturation for 5 min at 95°C, followed by 45 cycles of PCR amplification (denaturation at 95°C for 15 s, annealing, and extension at 60°C for 1 min).25 Reporting of results. Analyze the amplification plot using the approach recommended by the manufacturer. Given that all the controls are as expected, a sample is considered positive if the curve giving a Ct value has a proper shape. A sample is considered “not positive” if there is no Ct value or
if the curve does not have the proper shape regardless of the Ct value.
6.3 Conclusion and Future Perspectives NoVs are now recognized as the most important foodborne pathogens contributing to more outbreaks than all other known bacterial, viral, and protozoan pathogens combined. Therefore, efforts to prevent and control viral foodborne illnesses should be primarily directed toward NoVs. Foodborne transmission of NoV involves RTE food items contaminated with fecal material or vomit. Another important source of NoV contamination is water used for food washing or irrigation as well as shellfish growing waters contaminated by sewage infiltration or direct fecal contact. Which foods are implicated in a NoV outbreak is typically identified based on an epidemiological outbreak investigation where the relative risk of exposure to different food items is calculated. Standardized methods for the detection of viruses in foods other than shellfish are not yet available because until recently the methods used to recover and detect viruses from these foods were inadequate. However, the recent development of sensitive TaqMan-based real-time RT-PCR methods have greatly improved the sensitivity and specificity of the detection of NoVs but standardized upstream methods such as concentration and extraction methods have not been established. Using a cocktail of HBGAs that have been recognized as potential receptors of NoVs, or specific monoclonal antibodies to pre-enrich the virus particles regardless of the type of food, may lead to robust standardized protocols to detect one of the most important groups of foodborne pathogens.
Acknowledgments This work was supported by the Danish Veterinary and Food Administration (DVFA), the European Union Project BIOTRACER (FOOD-2006-CT-036272) and the National Food Institute, Technical University of Denmark (DTU). The authors would like to thank Soizick Le Guyader, Laboratoire de Microbiologie, IFREMER, Nantes, France for helpful discussions.
References
1. Allwood, P.B. et al. Occurrence of Escherichia coli, noroviruses, and F-specific coliphages in fresh market-ready produce. J. Food Prot., 67, 2387, 2004. 2. Ando, T. et al. Epidemiologic applications of novel molecular methods to detect and differentiate small round structured viruses (Norwalk-like viruses). J. Med. Virol., 47, 145, 1995. 3. Ando, T. et al. Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J. Clin. Microbiol., 33, 64, 1995. 4. Atmar, R.L. and Estes, M.K. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin. Microbiol. Rev., 14, 15, 2001. 5. Atmar, R.L. et al. Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl. Environ. Microbiol., 59, 631, 1993.
86
6. Atmar, R.L. et al. Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl. Environ. Microbiol., 61, 3014, 1995. 7. Baert, L., Uyttendaele, M., and Debevere, J. Evaluation of viral extraction methods on a broad range of Ready-To-Eat foods with conventional and real-time RT-PCR for Norovirus GII detection. Int. J. Food Microbiol., 123, 101, 2008. 8. Bertolotti-Ciarlet, A. et al. The 3′ end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol., 77, 11603, 2003. 9. Beuret, C., Baumgartner, A., and Schluep, J. Virus-contaminated oysters: a three-month monitoring of oysters imported to Switzerland. Appl. Environ. Microbiol., 69, 2292, 2003. 10. Bidawid, S., Farber, J.M., and Sattar, S.A. Rapid concentration and detection of hepatitis A virus from lettuce and strawberries. J. Virol. Methods, 88, 175, 2000. 11. Boom, R. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 28, 495, 1990. 12. Boxman, I.L. et al. Detection of noroviruses in shellfish in the Netherlands. Int. J. Food Microbiol., 108, 391, 2006. 13. Butot, S., Putallaz, T., and Sanchez, G. Procedure for rapid concentration and detection of enteric viruses from berries and vegetables. Appl. Environ. Microbiol., 73, 186, 2007. 14. Cannon, J.L. et al. Surrogates for the study of norovirus stability and inactivation in the environment: a comparison of murine norovirus and feline calicivirus. J. Food Prot., 69, 2761, 2006. 15. Cashdollar, J.L. and Dahling, D.R. Evaluation of a method to re-use electropositive cartridge filters for concentrating viruses from tap and river water. J. Virol. Methods, 132, 13, 2006. 16. Chen, R. et al. Inter- and intragenus structural variations in caliciviruses and their functional implications. J. Virol., 78, 6469, 2004. 17. Cheng, P.K. et al. Norovirus contamination found in oysters worldwide. J. Med. Virol., 76, 593, 2005. 18. Chironna, M. et al. Detection of hepatitis A virus in mussels from different sources marketed in Puglia region (South Italy). Int. J. Food Microbiol., 75, 11, 2002. 19. Chung, H., Jaykus, L.A., and Sobsey, M.D. Detection of human enteric viruses in oysters by in vivo and in vitro amplification of nucleic acids. Appl. Environ. Microbiol., 62, 3772, 1996. 20. Chung, H., Jaykus, L.A., and Sobsey, M.D. Detection of human enteric viruses in oysters by in vivo and in vitro amplification of nucleic acids. Appl. Environ. Microbiol., 62, 3772, 1996. 21. Cliver, D., Ellender, R.D., and Sobsey, J. Methods to detect viruses in foods: testing and interpretation of results. J. Food Prot., 46, 345, 1983. 22. Costafreda, M.I., Bosch, A., and Pinto, R.M. Development, evaluation, and standardization of a real-time TaqMan reverse transcription-PCR assay for quantification of hepatitis A virus in clinical and shellfish samples. Appl. Environ. Microbiol., 72, 3846, 2006. 23. Croci, L. et al. Detection of hepatitis A virus in shellfish by nested reverse transcription-PCR. Int. J. Food Microbiol., 48, 67, 1999. 24. Croci, L. et al. Determination of enteroviruses, hepatitis A virus, bacteriophages and Escherichia coli in Adriatic Sea mussels. J. Appl. Microbiol., 88, 293, 2000. 25. da Silva, A.K. et al. Evaluation of removal of noroviruses during wastewater treatment, using real-time reverse transcription-PCR: different behaviors of genogroups I and II. Appl. Environ. Microbiol., 73, 7891, 2007.
Molecular Detection of Foodborne Pathogens 26. Dalton, C. Commentary. An outbreak of Norwalk virus gastroenteritis following consumption of oysters. Commun. Dis. Intell., 21, 321, 1997. 27. De Medici, D. et al. Detecting the presence of infectious hepatitis A virus in molluscs positive to RT-nested-PCR, Lett. Appl. Microbiol., 33, 362, 2001. 28. De Medici, D. et al. Reverse transcription-booster PCR for detection of noroviruses in shellfish. Appl. Environ. Microbiol., 70, 6329, 2004. 29. Dolin, R. and Baron, S. Absence of detectable interferon in jejunal biopsies, jejunal aspirates, and sera in experimentally induced viral gastroenteritis in man. Proc. Soc. Exp. Biol. Med., 150, 337, 1975. 30. Dubois, E. et al. Modified concentration method for the detection of enteric viruses on fruits and vegetables by reverse transcriptase-polymerase chain reaction or cell culture. J. Food Prot., 65, 1962, 2002. 31. Dubois, E. et al. Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. Int. J. Food Microbiol., 108, 164, 2006. 32. Duizer, E. et al. Laboratory efforts to cultivate noroviruses. J. Gen. Virol., 85, 79, 2004. 33. Escobar-Herrera, J. et al. Construction of an internal RT-PCR standard control for the detection of human caliciviruses in stool. J. Virol. Methods, 137, 334, 2006. 34. Formiga-Cruz, M. et al. Distribution of human virus contamination in shellfish from different growing areas in Greece, Spain, Sweden, and the United Kingdom. Appl. Environ. Microbiol., 68, 5990, 2002. 35. Gassilloud, B. et al. Recovery of feline calicivirus infectious particles and genome from water: comparison of two concentration techniques. Water Sci. Technol., 47, 97, 2003. 36. Goswami, B.B. et al. A polymerase chain reaction-based method for the detection of hepatitis A virus in produce and shellfish. J. Food Prot., 65, 393, 2002. 37. Gouvea, V. et al. Identification of Norwalk virus in artificially seeded shellfish and selected foods. J. Virol. Methods, 48, 177, 1994. 38. Graham, D.Y. et al. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis., 170, 34, 1994. 39. Green, J. et al. A nested reverse transcriptase PCR assay for detection of small round-structured viruses in environmentally contaminated molluscan shellfish. Appl. Environ. Microbiol., 64, 858, 1998. 40. Green, K.Y. Fields reference: Caliciviridae: The Noroviruses. In Fields Virology, 5th ed., Lippincott Williams & Wilkins. Phildelphia, PA., 2007. 41. Green, K.Y. et al. Taxonomy of the caliciviruses J. Infect. Dis., 181 Suppl 2, S322–S330, 2000. 42. Green, K.Y. et al. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J. Infect. Dis., 185, 133, 2002. 43. Greening, G.E. and Hewitt, J. Norovirus detection in shellfish using a rapid, sensitive virus recovery and real-time RT-PCR detection protocol. Food Anal. Methods, DOI 10. 1007/ s12161-008-9018-3, 1, 109, 2008. 44. Guevremont, E. et al. Development of an extraction and concentration procedure and comparison of RT-PCR primer systems for the detection of hepatitis A virus and norovirus GII in green onions. J. Virol. Methods, 134, 130, 2006. 45. Gulati, B.R. et al. Efficacy of commonly used disinfectants for the inactivation of calicivirus on strawberry, lettuce, and a food-contact surface. J. Food Prot., 64, 1430, 2001.
Noroviruses 46. Hardy, M.E. Norovirus protein structure and function. FEMS Microbiol. Lett., 253, 1, 2005. 47. Harrington, P.R. et al. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol., 76, 12335, 2002. 48. Harrington, P.R. et al. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol., 78, 3035, 2004. 49. Hernroth, B.E. et al. Environmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report. Appl. Environ. Microbiol., 68, 4523, 2002. 50. Hewitt, J. et al. Gastroenteritis outbreak caused by waterborne norovirus at a New Zealand ski resort. Appl. Environ. Microbiol., 73, 7853, 2007. 51. Hohne, M. and Schreier, E. Detection and characterization of norovirus outbreaks in Germany: application of a one-tube RT-PCR using a fluorogenic real-time detection system. J. Med. Virol., 72, 312, 2004. 52. Huang, P. et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis., 188, 19, 2003. 53. Huang, P. et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol., 79, 6714, 2005. 54. Huang, P.W. et al. Norovirus and histo-blood group antigens: Demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol., 79, 6714, 2005. 55. Huffman, D.E., Nelson, K.L., and Rose, J.B. Calicivirus An emerging contaminant in water: State of the art. Environ. Engineer. Sci., 20, 503, 2003. 56. Hutson, A.M., Atmar, R.L., and Estes, M.K. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol., 12, 279, 2004. 57. Hutson, A.M. et al. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis., 185, 1335, 2002. 58. Jiang, X. et al. Norwalk virus genome cloning and characterization. Am. Soc. Adv. Sci., 1580, 1990. 59. Jiang, X. et al. Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J. Virol. Methods, 83, 145, 1999. 60. Jothikumar, N. et al. Rapid and sensitive detection of noroviruses by using TaqMan-based one-step reverse transcriptionPCR assays and application to naturally contaminated shellfish samples. Appl. Environ. Microbiol., 71, 1870, 2005. 61. Kageyama, T. et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol., 41, 1548, 2003. 62. Kageyama, T. et al. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to Norovirus in Japan. J. Clin. Microbiol., 42, 2988, 2004. 63. Kapikian, A.Z. et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis.